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Abstract 
 
The Wnt/β-catenin and the Wnt/planar cell polarity (Wnt/PCP) signalling 
pathways have been shown to play important roles in cardiogenesis and their disruption 
has been shown to cause severe disturbances in heart development. Spatially and 
temporally complex interplays between the two pathways have been described. One 
component of the PCP pathway is Jnk, a member of the highly conserved mitogen-
activated protein kinase (MAPK) family. This stress responsive mitogen is known to 
control a variety of cellular behaviours such as proliferation, apoptosis and cell 
migratory behaviour and as such, is likely to be of pivotal importance in cardiac 
development. 
The aim of this study was to investigate the role played by Jnk in vertebrate heart 
formation and the relationships between Jnk signalling and canonical Wnt signalling, 
using in silico and in vivo approaches in zebrafish and an in vitro approach on a mouse 
embryonic stem (ES) cell model of cardiogenesis. 
Firstly, using a range of bioinformatic methods, an analysis of jnk genes, splice 
variants and proteins, and an investigation of their phylogenetic relation with other 
species was undertaken. This suggested conservation of Jnk family members, but 
suggested that there were additional orthologues of jnk1 present in the zebrafish 
transcriptome. The spatial and temporal expression profiles of these genes were then 
examined by semi-quantitative PCR and in situ hybridisation. The functional role of Jnk 
proteins during zebrafish development was subsequently investigated using a specific 
chemical inhibitor, SP600125. Inhibition of Jnk signalling during gastrulation and 
somitogenesis caused a convergence extension-like phenotype and severe cardiac 
defects, including looping anomalies and alterations in atrial versus ventricular cell 
numbers. 
ES cells have the capacity to differentiate in vitro and give rise to cells of many 
different lineages, including cardiomyocytes. Canonical Wnt and Jnk components were 
manipulated during specific windows of differentiation as ES cells formed beating 
embryoid bodies. Examination of the spontaneous contractile behaviour of 
differentiating ES cells as they entered the cardiogenic lineage, and analysis of their 
developmental gene expression profiles, showed the beating behaviour of ES cell-
derived cardiac cells was enhanced in a temporally specific manner after inhibition of 
the non-canonical Wnt/Jnk pathway, while there was marked alteration of canonical 
Wnt signalling. To investigate whether there were reciprocal interactions between the 
 iii
two pathways, analysis of the system after activation of the canonical pathway was also 
undertaken. 
These studies indicated that the beating behaviour of ES cell-derived cardiac cells 
was enhanced in a temporally specific manner after inhibition of Jnk, while after 
activation of canonical Wnt/β-catenin signalling, the cardiogenic potential of 
differentiating ES cells was severely suppressed.  
The findings of this study extend our understanding of the role played by 
canonical and non-canonical Wnt signalling pathways in heart morphogenesis and 
highlight the interacting effects of related signalling pathways activity in cardiogenesis. 
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Chapter 1. Introduction 
  
In this thesis, the c-Jun N-terminal kinase (JNK) signalling pathway, part of the non-
canonical Wnt and Mitogen-activated protein kinase (MAPK) cascades, is discussed in 
the context of zebrafish embryogenesis and mouse embryonic stem (ES) cell 
differentiation. In particular, zebrafish cardiogenesis and ES cell-derived cardiac 
differentiation are of interest. This first chapter is a review of what is known to date 
about the main components of the thesis: zebrafish embryonic development, embryonic 
stem cells, heart induction, specification and differentiation as well as Wnt, JNK and 
MAPK signalling pathways.  
 
1.1. Congenital heart disease 
 
Congenital heart defects are cardiac malformations present at birth and they account for 
6 to 19 per 1000 live births (Hoffman and Kaplan, 2002). Their etiology is 
multifactorial, possibly both genetic and environmental, although the genetic 
components have only recently started to become understood and identified (Nora, 
1968, Jenkins et al., 2007). Septation and alignment defects are among the most 
common heart anomalies observed in newborns or infants and they include ventricular 
and atrial septal defects, common arterial trunk, double outlet right ventricle and 
tetralogy of Fallot. Many cardiovascular defects are associated with known syndromes 
or with other defects. Commonly, cardiovascular anomalies are coupled with 
craniofacial defects, as in CHARGE (Coloboma in the iris, Heart defects, Atresia of 
nasal passages, Retardation of mental and somatic development, Genital anomalies, Ear 
abnormalities) (Pagon et al., 1981), diGeorge (Funke et al., 1999, Kirkpatrick and 
DiGeorge, 1968, Yagi et al., 2003) and Noonan syndromes (Noonan et al., 1968, 
Tartaglia et al., 2004a, Tartaglia et al., 2004b), but it is not unusual to occur in 
association with limb, as in the Holt-Oram syndrome (Basson et al., 1997), or kidney 
abnormalities, as in the Smith-Lemli-Opitz syndrome (Smith et al., 1964). Despite our 
comprehensive knowledge of genes associated with the formation of the heart during 
embryogenesis, little is still known about the morphological processes that underlie this 
highly complex procedure and only a few genes have been directly linked to specific 
cardiac defects in humans (Schott et al., 1998). Therefore, our complete understanding 
 2
of the genetic networks and the morphogenetic movements that govern the formation of 
the heart is of primary importance for any future therapeutical applications.  
 
1.2. Early vertebrate embryonic development 
  
Laboratory models are used to investigate cardiac development and malformation. 
Cardiomyocytes are specified at the time of gastrulation and differentiate during 
somitogenesis. A description of relevent early vertebrate embryogenesis will be 
presented in order to understand the events of cardiogenesis. Mouse, chick and 
zebrafish are the organisms of interest. Most of the processes are firstly described in 
zebrafish and then, any striking differences in the mouse are highlighted.   
 
1.2.1. From formation of the zygote to the blastula period   
 
In zebrafish, at approximately 40 minutes after fertilization the first cell division 
(cleavage) takes place (Figure 1.1). At this stage, the cells (blastomeres) remain 
connected to each other and to the underlying yolk cell. The vegetal and animal poles 
appear at this time, with the first being the one with the highest yolk concentration and 
the latter being the opposite pole, where the blastoderm is and from which the embryo 
will form. Only maternal mRNA is present in the zygote (Kimmel and Law, 1985a). 
The cleavage period is followed by the blastula period (2.25 hours post ferilization, hpf, 
until 5.25 hpf). Essential processes take place throughout this phase, with mid-blastula 
transition (MBT), formation of the yolk syncytial layer (YSL) and the enveloping layer 
(EVL) and initiation of epiboly, being the most important. MBT begins at cycle 10 
(512-cell stage) and is mainly characterized by activation of the zygotic genome (Kane 
and Kimmel, 1993, Lindeman and Pelegri, 2010). The YSL, an extraembryonic 
structure that forms at the margin of the blastoderm (Kimmel and Law, 1985b), is 
known to function as a signalling centre, important, among others, for mesoderm 
induction and dorsoventral patterning (Chen and Kimelman, 2000, Sakaguchi et al., 
2006, Sakaguchi et al., 2002). Between the YSL and the EVL (the most superficial layer 
of the blastoderm) lie the cells that will give rise to the embryo (Kimmel and Law, 
1985b) (Figure 1.1.).  
These very early stages of embryonic development, described so far in zebrafish, 
are quite similar in mammals, although differences are also observed. After fertilization 
 and early cell divisions
cell mass of 16 cell-stage embryos (approximately 2.5 days post coitum, E2.5). 
Embryos of this stage are called blastocysts (E3.5
cell mass (ICM) cells that will give
trophoblasts cells that will give rise to the chorion 
1986, Wiley, 1984, Gilbert, 2003
Figure 1. 1: Schematic representation of zebrafish embryonic development. Stages from 
the zygote period until the mid
when the embryo is at the single
here at the one-cell stage, will develop into the blastoderm during subsequent stages of 
development. (b)-(g) The cleavage period starts at the two
cell stage (0.75-2.25 hpf). (h)
50% epiboly stage (2.25
syncytial layer (YSL) is shown in (i), (j) and (k). (q)
the end of the blastula period and ends at the bud sta
in (q) indicates the leading edge of the blastoderm. The dorso
morphologically visible at the shield stage (6 hpf, s). Simultaneous epiboly (blue arrows), 
convergence (green arrows) and extension (
(z) The segmentation period starts at 10 hpf and lasts until 24 hpf. Only the early stages of 
this last period are shown in this schematic, from 10 hpf until 16 hpf (14
The tail bud is shown by the
the brain anlage by the black arrowhead (x). AP/VP: animal/vegetal pole, Ant/Pos: 
anterior/posterior, hpf: hours post fertilization 
2007). 
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 in mice, a cavity, called blastocoel, forms in the centre of the 
-E4.5) and they consist of the inner 
 rise to the embryo proper and to the amnion, and of 
(Fleming, 1987, Pedersen et al., 
).  
-segmentation period are shown. (a) The zygote period, 
-cell level, is brief (0-0.75 hpf). The blastodisc (BD) shown 
-cell stage and lasts until the 64
-(p) The blastula period runs from the 128
-5.25 hpf). Formation of the enveloping layer (EVL) and the yolk 
-(u) The gastrulation period starts at 
ge (5.25-10 hpf). The blue arrowhead 
-ventral axis is first 
red arrows) movements are shown in (t). (v)
 red arrowhead (v), somites by the green arrowhead (w) and 
(figure taken from Webb and Miller
-
-cell stage until the 
-
-somite stage). 
, 
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1.2.2. Gastrulation and the formation of the germ layers  
 
Gastrulation is a highly conserved process across the animal kingdom and is responsible 
for establishment of the embryonic germ layers, from which all organs and structures of 
the embryo will arise. It is characterized by extensive cell movements (Figure 1.2) and 
ends with the formation of the embryonic germ layers (ectoderm, mesoderm and 
endoderm). During zebrafish gastrulation (5.25-10 hpf), epiboly (the thinning and 
spreading of the blastodisc and the YSL over the yolk), involution (inwards migration 
of marginal cells) and convergence-extension (CE) participate in the formation of the 
primary germ layers and define the embryonic axis. At the onset of gastrulation, when 
about half of the yolk cell has been covered by blastoderm cells (50% epiboly), a cell 
fate map is already established; this ascertains what regions and what organs the cells 
migrate into and what types of cells they differentiate to. At this stage, the superficial 
layer of the involuting blastoderm forms the epiblast (that will give rise to ectoderm and 
its derivatives), while the underlying layer is now called the hypoblast (which will give 
rise to mesendodermal derivatives) (Thisse et al., 1993). A local thickening, termed the 
embryonic shield, marks the future dorsal side of the embryo. Migration of cells and 
convergence-extension through the shield establishes the germ layers. The end of 
gastrulation is defined by completion of epiboly (100% yolk coverage) and formation of 
the tail bud.  
Mammalian gastrulation shares many similarities but also diverges from that of 
the fish. The epiblast, which will, as in the zebrafish, give rise to the embryo proper, is 
part of the blastocyst ICM. A defining structure of mammalian (avian and reptilian as 
well) gastrulation, absent in fish, is the primitive streak. This is a local thickening of the 
epiblast starting posteriorly and progressing anteriorly. Convergence and extension 
movements are responsible for increasing the length of the streak and narrowing its 
width. Gastrulation begins at the node, a regional thickening of cells in the primitive 
streak. Epiblast cells migrate (ingress) through the primitive streak. Mouse embryonic 
development presents a peculiarity: the epiblast is cup-shaped rather than disc-shaped as 
in chick and human. As a result of that, at the end of gastrulation, presumptive 
ectodermal cells lie on the inside and endodermal cells on the outside of the ‘cup’. 
Subsequent embryonic turning of the body brings the endoderm to the inside, the 
mesoderm in the middle and the ectoderm outside.  
 
  
Figure 1. 2: Illustration of epiboly, involution and convergence
during zebrafish gastrulation. (A) At the beginning of gastrulation the blastoderm 
engulfed half of the yolk cell by epiboly movements (purple arrows) and the shield 
thickening is visible (dorsally). Involution takes place at this stage, with cells from the 
overlying epiblast feeding cel
gastrulation stage, epiboly movements continue (75% epiboly has been achieved by this 
stage). These will stop when the blastoderm has engulfed the entire yolk by approximately 
9.5 hpf. Convergence movements towards the future dorsal side of the 
started (blue arrows). Concomitantly, extension is taking place along the anterior
posterior axis (orange arrows). (C) At the tail
covered by the blastoderm, convergence of lateral and dorsal cell p
dorsal side of the embryo is still underway (blue arrows). Concomitantly, extension along 
the anterior-posterior axis is taking place (orange arrows). V: ventral, D: dor
anterior, P: posterior 
 
At the end of the fish, avian and mammalian gastrula
have formed and the embryos look similar: ectoderm surrounds the embryo, endoderm 
lines the inside of the embryo and mesoderm lies in between. Subsequently, cells 
interact with one another, rearrange and form tissues and organs.
ectoderm will give rise to the neural tube, the surface ectoderm and neural crests. 
Mesodermal cells will
mesoderm and intermediate m
gastrointestinal tract and to the respiratory tube.  
 
1.2.3. Dorsal-ventral and anterior
 
The establishment of the body axes during development is crucial for proper 
morphogenesis of the organs and of the embryo itself.
development occurs simultaneously to, and relies on, body plan patterning along the 
anterior-posterior, ventral
ventral axes are established early in development and are defi
gradients, including Bone Morphogenetic Protein (
5
-extension movements 
ls into the underlying hypoblast (red arrows). 
-bud stage, when the entire yolk cell has been 
opulations towards the 
(figure taken and adapted from Roszko et al., 2009)
tion, the three germ layers 
 Cells from the 
 give rise to chordamesoderm, lateral plate mesoderm, paraxial 
esoderm. Lastly, endoderm will give
 
-posterior patterning of the body
 In particular, cardiac 
-dorsal and left-right axis. Anterior-posterior and dorsal
ned mainly by signalling 
BMP), retinoic acid and WNT 
has 
(B) At mid-
embryo have 
-
sal, A: 
.   
 rise to the 
 
-
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gradients (Nguyen et al., 1998, Schier, 2001), the position of the node (shield in 
zebrafish, Hensen’s node in chick and node in mammals) (Bachiller et al., 2000, 
Koshida et al., 1998) and the embryonic-extraembryonic axis (Brennan et al., 2001, 
Episkopou et al., 2001). The establishment of left-right patterning, which is of most 
interest in this study, is further discussed below.  
 
1.2.4. Left-right patterning of the body 
 
Left-right asymmetry, although not always visible externally, is essential for proper 
morphogenesis and positioning of internal organs. The onset of body symmetry 
breaking is postulated to occur at either cleavage stages or during gastrulation. Cilia, 
long and thin microtubule-based projections found in most mammalian cells (Poole et 
al., 1985), have been shown to be essential contributors to early left-right patterning 
events at the node (Nonaka et al., 1998). Recently, posterior positioning of the cilia 
within cells of the node was shown to be determined by Wnt/planar cell polarity (PCP) 
proteins Vangl1 and Vangl2 (for more details on this pathway see Section 1.4.2, page 
31) and to be essential for proper establishment of left-right identities in mouse 
(Borovina et al., 2010, Guirao et al., 2010, Okada et al., 2005, Song et al., 2010). Each 
cell within the node has a unique motile cilium that can rotate in a clockwise manner 
(Nonaka et al., 2005, Okada et al., 2005). The posterior cellular localization of the 
cilium enables its posterior tilting and determines its rotational axis (Nonaka et al., 
2005, Okada et al., 2005, Song et al., 2010). The leftward fluid flow that is generated by 
the rotation of the nodal cilia is thought to be a determining factor in establishing the 
left and the right sides of the embryo, possibly through an asymmetric calcium flux 
(McGrath et al., 2003, Tabin and Vogan, 2003, Yost, 2003).  
‘Transmission’ of the asymmetric signal(s) from the node to the lateral plate 
mesoderm (LPM) dictates the directionality of many downstream processes, such as 
looping of the heart and the gut (Aw and Levin, 2008, Capdevila et al., 2000, Collignon 
et al., 1996, Ibanes and Izpisua Belmonte, 2009, Kawasumi et al., 2011). Signalling by 
Nodal, a member of the TGFβ family, is thought to be a major regulator of the 
establishment of left-restricted expression of genes and to play a key role in transferring 
the asymmetric signal from the node to the LPM (Ahmad et al., 2004, Baker et al., 
2008, Duboc et al., 2005, Hamada et al., 2002, Kawasumi et al., 2011, Saijoh et al., 
2003). It is initially symmetrically expressed in nodal cells, but becomes asymmetrically 
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expressed at the LPM and establishes a left-restricted gene expression cascade, 
involving Lefty-1, Lefty-2 and Pitx-2 (Brennan et al., 2002, Saijoh et al., 2003).  
In zebrafish, the embryonic structure homologous to the murine node is the 
embryonic shield. After gastrulation, a group of cells within the shield give rise to a 
transient epithelial structure (appears at 10.33 hpf and is evident until 24-30 hpf) that is 
called the Kupffer’s vesicle. Kupffer’s vesicle cells were shown to contain a single 
cilium each (Essner et al., 2002) and to participate in left-right patterning, through a 
similar rotational ciliary movement and leftward fluid flow as in the mouse node 
(Amack and Yost, 2004, Essner et al., 2005). Nodal signalling genes in zebrafish, 
cyclops, squint and southpaw (Erter et al., 1998, Feldman et al., 1998, Long et al., 2003, 
Schier, 2009), are shown to be involved in establishing left-right asymmetrical gene 
expression in zebrafish embryos as well. The canonical Wnt pathway has, recently, been 
shown to be important for promoting normal development of the Kupffer’s vesicle and 
for regulating asymmetric signals in the LPM (Lin and Xu, 2009). Thus, the basic 
mechanisms dictating embryonic development in terms of dorsal-ventral, anterior-
posterior and left-right identities are conserved between vertebrate animal models. This 
common paterning will be extended to the patterning and development of the heart. 
 
1.3. Mesoderm and the origin of the heart 
 
The early events of vertebrate embryonic development, starting at fertilization and 
ending with the formation of the three germ layers and the patterning of the embryonic 
axes have been shown to be conserved between species. This section focuses on one of 
the germ layers, the mesoderm, and one of its main descendants, the heart. Here, 
zebrafish, chick and mouse heart formation is discussed. First, induction, specification, 
determination and differentiation of cardiac cells are presented (Sections 1.3.1-1.3.5), 
followed by an overview of heart development, morphogenesis and patterning (Sections 
1.6-1.10).  
A timeline of cardiogenesis in zebrafish, mouse and embryonic stem (ES) cells is 
shown in Figure 1.3. The main cardiogenesis-associated events are shown, along with 
the main transcriptional regulators and other cardiac genes involved in them. This figure 
will be used as a reference for comparison between the different aspects of this thesis. 
The correlation between ES cell differentiation and animal embryogenesis is not 
absolutely accurate because it depends to some extent on the properties of the cell line 
used, but provides a useful approximation.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 3: Schematic representation showing the time
is shown along with some of the early events of zebrafish and mouse embryogenesis. The time intervals during which induction,
determination of cardiac cells, as well as heart patterning and differentiation, are shown in boxes at the bottom of the figure. Some of the cardiac 
regulators are, also, shown at the bottom. Arrows do not indicate direct relationship, but rather highlight the sequence of e
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line of cardiac specification. Differentiation of mouse embryonic stem (ES) cells into cardiomyocytes 
 specification and 
vents.     
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1.3.1. Induction of cardiac fate 
 
An initial step in cardiogenesis is the induction of mesodermal cells to acquire a 
cardiogenic potential. This induction appears to be regulated by numerous complex, 
positive and negative signalling and transcriptional networks, involving members of the 
Wnt, BMP, sonic hedgehog (Shh), fibroblast growth factor (FGF) and Notch families. 
Recently, epigenetic events (Lickert et al., 2004) and micro-RNA translational 
regulation (Zhao et al., 2005, Ladd et al., 1998) have also been shown to play essential 
roles in fine-tuning cardiac gene and protein regulation.  
Ingression of the presumptive cardiac cells through the rostral and middle 
segments of the primitive streak (in mouse and chick) during gastrulation follows, as 
described in previous sections. Absence of the hypoblast does not allow for 
cardiogenesis to occur, suggesting that the hypoblast is an essential inducer of 
myocardial specification, possibly secreting activin and transforming growth factor 
(TGF) (Ladd et al., 1998). Similarly, in mouse the anterior visceral endoderm (the 
mouse homolog of the chick hypoblast) has been shown to be essential for 
cardiomyocyte specification (Arai et al., 1997, Nijmeijer et al., 2009). Migration of 
myocardial progenitors from the epiblast through the primitive streak to the LPM brings 
them close to instructive signals from the underlying endoderm that are essential for 
further cardiac specification (Schlange et al., 2000, Tam et al., 1997). The two bilateral 
fields within the LPM, where heart progenitors are now located are designated as the 
cardiogenic fields and will be discussed in following sections. In zebrafish, the 
extraembryonic YSL and the endoderm adjacent to the blastoderm margin have been 
shown to secrete signals (mainly gata-4, gata-5 and gata-6) that are essential for proper 
migration of cardiac precursors (Peterkin et al., 2009). Once in the anterior LPM, 
cardiac progenitors become further specified by receiving gata-5 (Peterkin et al., 2009, 
Reiter et al., 1999), fgf8 (Reifers et al., 2000) and bmp2 (Kishimoto et al., 1997, Reiter 
et al., 2001, Wang et al., 2007) signals, among others, originating mainly from the LPM 
itself.       
In amniotes (including mammals and avians), inducing signals from the 
underlying endoderm are thought to be modulated by inhibitory signals that arise from 
the overlying ectoderm and the neighbouring notochord. BMP (Ladd et al., 1998, 
Schneider and Mercola, 2001), FGF (Abu-Issa et al., 2002, Frank et al., 2002), Shh 
(Gianakopoulos and Skerjanc, 2005) and non-canonical Wnt (Garriock et al., 2005, 
Pandur et al., 2002, Terami et al., 2004) are commonly thought to be among the 
 inducing factors, whereas Notch 
(Jamali et al., 2001), and canonical Wnt 
2001) are thought to suppress cardiogenesis (Figure 1.4). Similarly, in zebrafish 
notochord cells are thought to play repressive roles in myocardial differentiation by 
restricting expression of 
1998, Serbedzija et al., 1998, Yelon and Stainier, 1999)
cardiomyocyte differentiation and heart development will be discussed in more detail in 
Section 1.4 (page 25)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 4: Vertebrate myocardial induction. Cardiac
endoderm and cardiac
cardiogenic region of the mesode
(BMP, FGF, Shh, Crescent, Noggin, canonical Wnt). 
 
Taken together, extraembryonic tissues seem to be important for initial induction 
of mesoderm; mesodermal cells gain the potential to acquire a card
accurately, to respond to cardiogenic signals. After migration and positioning of 
induced mesodermal cells to their future anterior LPM bilateral positions, the 
underlying endoderm specifies their cardiac signature by sending inductive si
while the overlying ectoderm restricts cardiac fate by secreting inhibitory factors. An 
overview of cardiac specification at the single
the sequence of gene activation and cardiac progression.  
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(Rones et al., 2000), Noggin (inhibitor of BMP) 
(Marvin et al., 2001, Schneider and Mercola, 
nkx2.5 in cells of the anterior LPM (Goldstein and Fishman, 
. The role of Wnts during 
.  
-inducing signals from the 
-inhibitory signals from the notochord and the ectoderm define the 
rm. Some representative signals are shown in the figure 
 
-cell level follows, with a description of 
 
iac fate or, more 
gnals, 
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1.3.2. Specification of cardiac progenitors  
 
The absence of cell surface markers specific for heart progenitors has hampered a clear 
definition of a unique cardiac progenitor population. Nevertheless, the specification 
process of early mesodermal cells towards their cardiogenic fate is well described.  
Mesodermal cells initially express Brachyury (Bry), a T-box transcription factor. 
Transient expression of Mesoderm Posterior-1 (Mesp1) marks mesodermal cells of 
cardiogenic potential. Expression of Mesp1 encompasses all cardiac progenitors, when 
they are still located in the primitive streak in the mouse embryo, and marks cells that 
will contribute to all four main types of cells in the heart (cardiomyocytes, endothelial 
cells, vascular smooth muscle cells and cardiac fibroblasts). Expression of Mesp1 is 
switched off when progenitor cells migrate away from the primitive streak and expand 
towards the LPM (Bondue et al., 2008, Wu, 2008, Ema et al., 2006, Garry and Olson, 
2006, Huber et al., 2004, Kattman et al., 2006).  
A first wave of Flk1 expression (Vascular endothelial growth factor receptor-2) 
differentiates Bry+ cells to haemangioblast precursors. After another wave of Flk1 
expression (E7.75 at the cardiac crescent stage), Bry+ cells will differentiate to 
mesodermal cardiac precursors. These, often referred to as cardiovascular colony-
forming cells, are common progenitors for cardiac myocytes of the primary (PHF) and 
secondary (SHF) heart field (Section 1.3.7, page 21), vascular smooth muscle and 
endothelial cells (Ema et al., 2006, Garry and Olson, 2006, Huber et al., 2004, Kattman 
et al., 2006, Moretti et al., 2006). Expression of Flk1 precedes the onset of expression of 
cardiac transcription factors, such as Gata-4, Nkx2.5 and Mef-2c, described in Section 
1.3.5 (page 14). Within the SHF at approximately E8-E8.5 Islet1 (Isl1), with Nkx2.5 and 
Flk1, defines a population of cells, called multipotential Isl1+ cardiovascular progenitor 
cells, which can give rise to cardiomyocytes, smooth muscle and endothelial cells 
(Moretti et al., 2006). In the PHF at approximately E9.5 Nkx2.5 bipotent progenitors 
were shown to give rise to cardiomyocytes and smooth muscle cells (Garry and Olson, 
2006, Wu et al., 2006).  
In summary, mesodermal cells that are induced by signals from surrounding 
tissues to attain a cardiac fate, initiate a transcriptional cascade that will result in 
acquisition of a specific cardiac identity. The differential specification process for atrial 
and ventricular cells is discussed in the next section.   
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1.3.3. Atrial and ventricular cell fate specification 
 
Myocardial induction and specification events promote the cardiogenic fate in 
mesodermal cells and set the scene for further differentiation. However, not all cells that 
are induced to attain a cardiac fate follow the same path. Cardiac cells that are destined 
to contribute to different compartments of the presumptive heart are thought to be 
distinctly located early in development and may, thus, be differentially regulated.  
In zebrafish, myocardial progenitors just prior to gastrulation (40% epiboly, 
approximately 5 hpf) are found within the first four tiers of blastomeres, next to the 
embryonic margin on both the left and right sides of the forming embryo (Warga and 
Nusslein-Volhard, 1999), as shown in Figure 1.5. Labelling of single cardiogenic 
blastomeres at this stage showed that labelled progeny resulted in either the ventricle or 
the atrium, but never in both chambers (Stainier et al., 1993). Ventricular progenitors 
are located closer to the embryonic margin and towards the dorsal midline compared to 
atrial precursors (Keegan et al., 2004) (Figure 1.5).  
 
Figure 1. 5: Fate map of myocardial chamber progenitors. Ventricular and atrial 
myocardial progenitors are spatially differentiated already at 40% epiboly. A) The 
coordinates of the fate map are projected onto a 40% epiboly-stage zebrafish embryo 
(lateral view shown). The latitude (vertical axis) is expressed in tiers from the margin. 
Each tier represents one cell diameter. The longitude (horizontal axis) is expressed in 
degrees around the circumference of the embryo. B) Fate map of the distribution of atrial 
and ventricular progenitors. The position of each bar (representing an individual 
experimental embryo) corresponds to the location of labeled blastomeres. Red bars show 
ventricular progenitors, yellow bars show atrial progenitors and black bars indicate non-
myocardial progeny. Data from both the left and right side of the embryo are summarized 
on this fate map. Ventricular progenitors are found 60-125o from dorsal in tiers 1, 2 and 3, 
while atrial progenitors are found 90-140o from dorsal in tiers 2, 3 and 4 (Keegan et al., 
2004).   
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Cardiogenic blastomeres are among the first to involute at the beginning of 
gastrulation at 5.25 hpf (Warga and Kimmel, 1990). Blastomeres from different regions 
of the lateral marginal zone were shown to migrate and form distinct regions of the 
LPM: ventricular progenitors become located medially and rostrally in relation to atrial 
progenitors (Keegan et al., 2004, Yelon and Stainier, 1999). Relative orientation of 
atrial and ventricular progenitors within the LPM is maintained as heart tube assembly 
is underway, as will be discussed in following sections (Yelon and Stainier, 1999). The 
expression patterns of atrial myosin heavy chain (amhc) and ventricular myosin heavy 
chain-2 (vmhc-2) subdivide the myocardial precursors into two cell populations that will 
give rise to the presumptive atrial and ventricular precursors, respectively. Expression 
of amhc starts at approximately the 19-somite stage (around 18.5 hpf), slightly later than 
the onset of vmhc expression at the 13-somite stage (around 15.5 hpf) (Yelon and 
Stainier, 1999).   
Nkx (nkx2.5 and nkx2.7) genes have been shown to differentially affect ventricular 
and atrial cell fates (Targoff et al., 2008). Specifically, it was shown that injection of 
anti-nkx2.5 and anti-nkx2.7 morpholinos in zebrafish embryos had differential effects on 
the forming ventricle and atrium: the ventricle appeared smaller and abnormal and 
contained less cells, while the atrium was stretched and enlarged (Targoff et al., 2008).    
FGF signals have, also, been suggested to affect chamber proportions. 
Specifically, zebrafish fgf8 mutants have small hearts with particularly small ventricles 
(Reifers et al., 2000), while mouse Fgf8 hypomorphs (Fgf8neo/-) exhibit hypoplastic 
right ventricles, along with other cardiovascular abnormalities (Abu-Issa et al., 2002). In 
chick, administration of exogenous Fgf2 or Fgf4 was shown to promote ventricular gene 
expression and to decrease atrial gene expression (Lopez-Sanchez et al., 2002). Lastly, 
after timely inhibition of fgf signalling in zebrafish embryos, greater sensitivity to the 
treatment was observed in ventricular cells compared to atrial cells (Marques et al., 
2008). Additional factors, shown to affect atrial-ventricular cell fate in mouse and chick 
are, among others, the basic Helix-Loop-Helix transcription factors Hand1 and Hand2 
(Firulli et al., 1998, Riley et al., 2000, Srivastava and Olson, 1997), Tbx5 (Bruneau et 
al., 2001) and Irx4 (Iroquois family of homeobox genes) (Bao et al., 1999).  
 
1.3.4. Cardiac determination and differentiation  
 
After initial specification of the cardiac fate in the LPM, cardiac progenitors will start 
expressing late cardiac genes, such as aMhc, vMhc, atrial myosin light chain-2 (Mlc-
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2a), ventricular myosin light chain-2 (Mlc-2v), Irx4, cardiac Troponin-I (cTnI), cardiac 
Troponin-C (cTnC) and Troponin Type-2 (Tnnt2), and become irreversibly committed 
and differentiated towards the cardiac lineage. When the murine linear tubular heart is 
formed (at approximately E8), Mlc2v and Irx4 are expressed in a large part of the tube 
{O'Brien, 1993 #81} and even after looping, they extend in areas outside the ventricles 
(atrioventricular canal, ventricles, proximal outflow tract etc) (Bruneau et al., 2000, 
Christoffels et al., 2000, O'Brien et al., 1993). As development proceeds, they become 
more and more ventricle-confined (Small and Krieg, 2004). Mlc-2a is an important 
component of the atrial myofibrillar apparatus and its genetic deletion in mice has been 
shown to diminish atrial contraction (Huang et al., 2003). However, Mlc-2a is not atrial-
specific throughout development; initially, its expression is ubiquitous in the linear 
heart tube and it becomes restricted to the atrial appendages between E10-E12 (Kubalak 
et al., 1994, O'Brien et al., 1993, Small and Krieg, 2004). Atrial Natriuretic Peptide 
(ANF) is another atrial-specific marker. It is a hormone that is specifically produced in 
and secreted by the atria and is thought to be involved in blood pressure regulation. Its 
upregulation in the ventricles has been shown to be correlated with hypertrophy (Chien 
et al., 1991). cTntI is a regulatory protein controlling the interaction between actin and 
myosin in the contractile apparatus (Sharma et al., 2004). This gene has been uniquely 
identified within the myocardium in mouse (Bodor et al., 1995). Tnnt2, another 
component of the contractile machinery of cardiac cells, is a tropomyosin-binding 
subunit of the troponin complex and is responsible for the regulation of muscle 
contraction (Ahmad et al., 2008, Nishii et al., 2008, Sumandea et al., 2009).  
Cardiac progenitors become differentiated cardiomyocytes after cardiac 
specification, determination and differentiation, as described in previous sections. 
Depending upon their position within the developing embryo and upon interactions with 
surrounding structures cardiac cells acquire their specific cardiac fate. Some essential 
transcription factors, already briefly mentioned, are discussed in more detail in the next 
section.      
 
1.3.5. Transcriptional regulation of cardiac cell differentiation  
 
This section provides an overview of the cardiac transcriptional network, encompassing 
specification, determination and differentiation of cardiac progenitors. A master 
regulator gene that can trigger the myocardial program probably does not exist. It is 
rather thought that the regulation of the myocardial program is achieved by the 
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synergistic action of multimeric complexes of transcription factors. Probably, the most 
important cardiogenic network, at least in mouse, is that of Gata-4, Tbx5 and Baf60c, 
suggested by Takeuchi and Bruneau in 2009 (Takeuchi and Bruneau, 2009). Gata-4 and 
Tbx5 are transcription factors essential for cardiogenesis, further explained in Sections 
1.3.5.2 and 1.3.5.3. Baf60c is a subunit of the Swi/Snf-like BAF chromatin-remodelling 
complex and was recently identified as a potential cardiogenic factor (Lickert et al., 
2004). The Gata-4, Tbx5 and Baf60c triad was shown to be sufficient for differentiation 
of non-cardiogenic mesoderm to cardiomyocytes. Nxk2.5, another essential cardiac 
transcription factor (Section 1.3.5.1), although not part of the minimal set of factors 
required for cardiac differentiation, it was subsequently induced by the combinatorial 
activity of Gata-4 and Baf60c (Takeuchi and Bruneau, 2009). Absence of Tbx5 in this 
context did not allow beating foci to appear (Takeuchi and Bruneau, 2009). More 
recently, another critical triad was suggested as the minimum transcriptional 
requirement for cardiogenic differentiation in mouse: Gata-4, Mef2c and Tbx5, selected 
among 14 cardiomyocyte-inducing candidates (Ieda et al., 2010). Ieda and colleagues 
(2010) showed that trans-differentiation of postnatal mouse cardiac and dermal 
fibroblasts into functional, beating cardiomyocytes was achieved by the combined 
activation of these three factors (Ieda et al., 2010). Although the minimal requirements 
for cardiogenesis suggested by the two groups (Takeuchi and Bruneau, 2009, Ieda et al., 
2010) do not fully agree, a discrepancy possibly due to the different target cells 
(mesodermal cells versus fibroblasts, respectively), the necessity for expression of 
Gata-4 and Tbx5 is common ground. Below, individual contributions of four master 
regulators of cardiogenesis (Nkx2.5, Gata-4, Tbx5 and Islet1) are discussed.  
 
1.3.5.1. Nkx2.5 
 
Nkx2.5 is one of the earliest markers of cardiac cells and plays a fundamental role in 
promoting the myocardial phenotype and in defining the cardiogenic fields across 
species (Evans et al., 1995, Harvey, 1999, Olson, 2006, Terada et al., 2011). In avian 
development it has been shown to be one of the earliest markers of mesoderm induced 
to attain a cardiac fate (Schultheiss et al., 1995). It is an important transcriptional 
regulator of a wide range of genes required for normal heart development, such as Mlc-
2v, Natriuretic peptide precursor type-a (Nppa), Natriuretic peptide precursor type-b 
(Nppb), Myocyte-specific enhancer factor 2c (Mef-2c) and others (Akazawa and 
Komuro, 2005, Bruneau et al., 2000). Surprisingly, commitment towards the cardiac 
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lineage occurs even in the absence of Nkx2.5; beating but small hearts develop in 
Nkx2.5 null mouse mutants but the embryos eventually die of heart failure (Lyons et al., 
1995). In zebrafish, nkx2.5 over-expression expands the cardiac fields and promotes 
expression of other cardiac genes, but fails to develop beating cardiomyocytes (Chen 
and Fishman, 2000a, Chen and Fishman, 2000b), suggesting that this gene is necessary 
but not sufficient for cardiogenesis. In humans, NKX2.5 mutations have been associated 
with Tetralogy of Fallot, atrial septal defects and atrioventricular conduction block 
(Goldmuntz et al., 2002, Schott et al., 1998). Although commonly used as an early 
cardiac marker, its expression is not restricted to the cardiogenic fields, it is also present 
in other tissues such as the pharyngeal endoderm, pharyngeal arches, gut and spleen 
(Eisenberg, 2002).  
 
1.3.5.2. Gata family transcription factors 
 
The GATA family of transcription factors has been shown to have important 
contributions to heart development. Three members of the GATA family are expressed 
in precardiac cells: Gata-4, Gata-5 and Gata-6 (Peterkin et al., 2009, Reifers et al., 
2000, Reiter et al., 2001). Members of this family are so called because they can bind to 
the consensus DNA sequence GATA and activate transcription of cardiac-specific 
genes. This occurs via the interaction of the GATA proteins with co-factors, such as 
Nkx2.5 and Mef-2C (Charron and Nemer, 1999, Charron et al., 1999, Molkentin et al., 
2000, Morin et al., 2000). Among their targets are genes that code for important 
components of cardiac cells, such as cTnC, cTnI and α-cardiac actin. Gata-4, 
specifically, has been shown to be an important activator of cardiac-specific genes, such 
as Nppa, Nppb, Myosin Heavy polypeptide 6 (Myh6, previously called α-myosin heavy 
chain), β-mhc (β-myosin heavy chain) and others (Molkentin et al., 2000, Pikkarainen et 
al., 2004) that are essential for cardiomyocyte maturation. Its deletion blocks formation 
of the primitive heart tube and inhibits terminal differentiation of cardiomyocytes (Garg 
et al., 2003, Kuo et al., 1997, Molkentin et al., 1997, Zeisberg et al., 2005). It has also 
been shown to contribute to cardiomyocyte differentiation, proliferation and survival 
(Peterkin et al., 2005) and to the development of the valves in the heart (Rivera-
Feliciano et al., 2006). Gata4 null mouse embryos exhibit formation of normal amounts 
of myocardial tissue, although the embryos go on to develop cardia bifida (Holtzinger 
and Evans, 2005, Kuo et al., 1997, Molkentin et al., 1997, Narita et al., 1996). It is, 
therefore, possible that there is significant redundancy with other GATA factors, such 
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as Gata-5 and Gata-6 (Holtzinger and Evans, 2005, Molkentin et al., 1997, Peterkin et 
al., 2007). This is also suggested by a study in zebrafish embryos, where loss of gata-4 
had little effect on specification and differentiation of cardiomyocytes (Serbedzija et al., 
1998), when gata-5 and gata-6 expression was not altered. Similarly to Nkx2.5, Gata-4 
is not uniquely expressed in cardiac progenitors and in the heart but also in pharyngeal 
endoderm, in the liver and in other endodermal and mesodermal derivatives (Burch, 
2005, Molkentin et al., 2000, Patient and McGhee, 2002). 
 
1.3.5.3. Tbx5 
 
Tbx5 (T-Box 5) is a T-box-containing transcription factor that plays an essential role in 
regulating many developmental processes. It is initially expressed throughout the 
cardiac crescent but later becomes restricted to the inflow compartment of the heart 
(Bruneau et al., 2001). Mutations of this gene have been mainly associated with the 
Holt-Oram syndrome, which affects the development of the heart and the upper limbs 
(Basson et al., 1997, Fan et al., 2003, Terrett et al., 1994). Although it has been shown 
to be essential for normal cardiac morphogenesis in Xenopus (Horb and Thomsen, 
1999) and for chamber specification in mouse (Liberatore et al., 2000) its specific 
cellular activities have not been defined. According to a recent publication, as described 
above, Tbx5 was suggested to be an essential contributor to initiation of spontaneous 
contraction, since its absence prevented beating foci to appear (Takeuchi and Bruneau, 
2009). In zebrafish, tbx5a (one of the tbx5 orthologs) is expressed in cardiac progenitor 
cells throughout development and, as in other vertebrates, it is an important regulator of 
fin (limb) development (Begemann and Ingham, 2000). It is thought to be mainly 
involved in late cardiomyocyte differentiation, rather than early progenitor 
specification, despite its early expression in the heart fields (Garrity et al., 2002). Tbx5b 
(the other zebrafish tbx5 gene) has lost the characteristic fin expression but has retained 
the eye and heart expression, partially overlapping with tbx5a (Albalat et al., 2010).  
 
1.3.5.4. Islet1 
 
Islet1 (Isl1) is another important regulator of cardiogenesis. It is a LIM-homeodomain 
containing transcription factor, transiently expressed in cardiac progenitors, mainly of 
the SHF, as discussed in Section 1.3.7 (page 21), before their migration into the heart 
tube and silenced as development proceeds (Cai et al., 2003). Isl1 is also expressed, 
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among others, in embryonic neurons (Thaler et al., 2004, Thor et al., 1999). Study of 
Isl1 knockout mice revealed moto-neuron defects, pancreatic development anomalies 
and premature death at E10.5-E11 (Ahlgren et al., 1997, Pfaff et al., 1996). In 
subsequent experiments, it was revealed that Isl1 knockout mice carried severe cardiac 
defects at E9.0 and E9.5 (Cai et al., 2003). Specifically, the hearts of Isl1 mutant 
embryos failed to undergo looping and had a common atrium and one ventricular 
chamber with left ventricular identity, while the right ventricle and the outflow tract 
were missing (Cai et al., 2003). Lineage tracing experiments showed that Isl1-
expressing cells colonize the outflow tract, the right ventricle, part of the atria and a 
minor portion of the left ventricle. Isl1 has also been shown to be required for the 
survival, proliferation and migration of SHF cells into the heart tube (Cai et al., 2003). 
However, subsequent investigations have shown that the expression of Isl1 is not 
restricted to the SHF, but may potentially also be expressed in the PHF. Isl1 protein, in 
contrast to Isl1 mRNA, was shown to be expressed at E7.5 in mouse embryos in regions 
that encompass both PHF and SHF (Prall et al., 2007). Similarly, as discussed in 
Section 1.3.7 (page 21), Isl1 has been found to be transiently co-expressed with Nkx2.5 
in the cardiac crescent (first heart field) in Xenopus embryos (Brade et al., 2007). These 
and similar data have suggested that Isl1 may in fact be a pan-cardiac progenitor 
marker. In zebrafish, islet1 has been shown to be expressed in ganglia, vascular 
endothelium and endoderm lying dorsal to the cardiac fields (Trinh and Stainier, 2004). 
Its ablation caused motility defects, cardiac contraction irregularity and reduced 
contractile frequency (de Pater et al., 2009).    
 
1.3.5.5. Summary of cardiac transcriptional regulation 
 
Although the major cardiac transcriptional regulators were described individually in the 
previous sections, they in fact do not work in isolation but interact extensively with each 
other. For example, as shown earlier, Gata-4 and Tbx5 work together (along with 
Baf60c) to promote cardiogenic differentiation of mouse mesodermal cells (Takeuchi 
and Bruneau, 2009). In Xenopus, the combination of gata4 and nkx2.5 is crucial for 
normal expression of atrial-specific genes (Small and Krieg, 2003), while in zebrafish 
gata-5 and nkx2.5 have been shown to work in coordination for the regulation of normal 
cardiogenesis (Reiter et al., 1999, Reiter et al., 2001). It is, therefore, important to 
consider the cardiac transcriptional system as a highly interacting network of genes, the 
expression and function of which is tightly temporally and spatially regulated.  
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1.3.6. Heart fields in the LPM and heart tube formation 
 
So far, the induction, specification, differentiation and transcriptional regulation of 
cardiogenic cells have been described. Next, the organization of these cells into early 
heart structures and their subsequent movement and morphogenesis, until the 
emergence of the chambered heart, are described. The development of the zebrafish 
heart is firstly described and any differences in the mouse and chick models are 
highlighted at the end.   
In zebrafish embryos, differentiation of cardiac precursors initiates while these 
cells reside at bilateral regions within the anterior lateral plate mesoderm (LPM), at 
approximately 16 hpf (McFadden and Olson, 2002, Yelon and Stainier, 1999). The 
assembly of a single heart tube in the midline requires the coordinated migration of 
these cell populations: medially located ventricular precursors move first, followed by 
laterally located atrial precursors. Myocardial cells reach the midline at approximately 
18 hpf and then cardiac fusion starts (Glickman and Yelon, 2002, Yelon and Stainier, 
1999). First, the ventricular precursors come in contact at the posterior fusion point and 
form a V-shape structure. Second, both atrial and ventricular precursors meet at the 
anterior fusion point and create a ring-like structure with a central lumen (Figure 1.6). 
On a lateral view, this structure resembles a cone and is thus called the cardiac cone, 
with ventricular cells residing in its apex and atrial cells in its base (Stainier and 
Fishman, 1992, Trinh and Stainier, 2004). At 19 hpf, atrial myocardial cells within the 
cardiac cone start migrating towards the left and anterior, resulting in the relocation of 
the myocardium to the left of the midline. Clockwise rotation and leftward jogging of 
the cone results in conversion of the initial dorsal-ventral axis of the cone to the 
anterior-posterior axis of the forming linear heart tube (Baker et al., 2008, Kathiriya and 
Srivastava, 2000). As the head lifts and the yolk sac regresses, atrial cells become re-
orientated caudally to the ventricular cells (Stainier and Fishman, 1992) (Figure 1.6). 
Formation of the mammalian and avian linear heart tube is similar to that of the fish 
(Figure 1.6). Cardiogenic cells residing bilaterally in the anterior LPM form the so-
called PHF (approximately E6.5 in mouse and stage 5 in chick). Fusion in the midline 
gives rise to a horse-shoe-shaped structure, called the cardiac crescent at E7-E8 in the 
mouse and stage 8-9 in the chick (Tam et al., 1997, reviewed by Moorman and 
Christoffels, 2003). As the mouse embryo undergoes folding (or turning at 
approximately E8, described in Section 1.2.2, page 4), cells within the cardiac crescent 
migrate along the midline and give rise to the linear heart tube by E8.5-E9 (Figure 1.6). 
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Chick embryos do not undergo folding but similarly form a linear heart tube (stage 10-
11) in the midline as the foregut pockets (deriving from endoderm and giving rise to the 
pharynx) fuse in the midline.  
For years it was believed that the early chick and mouse heart tube was pre-
patterned along its anterior-posterior axis (segmentation model) (Buckingham et al., 
2005, Harvey, 1999). More recently, a new idea has emerged based on evidence from 
lineage tracing experiments in mouse, according to which the cardiac crescent 
contributes largely to the atria and the left ventricle while the outflow tract and the right 
ventricle originate from the SHF or anterior heart field (Buckingham et al., 2005, Cai et 
al., 2003, Kelly et al., 2001, Mjaatvedt et al., 2001, Waldo et al., 2001, Zaffran et al., 
2004), described in detail in the next section. 
 
1.3.7. Secondary heart field (SHF) 
 
The discovery of the SHF in the chick (Mjaatvedt et al., 2001, Waldo et al., 2001) and 
in the mouse (Buckingham et al., 2005, Kelly et al., 2001) has shed more light in the 
complexity of the cardiogenic process. The SHF represents a cell population located 
medial and dorsal to the PHF and contributes myocardial, endocardial and smooth 
muscle cells to the arterial pole (Figure 1.7). It is part of the cardiogenic fields but it 
segregates and contributes to the heart (large part of the outflow tract, the presumptive 
right ventricle and the atria) only after looping has started (Buckingham et al., 2005, Cai 
et al., 2003, Kelly et al., 2001, Mjaatvedt et al., 2001, Waldo et al., 2001, Zaffran et al., 
2004). This delay is thought to be due to the close proximity of the SHF to the midline, 
where inhibitory Wnt signals emanate from (Srivastava, 2006). The SHF is marked by 
the transcription factor Islet1 (Cai et al., 2003), which was discussed in Section 1.3.5.4 
(page 17).  
Nowadays, there is a lot of discussion about whether the SHF represents a distinct 
cell population or whether it is actually only a subdivision of the PHF, of the same 
origin and expressing the same subset of cardiac genes but in a temporally distinct 
manner due to its position and its interactions with different combinations of 
transcription factors (Abu-Issa et al., 2004, Moorman et al., 2007). In recent studies, it 
has been suggested that the PHF-derived heart tube provides the scaffold upon which 
SHF-derived cells migrate and construct the cardiac chambers (Buckingham et al., 
2005) (Figure 1.7).  
 Taken together, t
programs. However, the differences in the time course of myocardial differentiation and 
the distinct spatial contributions of the two heart fields in the embryonic heart support 
the idea that, despite th
may have distinct transcriptional hierarchies, with 
both lineages and Isl1
 
 
Figure 1. 7: Schematic representation of the contributions of the primary and secondary 
heart fields in the developing mouse heart. 
and contribution of secondary heart field progenitors (shown in green) relative to the 
primary heart field cells (shown in red) from the cardiac crescent stage (E7.5) through to 
the looping stages of mouse heart development and to the final conformation of the four
chambered heart (E10.5). (B) Transverse sections of the hearts at corresponding 
developmental stages as in (A) are shown. The dashed lines in (A) indicate the position of 
the corresponding sections in (B). Secondary heart field is shown in green and primary 
heart field is shown in red. Cr/Ca: cranial/caudal, R/L: right/left, D/V: dors
DOFT: distal outflow tract, HFs: head folds, LA: left atrium, LV: left ventricle, ML: 
midline, PhA: pharyngeal arches, OFT: outflow tract, POFT: proximal outflow tract, RA: 
right atrium, RV: right ventricle 
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In lower vertebrates the presence of a SHF is not well established. In zebrafish, a 
SHF has not been conclusively identified. However, two spatially and temporally 
distinct phases of cardiomyocyte differentiation that contribute to heart tube growth 
have been identified (de Pater et al., 2009, Lazic and Scott, 2011). The initial phase is 
characterized by a continuous wave of differentiation that starts in the ventricle, ends in 
the atrium and requires isl1. During the late phase, new cardiomyocytes are added to the 
arterial pole (by 36 hpf) (de Pater et al., 2009). More recently, it was shown that most of 
the cells of the second wave originate from the same pre-gastrula region as the cells of 
the first phase, suggesting a common progenitor (Lazic and Scott, 2011). The two 
waves of cell addition to the heart (de Pater et al., 2009, Lazic and Scott, 2011) were 
shown to be required for regulation and growth of the zebrafish heart (especially up to 
48 hpf, when no cardiomyocyte proliferation is observed) and contribute to changes in 
the size and morphology of the heart. Their correlation with the presence of an 
additional heart field in zebrafish remains, however, elusive.       
 
1.3.8. Heart looping and morphogenetic patterning 
 
By 24 hpf, the zebrafish heart tube has formed in the midline, is functional and exhibits 
regular peristaltic contractions. Further morphogenetic movements, including looping 
and chamber formation, follow. Zebrafish heart looping takes place at approximately 30 
hpf (Figure 1.6). This process (rightward heart looping) involves a gradual bending 
between the forming ventricle and atrium that creates an S-shaped structure, bringing 
the ventricle to lie to the right of the atrium (Chen et al., 1997, Chin et al., 2000, 
Glickman and Yelon, 2002). Although heart looping starts at approximately 36 hpf, its 
direction has been determined earlier in development, during cardiac jogging (see 
Section 1.3.6, page 19). The directionality of jogging is dictated by asymmetric Nodal 
signalling and subsequent asymmetric gene expression at the LPM (see Section 1.2.4, 
page 6) (Baker et al., 2008). Modifications in cell proliferation, migration, 
differentiation and death are, also, suggested to be involved in the jogging and looping 
processes (Kathiriya and Srivastava, 2000). Disturbances of the left-right asymmetry or 
failure to interpret left-right cues can cause reverse jogging, reverse looping, no jogging 
or no looping (Ahmad et al., 2004, Chin et al., 2000). Incomplete jogging or looping 
towards the correct direction can also be observed (Chin et al., 2000).  
Similarly, the mouse and chick linear heart tubes start to elongate, beat and loop, 
soon after their formation in the midline. The elongation and simultaneous narrowing 
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take place both by expansion of the already existing tissue and addition of cells to the 
outflow and the inflow poles. The majority of the outflow tract is added during looping 
(stages 13-22 in chick, E8-E11 in mouse) and this happens by the addition of newly 
formed cells from the SHF (Kelly et al., 2001, Mjaatvedt et al., 2001, Waldo et al., 
2001), as mentioned earlier. Abnormalities in the looping process have been associated 
with defective left-right patterning in the mouse as well. For example, Pitx2-/- and 
Cited2-/- (a transcriptional co-activator of TfAp2) embryos exhibit abnormal cardiac 
looping, right isomerism and hyposplenia, correlated with defective establishment of 
left-right identities (Bamforth et al., 2004, Gage et al., 1999, Kitamura et al., 1999, Liu 
et al., 2001).  
 
1.3.9. Extra-cardiac additions to the heart 
 
Two important extra-cardiac cell additions supplement the forming avian and 
mammalian heart and contribute to its proper morphogenesis: epicardially-derived cells 
and neural crest cells. Epicardially-derived cells arise from the epicardium, which 
originates from cells outside the heart. Epicardially-derived cells populate the forming 
myocardium (E11.5-E12.5 in mouse, stages 16-20 in chick), contributing to coronary 
smooth muscle cells, endothelial cells and fibroblasts and providing support and 
signalling cues to the developing heart (Kwee et al., 1995, Moore et al., 1999, Perez-
Pomares et al., 2003). The existence of the epicardium has been confirmed in zebrafish 
as well, with its earliest progenitors firstly seen in the LPM (Serluca, 2008). It is 
thought to regulate myocardium maturation and establishment of the coronary 
vasculature, as in other vertebrates (Serluca, 2008). 
Cardiac neural crest cells are essential for normal heart development; they provide 
the parasympathetic innervation to the heart (Kirby et al., 1983) and the smooth muscle 
tunics of the great arteries (Bockman and Kirby, 1984), they contribute to the 
aorticopulmonary septum, which divides the outflow tract into the systemic and the 
pulmonary vessels (Kirby et al., 1983) and they participate in aortic arch remodelling 
(Waldo et al., 1996). In zebrafish, cardiac neural crest cells have also been identified 
(Sato and Yost, 2003); they contribute to the myocardium of the outflow tract, atrium, 
atrio-ventricular junction and ventricle (Sato and Yost, 2003).  
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1.3.10. The mature heart 
 
After initial morphogenetic movements and cell additions are complete in the heart, 
development of specialized conduction system, valve formation, ventricular wall 
thickening, trabeculae formation and further cardiac remodelling take place and form 
the mature heart (Glickman and Yelon, 2002, Hu et al., 2000, Hu et al., 2001). This, in 
mammals and birds, consists of a four-chambered structure through which two parallel 
blood circulations (pulmonary and systemic) are propelled around the body. In 
zebrafish, the mature heart consists of two chambers (an atrium and a ventricle) 
pumping in series, with no division between pulmonary and systemic circulation 
(Figure 1.6).  
 
1.4. The Wnt signalling network 
 
The Wnt pathway is an ancient and highly conserved cascade. Wnt are secreted 
glycoproteins, rich in cysteine and act in short-range as ligands for receptor-mediated 
signalling. In mammals, there are 19 members of the Wnt family, expressed in spatially 
restricted and dynamic patterns within the developing embryo and in adulthood (Kemp 
et al., 2005, Kemp et al., 2007). Therefore, it is not surprising that Wnt proteins are 
nowadays known to activate more than one signalling pathway. The best understood 
and most extensively studied of these pathways is the canonical, β-catenin-dependent, 
which plays crucial roles in a variety of early developmental processes such as cell 
proliferation and survival, cell fate specification, body axis formation and many more 
(thoroughly analysed in following sections, reviewed by Kemp et al., 2005, Kemp et al., 
2007). However, there are two more Wnt pathways that are independent of β-catenin 
and are called non-canonical Wnt pathways; these are the planar cell polarity (PCP) and 
the calcium cascades. All of the Wnt pathways share some of their upstream 
components, such as Frizzled and Dishevelled, but they are activated by diverse 
upstream Wnt ligands and diverge downstream, eliciting different cellular responses 
(Figure 1.8). For example, Wnt5a and Wnt11 have been shown to act preferentially 
through non-canonical Wnt, while Wnt3a and Wnt8 are thought to mainly act through 
canonical Wnt (reviewed by Veeman et al., 2003). Divergent downstream components 
are further discussed in the next sections.  
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and Kehoe, 2004) and upon their association with co-receptors (He et al., 1997, Mikels 
and Nusse, 2006). Similarly, Dishevelled proteins are known to interact with proteins of 
each pathway through different domains: their amino-terminal Dishevelled-Axin (DIX) 
domain binds to Axin and activates Wnt/β-catenin signalling (Fagotto et al., 1999, 
Schwarz-Romond et al., 2007a, Schwarz-Romond et al., 2007b), while their carboxyl-
terminal Dishevelled/Egl-10/Pleckstrin (DEP) domain binds to other proteins, involved, 
among others, in transduction of non-canonical Wnt signals (Gao and Chen, 2010, 
Wong et al., 2000) (Figure 1.8). Details about each pathway are discussed below.  
In summary, the Wnt signalling pathway consists of both shared and divergent 
components that form a network but also participate individually in one of the three 
Wnt branches (canonical Wnt, PCP and calcium pathways), dependent upon their 
interaction with other molecules and upon the cellular and timely context. These three 
pathways are individually presented below.   
 
 1.4.1. The canonical Wnt/ β-catenin pathway 
 
The canonical Wnt cascade is the best characterized among the Wnt pathways. In the 
absence of a Wnt ligand, β-catenin is recruited in an inhibitory complex, containing 
Adenomatosus Polyposis Coli (APC) and Axin, which enables its phosphorylation by 
Glycogen Synthase Kinase 3 (GSK3) and its subsequent proteolytic degradation. In this 
case, there are low levels of nuclear β-catenin, which is the form of the protein 
responsible for the propagation of the signal through gene expression activation. Upon 
binding of a Wnt ligand to members of the Frizzled family of receptors and low-density 
Lipoprotein Receptor-related Protein 5/6 (LRP5/6) co-receptors, Dishevelled is 
activated and recruited to the membrane, which in turn leads to degradation of Axin and 
inhibition of GSK3. The destruction of the Axin/APC/GSK3 complex results in the 
release of β-catenin, its accumulation in the cytoplasm and its translocation into the 
nucleus, where it can now interact with T-cell factor (TCF) and lymphoid enhancer-
binding factor (LEF) family members and activate target gene transcription (Figure 1.8). 
 
1.4.1.1. The canonical Wnt pathway during embryogenesis  
 
The canonical Wnt signalling pathway has been shown to play crucial roles during the 
development of vertebrate embryos. Although genes associated with canonical Wnt 
signalling are present very early during embryogenesis, already at blastocyst-stage 
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mouse embryos (Chapman et al., 2004, Eisenberg and Eisenberg, 2006, Skromne and 
Stern, 2001, Yamaguchi et al., 1999), there is no evidence for active β-catenin 
signalling during pre-implantation development (up to E5.0) (Kemler et al., 2004, Kemp 
et al., 2005, Lloyd et al., 2003). In fact, the first evidence of active canonical Wnt 
signalling is at the peri-implantation stage, where its tight regulation is essential for 
molecular patterning (Huelsken et al., 2000) and morphological patterning (Chazaud 
and Rossant, 2006) of the visceral endoderm and epiblast and for correct migration of 
visceral endodermal cells (Kimura-Yoshida et al., 2005). Failure to do so leads to 
absence of anterior-posterior polarization in pre-gastrula mouse embryos (Huelsken et 
al., 2000). β-catenin is also important for mesoderm induction (Gadue et al., 2006, 
Lindsley et al., 2006). Also, its absence is pivotal for the development of anterior-most 
tissues, such as anterior neural development (Glinka et al., 1998, Mukhopadhyay et al., 
2001, Tam and Steiner, 1999). As the embryo develops, the Wnts are found involved in 
many diverse processes, such as the regulation of proliferation in the central nervous 
system (Takada et al., 1994), axon remodelling and guidance and the proper formation 
of organs, such as the kidneys and the lungs (Parr et al., 2001, Stark et al., 1994). The 
involvement of the Wnt/β-catenin pathway in cardiac induction, specification and 
differentiation is presented below.  
 
1.4.1.2. The canonical Wnt pathway during heart development and in vitro cardiac 
differentiation 
 
The role of the canonical Wnt pathway in the induction, formation and morphogenesis 
of the heart has been much investigated. However, its precise role remains poorly 
defined. Initial studies in Drosophila embryos showed that the formation of the dorsal 
vessel, a primitive form of the vertebrate heart, is dependent on expression of the Wnt-1 
ortholog (Park et al., 1996). More recently, enhanced cardiac differentiation was 
observed after activation of β-catenin signalling during differentiation of pluripotent 
mouse carcinoma P19CL6 cells (Nakamura et al., 2003). However, subsequent studies 
in chick and frog embryos showed that Dickkopf-1 (Dkk-1) and Crescent, potent 
canonical Wnt inhibitors, could promote cardiogenesis in many contexts (Foley and 
Mercola, 2005, Marvin et al., 2001, Schneider and Mercola, 2001). Also, activation of 
β-catenin was shown to inhibit cardiac differentiation in vivo (Klaus et al., 2007) and in 
vitro (Yamashita et al., 2005). These data, in contrast to the data shown before, showed 
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that inhibition of canonical Wnt signalling was an absolute requirement for the 
development of heart tissue.  
Recent work has partially resolved this discrepancy by suggesting a biphasic and 
stage-specific role for the canonical Wnt/β-catenin signalling during cardiogenesis in 
differentiating mouse ES cells and during zebrafish development (Kwon et al., 2007, 
Naito et al., 2006, Ueno et al., 2007). It was shown that activation of the canonical Wnt 
pathway during in vitro ES cell differentiation (Naito et al., 2006, Ueno et al., 2007) and 
during early stages (before gastrulation) of zebrafish development (Ueno et al., 2007) 
promoted cardiogenesis, while later activation (after cardiac specification had taken 
place) had negative effects on cardiac differentiation (Kwon et al., 2007, Naito et al., 
2006, Ueno et al., 2007). It is, thus, possible that early activation of β-catenin is 
essential for mesoderm specification (Gadue et al., 2006, Lindsley et al., 2006, Naito et 
al., 2006) and for the development and proliferative expansion of cardiac progenitors 
(Kwon et al., 2007, Ueno et al., 2007), while during later differentiation it has negative 
effects on cardiogenesis and sets the boundaries of the heart-forming field (Naito et al., 
2006, Ueno et al., 2007). The early cardiogenic effect has been suggested to be a result 
of direct exposure to a high concentration of Wnt ligands in the primitive streak, which 
promote cardiac cell fate decisions (Kwon et al., 2007, Naito et al., 2006, Ueno et al., 
2007). Subsequent migration of committed cells into the heart-forming region through 
gastrulation movements exposes them to Wnt inhibitors, which is essential for their 
maturation (Figure 1.4) (Naito et al., 2006, Ueno et al., 2007).  
Although there is a lot of evidence to support the model presented above (early 
canonical Wnt promoting cardiogenesis and late canonical Wnt inhibiting it), two recent 
publications reinforced the traditional notion that β-catenin is inhibitory for 
cardiogenesis (Afouda et al., 2008, Wang et al., 2011). Afouda and colleagues (2008) 
showed that activation of the canonical Wnt pathway caused suppression of 
cardiogenesis, mediated by inhibition of Gata-4, in Xenopus explants (Afouda et al., 
2008). In turn, Wang and colleagues (2011) used two mouse ES cell lines to show that 
timely (and throughout differentiation) administration of Dkk-1 (an antagonist of 
canonical Wnt) (Kawano and Kypta, 2003, Mao et al., 2001) and XAV939 (a small 
molecule inhibitor of Wnt/β-catenin) (Huang et al., 2009) induced cardiomyogenesis 
(Wang et al., 2011).  
Of note, progenitors of the SHF have been shown to require Wnt/β-catenin 
signalling for their expansion (Ai et al., 2007, Cohen et al., 2007) This needs to take 
place at a time when PHF cells have already been specified and require suppression of 
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canonical Wnt signals for full differentiation and maturation. β-catenin was shown to 
downregulate Isl1 in vivo and in vitro and this decrease in Isl1 expression was believed 
to be essential for β-catenin-mediated expansion of cardiovascular progenitors (Kwon et 
al., 2009). In Isl1 knockdown ES cells, the appearance of beating foci was severely 
compromised as was the expression of cardiac sarcomeric genes (Kwon et al., 2009).  
In summary, it is evident that the spatio-temporal coordination and complex 
regulation of cardiac induction, specification and differentiation is of primary 
importance. The data presented above, also, highlight the fact that although a lot of 
studies have focused on elucidating the canonical Wnt contribution in cardiogenesis, the 
conflict about when and how this pathway acts remains unresolved.   
 
1.4.1.3. The canonical Wnt pathway in embryonic stem (ES) cell differentiation 
 
Wnt proteins play important roles in stem cell biology, reflecting their roles in 
embryonic development (see above), such as mesoderm differentiation (Gadue et al., 
2006, Lindsley et al., 2006, Wawrzak et al., 2007) and cardiac inhibition (Foley and 
Mercola, 2005, Marvin et al., 2001, Schneider and Mercola, 2001). Also, there is 
increasing evidence to suggest that the canonical Wnt pathway can contribute to the 
maintenance of mouse and human stem cells in their undifferentiated, pluripotent state, 
either independently of, or in conjunction with, LIF (discussed further in Section 
1.6.1.1, page 45) (Cartwright et al., 2005, Dravid et al., 2005, Miyabayashi et al., 2007, 
Ogawa et al., 2006, Sato et al., 2004, Singla et al., 2006, Takao et al., 2007). Whether 
this pathway is absolutely necessary for stem cell pluripotency, or whether it acts 
redundantly with other signalling pathways, remains to be elucidated (Dravid et al., 
2005, Huelsken et al., 2000).      
 
1.4.1.4. Canonical Wnt pathway; a summary 
 
The canonical Wnt pathway, one of the earliest signalling cascades established in 
embryogenesis, is involved in a variety of developmental processes, like mesoderm 
induction, body axis determination and cardiogenesis. However, its role in heart 
induction and development, although heavily investigated, remains poorly defined and 
highly contradictory.  
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1.4.2. The non-canonical Wnt/Planar cell polarity (PCP) pathway 
 
Another branch of the Wnt signalling network is the non-canonical Wnt/PCP pathway. 
It has traditionally been thought to be involved in polarization of tissues, hence the 
name, as firstly shown in Drosophila and later in vertebrates (reviewed by Simons and 
Mlodzik, 2008, Wang and Nathans, 2007). Until recently in the literature, there was a 
common belief that the main genes, known to be involved in PCP, acted in a single 
pathway. Briefly, this pathway was thought to consist of an upper level of proteins, 
including Fat (Ft), Dachsous (Ds) and Four-jointed (Fj), which interpret the direction of 
body axis polarization and transmit patterning information to the lower level group (or 
core group) (Ma et al., 2003, Seifert and Mlodzik, 2007, Yang et al., 2002). The core 
group comprises the non-canonical Wnt proteins Frizzled, Dishevelled, Prickle, Vang 
Gogh-strabismus (Vang), Diego and Flamingo-Starry night (Fmi), in Drosophila. These 
proteins, through elaborate interactions and asymmetric localization within the cells, 
establish cell polarization and amplify the polarization signal within the tissue, through 
downstream effectors, such as RhoA, Rac, Rho-associated kinase (ROCK) and JNK 
(Ma et al., 2003, Seifert and Mlodzik, 2007, Strutt and Strutt, 2009, Yang et al., 2002). 
However, a new idea has recently emerged. There is evidence to suggest that the 
Ft/Ds/Fj pathway (involved in tissue polarization) is in fact a parallel system to the core 
Wnt group and that Wnt ligands, at least in flies, may not be necessary for its activation 
(reviewed by Casal et al., 2006, Goodrich and Strutt, 2011, Henderson and Chaudhry, 
2011, Lawrence et al., 2007). In vertebrates, this scenario has not been elucidated. An 
overview of the so-called core Wnt/PCP group follows.    
The PCP pathway is β-catenin-independent but still involves Frizzled receptors 
and Dishevelled proteins. The main ligands that trigger this pathway are Wnt5a and 
Wnt11. Upon Wnt stimulation, a multiprotein complex containing Frizzled, 
Dishevelled, Prickle, Vangl2, Celsr and Diego is formed at the cell membrane. 
Activation of Dishevelled through recruitment of this complex leads to Dishevelled-
associated activator of morphogenesis-1 (Daam-1)-mediated interaction of Dishevelled 
with small GTPases of the Rho family (Figure 1.8). These further activate downstream 
kinase effectors, such as JNK and ROCK that bring about changes in the actin 
cytoskeleton and regulate migration, adhesion, elongation and polarity of the cell as 
well as gene transcription (reviewed by Barrow, 2006). Upon activation within a 
Dishevelled-Daam1-Rho complex, Rho stimulates the activity of ROCK, which along 
with Cdc42, participates in remodelling of the actin cytoskeleton (Ishizaki et al., 1997, 
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Leung et al., 1996, Marlow et al., 2002, Winter et al., 2001). Rac acts independently of 
Daam1 but also binds to Dishevelled and activates JNK (Boutros et al., 1998). In 
Drosophila and in cultured cells, JNK was shown to act downstream of Dishevelled and 
to mediate the PCP pathway (Boutros et al., 1998, Davis, 2000). In Drosophila, the JNK 
ortholog basket has been suggested to be involved in regulation of transcription of target 
genes during eye morphogenesis (Fanto et al., 2000, Weber et al., 2000). In Xenopus 
embryos, JNK was shown to be activated upon Wnt5a stimulation, to transduce the PCP 
signal and to mediate CE movement regulation (Yamanaka et al., 2002). JNK, although 
a downstream effector of the PCP pathway, has also been shown to activate 
transcription of Wnt11, one of the upstream ligands of the pathway in zebrafish (Seo et 
al., 2010). Of note, PCP effectors, often cell- or tissue- specific, exert their intracellular 
activities in response to PCP signals but cannot in turn affect the polarized localization 
of upstream PCP proteins (reviewed by Goodrich and Strutt, 2011).  
Overall, the PCP pathway is most commonly related to tissue polarization in 
Drosophila, but it has also been shown to play fundamental roles in a variety of 
morphogenetic processes in vertebrates that require coordination of cell polarity, cell 
motility and cell cohesion. More recently, PCP was also associated with human disease 
(reviewed by Roszko et al., 2009, Simons and Mlodzik, 2008).  
 
1.4.2.1. The non-canonical Wnt/PCP pathway during embryogenesis and convergence 
extension (CE) 
 
Non-canonical Wnt/PCP signalling was initially described as an important regulator of 
the coordinated polarization of cells within the plane of an epithelium, as well as 
polarized cell behaviour and cell shape. In Drosophila, where the identification of the 
core PCP proteins was achieved, this form of polarity is involved in the organization of 
the wing hairs and the ommatidia of the compound eye (Baena-Lopez et al., 2005, 
Matakatsu and Blair, 2004, Strutt, 2001), while in vertebrates it is mainly associated 
with inner ear cell organization (Curtin et al., 2003, Montcouquiol et al., 2003, Wang et 
al., 2006), hair follicle orientation (Guo et al., 2004), CE movements during gastrulation 
(Barrow, 2006, Heisenberg et al., 2000, Roszko et al., 2009, Wallingford et al., 2002) 
and neural tube closure defects (Ciruna et al., 2006, Murdoch et al., 2003). Less well 
described but widely accepted are the roles of PCP during vertebrate neuronal migration 
(Ciruna et al., 2006, Wada and Okamoto, 2009), ciliogenesis (Ross et al., 2005) and 
heart development (Eisenberg and Eisenberg, 1999, Garriock et al., 2005, Hamblet et 
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al., 2002, Henderson et al., 2001, Montcouquiol et al., 2003, Pandur et al., 2002, 
Phillips et al., 2008, Phillips et al., 2007, Torban et al., 2004).  
The regulation of CE during gastrulation is of most interest here, while the role of 
the PCP pathway in heart development is discussed in the next section. Gastrulation in 
vertebrates requires the coordinated migration of large amounts of cells around the 
forming body in order to establish the embryonic germ layers. CE movements are 
responsible for the narrowing of a tissue along one axis and its concomitant lengthening 
in the perpendicular axis, during which the body plan is defined. They have been 
extensively studied in frog and fish embryos, where movements of cells are easy to 
follow (Figure 1.2). The Wnt/PCP pathway is a key regulator of CE movements, as 
shown among others, in zebrafish embryos that carry mutations in PCP components. 
Trilobite, vangl2 mutant (Jessen et al., 2002), knypek, glypican-4 mutant (Topczewski 
et al., 2001), silberblick, wnt11 mutant (Heisenberg et al., 2000) and pipetail, wnta5/5b 
mutant (Kilian et al., 2003, Rauch et al., 1997) embryos exhibit defective CE 
movements during gastrulation that result in shortened (in the anterior-posterior axis) 
and wider (in the medial-lateral axis) bodies. Intracellular mediators of the non-
canonical Wnt pathway, such as rhoA, cdc42 and jnk, have also been shown to be 
important for regulation of CE movements in zebrafish and Xenopus embryos (Bakkers 
et al., 2004, Habas et al., 2003, Matsui et al., 2005, Yamanaka et al., 2002). Similarly, 
in mammals, mutations in PCP components impair CE during gastrulation and 
neurulation. Vangl2/Loop-tail (Kibar et al., 2001, Torban et al., 2004), Scribble/Circle-
tail (Murdoch et al., 2003), Celsr-Flamingo (Curtin et al., 2003), Dishevelled (Hamblet 
et al., 2002) and Sfrp (Wnt antagonists that deregulate PCP signalling) (Satoh et al., 
2008) mouse mutants display body shortening, notochord and somite widening and 
neurulation defects.    
 
1.4.2.2. The non-canonical Wnt/PCP pathway during heart development and in vitro 
cardiogenesis 
 
The non-canonical Wnt/PCP pathway has been shown to be an important player during 
cardiogenesis in several animal models. In quail embryos Wnt11, an upstream activator 
of the PCP cascade, was shown to promote ectopic formation of cardiomyocytes 
(Eisenberg and Eisenberg, 1999, Eisenberg et al., 1997) and in Xenopus explants it was 
shown to induce myocardial gene expression and to trigger contractile activity 
(Garriock et al., 2005, Pandur et al., 2002). Similarly, it has been shown to enhance 
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cardiogenesis in vitro: it increases the number of Nkx2.5 positive cells in mouse ES cells 
(Terami et al., 2004), it promotes cardiomyocyte formation in P19 cells (Pandur et al., 
2002) and it activates cardiac gene expression in mouse mesenchymal stem cells 
(Schulze et al., 2005) and bone marrow stem cells (Belema Bedada et al., 2005). 
Disruption of downstream PCP components has also been shown to cause cardiac 
abnormalities. Severe heart malformations have been reported in Dishevelled (Hamblet 
et al., 2002), Vangl2 (Henderson et al., 2001) and Scribble (Phillips et al., 2007) mouse 
mutants, mainly associated with cardiomyocyte organization, cardiac looping, aortic 
arch remodelling and outflow tract patterning. Also, ROCK-inhibited mouse and chick 
embryos were shown to exhibit cardia bifida (Wei et al., 2001). Similarly, in zebrafish 
embryos, selective deletion or downregulation of PCP members caused anomalies in the 
progression of cardiac morphogenesis. Zebrafish embryos expressing a dominant 
negative form of dishevelled (Dvl∆DEP, specifically affecting the PCP pathway) or a 
combination of morpholinos against wnt4a, wnt11 and wnt11-R (another wnt11 gene) 
exhibited cardia bifida, along with CE defects, described before (Matsui et al., 2005).  
 
1.4.2.3. The non-canonical Wnt/PCP pathway; a summary 
 
The non-canonical Wnt pathway has, for years, been associated with planar cell 
polarization, but recent evidence suggests that the link between the two is not universal. 
In some contexts, however, it has been confirmed to be involved in polarization of 
tissues and coordination of directional cell migration; Drosophila wing hair and 
ommatidia polarization, mouse inner ear polarization and CE are among the most 
heavily investigated and best understood contributions of Wnt/PCP during embryonic 
development. Its involvement in heart induction and morphogenesis is also well 
established.   
 
1.4.3. The non-canonical Wnt/Calcium pathway 
 
The Wnt/calcium pathway is also stimulated by non-canonical Wnt ligands and Frizzled 
receptors and triggers the release of intracellular calcium and the activation of calcium-
responsive enzymes like Protein kinase C (PKC), Calcium/calmodulin-dependent 
protein kinase II (CaMKII) and Calcineurin (Kuhl et al., 2000, Saneyoshi et al., 2002). 
Intracellular calcium release is mainly mediated through activation of the 
phosphatidylinositol (PI) cascade, which acts via a PI-specific phospholipase C 
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(Slusarski and Pelegri, 2007). This, in turn, hydrolyses phosphatidylinositol (4,5) 
bisphosphate (PIP2) at the cell membrane and generates diacylglycerol (DAG) and 
inositol 1,4,5-trisphosphate (IP3). Finally, IP3 stimulates release of calcium into the 
cytosol (Westfall et al. 2003). The role of the Wnt/calcium pathway in promoting 
ventral cell fate in Xenopus, in regulating gastrulation movements and orchestrating 
heart development has been well studied (Kuhl et al., 2000, Pandur et al., 2002) but will 
not be analysed further here.       
 
1.4.4. Cross talk between the Wnt branches 
 
The three branches of the Wnt pathway are usually described and studied 
independently. However, Wnt proteins are now thought to activate a complex signalling 
network within the cell, rather than individual pathways (Figure 1.8). The specific 
outcome of the activation of this network is time- and context- dependent. This idea is 
strongly supported by a series of evidence in the literature that show clear cross talk 
between the different Wnt branches.  
Firstly, upstream Wnt components (ligands, receptors and co-receptors), although 
shown to preferentially act through either the canonical or non-canonical Wnt pathway 
(see beginning of this section), can in fact, under different conditions, participate in both 
pathways. For example, Wnt-11, which is a generally considered non-canonical Wnt 
ligand, was suggested to have the ability to repress the canonical Wnt pathway in 
carcinoma P19 cells (Maye et al., 2004). Similarly, Dkk-1, a common antagonist of the 
canonical Wnt pathway that acts through binding to and inactivating the LRP6 co-
receptor (Davidson et al., 2005, Tamai et al., 2000, Zeng et al., 2005), was recently 
shown to activate the PCP pathway and regulate CE movements in zebrafish (Caneparo 
et al., 2007).  
Downstream Wnt components and effectors have also been shown to allow 
considerable cross talk between the canonical and non-canonical pathways. For 
example, Rac-1, a downstream effector of the PCP pathway, has been suggested to 
participate in β-catenin signalling and to activate TCF, through JNK (Esufali and Bapat, 
2004, Wu et al., 2008). Inhibition of JNK in this context decreased Lef-1 luciferase 
expression and inhibited nuclear accumulation of β-catenin (Wu et al., 2008). An 
important link between JNK and β-catenin has also been established. Inhibition of jnk 
signalling in Xenopus embryos was shown to induce β-catenin target gene expression, 
through a GSK3-independent mechanism (Liao et al., 2006). These effects were 
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associated with hyperdorsalization of the embryonic body and increased levels of 
nuclear and non membrane-bound β-catenin. Similarly, Jnk was shown to inhibit β-
catenin-mediated gene transcription in mammalian cells and to favour export of β-
catenin from the nucleus (Liao et al., 2006). In contrast, activation of Jnk suppressed 
transcription of β-catenin target genes and blocked β-catenin–induced axis duplication 
(Liao et al., 2006).  
The list of examples that highlight the complex interactions governing the Wnt 
network is long and only a few of them are presented here. It is, however, evident that 
the combination of various ligands and intracellular components differentially 
orchestrates the Wnt signalling network depending on the cell type, the timing and the 
input from surrounding signalling centres (reviewed by Kestler and Kuhl, 2008). 
Therefore, the distinction between Wnt pathways is an arbitrary, albeit sometimes 
useful, convention and not a representation of the reality within the cell.  
 
1.5. JNK signalling   
  
JNK is a member of the evolutionarily conserved family of Mitogen-activated protein 
kinases (MAPK). As part of this family, JNK amplifies and integrates signals from a 
wide range of stimuli, giving rise to varied cellular responses (Figure 1.9). As 
mentioned before, JNK is also an important downstream member of the non-canonical 
Wnt signalling pathway, shown to be essential for PCP signal propagation (Boutros et 
al., 1998, Habas et al., 2003, Yamanaka et al., 2002). 
The importance of JNK during development (Boutros et al., 1998, Davis, 2000, 
Fanto et al., 2000, Seo et al., 2010, Yamanaka et al., 2002) and in adulthood (reviewed 
by Bogoyevitch, 2006, Rose et al., 2010, Bogoyevitch and Kobe, 2006) has been known 
for years in both vertebrates and invertebrates. It is known to play crucial roles in 
regulating embryogenesis, proliferation, apoptosis, differentiation, gastrulation 
movements, CE and tissue polarization in vertebrates (Bogoyevitch and Kobe, 2006, 
Krens et al., 2008, Yamanaka et al., 2002). Also, its function during cardiac 
development and at many stages of heart disease progression is widely recognized 
(reviewed by Bogoyevitch and Kobe, 2006, Rose et al., 2010). 
 
  
Figure 1. 9: MAPK and JNK signalling. Activation of JNK occurs in response to a number 
of different stimuli: cellular stresses (heat shock, hype
protein-coupled receptors and non
become activated through phosphorylation by upstream kinases. Activated JNK has a vast 
array of downstream substrates, both cytoplasmic and nuclear. Depending on the 
stimulus, JNK has the ability to move between cytoplasm and nucleus to exert its effects.
Not all connections represent
steps, not all of which are defined. SP600125, a pharmacological inhibitor of JNK, further 
discussed in Chapter 4
RTK: receptor tyrosine kinase, MKP: MAPK phosphatase
from Rose et al., 2010)
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1.5.1. An overview of JNK signalling 
 
JNK is a component of both the non-canonical Wnt/PCP and the MAPK pathways and 
is involved in crucial cellular processes associated with both these cascades. Members 
of the MAPK family are present in almost all eukaryotic organisms, including animals, 
fungi and plants, where they form complex signalling networks. MAPK are organized 
and act in a sequential manner: the top-most kinases called MAPK kinase kinases 
(MAPKKK, also known as MEKK) phosphorylate MAPK kinases (MAPKK, also 
called MAPK/Extracellular-signal-regulated kinases, ERK or MEK) that in turn 
phosphorylate MAPK. Finally, activated MAPK phosphorylate downstream targets, 
such as transcription factors (including c-Jun, AP-1, NFAT, c-Myc) and other proteins 
(including apoptosis-related proteins). The deactivation of these kinases occurs via 
dephosphorylation by specialised phosphatases.  
JNK belong to the most downstream kinases of the cascade described above. They 
are mainly activated by cytokines and exposure to environmental stress, hence they are 
also known as Stress-Activated Protein Kinase or SAPK. Upon stimulation, they 
phosphorylate and either activate or inhibit downstream targets. A variety of molecules 
have been identified as phosphorylation targets of JNK, residing in the nucleus, the 
mitochondria or in other parts of the cell, revealing the vast range of processes these 
kinases are involved in. Their most recognized and firstly identified target is the 
transcription factor c-Jun (Derijard et al., 1994), but a variety of transcription factors, 
such as ATF-2 (Gupta et al., 1995), AP-1, Elk-1 (Yang et al., 1998), NFAT (Chow et 
al., 1997) and p53 (Das et al., 2007), populate the list of JNK targets. Additional and 
equally important targets of JNK are mitochondria-associated proteins, such as Bim-
related members of the Bcl2 family, which through JNK activation lead to Bax-
dependent apoptosis (Lei and Davis, 2003).  
 
1.5.2. Jnk genes  
 
Jnk orthologs have been identified in a variety of organisms and an astonishing 
evolutionary conservation is observed between different species. In Drosophila one 
single jnk gene has been identified, called basket, shown to be important for dorsal and 
thorax closure during mid-embryogenesis (Stronach and Perrimon, 1999). However, in 
other multicellular organisms, more than one jnk genes have been identified (see 
below).  
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In mammals there are three Jnk genes, Jnk-1, Jnk-2 and Jnk-3 (also known as 
mapk8, mapk9 and mapk10, respectively), located on different chromosomes, which 
through alternative splicing encode at least ten different protein isoforms. Mouse Jnk1 
and Jnk2 are ubiquitously expressed, while Jnk3 is predominantly expressed in the brain 
and to a lesser extent in the testes and the heart (Martin et al., 1996, Mohit et al., 1995). 
Although the precise differences between the isoforms are not clearly defined, it is 
known that they differentially recognize, bind and phosphorylate their downstream 
effectors (Bogoyevitch et al., 2004, Gupta et al., 1996). For example, Jnk1 was found to 
selectively interact with Jamp (Kadoya et al., 2005), while Jnk3, but not Jnk1 or Jnk2, 
was found to bind to β-arrestin 2 (McDonald et al., 2000).  
Zebrafish jnk genes have not been extensively studied. The first attempt to 
identify zebrafish orthologs revealed a single jnk1 isoform that showed 87%, 77% and 
80% identity to human, mouse and rat Jnk1, respectively, and 71% identity to human, 
mouse and rat Jnk2 orthologs (Krens et al., 2006). Zebrafish jnk1 was shown to be 
weakly expressed in early developmental stages, highly expressed from late gastrula 
stages to segmentation (10-24 hpf) and after a significant decrease between days 1 and 
5, its expression reached highest levels in adulthood. Expression of jnk1 at 24 hpf was 
localized in the brain. At 48 hpf its expression pattern became more defined and was 
found in the telencephalon, the cerebellum, the hindbrain, the hypothalamus, the 
pectoral fins and the presumptive gut (Krens et al., 2006). Recently, four jnk isoforms 
were reported: jnk1a-1, jnk1a-2, jnk2 and jnk3, closely resembling their three 
mammalian orthologs (Seo et al., 2010).  
The high conservation of JNK and its varied cellular targets and activators 
highlight the complexity and diversity of JNK signalling, even in simple organisms, and 
emphasizes its importance in biological processes in diverse eukaryotic species.  
 
1.5.3. Mouse Jnk genes during development 
 
In mammalian systems, the study of Jnk has been more intensive. Jnk1 and Jnk2 were 
initially thought to have redundant roles; however, it has recently been shown that they 
activate different substrates and thus participate in distinct cellular responses (reviewed 
by Bogoyevitch, 2006). For example, activation of Itch by Jnk1 caused excessive 
apoptotic death (Gao et al., 2004), while Jnk2 was shown to activate Tau (a 
microtubule-associated protein), not regulated by Jnk1 (Yoshida et al., 2004). All three 
genes (Jnk1, Jnk2 and Jnk3) have been studied in transgenic mouse models by selective 
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disruption or deletion. Single Jnk mutant mice (Jnk1-/-, Jnk2-/- or Jnk3-/-) are born 
normally and thus, allow for a close examination of the defects that arise from deletion 
of each gene. However, putative redundancy effects between the highly similar Jnk 
genes and their products cannot be overlooked in these cases. Double mutants between 
Jnk1 or Jnk2 and Jnk3 (Jnk1-/-;Jnk3-/- and Jnk2-/-;Jnk3-/-) are also viable until birth and 
develop fairly normally (Aouadi et al., 2006, Gerits et al., 2007). In contrast, Jnk1 and 
Jnk2 double mutants (Jnk1-/-;Jnk2-/-) die early in gestation (E11-E12) due to abnormal 
levels of apoptosis in the brain (Kuan et al., 1999).  
Selective disruption and targeted deletion of upstream activators and downstream 
targets of JNK have also been performed but their contribution to our understanding of 
JNK signalling has been limited (Derijard et al., 1994, Gerits et al., 2007). This is 
mainly due to the fact that JNK is not uniquely activated by one molecule and does not 
act on a single substrate. By the studies presented above, it becomes clear that JNK-
regulated events cover a broad spectrum of conserved cellular and morphogenetic 
processes and although the potential for therapeutic applications is evident, the potential 
for unwanted side effects cannot be disregarded. A description of the phenotypes seen 
after deletion of each mouse Jnk gene or combinations of Jnk genes follows.   
 
1.5.3.1. Jnk1 and Jnk2 
 
Jnk1 and Jnk2 have been shown to have essential roles in regulating and modulating the 
function of immune cells by mediating alternative T-cell lineages. Specifically, loss of 
either gene causes aberrant T-cell activation and proliferation and defective 
differentiation (Dong et al., 1998, Resnick and Fennell, 2004, Sabapathy et al., 1999, 
Yang et al., 1998). Increased levels of cell death in the forebrain and decreased levels in 
the lateral areas of the hindbrain in developing mouse Jnk1-/-;Jnk2-/- mutant embryos 
(the reason for their in utero death) revealed the involvement of these two genes in 
regulation of apoptosis levels in the developing brain (Kuan et al., 1999). Recently, 
distinct roles for Jnk1 and Jnk2 have also been demonstrated. Jnk1-/- mice show 
microtubule assembly defects (Chang et al., 2003), activation of neovascularization by 
thrombospondin-1 (Jimenez et al., 2001), protection against obesity-induced insulin 
resistance (Hirosumi et al., 2002) and deregulation of intestinal homeostasis 
accompanied by spontaneous tumour formation (Tong et al., 2007). Only a small 
number of studies on Jnk2-/- mice are available to date. These have shown that Jnk2 
 41 
mediates inflammatory and innate immune responses by inducing interferon and 
activating gene expression (Chu et al., 1999, Han et al., 2002).  
The study of combined deletions of Jnk1 and Jnk2 has not been possible, as 
described before, due to embryonic lethality of compound mutants (Jnk1-/-;Jnk2-/-) 
(Kuan et al., 1999). Studies, in which at least one of the wild type alleles was retained, 
have allowed a deeper understanding of the combined roles of these two genes in 
mammals. Jnk1-/- ; Jnk2+/- mice revealed that Jnk proteins are essential for optic fissure 
closure (Weston et al., 2003). Mouse mutants with only one Jnk1 allele (Jnk1+/-;Jnk2-/-) 
showed reduced obesity-induced insulin resistance and lower inflammatory cytokines 
(Tuncman et al., 2006). Overall, both Jnk1 and Jnk2 were shown to be important in the 
regulation of lipid and glucose metabolism in the whole organism, with each one 
involved in distinct processes; for example, Jnk1 is suggested to be mainly involved in 
type II diabetes, while Jnk2 in type I diabetes (Aouadi et al., 2006, Gerits et al., 2007, 
Jaeschke et al., 2005).  
 
1.5.3.2. Jnk3 
 
Loss of Jnk3 has not been associated with an obvious abnormal phenotype. However, 
Jnk3-/- mice are shown to be protected from glutamate- and kainic acid-induced 
neurotoxicity that is commonly associated with elevated and/or sustained levels of 
activated Ap-1 and c-Jun (Aouadi et al., 2006, Yang et al., 1997). This finding made 
Jnk3 an interesting potential target for the treatment of diseases such as stroke, 
Parkinson’s or Alzheimer’s disease, in which neuronal death is to be prevented 
(reviewed by Bogoyevitch et al., 2004).  
 
1.5.4. Zebrafish jnk genes during embryonic development  
 
The four newly identified jnk genes in zebrafish (Seo et al., 2010) were studied during 
gastrulation only (5.25-10 hpf) and were assessed on their ability to control and guide 
normal gastrulation. It was shown that during gastrulation jnk1a-1, jnk1a-2 and jnk2 
were present, but it was mainly the expression and activity of Jnk2 that was important 
for controlling convergence and extension (CE) movements, as shown by morpholino 
injections. However, a more detailed analysis of the temporal and spatial expression 
pattern of the genes, as well as a more in depth investigation of their potential roles 
during zebrafish development were not carried out.  
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Surprisingly, although zebrafish jnk genes and the corresponding proteins have 
not been examined in detail, a considerable number of publications that have used 
chemical inhibitors or morpholino injections against jnk are available. Rui and 
colleagues (2007) showed that jnk has a dorsalizing activity during zebrafish 
development and body axis formation (Rui et al., 2007) and Schwarz-Romond and 
colleagues (2002) suggested that either activation or inhibition of jnk leads to disturbed 
gastrulation movements (Schwarz-Romond et al., 2002), an idea supported by a more 
recent publication that showed body axis shortening and defective CE movements after 
jnk inhibition (Matsui et al., 2005). It has also been shown that inactivation of jnk can 
cause macrophage migration defects (Zhang et al., 2008), microcephaly and 
micropthalmia (Matsui et al., 2005). 
 
1.5.5. JNK in embryonic stem (ES) cell culture and differentiation 
 
The role of JNK has been studied in stem cell culture as well, either by using mouse ES 
cells isolated from Jnk knockout mice or by chemically inhibiting the proteins of 
interest. ES cells deficient for either Jnk1 or Jnk2 showed defective endoderm 
differentiation (Binetruy et al., 2007). Additionally, although Jnk was shown to be 
dispensable for renewal and proliferation of ES cells, it was shown to be involved in 
their differentiation. Defective cavitation (absence of cavity formation in differentiating 
embryoid bodies) has been associated in the past with abnormal differentiation 
(Hernandez-Garcia et al., 2008), suggesting a putative role for Jnk in cavity formation 
and differentiation progression. Also, cell proliferation seems to be defective in the 
absence of both Jnk1 and Jnk2, while apoptosis levels are not significantly affected (Xu 
and Davis, 2010). Jnk deficiency was also shown to cause severe defects in mesodermal 
and mild defects in endodermal and ectodermal development in vitro (Xu and Davis, 
2010). Interestingly, absence of Jnk1, but not Jnk2 or Jnk3, in differentiating ES cell 
culture caused enhanced epithelial differentiation, marked by increased E-cadherin, in 
the expense of neurogenesis. It was shown that this shift in cell fate was accompanied 
by markedly increased expression of Wnt4, Wnt6 and Bmp4 (Amura et al., 2005), 
known players in lineage commitment during ES cell differentiation (Aubert et al., 
2002, Munoz-Sanjuan and Brivanlou, 2002). 
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1.5.6. JNK in heart disease 
 
Members of the MAPK cascade and the Wnt pathway (Section 1.4) have been shown to 
be important players in cardiac development, physiology and disease. The role of JNK 
in the heart, related mainly to hypertrophy, regulation of cell death and remodelling has 
been an area of great interest and intense controversy (reviewed in (Rose et al., 2010). It 
was initially shown that upon infection of cultured neonatal rat cardiac myocytes with 
vectors expressing a constitutively active form of MKK7 (upstream regulator of JNK), 
hypertrophy and cellular pathology developed: cell size was increased, expression of 
ANF was upregulated and sarcomere organization was disturbed (Wang et al., 1998). 
Subsequent in vivo experiments in adult mice, deficient for MEKK1 (another upstream 
activator of JNK), did not confirm this finding (Liang and Molkentin, 2003, Sadoshima 
et al., 2002). Conversely, adenovirus-mediated gene transfer of MKK4 (upstream 
regulator of JNK) in the adult rat heart caused loss of function of Jnk and blocked 
hypertrophy in vivo (Choukroun et al., 1999, Minamino et al., 2002). However, genetic 
inactivation of individual Jnk genes, combinations of them (Tachibana et al., 2006) or 
of individual downstream targets (Hilfiker-Kleiner et al., 2006, Liang and Molkentin, 
2003, Shao et al., 2006) did not have the same effect.  
Similarly, controversial roles for JNK have been reported in cardiomyocyte death 
regulation: JNK activity has been shown to play an important role in cardiac myocyte 
apoptosis after ischemia/reperfusion (Ferrandi et al., 2004, Hreniuk et al., 2001) and in 
cardiac myocyte survival and cardioprotection (Andreka et al., 2001, Dougherty et al., 
2002, Kyoi et al., 2006, Sadoshima et al., 2002, Shao et al., 2006) Additionally, 
constitutive Jnk activation, by a Cre/loxP-mediated gene switch for targeted expression 
of an upstream activator of Jnk (MKK7D), in mouse ventricular myocytes caused 
contractile dysfunction, induction of the fetal gene programme and premature death (7 
weeks after birth) with signs of heart failure (Petrich et al., 2004).  
A connection between the structure of the cardiac cell gap junctions and JNK has 
also been established. Adenovirus-mediated activation of MKK7 in cultured myocytes 
caused prolonged activation of Jnk and was reported to cause reduction in Connexin-43 
(Cx43) expression at both the mRNA and protein levels and impaired cell 
communication (Petrich et al., 2002). Similarly, using a Cre/loxP system for activation 
of MKK7 and thus Jnk in the myocardium of mouse embryos, downregulation of Cx43, 
loss of gap junctions and slowed conduction velocity in the heart were observed (Petrich 
et al., 2002, Ursitti et al., 2007).  
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Although significant progress has been made in understanding and unravelling the 
role of MAPK and JNK, in particular, in the heart, basic questions about the functional 
roles of these kinases in the regulation of major events during heart development and 
disease remain unanswered. Discovering additional interacting partners and their 
intricate contribution to MAPK signalling, and dissecting primary and secondary effects 
of their activity, will greatly improve our knowledge and will provide useful insight into 
potential therapeutic or preventative approaches.  
 
1.5.7. JNK signalling; a summary 
 
JNK is a kinase, member of the MAPK family and a downstream effector of the non-
canonical Wnt/PCP pathway. Three Jnk genes have been identified in mammals and 
four in zebrafish. Their presence has been confirmed in early developmental stages and 
throughout embryogenesis. JNK is a pleiotropic molecule; it is regulated by a multitude 
of signals and, in turn, regulates the activity of a variety of downstream targets. 
Proliferation, cell death, migration and differentiation are only a few of the processes to 
which JNK has been shown to contribute. Its involvement in heart disease is well 
reported, although highly controversial. In contrast, its contribution to induction and 
differentiation of the embryonic heart remains elusive and is mainly correlated with the 
PCP pathway.      
 
1.6. Experimental models of embryonic development 
 
Embryonic development comprises an array of processes, from cell proliferation, 
migration and differentiation to tissue interactions and morphogenetic patterning. 
Popular models for studying these events are the mouse, chick, zebrafish and frog 
embryos for in vivo analyses and cell culture systems of either primary or pluripotent 
cells for in vitro analyses. In the next two sections, zebrafish embryos and mouse 
embryonic stem cells, which were used as models in the present study, are presented.  
 
1.6.1. Mouse embryonic stem (ES) cells  
 
Mouse ES cells were first isolated in 1981 (Evans and Kaufman, 1981, Martin, 1981) 
and have since become an important tool in biomedical research. At approximately E4, 
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some cells of the inner cell mass (ICM) of blastocyst-stage mouse embryos form the 
epiblast that will give rise to the embryo proper. These cells are undifferentiated and 
pluripotent, which means that they can differentiate towards all embryonic (but not 
extraembryonic) cell lineages and contribute to the formation of the presumptive tissues 
and organs. This population of undifferentiated, pluripotent ES cells can be isolated and 
grown in culture. They preserve their undifferentiated state and their pluripotency when 
grown under appropriate conditions in vitro and they can be induced to differentiate 
towards a multitude of cell lineages, recapitulating (to some extent) their in vivo 
differentiation potential, which would result in the formation of a whole embryo.    
 
1.6.1.1. Mouse ES cell maintenance 
 
The culture of mouse ES cells is demanding and requires supplementation of factors, 
normally provided by their in vivo environment in order to keep them undifferentiated 
and pluripotent. Leukemia inhibitory factor (LIF, also known as differentiation 
inhibitory activity, Dia) is one such supplement. LIF is a glycoprotein cytokine (Smith 
et al., 1988), expressed in the trophoectoderm surrounding the ICM, while its receptor 
(LIF-R) is expressed in the ICM. ES cells reside in the ICM, so removing them from 
that area also removes their source of LIF. Absence of LIF facilitates differentiation, so 
during mouse ES cell culture, when pluripotency and stemness need to be maintained, 
LIF needs to be added to the medium or supplied (secreted) by an underlying layer of 
feeder cells (mitotically inactivated fibroblasts, discussed in Section 5.1.2, page 173). 
Briefly, LIF exerts its effect by binding to a receptor (LIF-R) on the cell 
membrane and activating downstream kinases, such as Janus tyrosine kinase (JAK) and 
antiphosphotyrosine immunoreactive kinase (TIK). These, in turn, activate downstream 
components, such as the signal transducer and activator of transcription-3 (STAT3), 
which then translocates to the nucleus. After transduction of the signal to the nucleus, 
transcription factors, such as Oct4 and Nanog, cause changes in gene expression 
associated with phenotypic traits of ES cells (Boeuf et al., 1997, Matsuda et al., 1999, 
Niwa et al., 1998). Oct4, Nanog and Sox2 are commonly used as pluripotency markers 
for ES cells in vitro and are further discussed in Section 6.1.1 (page 223).  
Serum (usually foetal calf serum, FCS) is also commonly used as a supplement in 
cell culture media. It provides a variety of molecules, nutrients and other proteins 
(hormones, growth factors), necessary for in vitro growth of cells, but it also adds 
buffering capacity to the media and neutralizes toxic compounds (Gissel et al., 2006, 
 Goldman and Wurzel, 1992, Sachinidis et al., 2003)
proper growth and different
important role during stem cell differentiation, likely providing a BMP 
turn, is essential for Wnt signalling 
mixtures of growth factors and inhibitors that serum contains are mostly undefined. It 
is, therefore, preferable to omit serum during ES cell culture in order to avoid unknown 
confounding effects and to supplement, if necessary, with artificial,
combinations of growth factors, available commercially (serum replacement factors) 
(Sachinidis et al., 2003)
 
 
Figure 1. 10: The origin and differentiation potential of mouse embryonic stem (ES) cells. 
ES cells are derived from the inner cell mass 
blastocysts and can be maintained 
stimulation, they can start differentiating and give rise to cells of all embryonic germ 
layers, ectoderm, endoderm and mesoderm. Cardiac progenitors are mesodermal 
derivatives and can be easily visualized because of their spontaneous contraction.
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 47 
1.6.1.2. ES cell differentiation recapitulates aspects of early embryonic development 
 
Differentiation of ES cells can be achieved by removal of LIF and of any other factors 
(such as the feeder cells) that keep cells in an undifferentiated state. Differentiation of 
ES cells in culture is commonly, but not uniquely, mediated by the formation of 
embryoid bodies (EB). These are three-dimensional, spherical cell aggregates 
resembling early peri-implantation embryos, hence the name. EB can form 
spontaneously and irreversibly from differentiating ES cells in the appropriate 
environment (Keller et al., 1993). They can form either by spontaneous aggregation of 
ES cells in suspension (in low attachment dishes or in the presence of methylcellulose) 
or by culture of ES cells in hanging drops. The latter culture method gives rise to 
uniform sized EB but it is not applicable for high throughput studies and is technically 
more challenging (Dang et al., 2002, Kurosawa et al., 2003). It is the preferred method 
in the current study.  
Evidently, EB cannot develop into a real embryo as they lack the node (and 
primitive streak), extraembryonic structures and many other environmental factors that 
are essential for embryo patterning, but they can recapitulate, to some extent, early 
events of embryogenesis. For example, differentiation of the initially naïve cells into 
cells of the three germ layers (endoderm, mesoderm and ectoderm) and derivation of 
descendants of these layers can be recapitulated in vitro (Liersch et al., 2006, Risau et 
al., 1988, Smith, 2001). Although the spatial complexity of in vivo embryogenesis and 
organogenesis is not achieved during EB maturation, the dynamics of gene expression 
in vitro mimics the early stages of embryonic development (Bruce et al., 2007, Keller, 
2005, Keller et al., 1993) Comparative studies of murine in vivo embryonic and in vitro 
EB development have shown that prior to day 3 EB are equivalent to pregastrulation-
stage embryos (E4.5-E6.5), between days 3 and 5 EB correspond to gastrulating 
embryos (E6.5-E7.5) and after day 6 EB are comparable to early organogenesis-stage 
embryos (E7.5) (Leahy et al., 1999, Vallier et al., 2001, Xiong et al., 1998) (Figure 1.3). 
Since EB give rise to almost all cell lineages and recapitulate the early events of 
embryogenesis, their use in studying embryonic development and the signalling events 
that orchestrate it has been of great importance.  
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1.6.1.3. Differentiation of ES cells can recapitulate early stages of cardiogenesis 
 
The development of ES cells in culture recapitulates to a large extent the temporal 
molecular interactions and cellular transitions during specification of naïve cells to 
progenitors of defined lineages, as discussed above. This system has been particularly 
useful for studying normal development of cardiac progenitors, for understanding the 
underlying signalling networks that govern the whole process and for identifying the 
hierarchy of precursor relationships.   
Many studies have shown that the contractile ability and the morphological 
characteristics of ES cell-derived cardiomyocytes are similar to that of primary 
cardiomyocytes (Xi et al., 2010). ES cell-derived EB, at any given point during 
differentiation, contain cardiomyocytes (approximately 30% of the volume of the 
culture) in different developmental stages with different chamber specificities, 
electrophysiological properties and myofibrillar organization; ventricular, atrial, His-
purkinje and pacemaker (node-like) cells can be found among an ES cell-derived 
cardiac cell population (Boheler et al., 2002, Fijnvandraat et al., 2003, Hescheler et al., 
1997, Hidaka et al., 2003, Sachinidis et al., 2003). Cardiac genes, general or chamber-
specific, seem to be expressed in equivalent levels in ES-derived cardiac cells as during 
early heart development in vivo; Nkx2.5, Gata-4, Mef2c, Irx4, Anf and Connexin40 are 
only a few of the genes that have been examined (Fijnvandraat et al., 2003). 
Also, cardiogenesis in vitro can be enhanced or accelerated by a variety of 
different factors as it happens in vivo. Inductive signals, such as BMP2 and TGFβ, have 
been shown to promote cardiogenic differentiation of ES cells (Menard et al., 2004). In 
line with these findings, endodermal factors have also been reported to direct 
differentiation of mouse and human ES cells to the cardiac lineage (Mummery et al., 
2003, Rudy-Reil and Lough, 2004). Notch and FGF signalling are implicated in 
affecting cardiomyocyte fate as well (reviewed by Evans, 2009).  
 
1.6.1.4. Other stem cell categories 
 
Embryonic stem cells have been isolated from other organisms as well, including 
zebrafish (Collodi et al., 1992) and human (Thomson and Marshall, 1998). Zebrafish ES 
cells are isolated from blastula-stage embryos and can be maintained in culture in an 
undifferentiated state on feeder layer cells (Collodi et al., 1992, Fan et al., 2004, Ma et 
al., 2001, Sun et al., 1995). Despite their isolation almost 20 years ago, a detailed 
 49 
transcriptome and proteome analysis of different zebrafish ES cell lines remains to be 
completed (reviewed by Hong et al., 2011). Human ES cells are isolated from 
blastocyst-stage in vitro fertilised embryos or from termination material. They differ 
substantially in their growth requirements from mouse ES cells, they are more 
demanding, they do not respond to LIF and they grow poorly on feeder cells when 
dissociated to single cells (Pera et al., 2000, Thomson and Marshall, 1998). However, 
their potential for direct therapeutic application and for advancing our understanding of 
human embryonic development and disease, has made them an attractive tool since their 
isolation.  
Stem cells can be also isolated from adult tissues, including bone marrow, 
mesenchymal and haematopoietic stem cells (reviewed respectively by Augello et al., 
2010, Medvinsky et al., 2011, Walkley, 2011) and from cord blood (reviewed by 
McKenna and Brunstein, 2011). These cells have the potential to differentiate to a more 
limited number of cell lineages and will not be examined further here.         
 
1.6.2. Zebrafish  
 
Zebrafish (Danio rerio or Brachydanio rerio) is a tropical fresh water fish, of Indian 
origin, that belongs to the Cyprinidae family. Adults are typically 4 centimeters (cm) in 
length, although they can grow up to 6.4 cm. They usually live for approximately 2-3 
years but depending on the conditions, their life span can extent to up to 5 years. Mating 
zebrafish in an aquarium is easy and relatively cheap and can be performed throughout 
the year. Each female can lay hundreds of eggs in each clutch. These eggs will only 
grow and develop after external fertilization by the male (spawning). Upon fertilization 
embryonic development begins. Early cleavage and gastrula stages have been described 
before and resemble the corresponding stages of other vertebrates. During segmentation 
(10-24 hpf) somites develop, organ rudiments appear (including the heart, brain, eyes, 
ears), the embryo elongates, tail morphogenesis is prominent, morphological 
differentiation of cells takes place and the first bodily movements are observed. The 
pharyngula period that follows (24-48 hpf) is characterized by the appearance of 
pectoral fins, pigmentation, blood circulation, pharyngeal arch development and 
behavioural traits. Development progresses rapidly so that precursors and rudiments of 
all major organs appear within the first days (up to 48hpf) (Westerfield, 1993). A 
representative image of a 48 hpf zebrafish embryo is shown in Figure 1.11.  
 
  
Figure 1. 11: Representative image of a 48 hpf zebrafish 
interest, like the heart, otic ve
are shown.  
 
1.6.2.1. Zebrafish as a model for vertebrate embryogenesis and cardiogenesis
 
Zebrafish is being used extensively 
the embryos are transparent and develop 
followed in real time throughout development, a characteristic that has increased its 
popularity as a developmental 
Grossniklaus, 2010). As 
with mammalian species and it shares with them fundamental developmental pathways 
(Ackermann and Paw, 2003, Ingham, 1997
exposure to pharmacological agents, by injection with knockdown systems (for example 
antisense morpholino oligonucleotides) and by generation of transgenic lines, such as 
GFP and dsRed. Danio rerio
behind the early steps of heart formation. Although its heart consists of a single atrium 
and a single ventricle and there is no pulmonary circulation, it is believed that the 
early stages of heart cell specification, commitment and differentiation are common in 
all vertebrate species 
of the zebrafish to survive without a fully functional and normal cardiovascular system 
for up to five days of development
This allows investigation of mutations or drug treatments that cause early leth
other species. 
 
1.7. Summary 
 
In this thesis, the canonical Wnt and the JNK signalling pathways are investigated in the 
context of in vitro and 
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embryo in a lateral view. Areas of 
sicle (or capsule), eye, brain, muscle (somites) and others, 
as an animal model in developmental biology. As 
ex utero they can be directly observed and 
research model (Grunwald and Eisen, 2002, Muller and 
a vertebrate, it has a high degree of evolutionary conservation 
). Also, it is amenable to manipulation by 
 is particularly well suited for the study of the genetics 
(Grimes and Kirby, 2009). An additional advantage is the ability 
 (Ackermann and Paw, 2003, Rocke et al., 2009)
 
in vivo cardiac differentiation. In the preceding sections, all areas 
 
very 
. 
ality in 
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of interest were presented in brief. First, an overview of embryonic development 
introduced the basic concepts and terms of embryonic development. Second, one of the 
germ layers, mesoderm, and its main derivative, the heart, were thoroughly analysed, 
focusing on induction, specification, determination and differentiation of cardiac cells, 
as well as formation and morphogenetic patterning of the heart. Next, the signalling 
networks of interest were presented, with emphasis on the canonical Wnt, non-canonical 
Wnt/PCP and JNK. Last, the two experimental models (mouse ES cells and zebrafish 
embryos) that were selected for the present study were introduced. The hypotheses on 
which this thesis was based, along with the aims that were set in order for these 
hypotheses to be tested, are introduced in the next section.   
 
1.8. Aims of the thesis 
 
The regulation of cardiac differentiation is complex and multifactorial and diverse 
signalling networks and transcriptional cascades have been shown to influence it. In this 
thesis, two signalling pathways, tightly interconnected between them, were investigated 
in the context of cardiogenesis; the JNK and the canonical Wnt pathway.   
 
1.8.1. JNK signalling 
 
JNK signalling is the main focus of the current thesis. JNK is a kinase, member of the 
MAPK family and also, a downstream effector of the non-canonical Wnt/Planar cell 
polarity (PCP) pathway. The differentiation of the heart and the progression of cardiac 
disease are two fields in which MAPK members have proven to be very important. 
Similarly, the Wnt/PCP pathway has been shown to play a defining role in cardiac 
induction, specification and morphogenesis.  
This work was, therefore, based on the hypothesis that JNK, as a mediator of two 
essential signalling cascades during embryonic development, could represent a central 
regulator in processes associated with early stages of cardiac induction and 
specification, with previously unrecognized roles. I, therefore, set out to investigate the 
involvement of JNK signalling during in vitro (mouse ES cell) and in vivo (zebrafish 
embryonic) cardiogenesis. The following aims were set: 
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1. Characterize all zebrafish jnk orthologues that have not been thoroughly 
investigated previously, with the specific aim of identifying putative new jnk 
genes that arose after the fish genome duplication  
2. Elucidate the phylogenetic relations of zebrafish jnk genes with their orthologs 
in other species, including the mouse 
3. Establish the expression profiles of jnk genes in developing zebrafish embryos 
and define the role of jnk proteins during zebrafish embryogenesis with a 
specific focus on cardiogenesis  
4. Determine the involvement of Jnk signalling during mouse ES cell 
differentiation, looking more closely at the generation of ES-derived 
cardiomyocytes and at the transcriptional networks that govern this process  
 
1.8.2. Canonical Wnt/β-catenin pathway 
 
In addition to JNK, the canonical Wnt pathway is examined in this thesis, in the context 
of ES cell-derived cardiogenesis, as it has been shown to cross talk extensively with Jnk 
(Esufali and Bapat, 2004, Liao et al., 2006, Wu et al., 2008). This pathway has long 
been thought as inhibitory for cardiac induction but recent data suggest that its 
contribution may be much more complex than initially thought. The intricate 
relationship and multifaceted cross talk between the canonical and non-canonical Wnt 
pathways could be one of the factors that add to the suggested complexity of the system. 
Therefore, the complex and bi-phasic response of cardiogenesis to the canonical Wnt 
pathway was investigated further with emphasis on the putative cross talk between the 
canonical and non-canonical branches of the Wnt cascade. It was hypothesized that, as 
shown before, early activation of the canonical Wnt pathway will have beneficial effects 
in promoting cardiogenesis, while its late activation will inhibit further cardiac 
progression. In order to explore this hypothesis the following aims were set: 
 
1. Elucidate the temporally complex role of the canonical Wnt pathway in 
cardiogenesis in vitro 
2. Establish potential alterations in the cardiac transcriptional regulatory network 
after canonical Wnt manipulation 
3. Unravel the relationship between canonical and non-canonical Wnt pathway and 
elucidate how their interaction could affect the process of cardiogenesis 
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Chapter 2: Materials and methods 
 
All measurements presented in this thesis are shown in SI units and chemicals were 
obtained from Sigma-Aldrich unless otherwise stated. Some general buffers, reagents 
and solutions are shown in Table 2.1, while buffers specific for each technique are 
shown in individual tables.   
General buffers, reagents and solutions  
E3 LB 3% methyl-
cellulose PBS DEPC H2O 
5mM NaCl 0.17M NaCl 0.08% Tricaine 
10 PBS 
tablets 
(Oxoid 
BR14) 
500µl DEPC 
(Sigma 
D5758) 
0.17mM 
KCl 
1% 
tryptone 
3% 
methylcellulose H2O to 1L H2O to 1L 
0.33mM 
CaCl2 
0.5% yeast 
extract E3 to 1L autoclaved autoclaved 
0.33mM 
MgSO4 
autoclaved    
0.1% 
methylene 
blue 
    
H2O to 1L     
 
Table 2. 1: Table with general buffers, reagents and solutions. The recipes for E3 water, 
used for zebrafish embryo maintenance, LB (Luria Broth), used for bacteria growth, 3% 
methylcellulose, used for orientation of zebrafish embryos during microscopic imaging, 
PBS (phosphate buffered saline), used extensively in many techniques and DEPC 
(diethylpyrocarbonate) water, free of RNases and used for RNA work, are included in this 
table.   
 
2.1. Zebrafish techniques 
 
2.1.1. Zebrafish lines 
 
Two transgenic zebrafish lines were used in this study: Tg(cardiac myosin light chain 2 
(cmlc2):GFP) (Huang et al., 2003) and Tg(cmlc2:Discosoma (Ds)Red2- nuc) (Mably et 
al., 2003). In both lines the cmlc2 promoter drives the expression of marker proteins. 
Cardiac-specific GFP expression is observed soon after the onset of cmlc2 expression 
(approximately 18 hpf) in cardiomyocytes of Tg(cmlc2:GFP) embryos. Cardiac-specific 
nuclear production of DsRed fluorescent protein in Tg(cmlc2:DsRed2-nuc) embryos is 
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firstly observed after 30 hpf (at least 12 hours after its initial activation by cmlc2 onset, 
but usually quite later).  
A wild type zebrafish line, Golden (Zebrafish International Resource Centre, 
ZIRC), was also used. These embryos have reduced levels of pigment on their skin, 
which allows for easier visualisation of organ formation and of the signal from 
wholemount staining. This zebrafish line was used for whole mount in situ 
hybridization and for RT-PCR analysis.   
 
2.1.2. Zebrafish breeding and mating 
 
Adult Tg(cmlc2:gfp), Tg(cmlc2:dsNucRed) or Golden fish were put together in special 
mating tanks that keep them separated overnight and the next morning they were 
transferred into a single tank to lay eggs. Eggs were collected in 100 mm petri dishes as 
soon as they were layed. Fertilized eggs (transparent) were separated from unfertilized 
ones (white) and incubated at 28.5oC at all times, for optimal growth and development. 
Fish embryos were then used at the appropriate time point depending on the demands of 
each experiment. If younger than 48 hpf they had to be manually dechorionated before 
use.  
 
2.1.3. Drug treatment 
 
Fish embryos were incubated in 24-well plates in E3 water (Table 2.1) alone (E3 
control) or in E3 water containing the SP600125 drug or dimethylsulfoxide (DMSO) 
alone (DMSO control), at the appropriate concentration for the required amount of time 
(5.25-72, 5.25-10, 10-22 and 22-30 hpf). The embryos were then transferred into new 
wells and washed thoroughly in fresh E3 water until further analysis.  
 
2.1.4. Phenotype scoring, body measurements and embryo collection 
 
Untreated, DMSO-treated and drug-treated fish embryos were phenotypically scored at 
24, 48 and 72 hpf under a fluorescence stereoscope (Leica MZ16F stereomicroscope 
with a Leica DFC 420C digital camera). When necessary, embryos were transferred in 
3% methylcellulose (Table 2.1) for better orientation and imaging. Images of the dorsal 
view of the embryos were taken in order to perform various body measurements (body 
length, head width, ocular distance, body width). These measurements were done in the 
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AxioVision image analysis software (AxioVision Rel. 4.8) by drawing lines over the 
areas of interest and converting pixel differences to metric differences in microns 
(Figure 2.1).  
When necessary, measurements were normalised against values that account for 
size and length differences for an easier and more accurate comparison of different 
groups. The ocular distance was normalised against the width of the head so that smaller 
heads with eyes positioned normally and not further apart or closer together would show 
the same values as normal sized heads with normally positioned eyes. Under these 
settings, low values signify eyes located closer together and higher values mark 
increased eye distances, irrespective of the size of the embryos. Similarly, the width of 
the body was normalised against the length of the body, as short but normally 
proportioned fish embryos would be expected to have narrower bodies; so, again in this 
case high ratios will signify broader bodies, similar to the convergence-extension 
phenotype, and low ratios will mark narrower bodies. 
 
 
Figure 2. 1: Body measurements on 72 hpf zebrafish embryos. Head measurement, such as 
width of the head and ocular distance (panel A), and general body measurements, such as 
body length and body width (panel B) were taken by drawing lines over the areas of 
interest in the AxioVision (Rel 4.8) software and then converting pixels to microns using a 
micrometer.  
 
2.1.5. Heart cell counting 
 
Intact immuno-stained (as described in the next section) Tg(cmlc2:DsRed2-nuc) 
embryos were firstly imaged under a fluorescence microscope (Zeiss Axioplan2) and 
pictures were taken if necessary. For subsequent counting of the cells within their 
hearts, embryos were placed on a slide (commonly 2-3 embryos at a time) with their 
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hearts facing upwards. The embryos were then carefully covered with a coverslip and 
by applying continuous pressure with the thumb on it, squashing of the embryos and 
their hearts was achieved. The samples were then imaged under the microscope using 
the appropriate filters. All heart cells in Tg(cmlc2:DsRed2-nuc) embryos had red 
fluorescent nuclei after 48 hpf. The cytoplasm of atrial cells was also counterstained 
with the S46 antibody; therefore, ventricular cells had red nuclei, while atrial cells had 
red nuclei and green cytoplasms and could be easily distinguished and counted 
separately (Figure 2.2). After imaging under the microscope, all pictures were then 
transferred in an image analysis software (AxioVision Rel 4.8), where nuclei were 
counted.    
 
Figure 2. 2: Image of the heart of a Tg(cmlc2:DsRed2- 
nuc) zebrafish embryo after counterstaining with anti-
DsRed, shown in red, and S46, shown in green, antibodies. 
The nuclei of all cardiomyocytes are stained red but only 
the cytosplasms of atrial cells are stained green.  
 
 
 
 
2.1.6. Wholemount fluorescence immunohistochemistry  
 
Tg(cmlc2:DsRed2-nuc) zebrafish embryos were fixed in 4% parafolmadehyde (PFA) 
(Sigma P6148) at 4oC overnight. The next day embryos were washed twice in PBS, for 
5 min each time, at RT and were then transferred into blocking solution consisting of 
10% FCS, 2 mg/ml bovine seurm albumin (BSA) (Sigma A2153) and 0.2% saponin 
(Sigma 84510). Blocking lasted for 1 hour at RT and embryos were then washed 3 
times in PBS with 0.2% saponin. Incubation in primary antibody solution followed: 
anti-dsRed polyclonal antibody was diluted (1:400) in neat mouse monoclonal atrial 
myosin heavy chain SV46 antibody solution containing 0.2% saponin (Table 2.2). 
Incubation was performed overnight at 4oC in a humidified chamber in the dark. The 
following day the primary antibody solution was washed off with two consecutive 
washes in PBS with 0.2% saponin, at RT, 10 min each. A 2 hours incubation in 
secondary antibody solution at RT in a dark humidified chamber followed: swine anti-
rabbit, TRITC-conjugated and goat anti-mouse IGg1 488 antibodies were used in the 
appropriate dilutions (1:50 and 1:100, respectively) in PBS (Table 2.2). After two brief 
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washes in PBS containing 0.2% saponin, samples were stored in the dark at 4oC until 
further use for fluorescence imaging and heart cell counting (Section 2.1.5, page 55).  
 
Primary antibody Secondary antibody 
Target  Species Dilution Provider Details Dilution Provider 
dsRed Rabbit 1:400 Glontech Swine anti-
rabbit, 
TRITC 
1:50 DAKO 
R0156 
S46 Mouse  Neat Developmental 
Studies 
Hybridoma 
Bank 
Goat anti-
mouse, 
IGg1, 488 
1:100 Invitrogen, 
Alexa 
Fluor, 
A21121 
Table 2. 2: Antibodies used for immunostaining on zebrafish embryos.  
 
2.1.7. Wholemount in situ hybridization  
 
All solutions during the first day were made up with DEPC water (Table 2.1) to prevent 
the activity of RNases. After day 2 there was no need for DEPC-treated water. After 
fixation in 4% PFA in DEPC-PBS, embryos were transferred in 100% methanol and 
stored at -20ºC for at least 2 hours in order to prevent the formation of gas bubbles, until 
further use. Solutions and buffers used during in situ hybridisation are listed in Table 
2.4.  
The first day embryos were rehydrated passing through a series of methanol / PBT 
(PBS with 0.1% Tween20) gradient of 75%, 50% and 25% for 5 minutes each, and four 
washes in 100% PBT, 5 minutes each. Embryos older than 36 hpf were then bleached 
for 2-3 minutes in a 10% solution of H202 in 0.5xSSC and 5% formamide. After a brief 
wash in PBT they were subjected to treatment with proteinase K (10 µg/ml) in PBT 
(Table 2.3 for incubation times). Embryos were then refixed in 4% PFA (in PBS) for 20 
minutes and washed in PBT 5 times for 5 minutes each time. After being moved into 
flat-bottom eppendoft tubes they were incubated in 800µl of pre-heated pre-
hybridisation mix for 2-5 hours (typically 3 hours) at 65ºC. After removal of the pre-
hybridisation solution, 200 µl of hybridisation mix containing 100-200 ng of 
digoxygenin (DIG)-labelled antisense RNA probe was added to each tube. Embryos 
were incubated overnight in a waterbath at 65ºC. 
After removal of the hybridisation mix, embryos were briefly washed in 
hybridisation solution not containing probe at 65ºC. Further washes were carried out in 
a series of hybridisation mix / 2xSSC gradient of 75%, 50% and 25% for 15 minutes 
each at 65ºC, followed by a final wash in 2xSSC at 65ºC for another 15 minutes. 
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Embryos were then further washed in 0.2xSSC at 65ºC twice for 30 minutes and then 
were passed through a series of 0.2xSSC / PBT gradient of 75%, 50% and 25% for 10 
minutes each. After a 10 minute wash in PBT embryos were incubated in 1% blocking 
solution (Roche, Sigma) in maleic acid buffer (MAB) with 0.1% Tween20 (MABT) for 
2 hours to cover non-specific binding sites. Anti-DIG antibody (Roche 11093274910) 
was added to 1% blocking solution / MABT at a 1:5000 dilution and left to pre-absorb 
at 4ºC for 1hour, before being added to each tube for an overnight incubation under 
gentle shake at 4ºC.  
 
Developmental stage Proteinase K treatment 
blastula / gastrula 30 seconds 
late somitogenesis (14 to 22 somites) 5 minutes 
24hpf 15 minutes 
36 / 48hpf 30 minutes 
72 / 96hpf 40 minutes 
Table 2. 3: Incubation times of proteinase K treatment for different zebrafish embryo 
ages. The older the embryo the longer the treatment has to be.   
 
The third day embryos were subjected to a brief PBT wash, which was followed 
by seven 15 minute PBT washes. Washes were usually carried out for 2-4 days at RT in 
24-well plates before the staining reaction would be initiated. The staining proocedure 
started with three 5 minute incubations in NTMT staining buffer. The increased pH of 
the NTMT buffer is optimal for the reaction of the NBT/BCIP (1,4-nitro-blue-
tetrazolium-chloride / 5-bromo-4-chloro-3-indoyl-phosphate, Roche 11681451001) 
developing solution. 50 mg/ml of NBT/BCIP mix were added to the NTMT buffer and 
1 ml of this staining solution was added to each well. The plates were left at 4ºC in the 
dark until staining was detectable. When the desired level of development was reached, 
the reaction was stopped with extensive PBT washes. Embryos were re-fixed in 4% 
PFA for 20 minutes and then washed in an increasing gradient of PBT / Methanol (25%, 
50%, 75% methanol) finishing in 100% methanol. Embryos were left in 100% methanol 
at least for 1 hour before being washed  down to PBS through a series of decreasing 
gradient of PBS / Methanol (25%, 50%, 75% PBS) finishing in 100% PBS. Observation 
of stained embryos was achieved under a dissecting microscope (Leica MZ16F 
stereomicroscope with a Leica DFC 420C digital camera) with embryos being mounted 
in 3% methylcellulose for easier orientation.  
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Negative and positive controls were used for this assay. Tbx5 (tbx5a) was used as 
a positive control. This provided an excellent comparison measure as it is expressed in 
most of the areas of interest: the heart, the pectoral fins (or fin buds) and the eyes (or 
optic primordia) (Begemann and Ingham, 2000, Garrity et al., 2002). In all experiments 
sense probes were, also, used; these are usually expected to give negative results, as 
they bind to antisense endogenous mRNA, which is uncommon. However, it has been 
shown that antisense mRNA is occasionally produced as a control mechanism for gene 
regulation. It is also known that probes can bind to non-specific targets, due solely to 
their chemical properties. The sense probe, therefore, gives a measure of non-specific 
binding, which will be similar to the antisense probe, and accounts for specificity of the 
signal. In all cases, the sense probe is a valuable internal control; it will either give a 
negative result or it will show the same or an overlapping expression pattern as the 
antisense probe, confirming in both cases the specificity of the staining. Sense probe 
staining patterns are included in the images along with the antisense probe staining for 
easier comparison. Negative controls, without addition of any probe, were also 
included.  
 
  Solutions and buffers for in situ hybridization 
20xSSC NTMT MAB 
Pre-
hybridization 
buffer 
Hybridization 
buffer 
1.2M NaCl 100 mM NaCl 
0.1M 
maleic acid 
50% 
formamide 
Pre-
hybridization 
buffer 
0.3M tri-
sodium 
citrate 
100 mM 
TrisHCl pH 
9.5 
0.15M 
NaCl 5xSSC 
Probe of 
interest at 
1µg/ml 
 
50 mM 
MgCl2 
Ph7.5 50 mg/ml yeast tRNA  
 
0.1% 
Tween20  
0.1% 
Tween20  
   
50 µg/ml 
heparin  
   
9.2 mM citric 
acid pH 6.0  
Table 2. 4: Solutions and buffers for in situ hybridization. The ingredients of 20xSSC, 
NTMT, MAB (maleic acid buffer), pre-hybridization and hybridization buffers are shown.   
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2.1.8. RNA extraction  
 
Total RNA was extracted from zebrafish embryos using the Trizol Reagent RNA 
extraction protocol (Invitrogen 15596-026) as described in the manufacturer’s 
instructions. Briefly, 1 ml of Trizol was added to each tube containing approximately 
20-30 embryos, depending on the age. Trizol maintains RNA integrity during tissue 
homogenization, while breaking cells and cell components. After thorough mixing for 
adequate homogenization, tubes were either stored at -80oC until further use or were 
immediately processed. Tissues were then further homogenized by multiple passing 
through 21G and 25G syringes, sequentially. After a short incubation at room 
temperature to ensure complete dissociation of nucleoprotein complexes, 0.2 ml of 
chloroform were added (per 1ml of Trizol). Rigorous shaking for 15 seconds allowed 
for proper mixing of the ingredients. Subsequent centrifugation at 12000xg at 4oC for 
15 minutes enabled phase separation: the low, organic phase containing mainly 
chloroform and protein, the intermediate phase (interphase) containing DNA and the 
upper aqueous phase, containing nearly all of the RNA. The upper phase 
(approximately 60% of the initial Trizol volume) was then transferred into a new tube 
and RNA was precipitated from it by adding 0.5 ml of isopropyl alcohol (per 1 ml of 
Trizol). Precipitation was enhanced by incubation at RT for 10 minutes and subsequent 
centrifugation at 12000xg at 4oC for another 10 minutes. Removal of the supernatant 
was followed by ethanol washing of the pellet (1 ml of ethanol for 1 ml of Trizol). Short 
vortexing that ensures complete ethanol penetration and centrifugation at 7400xg at 4oC 
for 5 minutes, resulted in a clean RNA product in the pellet that could then be diluted in 
the appropriate volume of DEPC-treated H2O (commonly 11 µl). RNA products were 
then quantified using the NanoDrop ND-1000 Spectrophotometer and by gel 
electrophoresis in 1% agarose gels, as described in Section 2.1.11 (page 61). Extracted 
RNA was stored at -80oC until further use.    
 
2.1.9. cDNA synthesis  
 
1 µg of RNA (extracted and quantified as explained in the previous section) was treated 
with 1 µl DNase I (Invitrogen 18068-015) in a 9 µl solution containing DEPC-treated 
H2O and DNase buffer, at RT for 15 minutes, in order to eliminate any DNA 
contamination. 1 µl of 25 mM EDTA was then added to the mix for the inactivation of 
the enzyme at 65°C for 10 minutes. The SuperScript II RTase kit (Invitrogen 18080-
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044) was used for the reverse transcription of the DNased RNA. 10µl of the DNased 
mixture were transferred into a tube containing 2µl random primers (200ng) (15-mers, 
Sigma A1312-002), 10µl  dNTPs 10mM, 2µl  DEPC-H2O, 8µl 5x1st strand buffer, 4µl  
0.1M DTT, 2µl  RNase inhibitor (Promega N2111) and 2µl Reverse Transcriptase. The 
mix was incubated for at least 1½ hours at 37°C, allowing enough time for reverse 
transcription to take place. At the end of the incubation, 60µl distilled water were added 
to the mix. The synthesized cDNA was stored at -20oC until further use.  
 
2.1.10. Polymerase Chain Reaction (PCR) 
 
All amplifications were performed using the PTC-200 (Peltier Thermal cycler) under 
optimised conditions for each primer set (manually designed and provided by MWG). 
The PROMEGA Go-taq polymerase kit (Promega M3175) was used for all PCR. All 
primers were designed to span exon-exon boundaries, where possible, so that genomic 
DNA contamination is avoided (the sequences and the binding location of jnk primers is 
shown in Chapter 3). The housekeeping gene β-actin was used as an internal reference 
because of its invariable expression during embryonic development and after drug 
treatments, as shown recently (McCurley and Callard 2008). The annealing temperature 
was 58oC and the product sizes along with the primer sequences are shown in Table 3.2 
(page 109). Briefly, a 20µl reaction was prepared, containing 2µl dNTP, 4µl 5x buffer, 
0.2µl taq enzyme, 1µl of each primer (10µM each), the appropriate amount of cDNA 
(according to the β-actin PCR results) and distilled H2O to make up the final volume.  
 
2.1.11. Agarose gel electrophoresis 
 
Fresh 2% and 1% agarose (SeaKem LE agarose) gels in 1x Tris-Acetate-EDTA (TAE) 
were used for electrophoresis of PCR and RNA products, respectively. 100 base pair 
DNA ladder was used as a size marker (Invitrogen 15628-050). Gel images were 
captured under ultraviolet light on a SYNGENE transilluminator using the GeneSnap 
software.  
 
2.1.12. Probe design 
           
All Jnk probes (jnk3.3, pan-jnk3, pan-jnk1a and jnk2) were manually designed against 
the desired gene and isoform (sequences are listed in Table 3.3, page 109). A PCR 
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reaction (see Section 2.1.10) was then performed on a control cDNA (a sample that is 
known to express this gene/isoform) in a large volume reaction (50µl). The PCR 
product was then ran on an agarose gel (see Section 2.1.11), the band was extracted (see 
next section) and ligated with the appropriate vector (see Section 2.1.12.2) and after 
bacterial transformation (see Section 2.1.12.3) and selection of the white colonies, 
plasmid DNA was extracted and linearized (see Section 2.1.12.4). Finally, after 
confirmation of the orientation of insertion (either by restriction enzyme analysis or by 
sequencing, see Section 2.1.12.5), the probes were Dig-labelled (see Section 2.1.12.6) 
and were then ready to use for in situ hybridization.   
 
2.1.12.1. Gel extraction 
 
After gel electrophoresis, DNA bands were extracted using the QIAquick Gel 
Extraction kit (Qiagen), according to the manufacturer’s instructions. Briefly, the band 
was dissected out of the agarose gel using a new, DNA-free scalpel and was incubated 
at 55oC in QG solution, until its complete dissociation. The solution was then moved in 
a column and centrifuges at 13000 rpm at RT for 1 minute. The DNA fragments are 
expected to bind to the column membrane. After two washes in PE buffer and 
subsequent centrifugations, the DNA product was eluted in a fresh tube with ddH2O. 
Extracted products were stored at -20oC until further use.  
 
2.1.12.2. Ligation 
 
The extracted PCR product was flanked on both sides by adenosine (A) and could be 
readily ligated with a pGEM-T-easy vector (Promega) that contained free thymidine (T) 
sites within the multi-cloning site (Figure 2.3). 3 µl PCR product were mixed with 1 µl 
pGEM-T-easy vector, 1 µl T4 DNA ligase and 5 µl ligase buffer (Promega M1801). The 
mixture was left at RT for 1 hour and was then ready for transformation of competent 
cells (see below).  
 
 
 
 
 
 
 63 
 
 
 
Figure 2. 3: pGEM-T easy 
vector map and sequence 
reference points. 
 
 
 
 
 
 
 
 
2.1.12.3. Bacterial transformation 
 
Competent DH5α bacterial cells (Invitrogen 18265-017) were transformed with pGEM-
T-easy plasmids ligated with the gene sequences of interest, as described above. 10-50 
ng of ligated plasmid DNA, was added to 25 µl of competent cells and these were left 
on ice for 30 minutes. The samples were then heat shocked at 37ºC for 90 seconds, then 
chilled on ice for 3 minutes allowing the plasmids to be inserted into the bacterial cells 
more efficiently. 950 µl Luria broth (LB, Table 2.1) were added and the samples 
incubated at 37ºC shaking for 1 hour, allowing for the gene conferring resistance to 
amplicillin to be expressed. 200 µl of the culture were plated onto X-Gal (5-bromo-4-
chloro-3-indolyl-beta-D-galacto-pyranoside, 20mg/ml in 99% dimethylformamide), 
IPTG (isopropyl-beta-D-thiogalactopyranoside) and ampicillin containing LB plates and 
left to incubate overnight at 37ºC. The presence of X-Gal allows cells containing 
plasmids to be identified; they grow white colonies in contrast to the cells not carrying 
the plasmid that form blue colonies. The production of white colonies is due to the 
disruption of the gene that encodes for β-galactosidase, the enzyme that catalyzes the 
reaction that turns the substrate X-Gal into a blue precipitate, caused by the insertion of 
the gene sequence of interest into the multi cloning site. In contrast, when there is no 
insert, β-galactosidase is produced and blue precipitate can be observed. The next day, 
single white colonies were picked from the plates with a P20 tip and grown in 10 ml LB 
supplemented with 10 µl 500 mg/ml ampicillin overnight shaking at 37ºC. 
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2.1.12.4. Extraction of plasmid DNA  
 
Plasmid DNA was extracted from bacterial cultures using a miniprep kit (Qiagen 
27104) according to the manufacturer’s instructions. Briefly, overnight incubation of 
the transformation mix (see previous section) at 37oC in LB containing ampicillin, has 
allowed the growth of the bacterial colonies that contain plasmids (which confer 
ampicillin resistance). Centrifugation of the mixture at 3000 rpm at RT for 5 minutes 
allows the precipitation of the cells. The supernatant was discarded and the pellet was 
then resuspended in P1 solution. Alkaline lysis and neutralization of the cells was 
followed by precipitation of chromosomal DNA and protein debris, while plasmid DNA 
remained in the supernatant and was collected. After purification in a column, plasmid 
DNA was eluted with ddH2O. Tha exracted DNA was stored at -20oC until further use.  
 
 
2.1.12.5. Restriction enzyme digestion for confirmation and orientation of insertion 
 
With EcoRI digestion of the linearized plasmid it was possible to confirm insertion of 
the product, since EcoRI restriction sites flank the multi-cloning region and are absent 
from the rest of the vector. If additional EcoRI sites were located within the insert, more 
that two different sized products were expected to appear. The NEB (New England 
Biolabs) cutter V2.0 server was used to predict additional EcoRI cutting sites within the 
insert. 2-5 µg of circular plasmid were incubated at 37ºC with 2 µl buffer, 2 µl EcoRI 
and up to 20 µl with H2O for 2 hours.  
After confirmation of the successful insertion of the product, the orientation of the 
insertion was pursued. Restriction sites uniquely present on the vector and within the 
insert were chosen, so that after digestion different bands would be generated depending 
on the orientation of insertion. Failure to identify appropriate cutting sites necessitated 
sequencing of the ligation products (MWG sequencing service) in order to get 
information about the orientation of the insert. The NEB (New England Biolabs) cutter 
V2.0 server was used for identification of restriction cutting sites within the insert 
sequence.  
 
 
 
 65 
2.1.12.6. Digoxygenin labelling of RNA probes 
 
After confirmation of the insertion and orientation of the right product into the vector, 
the probes could then be generated. DNA was transcribed into RNA using the 
appropriate polymerase, either T7 or SP6 (Table 2.5), in the presence of DIG-UTP that 
allows for labeling of the riboprobes. Specifically, 1 µg of linearised plasmid DNA was 
mixed with 2 µl 10x transcription buffer and 2 µl DIG-labelling mix from the Dig-RNA 
labeling kit (Roche 11277073910), along with 1µl RNase inhibitor (Promega N2111), 
up to 20 µl DEPC-H20 and 1 µl of the appropriate RNA polymerase (Table 2.5). 
Samples were incubated for 2½ hours at 37ºC to allow the synthesis of riboprobes 
containing Dig-UTP. The RNA probes were precipitated by adding 100 µl DEPC TE, 
12 µl DEPC sodium acetate, 264 µl 100% ethanol and 1 µl tRNA (Baker’s yeast) and 
leaving the reaction at -20ºC overnight or at -80ºC for 2 hours. Then samples were 
centrifuged for 20 minutes at 13000 rpm at 4ºC. The supernatant was removed and the 
RNA pellets washed with 70% DEPC-ethanol. After centrifuging for 5 minutes at 
13000 rpm and 4ºC, the ethanol was removed and the pellets were allowed to air dry. 
Pellets were resuspended in 100 µl DEPC-H20 and stored at -20ºC. The correct 
production of a probe was confirmed by 1% agarose gel electrophoresis. 
 
Probe Orientation of insertion 
confirmed by 
RE and promoter 
for 
sense probe 
RE and promoter 
for 
antisense probe 
Pan-jnk1 Sequencing SalI - T7 ApaI - Sp6 
Jnk2 BstxI restriction site 
cutting SalI - T7 ApaI - Sp6 
Pan jnk3 ApaI restriction site 
cutting SalI - T7 ApaI - Sp6 
Jnk3.3 Sequencing NcoI - Sp6 SalI - T7 
 
Table 2. 5: Details about all jnk probes. All probes were inserted into pGem-T easy 
vectors, which contained an ampicillin-resistance gene. Linearized products were sent for 
sequencing when restriction enzyme digestion could not reveal the orientation of insertion. 
RE: restriction enzyme.  
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2.2. Embryonic stem (ES) cell culture techniques 
 
2.2.1. STO fibroblast culture maintenance 
 
Sim-Thioguanine-Ouabain (STO) fibroblasts, obtained from the American Type Culture 
Collection (ATCC, CRL-1503), were grown in T75 flasks (Iwaki, 3123-075) in 15 ml 
STO media (Table 2.6). When cells reached 70-80% confluency, the media was 
removed and the cells were briefly washed in 10 ml Dublecco’s PBS (Gibco 14190). 3 
ml of 0.05% trypsin (Gibco 25300) were then added in the flask for 5 minutes at 37oC 
or until cells get dettached from the bottom. Trypsin was inactivated by the addition of 
9 ml of STO media and single cell suspension was achieved by continuous pipetting, 
avoiding the formation of bubbles. Flask content was then transferred into 15 ml falcon 
tubes and centrifuged at 1000rpm for 5 minutes at RT. After removal of the supernatant 
the pellet was resuspended in 5-7 ml of STO media (depending on the dilution required, 
typically 1:5 or 1:7). 1 ml of the cell suspension was then plated in a new T75 flask 
containing 14 ml of STO media. Cells were incubated at 37oC under 5% CO2 in a 
Heraeus (HERA cell) incubator.  
E14 ES-D3 STO Differentiation Freezing 
20% FCS 
(Gibco 10439-
024) 
15% FCS 
(ATCC 30-
2020) 
10% FCS 
(ATCC 30-
2020) 
10% FCS (Gibco 
10439-024) 
40% 
FCS  
1% L-Glutamine 
(Gibco 25030-
024) 
0.1mM 2-
mercaptoethanol 
(Gibco 
31350010) 
90% DMEM 
(ATCC 30-
2002) 
1% L-Glutamine 
(Gibco 25030-
024) 
50% 
DMEM 
1% NEAA 
(Gibco 11140-
035) 
85% DMEM 
(ATCC 30-
2002) 
 1% NEAA 
(Gibco 11140-
035) 
10% 
DMSO 
0.1mM 2-
mercaptoethanol 
(Gibco 
31350010) 
  0.1mM 2-
mercaptoethanol 
(Gibco 31350010) 
 
78% DMEM 
(Gibco 21063-
029) 
  88% DMEM 
(Gibco 10439-
024) 
 
LIF (Produced 
in house, 1:500) 
    
Table 2. 6: Stem cell, differentiation and freezing media. Different stem cell media were 
used for the culture of E14 and ES-D3 ES cells but during the differentiation assay the 
same media was employed. Different FCS and DMEM were used for each cell line, 
depending on the cell provider’s instructions for optimal growth and maintenance. In the 
freezing media the appropriate FCS and DMEM for each cell line were used. 
Abbreviations: DMEM: Dulbecco’s modified eagle medium, NEAA: Non-essential amino 
acids, DMSO: Dimethylsulfoxide, LIF: Leukemia inhibitory factor, FCS: fetal calf serum.      
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2.2.2. Preparation of feeder cells by mitotic inactivation of STO fibroblasts 
 
Fibroblast cells (STO) grown as described above, were then used for mitotic 
inactivation and feeder cell preparation. Mitomycin-C is a light-sensitive compound and 
had to be handled under minimum light exposure. 2 ml of STO media (Table 2.6) were 
inserted with a 21G needle (0.45µm) into a fresh mitomycin-C bottle (Sigma M0503). 
Vigorous shaking mixed the contents of the bottle to a 1 mg/ml solution of mitomycin. 
The solution was then filtered through a 0.45 µm filter and transferred into a 15 ml 
falcon tube, covered in foil. 100 µl of the falcon content were added to a T75 flask 
containing confluent (approximately 75% confluent) STO cells in 10 ml of STO media 
(final concentration of mitomycin-C was 0.01 mg/ml). A 2 hour incubation at 37oC 
allowed for mitomycin-C to penetrate the cells and inactivate their mitotic cycle. The 
flask was then washed thoroughly for at least 3 times in 10 ml of DPBS. Traces of 
mitomycin-C can severely affect cell culture in downstream procedures. Inactivated 
STO cells, now called feeder cells, were then counted with a haematocytometer and 
frozen accordingly, as described below. Typically, 6x106 and 2x106 feeder cells were 
aliquoted in each cryovial, which would then be used for feeder and stem cell culture in 
T75 and T25 flasks, respectively. Freezing cells at the correct concentration needed for 
downstream procedures is essential at this step, since feeder cells cannot proliferate and 
full coverage of the flask surface is pivotal for optimal ES-D3 cell culture. One day 
before initiation of ES-D3 cell culture or one day before ES-D3 cell passaging, feeder 
cells were thawed, as described below, and cultured in STO media. Feeder cells can be 
kept in culture, with daily media change, for 7-9 days at 37oC under 5% CO2.  
 
2.2.3. ES-D3 stem cell culture maintenance 
 
ES-D3 cells (ATCC CRL-11632) (Doetschman et al., 1985) require the presence of 
feeder cells, which secrete leukemia-inhibition factor (LIF) and growth factors, for their 
optimal maintenance. Cells were typically cultured in T75 or T25 flasks on a confluent 
layer (approximately 6x106 and 2x106 cells, respectively) of mitotically inactivated STO 
fibroblasts (feeder cells, as described above) in 12 or 4 ml ES-D3 media (Table 2.6), 
respectively. Cell passaging was similar to that described for STO cells (Section 2.2.1, 
page 66) with the following differences: 0.25% trypsin (GIBCO 25200-056) was used 
for cell dettachment and ES-D3 media was used throughout. Achieving single cell 
suspension was crucial for the maintenance of stemness, as cells in clumps have been 
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shown to readily differentiate towards endodermal derivatives (Notarianni and Evans, 
2006). Cells were incubated at 37oC under 5% CO2. 
 
2.2.4. E14 stem cell culture maintenance 
 
Wild type E14Tg2A mouse ES cells, isolated from 129P2/OlaHsd mouse blastocysts 
(Brennan and Skarnes, 1999, Hooper et al., 1987, Magin et al., 1992) were provided by 
Dr. Colin Miles (Newcastle University) and were cultured in E14 media (Table 2.6) 
containing LIF (produced in house, described in section 2.2.11, page 72) on gelatinised 
T25 flasks: 0.1% gelatin (Sigma G9391) in PBS was applied on the flasks for 5 minutes 
at 37oC and then removed. Cells were passaged every 2 days, after trypsinisation with 
0.05% Trypsin and resuspension in fresh media, as described before. The incubation 
conditions were 37°C in the presence of 5% CO2. 
 
2.2.5. Freezing and thawing cells 
 
After trypsinization and centrifugation, as described before, cells were resuspended in 
freezing media (Table 2.6). The amount of media depends on the cell density and the 
required freezing concentration. 1 ml of cells in freezing media was quickly transferred 
in each cryovial. All cryovials were kept in an isopropanol container at -80oC for 24-48 
hours for slow freezing and then were moved in a liquid nitrogen tank for long-term 
storage. DMSO at RT is harmful for the cells so all procedures involving DMSO as a 
cryo-protective agent were performed rapidly.  
Cells were thawed by rapid incubation of the cryovial of interest in a 37oC water 
bath. The cryovial content was then transferred drop by drop, to avoid cell shocking, in 
a 15 ml falcon tube containing 9 ml of the appropriate media (STO, ES-D3 or E14). 
After a 5 minute centrifugation at 1000 rpm at RT and removal of the supernatant, cells 
were resuspended in 1 ml of media and plated in T25 or T75 flasks already containing 3 
or 11 ml of media, respectively. For ES-D3 cells the flask needs to be layered with 
feeder cells and for E14 cells the flask needs to be coated with 0.1% gelatin.  
 
2.2.6. The differentiation assay 
 
The hanging drop method was used for the differentiation of stem cells (E14 and ES-
D3) into embryoid bodies (EB) (Figure 2.3). After trypsinization and centrifugation, as 
 described before, cells were resuspended in 2 ml of 
ES-D3 cells had to be pre
deter differentiation by producing LIF and other factors that keep cells in an 
undifferentiated state. The ES
flask for 40 minutes (experimentally defined); most of the feeder layer c
to be attached to the bottom of the flask by that time, while most of the ES cells were 
still floating. Therefore, the supernatant contained mainly ES cells and was used for 
subsequent experiments. E14 cells that were not grown on a feeder 
this pre-plating step. Cells (ES
trypsinization) were then counted with a haematocytometer. A suspension of 15000 
cells was achieved by appropriate dilution and 30 
hanging drops. Approximately 80
on the lid of each 100 mm dish (Iwaki, 3020
Multipipette Plus). 10 ml of DPBS covered the base of the petri dish in order to
dessication of the hanging drops. This first day of the experiment was designated as day 
0 (d0). After uninterrupted incubation at 37
hanging drops were transferred in suspension in 10 ml differentiation medi
petri dishes and were allowed to grow for another 3 days. At day 5 (d5) EB from ES
and E14 cells were transferred individually in 48 (NELS 3830
Scientific TKT-521-110P) well plates in 500 or 200 
would adhere to the bottom of the wells, spread and gro
days. Plated EB were microscopically observed and imaged daily until day 11 (d11). At 
regular intervals throughout the assay (d0, d5, d11) cells were collected fo
analysis.  
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differentiation media (Table 2.6
-plated in order to get rid of the feeder layer
-D3 and feeder layer mixture was thus plated on a T25 
-D3 cells after pre-plating and E14 cells after 
µl of this suspension was 
-90 hanging drops, containing 450 cells each, were set 
-100) using a multipipette (Eppendorf 
oC, 5% CO2, the EB that formed within the 
-048) or 96 (Fischer 
µl of media, respective
w over the course of the next 6
 
 
 
 
Figure 2. 4: Timeline of the ES cell
assay. ES cells were set into hanging drops at d0 and by 
d2 EB have formed. EB were then transferred into 
suspension between days 2 and 5. At d5, EB were 
plated into the appropriate dishes (for details see text, 
section 2.2.6) and allowed to attach, spread, grow and 
differentiate until d11 (or d15 for some experiments, as 
described in Chapters 5 and 6).  
 
). 
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When cells were needed for future immuno-cytochemical applications, EB were 
plated on round glass coverslips in 24-well plates at d5 and allowed to grow as 
described above until d11. Coverslips were treated with 0.1% gelatin and autoclaved. 
For ES-D3 cell experiments, FCS-containing media was used throughout the 
differentiation assay, while for E14 cell experiments FCS-free media was used after d5.  
 
2.2.7. Use of chemical inhibitors 
 
The appropriate concentration of drug (BIO or SP600125) or DMSO was added at the 
relevant time points in the culturing media. Thorough washes in DPBS followed 
removal of the drug or the DMSO to ensure that no traces remained. Drug dilutions 
were prepared fresh, just before use, from the stocks (Table 2.7).  
 
Compound 
 
 
 
Target 
protein 
Stock 
concentration 
Working 
concentration 
Experimental 
solvent 
Experimental 
control 
BIO  
(Sigma B1686) GSK3 1mM 
0.2µM / 1µM 
on ES-D3 and 
E14 ESC 
99.5% DMSO 0.1% DMSO 
SP600125 
(BioMol EI-305) Jnk 10mM 
3µM on 
zebrafish 
embryos / 
5µM on ES-
D3 and E14 
ESC 
99.5% DMSO 
0.03% DMSO 
 
0.05% DMSO 
 
Table 2. 7: Concentrations and details of the inhibitors used. BIO is an inhibitor of GSK3, 
was kept in a 1 mM stock in DMSO and was used at a concentration of 1 µM on E14 and 
ES-D3 cells. SP600125 is an inhibitor of Jnk, was kept in a 10 mM stock in DMSO and was 
used at a concentration of 3 µM and 5 µM on zebrafish embryos and cells (E14 and ES-
D3), respectively.  
 
 
2.2.8. Beating scoring and cell imaging  
 
Scoring of beating was performed daily under a brightfield microscope (Zeiss AxioVert 
25) and images were taken under a brightfield microscope (Zeiss AxioVert 200M) 
connected to a desktop computer.    
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2.2.9. Cell counting 
 
Counting of cells at days 5, 8 and 11 was performed using the Vi-Cell XR-2.03 Counter 
(Beckman Coulter, Inc., FACS facility, IHG). This is a video imaging system that 
automates the widely used trypan blue dye exclusion protocol, which is based on the 
fact that when cells die their membranes become permeable and allow for the uptake of 
the trypan blue dye. Therefore, dead cells will appear darker than viable cells; viability 
can easily be calculated by measuring this contrast. The system can also measure the 
diameter of the cells (in microns) and their circularity (in units, where 1 represents a 
perfectly circular cell and 0 the least circular cell). Additionally, a de-clustering tool is 
available that increases the ability of the software to detect cells that are clumped 
together and can therefore measure and count them individually. This is of particular 
importance in this assay as cells within the EB are tightly clumped together and 
although trypsinization and manual disaggregation is applied before the measurements, 
this cannot be extended for long as it jeopardizes the quality and integrity of the cells to 
be analyzed. An extra level of control is provided by the fact that all imported images 
can be manually analyzed and corrected.  
Single cell suspension of the samples of interest was prepared after thorough 
trypsinization, centrifugation and resuspension of cells in DPBS. Typically, 8-10 EB 
were used for each sample. Cells were then transferred into special cuvettes, provided at 
the FACS unit, and introduced in the cell counter.  
 
 
2.2.10. Collection of cells for RNA extraction    
 
At days 0, 5 and 11 cells were collected for RNA extraction and qPCR analysis. Day 0 
and day 5 cells were in suspension and were collected in 15 ml falcon tubes. Day 11 
cells were already plated so they had to be trypsinized, centrifuged and then collected in 
falcon tubes. 1 ml of Trizol reagent (Invitrogen 15596-026) was added to each falcon 
tube and after thorough mixing the samples were rapidly frozen at -80oC, until further 
use. The downstream procedures (RNA extraction and cDNA synthesis) are described 
in Sections 2.1.8 and 2.1.9 (page 60).    
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2.2.11. Production of LIF 
 
COS-7 cells were transfected with the LIF-producing plasmid pCAGGS-LIF (provided 
by Dr. Colin Miles, Newcastle University) using the Lipofectamine Transfection 
Reagent (Invitrogen 11668-027) according to the manufacturer’s instructions. In brief, 
24µg of the plasmid DNA were diluted to 50 µl and mixed with 1.5 ml of OptiMEM 
(Invitrogen 51985-026), while 60 µl Lipofectamine Reagent was mixed with 1.5 ml 
OptiMEM. These solutions were mixed together after a short 5 minute incubation at RT 
and then added to COS-7 cells, plated at 90-95% confluency in media lacking 
antibiotics. 6 hours past transfection the transfection mix was removed and replaced 
with 10% FCS-containing media. Transfected cells were cultured at 37°C, 5% CO2 
uninterrupted for 48 hours. Media containing LIF was generated from four 100 mm 
dishes (Iwaki 3020-100) and collected after filtration (0.2 µm filters). Testing was 
carried out for 42 days at various dilutions (1:250, 1:500, 1:1000, 1:2000, 1:4000) on 
wild type E14 ES cells plated on 6-well plates (Iwaki 3810-006), with each 
concentration tested in duplicate, in order to identify the optimal concentration for ES 
cell maintenance. A final concentration of 1:500 was decided as determined by 
comparison with a known LIF batch, produced and provided by Dr. Colin Miles.    
 
2.2.12. Immunocytochemistry on coverslip-grown EB  
 
EB grown on coverslips in 24-well plates were initially washed thoroughly in PBS in 
order to get rid of all remains of cell media. Because of the three dimensional structure 
of the EB prolonged fixation and permeabilization steps were applied and 0.03% 
Tween-20 (Sigma P1379) was included in all of the washes and incubations. EB were 
fixed in 4% PFA for 15 minutes at RT and then washed twice in PBS containing Tween 
for 5 minutes each time. Permeabilization of the cells was achieved by a 15 minute 
incubation in PBS containing 0.5% Triton-X100 (Sigma T8787), followed by two 
washes in PBS with Tween, as before. Incubation of the sections in PBS containing 
10% fetal bovine serum (FBS, Sigma F7524) efficiently blocked non-specific binding 
sites. EB were then incubated in primary antibody solution overnight at 4oC in a 
humidified chamber. The desired dilution of the antibody of interest was performed in 
PBS containing 2% FCS (Table 2.8). The next day sections were washed twice in PBS, 
for 5 minutes each time, before being re-blocked in PBS with 10% FCS for another 10 
minutes. Incubation in secondary antibody solution in PBS with 2% FCS was 
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performed for 1-2 hours at RT in a humidified dark chamber. Alexa Fluor (Invitrogen) 
secondary antibodies were typically used at 1:400 (Table 2.8). Hoerscht solution 
(Invitrogen) was used for staining the nuclei: 1:1000 dilution of the stock in PBS was 
applied for 15 minutes at RT in the dark. Two 5 minute PBS washes followed. The 
round glass coverslips with the EB on them were, then, transferred with forceps on a 
histobond slide and mounted in Vectashield (Vector Laboratories H-1400) with 
25x50mm glass coverslips (VWR 631-0166).   
 
Primary antibody Secondary antibody 
Target  Species Dilution Provider Details Dilution Provider 
Cardiac 
TroponinI 
Rabbit  1:300 AbCam 
58544 
Donkey 
anti-rabbit, 
488 
1:400 Invitrogen, 
Alexa 
Fluor, 
A21206 
Table 2. 8: Details of all antibodies used for immunostaining on EB grown on coverslips 
(cardiac TroponinI staining).  
 
 
 
2.2.13. Quantitative (real-time) PCR 
 
2.2.13.1. An introduction to qPCR 
 
Quantitative PCR (qPCR) is a very useful tool for assessing the levels of expression of 
genes of interest (Nolan et al., 2006). The SYBR-Green fluorescence technology was 
used (Ponchel et al., 2003). We used relative qPCR, whereby the relative levels of gene 
expression of different samples are compared to an internal calibrator. In this case the 
calibrator was the day 0 sample and its value was set by definition to 1; the levels of all 
other groups were expressed as fold changes of that. All samples were normalised 
against two housekeeping genes: β-actin (one of the components of the actin 
cytoskeleton of the cells) and Rps9 (coding for the 40S ribosomal protein S9, a 
component of the small ribosomal subunit). Both were found to be expressed 
constitutively and in fairly stable levels throughout the experimental settings and were 
evaluated as good candidates. On the contrary, Gapdh, which is commonly used as a 
housekeeping gene in qPCR assays, was found to have a variable expression pattern in 
our system and was rejected. Therefore, all qPCR data presented in this study have been 
previously normalized against these two housekeeping genes. A negative control, 
lacking cDNA template, was included in every reaction and was always performed in 
triplicate.  
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2.2.13.2. The reaction 
 
The reactions were prepared to a final volume of 10µl, containing 5µl SYBR Green mix 
(Sigma, S4438), 3µl distilled water, 0.5µl of each primer (10µM each, provided by 
MWG) and 1µl of cDNA (diluted 10 times). The reactions were set in 384-well plates 
(Greiner, 785290) under minimal light exposure. The plates were spun down before the 
run at 4000 rounds per minute for 5 minutes (Sorvall Evolution). For optimized 
conditions for each primer set see Table 2.8. After a 15 minute activation step at 95oC, 
the cDNA template was denatured for 30 seconds at 95oC, followed by primer 
annealing at 60/65oC (experimentally defined) for 30 seconds and extension for 30 
seconds at 72oC. The denaturation-annealing-extension cycle was repeated another 39 
times. Data collection for each cycle was performed at a temperature of choice, 
experimentally defined to match the temperature just before the peak of the melting 
curve. A dissociation curve was ran at the end of the 40 cycles, starting at a temperature 
typically 10 degrees lower than the data collection temperature and reaching a 
maximum of 99oC. This curve was important for assessing the specificity of the 
fluorescence signal against, mainly, primer dimers.     
 
2.2.13.3. qPCR optimisation  
 
The annealing and melting temperatures of all primers were optimised before use in 
order to achieve satisfactory efficiencies and optimal amplification plots. Also, the 
efficiency of all primer sets was evaluated. To achieve this 10 fold dilutions of a control 
cDNA were used as templates for qPCR reactions with all primers. Efficiency slopes 
were then constructed and the efficiency of each primer set evaluated. The efficiency of 
all primer sets was found between 1.75 and 1.95. Specificity of each primer set was 
confirmed by running the qPCR products in a 2% agarose gel.   
 
2.2.13.4. qPCR data analysis: the ∆∆Ct method 
 
qPCR data were analysed by relative quantification. This means that different cDNA 
were compared to each other and to a calibrator (one of the cDNAs examined that is set, 
arbitrarily, as 1) and that absolute values were not provided. The ∆∆Ct method was 
used for calculation of the relative quantities (Pfaffl, 2001). Ct is the threshold cycle 
during a qPCR cycle. It represents the cycle at which the levels of fluorescence for a 
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given sample reach the threshold. The threshold is manually set, has to be the same for 
all runs and represents the time when the amount of fluorescence detected surpasses 
background fluorescence levels.   
 
Gene Ta Tm Melting curve peak 
Rps9 60°C 84°C 87°C 
β-actin 60°C 84/85°C 88-89oC 
Tbx5 60°C 83°C 86°C 
Nkx2.5 65°C 85°C 89oC 
β-catenin 65°C 81°C 85-86°C 
Mlc2v 65°C 81°C 85°C 
Mlc2a 65°C 83°C 86°C 
Gata-4 65°C 85oC 89-90oC 
Brachyury 65°C 85°C 88-89oC 
Goosecoid 60°C 83°C 87-88°C 
Nanog 65°C 83°C 86-87oC 
Oct-04 65°C 83°C 86-87oC 
Sox2 65°C 83°C 88oC 
Lef-1 65°C 78°C 81-82oC 
Cardiac troponinI 60°C 82°C 85-86oC 
Flk1 65°C 82°C 85-86oC 
Tnnt2 60°C 82°C 85-86oC 
Islet1 60°C 81°C 84-85°C 
c-Myc 60°C 81°C 84°C 
Cyclin-D2 60°C 83°C 86-87oC 
Jnk 65°C 78°C 83°C 
Connexin43 65°C 79°C 83-84°C 
CD31 65°C 82°C 86°C 
Hex 65°C 84°C 87-88°C 
Dkk1 60°C 82°C 86°C 
 
Table 2. 9: Optimised conditions for all mouse primers used in qPCR analysis. Ta: 
annealing temperature, Tm: melting temperature. For primer sequences see appendix.  
 
Initially, samples had to be normalized against the housekeeping gene(s). So, the 
Ct value of the housekeeping gene for each sample (cDNA) was substracted from the Ct 
value of the gene of interest for the same sample. This value represents the ∆Ct value. If 
more than one housekeeping gene was used, then the average of the Ct values of the 
housekeeping genes was used for calculation of the ∆Ct values. Then, the Ct difference 
of one sample relative to the calibrator was calculated: the ∆Ct value of the calibrator 
was substracted from the ∆Ct value of the sample of interest. This represents the ∆∆Ct 
value. Finally, the relative fold expression was calculated by the following formula: 2–
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∆∆Ct
. Number 2 represents the amplification efficiency of each gene: this will equal 2 
only if after every PCR cycle each amplicon is duplicated. This is, however, not always 
true and the real primer efficiency of most primer sets is lower than 2. In Section 
2.2.13.3 (page 74), it is explained how the efficiency of each gene can be calculated for 
more accurate results. In fact, in relative quantification the efficiencies of the gene of 
interest and of the housekeeping gene have to be quite similar; if not the results are not 
reliable. Below an example of ∆∆Ct calculations is given: 
 
Let’s hypothesize that we have Tbx5, as the gene of interest, and Rps9, as the 
housekeeping gene, and we want to test the expression levels of Tbx5 in two 
cDNA samples: d0 (cDNA0) and d11 (cDNA11). We arbitrarily set cDNA0 as the 
calibrator. The ∆Ct values will be ∆Ct0=Ct(Tbx5.0)-Ct(Rps9.0) for cDNA0 and 
∆Ct11=Ct(Tbx5.11)-Ct(Rps9.11) for cDNA11. The ∆∆Ct value of Tbx5 will be ∆∆Ctn= 
∆Ctn-∆Ct0, where n is any cDNA. So, the ∆∆Ct of Tbx5 for cDNA0 will be 0 
(∆∆Ct0= ∆Ct0-∆Ct0) and the ∆∆Ct for cDNA11 will be ∆∆Ct11= ∆Ct11-∆Ct0. The 
relative fold change of Tbx5 for cDNA0 will be 1 (20) and for cDNA11 it will be 2–
∆∆Ct
11.  
 
 
2.2.14. Western blotting 
 
Western blotting was performed on ES-D3 cell lysates at d5 for the detection of 
phospho-Jnk levels. The housekeeping β-tubulin protein levels were used as a loading 
control. Antibodies used in western blotting are shown in detail in Table 2.9. All buffers 
used for this technique are described in Table 2.10.  
 
2.2.14.1. Cell lysis 
 
Cells were initially lysed in lysis buffer containing a protease inhibitor cocktail (freshly 
made solution, ThermoScientific 1862209) in order to maintain proteins intact. Pelleted 
cells were re-suspended in lysis buffer and incubated shaking on ice for 20 minutes. 
Any remaining cell clumps were dissociated using a 45µm needle. Samples were then 
centrifuged at 4oC, 12000 rcf for 20 minutes.  
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2.2.14.2. Protein measurement 
 
A small aliquot of each sample was then used for protein measurement in the Nanodrop. 
The BCA assay kit (Thermo Scientific 23225, kindly provided by Dr. Elise Glen, IGM) 
was used for this purpose, as described by the manufacturer. A protein standard curve 
was firstly prepared through serial dilutions of an albumin stock of known concentration 
(2.0 mg/ml, provided with the kit). The albumin concentrations prepared were 0, 5, 25, 
50, 125 and 250 µg/ml. Each albumin sample was mixed in a 1:20 ratio with a mixture 
of A and B reagents (provided with the kit), mixed in a 50:1 ratio. Samples were then 
incubated for 30 minutes at 37oC. By measuring the absorbance of the purple-coloured 
product using the NanoDrop ND-1000 Spectrophotometer at 562 nm, a standard curve 
was prepared. By following the same procedure for the unkown protein samples it was 
possible to measure the amount of protein in the cell lysates.  
 
2.2.14.3. SDS-PAGE gel running 
 
Equal amounts of all protein samples (10 µg) were incubated with 2x laemli buffer in a 
2:1 ratio for 3 minutes at 95oC. This allowed denaturation and charging of the proteins. 
Samples were then left to cool at RT and were ran in a 10% sodium dodecyl sulfate 
polyacrylamide gel (SDS-Page, ready precast gels, BioRad 161-1155) along with a pre-
stained protein standard size marker (Invitrogen, LC5800). Running buffer was used to 
fill the tank and the gap between the gel holders. The gel was ran at 100 volts at RT for 
1-2 hours, or until the bands separated sufficiently. The proteins were then transferred 
from the gel to a nitrocellulose membrane, previously incubated for 30 seconds in 100% 
methanol, 2 minutes in distilled water and 20 minutes in transfer buffer. Blotting papers 
and sponges were also immersed in transfer buffer. The ‘sandwich’ structure for the gel 
transfer was as follows, starting from the cathode (negatively charged electrode): 
sponge, 2 blotting papers, gel, membrane, 2 blotting papers, sponge. Negatively charged 
proteins were transferred from the gel to the nitrocellulose membrane forced by the 
current from the anode to the catode for 1 hour at 4oC at 100 volts.  
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2.2.14.4. Antibody incubation 
 
After the transfer, the membrane was transferred into a weighing boat, where non-
specific binding sites were blocked in Tris-Buffered Saline (TBS) containing Tween20 
(TBST) and 5% block reagent (BSA, Sigma A2153, or milk powder) for 1 hour, 
shaking at RT. The membrane was then incubated in primary antibody solution 
overnight (Table 2.10), rocking at 4oC, wrapped in sealable bags, cut to size. The 
appropriate primary antibody was used at 1:1000 dilution in TBST with 5% block 
reagent (BSA or milk). The next day, after three washes in TBST with 5% block reagent 
(BSA or milk) in a weighing boat shaking at RT, the membrane was incubated in 
secondary antibody solution. The appropriate secondary antibody conjugated with 
horseradish peroxidase (HRP) was used at 1:2000 dilution in TBST with 5% block 
reagent (BSA or milk), shaking for 1 hour at RT. Three washes in TBST with 5% block 
reagent (BSA or milk) for 15 minutes each, shaking at RT were followed by another 
three similar washes in TBST alone.  
 
2.2.14.5. Chemiluminescence and film development 
 
The membrane was then put flat, facing up, on a straightened piece of cling film. 1-3 ml 
(depending on the size of the membrane, enough to cover the whole surface) of West 
Dura chemiluminescent substrate (Fischer Scientific, 37071) was added on top of the 
membrane for 5 minutes at RT. After removing the excess of liquid, the membrane was 
covered by another piece of cling film, straightened and transferred into a dark box, 
facing up. In a dark room under red light a piece of photographic film (GE healthcare 
28-9068-36) was then placed on top of the membrane. Light emitted by the reaction 
catalysed by HRP was directly correlated with the location and the amount of the 
protein of interest and was accurately transferred onto the film. Film development took 
place in a Medical Film Processor (Model slx-101A).  
 
2.2.14.6. Membrane stripping 
 
After the first chemiluminescence reaction, the membrane can be stripped off the bound 
antibodies and re-probbed with an antibody against another protein of interest, here β-
tubulin. The membrane was incubated in stripping buffer twice for 10 minutes each 
time, at RT, shaking. It was then sequentially washed in PBS twice, 10 minutes each 
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time and then in TBS twice, 5 minutes each time, shaking at RT. Then the membrane 
was ready to be re-blocked and re-probed, as described in Section 2.2.14.4 onwards.  
 
Blocking 
agent 
Primary antibody Secondary antibody 
Target  Species  Dilution Provider Details Dilution Provider 
BSA Phospho-
Jnk 
Rabbit 1:1000 Cell 
Signalling 
9251 
Goat 
anti-
rabbit 
HRP 
1:2000 Dako 
P0448 
Milk β-tubulin Mouse 1:1000 Sigma T-
5293 
Rabbit 
anti-
mouse, 
HRP 
1:2000 Dako 
P0260 
Table 2. 10: Primary and secondary antibodies used for western blotting. Milk, although 
cheaper and more commonly used, could not be used as a blocking agent for phospho-Jnk 
probed membranes, as milk casein is a phospho-protein itself and can cause high 
background.    
 
Buffers and solutions for western blotting 
10xTBS 10xRunning buffer 
10xTransfer 
buffer 
Lysis 
buffer 
(NP40) 
2xLaemli 
buffer 
Stripping 
buffer 
24.23g 
Trizma-
HCl 
25mM Tris 
base 
48mM Tris 
base 
150mM 
NaCl 4% SDS 
15g 
Glycine 
80.06g 
NaCl 
190mM 
Glycine 
29mM 
Glycine 
1% NP-40 
(or 
TritonX-
100) 
10% 2-
mercaptoethanol 1g SDS 
H2O to 1L 0.1% SDS 0.04% SDS 40mM Tris 
0.004% 
bromophenol 
blue 
10ml 
Tween20 
pH 7.6 pH 8.3  pH 8.0 20% glycerol H2O to 1L 
    
0.125M 
TrisHCl pH 2.2 
    pH 6.8  
Table 2. 11: Buffers and solutions used for western blotting. Ingredients of lysis buffer, 2x 
Laemli buffer, stripping buffer and 10x TBS, running buffer and transfer buffer are 
shown.   
 
2.3. In silico techniques 
      
2.3.1. Servers and databases used 
      
Initially, the genes of interest were investigated in online databases, namely Ensembl 
and NCBI. Through these servers orthologs and homologs of the genes of interest were 
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investigated. Due to regular updates of online databases it is important to note that the 
current study was conducted using information mainly from Ensembl release 62. The 
sequences of different splice variants and protein isoforms were compared between 
them and with other genes using ClustalW. This server comprises a fully automated 
program for global multiple alignment of DNA and protein sequences. Global 
alignments progressively align sequences across their entire length and need to use gaps 
representing insertions or deletions. Protein analysis and conserved motif investigation 
were achieved using online servers, such as Prosite, EML, InterProScan, Psipred and 
others. All databases and servers used in this study are listed in Table 2.12.    
 
Database / Server Function URL 
National Center for 
Biotechnology 
Information (NCBI) 
genome 
database http://www.ncbi.nlm.nih.gov/ 
Ensembl genome database http://www.ensembl.org/index.html 
Eukaryotic Linear Motif 
(ELM) 
 protein 
functional 
sites search 
http://elm.eu.org/ 
InterProScan (EMBL-
EBI) 
protein 
sequence 
analysis and 
classification 
http://www.ebi.ac.uk/Tools/InterProScan/ 
PPSearch (EMBL-EBI) protein motif 
search http://www.ebi.ac.uk/Tools/ppsearch/index.html 
PSIPRED 
protein 
structure 
prediction 
http://bioinf.cs.ucl.ac.uk/psipred/ 
ClustalW2 (EMBL-EBI) sequence 
alignment http://www.ebi.ac.uk/Tools/clustalw2/index.html 
 
Table 2. 12: Databases and servers used during the bionformatics approach. Their 
applications and their URL are shown. Most of the in silico results shown in the next 
chapter (Chapter 3) are a summary of the information collected from all these websites.  
 
2.3.2. Phylogenetic analysis 
 
Phylogenetic and molecular evolutionary analyses were conducted using the Molecular 
Evolutionary Genetics Analysis (MEGA) software version 5 (Tamura et al., 2011). The 
method that was used in this study for the construction of phylogenetic trees was the 
character-based, maximum likelihood method (Felsenstein, 1981, Kishino and 
Hasegawa, 1990), based on the Jones-Taylor-Thornton  (JTT) model for amino acid 
sequences (Jones et al., 1992) or on the Tamura-Nei model for nucleotide sequences 
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(Tamura and Nei, 1993), using the nearest-neighbour-interchange (NNI) heuristic 
method of tree inference, with a 95% site coverage cut-off and 500 repetitions of 
bootstrap testing. 
The JTT model estimates the probabilities of change from one amino acid to 
another and is able to correct for multiple substitutions (Jones et al., 1992). It is, 
nowadays, used as a default setting in many maximum likelihood-based phylogenetic 
analysis tools. The Tamura-Nei model (Tamura and Nei, 1993) corrects for multiple 
hits, by taking into account the differences in substitution rates between nucleotides and 
the differences in nucleotide frequencies. It, also, distinguishes substitution rates of 
transitions (interchange of purines or pyrimidines) and transversions (change of purines 
to pyrimidines or vice versa).  
The NNI method improves the likelihood of a tree by swapping individual 
subtrees with their neighbours in an attempt to get the tree with the highest probability 
of occurring. A 95% site coverage cut-off means that all positions that contain fewer 
than 95% alignment gaps and missing data were eliminated. Bootstrap analysis, 
explained in Section 3.1.6 (page 89), is essential for ascertaining the reliability of a 
given tree. 500 bootstrap analysis steps were performed for each inferred tree in the 
current study.   
 
2.4. Statistical analysis 
2.4.1. Experimental design  
 
All experiments were conducted on at least three independent biological replicates (the 
exact number of repetitions is stated in the respective results sections). For cell 
experiments one biological replicate represents cells from one frozen batch, while for 
zebrafish experiments one biological replicate represents one clutch. The number of 
samples used in each replicate is stated along with the results of each experiment. PCR 
reactions and immunocytochemistry were performed in triplicate for each biological 
replicate because of the intrinsic variability of the techniques. In all cases, averages (for 
numerical data) or representative results (for qualitative data) are shown in the next 
chapters.  
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2.4.2. Statistical calculations 
 
All statistical calculations were carried out in the Statistics Package for the Social 
Sciences (SPSS). For numerical data the normality of the distribution of the values was 
firstly assessed using the Kolgomorov-Smirnov test. If normality was confirmed, the 
appropriate parametric test was then carried out. If normality was rejected, the data were 
transformed to their logarithmic values. The normality of the logarithmic values was, in 
turn, assessed; if the logarithmic values were found to be normally distributed, the 
appropriate parametric tests were applied on these data, whereas if the logarithmic 
values were not found to be normally distributed, the appropriate non-parametric tests 
were applied in the original (linear) data (Ennos, 2006).  
The most commonly used test for parametric data in this study was one-way 
Anova; if significance was found with one-way Anova testing between any of the 
groups examined, then a post hoc 2-sided Dunnett test would follow and this would 
show between which groups there were significant changes (and the exact p values). 
The most commonly used non-parametric test was the Mann Whitney test. Statistical 
significance throughout the document will be reported alongside the statistical test used 
for each specific group of data. For categorical data the chi-squared (χ2) test or the χ2 
test for associations were used. These tests had to be carried out on raw numbers and 
not percentages, so, when necessary, statistical testing was conducted before further 
processing of the data (Ennos, 2006). Throughout this study statistical significance is 
indicated with asterisks in the corresponding graphs, with *p<0.05 and **p<0.01. P 
values lower than 0.000 (for example 10-6) are not provided in SPSS and therefore are 
stated as 0.000 values here.  
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Chapter 3. Identification of jnk genes in zebrafish 
 
3.1. Introduction 
 
In this chapter, the zebrafish jnk genes are presented. Initially, in silico investigation led 
to the identification of all jnk genes and isoforms available to date. Further analysis of 
the structure and conservation of these genes and their corresponding proteins with 
bioinformatics tools revealed great similarities with known jnk genes in other species 
and confirmed the potential for functional conservation of the kinase activity of 
zebrafish jnk isoforms. Lastly, exploration of the expression pattern of jnk genes 
throughout zebrafish embryogenesis showed that mRNA of the genes and isoforms 
examined is produced in vivo at early developmental stages.     
 
3.1.1. Fish-specific genome-wide duplication 
 
The first goal of the current study was the identification of jnk genes in zebrafish. It was 
hypothesized that jnk genes additional to the three known mammalian Jnk1, Jnk2 and 
Jnk3, might exist in the zebrafish genome, because of a fish-specific genome-wide 
duplication event. This took place in the lineage of ray-finned fish after it diverged from 
the lobe fin lineage (that included avian and mammalian species) approximately 350 
million years ago and resulted in many of the genes of land vertebrates being duplicated 
in the zebrafish genome (Meyer and Van de Peer, 2005, Postlethwait et al., 2000) 
Examples of such duplications are the discovery of tbx5a/tbx5b (Albalat et al., 2010) 
and hoxa13a/hoxa13b (Ahn and Ho, 2008). It is common for one of the members of the 
duplicated pair (either the original copy or the gene that arose from the duplication) to 
accumulate mutations over the years, due to reduced evolutionary pressure, and to 
become inactivated (Postlethwait et al., 2000, Watterson, 1983). So, the number of 
duplicated genes present in two copies in the zebrafish genome to date is not known 
(Amores et al., 1998, Ellies et al., 1997, Postlethwait et al., 2000) and it is likely that 
many such duplicates remain unidentified. Thus, additional, still unidentified, jnk 
duplicates were hypothesized to exist in the zebrafish genome.  
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3.1.2. Conserved motifs for the regulation and specificity of Jnk signal transduction 
 
The MAPK cascade has the ability to convert a variety of different extracellular stimuli 
into very specific and targeted cellular responses; therefore its tight regulation, 
coordination, timing and intensity are of paramount importance for reliable and efficient 
signal relay. In this section, some of the most important motifs of MAPK in general and 
JNK in particular are presented, principally associated with activation, inactivation and 
function of the proteins but also with their interactions with other cellular components.   
A key point in the regulation of the MAPK pathway is through the change in the 
phosphorylation status of the proteins. The conserved T-X-Y motif (where X is 
glutamic acid, proline or glycine) found in the activation loop of MAPK is essential for 
their activation. Specifically, JNK proteins exhibit a T-P(proline)-Y motif, where they 
get phosphorylated, and therefore activated, by MKK4 and MKK7 (Derijard et al., 
1994, Lin et al., 1995, Martin et al., 2005, Pearson et al., 2001, Roux and Blenis, 2004). 
The presence of such a motif (TPY) is essential for the kinases to be activated and 
further phosphorylate downstream targets.  
Most of the kinases in an organism act in a very similar way, targeting in most 
cases very similar motifs on their substrates. For example, JNK, as proline-directed 
serine/threonine (S/T) kinases, they can phosphorylate either serine or threonine (S/T) 
residues within a proline (P)-containing sequence (S/T-P). These motifs are found in 
approximately 80% of all proteins so additional mechanisms that confer specificity and 
direct individual kinases towards their correct targets are required (Bardwell and Shah, 
2006). One such mechanism is the existence of conserved motifs in molecules that 
interact with JNK. These motifs are called docking sites or domains (D-sites/domains) 
and mediate high affinity protein-protein interactions (Bardwell and Shah, 2006, 
Tanoue et al., 2000, Tanoue and Nishida, 2003). Such sites have been identified in 
activators, substrates and suppressors of JNK. Similarly, a motif within JNK containing 
acidic residues has been suggested to establish strong interactions with the basic 
residues of the D-sites. This domain is called the common docking domain (CD) 
(Biondi and Nebreda, 2003). 
Although a high degree of specificity is conferred at many different levels of 
MAPK signalling, there is also significant overlap that should not be overlooked. 
Different subfamilies may share upstream activators and downstream targets, 
potentially allowing for cross talk and feedback between them (Qi and Elion, 2005, 
Rose et al., 2010, Turjanski et al., 2007). Additionally, proteins activated by one 
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pathway may act as negative regulators of another pathway (Juntilla and Koretzky, 
2008), further complicating the interactions between the different cascades. In 
conclusion, MAPK form complex signal transduction networks, induced by a variety of 
stimuli and propagated through a vast array of mechanisms that confer specificity in 
order to achieve their multi-functional intracellular goals. 
 
3.1.3. Phylogenetic analysis  
 
In this study, analysis of the phylogenetic relationship of zebrafish jnk genes with their 
homologs from other species was pursued. It is, thus, important to introduce some of the 
basic concepts of phylogenetic analysis, including phylogenetic tree construction and 
bootstrapping. 
Phylogenetics is the study of the evolutionary relationship between different 
groups of organisms, commonly using molecular and morphological data (Wiens, 
2006). As evolution is a branching process, whereby species diverge, speciate or 
disappear, phylogenetic estimations are often represented as branching diagrams or 
trees, called phylograms. The length of the tree branches is proportional to the amount 
of inferred evolutionary change and, therefore, provides an estimation of the 
evolutionary relation of different molecules in various organisms. Simplistically put, the 
divergence between different branches (representing species, genes, taxa etc) is an 
illustration of how many differences there are between the sequences.    
An important concept in phylogenetic analysis is the molecular clock. The 
molecular clock hypothesis states that DNA and subsequently protein sequences evolve 
at a relatively constant rate over time and among different organisms (Kimura, 1968, 
Kumar, 2005). A direct consequence of this hypothesis is that the differences between 
genetic sequences in any two species will be proportional to the time during which these 
two species have diverged from their common ancestor. Therefore, this hypothesis 
provides a useful method for estimating evolutionary relationships. However, this 
hypothesis does not hold true in all cases and is nowadays thought to be quite simplistic, 
since the rates of molecular evolution can vary significantly between different species. 
Most of the models employed today for molecular phylogenetic analysis use the so-
called ‘relaxed’ molecular clocks, which allow the molecular evolutionary rates to vary 
among organisms, but in a limited way or within a specific range (Bromham and Penny, 
2003, Weir and Schluter, 2008). 
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According to the molecular clock hypothesis, the type of mutation that is 
particularly useful in inferring evolutionary changes is the substitution, the change of 
one base for another at one specific locus within a DNA sequence. Substitutions are 
random and therefore, as the model suggests, more time means more chance for them to 
occur. Based on chemical properties, certain substitutions happen more often than 
others, and this can be represented by probabilities that are commonly embedded in 
phylogenetic models. For example transitions, which are interchanges of purines (with 
two-ring bases, such as Adenine or Guanine) or pyrimidines (with one-ring bases, such 
as Thymidine or Cytosine), are more frequent than transversions, which are 
interchanges of purines for pyrimidines and vice versa (Keller et al., 2007). In contrast 
to substitutions, insertions and deletions, with which large chunks of a gene can be 
inserted or deleted, respectively, in a short period of time, do not always agree with the 
molecular clock hypothesis but can be detected and accounted for by sequence 
alignments (Keller et al., 2007, Schwartz and Mueller, 2010).  
 
3.1.4. Phylogenetic trees 
 
The evolutionary hypothesis of a phylogeny, as instructed by specific models, can be 
graphically represented in a phylogenetic tree (Figure 3.1). The tree consists of nodes 
and branches. The tips of the tree (leaves) represent taxa or operational taxonomic units 
(OTU), which can be any biological unit (an individual, a species or a higher grouping). 
The branches of the tree connect different leaves and represent the inferred evolutionary 
divergence between them. Trees can be either rooted or unrooted. A rooted tree has a 
defined common ancestor, whereas an unrooted tree does not. An outgroup, an OTU 
that is the least related to the group of taxa of interest, can be used as a tool for rooting 
trees (Figure 3.1). The nodes are the points where branches separate and represent 
hypothetical common ancestors. The order of the nodes and the branching pattern of the 
tree determine its topology and describe how different units have diverged from one 
another over the course of time. Trees can be rotated at their nodes without changing 
their topology.  
Traditionally, phylogenetic trees were constructed using descriptive 
morphological observations but nowadays, with the growth of genetic information, it is 
possible (and common) to use molecular data for inferring evolutionary history. This 
type of phylogeny is called molecular phylogeny and is typically based on DNA or 
protein sequences (Felsenstein, 2001).  
  
 
Figure 3. 1: Example of a phylogenetic tree with some points of reference. The tips of the 
tree, often referred to as leaves, are where the taxa are. A taxon or OTU can be any 
biological unit: a species, a family or even a whole kingdom. The branches are the lines 
that connect the leaves and represent the inferred evolutionary relationship between them. 
The nodes are the points where the branches bifurcate and represent hypothetical 
ancestral units. The outgroup is used as a basis for the analysis of the phylogenetic 
relationships.        
 
3.1.5. Constructing molecular phylogenetic trees
 
There are many different ways for constructing a phylogram, each with its own 
advantages and disadvantages. The two main categories for constructing molecular 
phylogenies are distance
Holmes, 2003, Whelan et al., 2001)
pairwise measure of genetic ‘distance’
these methods convert the observed character differences (differences in amino acids or 
nucleotides) into distances, comparing two sequences at a time. The main disadvantage 
of these methods is their inability to use all sequence information at once, as they 
reduce characters to distances and a lot of information is lost; for example multiple hits 
and back mutations cannot be detected. Also, because of the pair
comparisons, the distances are never independent. However, they are extremely fast and 
easy to perform and most of the times they give a good estimate of phylogeny. Two 
widely used methods of this category are Unweighted Pair Group Method using 
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-based and character-based methods (Felsenstein, 1996, 
. The first type is semiparametric and relies on a 
 from multiple sequence alignments. Essentially, 
-wise nature of the 
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Arithmetic averages (UPGMA) and Neighbour Joining (Bruno et al., 2000, Whelan et 
al., 2001).  
The second category for phylogeny construction comprises character-based 
methods, which use all individual characters (amino acids or nucleotides) in order to 
infer phylogeny. They estimate the total number of mutations required to explain the 
observed character sequences and they make use of all known evolutionary information 
in order to determine the most likely ancestral relationships. The most frequently used 
character-based methods are the maximum parsimony method, which constructs trees 
that require the minimal number of changes to explain the current data, and the 
maximum likelihood method, which creates trees with the highest likelihood of 
occurring with the given data (Rogers, 1997, Steel and Penny, 2000, Whelan et al., 
2001). Although more labour-intensive, computationally demanding and time-
consuming than distance-based methods, they give a more reliable phylogenetic tree 
estimation. A main drawback is the fact that they use the two models of evolution (that 
of parsimony and maximum likelihood, respectively), which are not necessarily true for 
all characters (Holmes, 2003).   
The approach to adopt is chosen depending on the available data and the required 
outcome, as exemplified below. UPGMA assumes that all lineages evolve at the same 
rate (molecular clock hypothesis, explained in detail in Section 3.1.3, page 85), which is 
sometimes an inaccurate assumption, but is able to provide a rooted tree rapidly. 
Neighbour Joining is preferable when evolutionary rates are known to vary. Maximum 
parsimony is ideal for closely related sequences. Maximum likelihood is the most 
general and statistically robust of all because its assumptions are explicit and can be 
modified to suit the needs (Holmes, 2003).  
The method that is used in this study for the construction of phylogenetic trees is 
the character-based, maximum likelihood method (Felsenstein, 1981, Kishino and 
Hasegawa, 1990). This method tests a hypothesis by assessing the probability that the 
proposed model and the hypothesized evolutionary history would generate the observed 
data set. The history with a higher probability of generating the current alignment is 
preferred and the tree with the maximum likelihood is generated. A simplified step-wise 
description of the procedure would be as follows: an evolutionary model is selected, all 
possible tree structures are generated for each position of the alignment, the likelihood 
of all positions in these trees is calculated based on the chosen model, the likelihood for 
each tree is calculated by multiplying the likelihood for each position within that tree 
 89 
and the tree with the greatest likelihood is chosen (Guindon and Gascuel, 2003, Holmes, 
2003).  
A detailed description of how the maximum-likelihood trees were constructed is 
provided in Chapter 2 (Section 2.3.2, page 80). Briefly, the amino acid or DNA 
sequences of interest were aligned in ClustalW (Section 2.3.1, page 79) and were then 
further analyzed in the MEGA5 software (Tamura et al., 2011). The appropriate models 
(JTT or Tamura-Nei) were selected for estimation of the substitution rates, as described 
in Section 2.3.2 (page 80).   
 
3.1.6. Bootstrapping 
 
Another important concept in phylogenetic analysis is bootstrapping. Similar to 
statistics, where the significance of the data is shown with p-values, the evaluation of 
the reliability of a phylogenetic tree is done by bootstrap analysis (Felsenstein, 2001, 
Holmes, 2003). The basic idea behind bootstrapping is the re-shuffling of the characters 
in the alignment data and the construction of a new tree based on the re-shuffled values 
(Efron et al., 1996). Then, the topology of the new tree is compared to the topology of 
the original tree. If the new tree is similar to the original tree, then the confidence in the 
original tree increases. On the other hand, if the new tree is very different to the original 
tree then the reliability of the original representation is low (Efron et al., 1996, 
Felsenstein, 2001, Holmes, 2003). This comparison is done by scoring all individual 
branches of the trees before and after re-shuffling: each interior branch of the original 
tree that is different from the boostrapped tree is given a score of 0, while interior 
branches that remain the same after re-shuffling are given a score of 1. By repeating this 
procedure a number of times (typically hundreds of times), it is possible to score the 
reliability of each branch of the original tree by calculating the percentage of times each 
branch was given a value of 1; the higher the bootstrap score the greater the reliability. 
A score of 95% or higher indicates that the branching is ‘correct’ (Nei and Kumar, 
2000).  
Boostrap analysis can be performed in the MEGA5 software package (Tamura et 
al., 2011) used in this study. 500 bootstrap repetitions were performed in this study for 
each tree in order to quantify certainty and estimate confidence in the constructed trees. 
The percentage of trees in which the taxa of interest clustered together in 500 boostrap 
replicates, is shown next to the branches in each tree.   
 
 90 
3.2. Aims of the chapter 
 
Jnk genes and proteins have been identified and studied in many organisms. In 
zebrafish, although a number of studies have explored the putative roles of jnk during 
embryonic development, the jnk genes have not been extensively studied. In this study, 
I set out to investigate the jnk genes and proteins in zebrafish. In order to achieve this 
the following aims were set: 
 
• Characterize all zebrafish jnk orthologues, with a specific focus on identifying 
new jnk genes that arose after the fish genome duplication  
• Determine jnk splice variants and jnk protein isoforms 
• Elucidate the primary and secondary structures of the proteins of interest and 
identify evolutionarily conserved motifs 
• Establish their phylogenetic relations with other species 
• Determine their spatial and temporal expression pattern in developing zebrafish 
embryos 
 
3.3. In silico analysis 
 
Initially, I set out to identify and study all jnk genes and isoforms in zebrafish. For this 
purpose, genome databases were examined for the presence of zebrafish jnk genes. 
Among the three available genomic databases (Ensembl, NCBI, UCSC), Ensembl was 
preferred. Genes in Ensembl are annotated automatically, based on experimental 
evidence. Manual curation by the HAVANA team supports the automatic annotations. 
In turn, gene annotation in NCBI (National Centre for Biotechnology Information) is 
based on published information and is therefore more limited. The UCSC browser 
accommodates both published and experimentally predicted annotations but does not 
have a zebrafish entry. Therefore, by using Ensembl (and comparing with NCBI when 
necessary), it was possible to identify all predicted zebrafish jnk genes and study them 
in detail. Ensembl releases new genebuild findings and updates its browser frequently; 
since new information is included in every new release, it is important to note that the 
current data are based on Ensembl Release 62.  
Four features of the jnk genes were of main interest: the different splice variants 
of each gene, the structure of the proteins produced by these variants and the similarities 
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between them, the presence of conserved motifs and the phylogenetic relationship with 
their orthologues in other species. The findings from the in silico investigation are 
presented below.   
 
3.3.1. Jnk orthologues in zebrafish; characterization of an extra jnk gene 
 
As mentioned earlier, one of the main focus of this study was to identify new jnk genes 
in zebrafish, additional to the three known mammalian genes, that might have arisen 
from the fish-specific genme-wide duplication event (Meyer and Van de Peer, 2005, 
Postlethwait et al., 2000). When the current study was being carried out only one jnk 
gene (jnk1) had been identified and studied (Krens et al., 2006). At present, four jnk 
genes have been identified in zebrafish, named jnk1a-1, jnk1a-2, jnk2 and jnk3 (Seo et 
al., 2010), as described in Sections 1.5.2 and 1.5.4 (pages 38 and 41). However, they 
have not been studied and characterized. In parallel with the aforementioned publication 
(Seo et al., 2010), the current study was being carried out, focusing on characterizing 
and further analyzing the identified genes. Following the official nomenclature for 
duplicated genes proposed by the National Zebrafish Model Organism Database (ZFIN, 
zebrafish nomenclature guidelines) zebrafish jnk genes are named in this study jnk1a, 
jnk1b, jnk2 and jnk3.     
In silico investigation of online databases revealed four orthologues of the three 
mammalian Jnk genes, named (in Ensembl) as follows: mapk8 (jnk1, here called jnk1a), 
mapk8 (jnk1, here called jnk1b), mapk9 (jnk2) and mapk10 (jnk3). Jnk1a is located on 
chromosome 12, jnk1b on chromosome 13, while jnk2 and jnk3 lie on chromosome 21. 
A table with details about all four genes is presented below (Table 3.1). At the time that 
this work was being carried out the genes jnk1b and jnk2 had not been identified yet and 
appeared as unknown, predicted genes (experimentally defined but not published). It 
was, thus, important to establish whether jnk1b arose from a duplication of jnk1a, jnk2 
or jnk3, as its name at the time did not reveal its origin. In order to elucidate this, three 
methods were employed: comparison of the divergence of the cDNA sequences of the 
four genes, analysis of their evolutionary relationship and comparison of the 
chromosome loci that they occupy. Searching for homology between jnk1b on one hand 
and jnk1a, jnk2 and jnk3 on the other, it was confirmed that jnk1b is likely to have 
arisen from the duplication of jnk1a and not jnk2 or jnk3, as presented below. 
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Gene 
Name  
Transcript 
Name 
Ensembl Accession 
Code  
Transcript 
length (bp) 
No of 
exons 
Protein 
length (aa) Location 
jnk1a  
jnk1a.1 ENSDART0000145213 1029 7 256 
 
 
Chr.12 
 
jnk1a.2 ENSDART0000086510 943 8 260 
jnk1a.3 ENSDART0000128677 1287 11 428 
jnk1a.4 ENSDART0000022471 2059 12 384 
jnk1b 
jnk1b.1 ENSDART0000049180 1618 11 427  
 
 
Chr.13 
jnk1b.2 ENSDART0000139591 1796 12 427 
jnk1b.3 ENSDART0000132129 2211 12 427 
jnk1b.4 ENSDART0000146250 421 3 88 
jnk2 jnk2 ENSDART0000112550 1758 12 421 Chr.21 
jnk3 
jnk3.1 ENSDART0000086521 1293 13 430 
 
 
 
Chr.21 
 
 
 
 
jnk3.2 ENSDART0000042429 1155 11 384 
jnk3.3 ENSDART0000134892 1756 14 433 
jnk3.4 ENSDART0000141848 1863 15 430 
jnk3.5 ENSDART0000086509 1850 16 430 
jnk3.6 ENSDART0000134195 1887 14 384 
jnk3.7 ENSDART00000142547 861 6 210 
jnk3.8 ENSDART0000014434 674 5 102 
 
Table 3. 1: Zebrafish jnk genes and isoforms. Chromosome location, transcript and 
protein length, as well as the gene identities in Ensembl are shown here. Aa: amino acids, 
bp: base pairs, chr: chromosome.  
 
 
Initially, pairwise comparisons of transcripts from all zebrafish jnk genes were 
performed in order to assess the sequence divergence of the genes. For this purpose, 
cDNA sequences of jnk transcripts were aligned using the ClustalW server (Table 2.12, 
page 80) and then pairwise comparisons were performed using the MEGA5 software 
(Tamura et al., 2011). Specifically, p-distances between pairs of cDNA sequences were 
estimated. A p-distance is the proportion of nucleotide sites at which two sequences are 
different and is obtained by dividing the number of nucleotide differences by the total 
number of nucleotides. Comparison of the sequence differences between jnk transcripts 
showed that jnk1a and jnk1b are more similar (in terms of their cDNA sequence) to 
each other than they are to jnk2 and to jnk3 (Figure 3.2). All transcripts of each gene 
were compared to all transcripts of another gene for an unbiased evaluation and the 
mean values are presented in Figure 3.2.   
An analysis of the evolutionary relations of the four jnk genes and their transcripts 
was also performed and is shown in the tree in Figure 3.3. Coding transcripts (cDNA 
sequences) of all genes were initially aligned using the ClustalW server and were then 
further analysed in MEGA5 (Tamura et al., 2011). Evolutionary history was inferred by 
using the maximum likelihood method based on the Tamura-Nei model (Tamura and 
Nei, 1993), using the nearest-neighbour-interchange (NNI) heuristic method of tree 
 inference, with a 95% sit
Section 2.3.2 at page 80 
jnk1a and jnk1b transcripts seem to be evolutionarily more closely related between them 
than either of them is with 
transcripts of jnk1a and 
(100%), which ascertain the reliability of the tree topology. A bootstrap value of 100% 
means that all the trees that were constructed after re
agreed on the current topology of the branches. Therefore, it seems likely that 
jnk1b are members of a duplicated gene pair.  
 
 
Figure 3. 2: Graphic representation of the percentage of sequence divergence between 
zebrafish jnk cDNA. Pairwise distances were calculated using the MEGA5 software and 
were converted to sequence divergence percentages.  Information from al
each gene was included in the calculations. Shown are the mean values of all transcripts 
for one gene against the mean values of all transcripts for another gene: for example the 
differences between jnk1a
More differences mean more distantly related genes. Non
was used (Mann Whitney test). Asterisks indicate statistical significance compared to the 
jnk1a/jnk1b values. *p<0.05.
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Figure 3. 3: Molecular analysis showing the evolutionary relation of 
inferred by using the maximum likelihood method based on the Tamura
replicate trees in which the associated groups clustered together in the bootstr
scale with branch lengths measured as the number of substitutions per site (the scale bar indicates 0.05 substitutions per si
nucleotide sequences and was conducted in MEGA5. 
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jnk nucleotide sequences in zebrafish (Danio rerio
-Nei model. The tree with the highest likelihood is shown. The percentage of 
ap test (500 replicates) is shown next to the branches. The tree is drawn to 
, DR). Evolutionary history was 
te). The analysis involved 14 
 Additionally, the chromosome locations of the zebrafish 
compared, because any genome duplication event would have included duplication of 
large areas of the chromosome, spanning probably more than one gene. The gene
surrounding the jnk1a
found to share high levels of paralogy: four genes, namely FRMPD2, ARHGAP22, 
LRRC18 and C10orf72 lie on either side of 
genes lie on either side of 
3.4). Similar comparisons of the 
similar associations. This observation reinforces the notion that 
pair of duplicated genes, with one having arisen from the other. 
Although jnk1a
was the chromosomal locus around 
to the other gene. Duplication of the regions around 
(Ensembl release 62) but future Ensembl releases may reveal additional genes.  
 
 
Figure 3. 4: Comparison of the jnk loci in chromosomes 12, 13 and 21. 
4 genes, copies (paralogues) of which are also found around 
genes that is adjacent to 
genes flanking jnk1a are also found in the chromosome
represented in boxes. Same coloured boxes indicate paralogy. Black boxes indicate genes 
that were found not to have any associations between the different chromosomes. 
length of the boxes is not necessarily proporti
 
 
3.3.1.1. Alternative splice variants of jnk1a, jnk1b, jnk2 and jnk3 
 
After identification of the zebrafish 
transcript variants was of interest. 
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 and jnk1b loci in chromosomes 12 and 13, respectively, were 
jnk1a, while putative paralogues of these 
jnk1b (ntpn20, ARHGAP22, LRRC18, C10orf72) (Figure 
jnk1b loci with the jnk2 and jnk3 
jnk1a
 
 was identified first (jnk1 in Krens et al. 2006), it is not clear if it 
jnk1a or jnk1b that became duplicated and gave rise 
jnk2 and jnk3 
jnk1b. A copy of one of the 
jnk1a is also found in the area where jnk2 lies, while copies of two 
 21 locus where 
onal to the length of the genes.
 
jnk genes in online databases, analysis of their 
Jnk2 contains one transcript of 1758 base pairs in 
genes were 
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length, which contains 12 exons and encodes a 421 amino acids protein (Table 3.1). In 
contrast, jnk1a, jnk1b and jnk3 were found to contain more than one transcript, which 
through alternative splicing lead to the production of different protein isoforms. 
Specifically, jnk1a was found to contain four splice variants, 1287, 2059, 943 and 1029 
base pairs in length, containing 11, 12, 8 and 7 exons and coding for 428, 384, 260 and 
256 amino acids proteins, respectively. Similarly, jnk1b was found to contain four 
protein-coding splice variants (and one non-protein coding transcript), 2211, 421, 1618 
and 1796 base pairs in length, containing 12, 3, 11 and 12 exons and coding for 427, 88, 
427 and 427 amino acids proteins, respectively. Jnk3 has eight protein-coding splice 
variants (and one non-protein coding), 1155, 1850, 1293, 861, 674, 1756, 1863 and 
1887 base pairs in length, containing 11, 16, 13, 6, 5, 14, 15 and 14 exons and encoding 
384, 430, 430, 210, 102, 433, 430 and 384 amino acids proteins, respectively (Table 
3.1). Most of the differences between the transcripts of each gene lie in the 5’ and 3’ 
untranslated regions and in the first few or last few exons. The central exons are shared 
between all transcripts, indicating, as will be shown in the next few sections, that the 
core domain of the proteins that are produced by these transcripts is present in all of 
them. In fact, most of the exons are shared between isoforms of all four genes (Figure 
3.4). One extra exon appears to be present in jnk3 splice variants, missing altogether 
from jnk1a, jnk1b and jnk2.  
Taken together, the four jnk genes that were identified in the zebrafish genome in 
online databases have 19 transcripts (splice variants), 17 of which code for proteins of 
different sizes. Next, the jnk proteins were studied in more detail, by looking at their 
primary and secondary structure.    
 
3.3.1.2. Primary structure of jnk proteins in zebrafish 
 
Next, the primary structure of all variants of the jnk proteins was investigated in order 
to evaluate where the differences and similarities between them lie. This was performed 
by pairwise alignment of their amino acid sequences in ClustalW. Only small 
differences could be observed (Figures 3.4 and 3.5) between the amino acid sequences 
of the examined proteins. Jnk1a.1 and jnk1a.2 only have minor differences in the 
carboxyl (C)-terminal region. Similarly, jnk1a.3 and jnk1a.4 differ only in their last 
amino acids. The differences between jnk1a.1 and jnk1a.2 on one side and jnk1a.3 and 
jnk1a.4 on the other are again restricted in their C-terminal region, making the two latter 
variants (jnk1a.3 and jnk1a.4) longer than the former ones (jnk1a.1 and jnk1a.2).   
  
 
 
 
Figure 3. 5: Schematic representation of jnk genes in zebrafish. Splice variants of all genes are shown here: four transcripts of 
jnk1b, one transcript of jnk2 and eight transcripts of jnk3
nucleotide and amino acid length. Introns are not shown in this diagram. The horizontal thin grey lines in 
highlight the area where the ‘green’ exon of jnk3 is. This exon is absent in 
where important motifs of the proteins lie, as discussed in Section 3.3.1.3
from nucleotide and amino acid sequences of all transcripts.    
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. Alternate exons are shown in alternate colours. The length of each exon is proportional to its 
jnk1a, jnk1b
jnk1a, jnk1b, jnk2 and some jnk3 isoforms. Vertical black lines represent areas, 
 (page 99). This schematic representation was manually drawn using information 
jnk1a, four transcripts of 
, jnk2 and some jnk3 isoforms 
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Figure 3. 6: Alignment and comparison of the zebrafish jnk amino acid sequences. Only non-redundant sequences were used. The alignment is shown in 
two columns. Highlighted in red is the core area of high conservation. (*) shows identical residues in all sequences of one column, (:) shows conserved 
substitutions (substitution of one amino acid with another one of similar properties) and (.) shows semi-conserved substitutions (substitution of one amino 
acid with another of similar steric conformation but different chemical properties). The sequences are presented in single letter code. The alignment was 
performed using the ClustalW online server. 
 Jnk3.1, jnk3.3, jnk3.4 and jnk3.5 exhibit only a few amino acid differences in their 
amino (N)-terminal domain but are identi
jnk3.6 are identical in length and present negligible amino acid substitutions. 
Interestingly, all jnk protein isoforms of all four genes seem to share approximately 69
82% of their amino acid sequence, with chan
(middle) region of the protein and located at its termini (Figures 3.5 and 3.6). Whether 
these seemingly insignificant amino acid differences bear structural or functional 
importance is examined below.   
 
3.3.1.3. Secondary structure and conserved motifs of jnk proteins in zebrafish
 
The next aim of the current study was to detect conserved motifs in the newly identified 
protein isoforms that would relate to the functionality of the proteins. Therefore, the 
amino acid sequences of jnk were further analysed using online databases and servers 
that can predict the secondary and tertiary structure of the proteins, as well as indicate 
conserved domains and short motifs related to their functionality and activity. The 
bioinformatics tools used in this study are listed in Table 2.1
information provided below represents a summary of all the findings collected from 
these tools. 
First, the secondary structure of the proteins of interest was examined. It was 
shown that the secondary structure of all proteins was similar, containing mainly 
strands on the N-terminus and 
perfectly the typical eukaryotic protein kinase fold, which comprises two lobes, the N
terminal one that is rich in 
(Bogoyevitch, 2006). 
typically 3-10 amino acids, in an almost fully extended conformation. In fact, the 
proteins examined seem to dif
helices they contain in the C
molecule appear indistinguishable (Figure 3.7). 
 
Figure 3. 7: Secondary structure of zebr
here for a clearer representation
brown boxes. Strands are connected laterally by 2
Helices, shown in yellow, repres
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cal in the rest of the sequence. Jnk3.2 and 
ges mainly observed outside the core 
 
2 (page 80) 
α-helices in the C-terminus. This conformation matches 
β-structures and the C-terminal one, rich in 
β-structures or β-strands are stretches of polypeptide chains 
fer only in their length and therefore in the number of 
-terminus, while the N-terminus and the core of the 
 
afish jnk proteins. Only one sequence is shown 
 but all of them were identical. β-strands are shown with 
-3 hydrogen bonds, forming 
ent α-helices. 
-
 
and the 
β-
-
α-helices 
β-sheets. 
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Additionally, using the EML and InterProScan databases all of the jnk isoforms 
were found to comprise the same conserved domains: among others, a serine/threonine-
protein kinase domain, a MAPK conserved site and an ATP-binding site, all of which 
are important for the activity of the MAPK and therefore the JNK proteins (Figure 3.8). 
Characteristic of JNK proteins is the presence of a glycine (G)-rich motif in the vicinity 
of a lysine (K), involved in ATP binding, and an aspartic acid residue (D), important for 
the catalytic activity of the kinase (Knighton et al., 1991). As shown in Figure 3.8 these 
conserved residues were found in all predicted jnk proteins examined. Additionally, T-
P-Y motifs, which are essential for activation by upstream kinases, were found in all 
protein structures (shown with black lines in Figure 3.5). The MAPK signature motif, 
which is located adjacent to the TPY motif, was, also, identified in all isoforms. This 
region contains a phenylalanine (F) and a cysteine (C) at the two extremities of the 
region of interest that are MAPK-specific. The arginine (R) and glutamic acid (E) in the 
first part of the pattern, and the arginine (R), aspartic acid (D) and lysine (K) in the 
second part, are shared by many additional protein kinases (Dorin et al., 1999). 
Detection of the aforementioned conserved motifs in the newly studied jnk 
proteins is a good indication of the potential functionality of the isoforms. Although the 
presence of the domains, which are essential for kinase activation and activity, is 
essential for the proteins to work, it does not ascertain that the proteins are actually 
produced and are active in vivo. Their in vivo production can only be confirmed by 
western blot analysis and in situ staining and cannot be predicted by in silico studies. 
The next goal was to determine the phylogenetic relationships of the zebrafish jnk genes 
and proteins with their known homologues in other species.       
 
3.3.2. Evolutionary conservation of jnk amino acid sequences 
 
The evolutionary conservation of the proteins of interest was evaluated and their 
structures were compared to their Caenorhabditis elegans (roundworm), Drosophila 
melanogaster (fruit fly), Gallus gallus (chicken) and Mus musculus (mouse) 
orthologues (Figure 3.9). C.elegans was selected as a simple, multicellular, low 
eukaryote, D.melanogaster as an invertebrate arthropod, G.gallus as an amniotic 
vertebrate and M.musculus as a mammal. Non-redundant amino acid sequences from all 
species were used for the construction of a phylogenetic tree. We were interested in 
looking at the conservation of the protein structure between different organisms, as this 
would, to some extent, entail conservation of protein function. 
  
 
Figure 3. 8: Conserved residues in catalytic motifs of 
stretch of residues (highlighted in yellow) in the N
region (G-X-G-X-X-G
(highlighted in green), shown to be involved in ATP binding. A conserved D (highlighted 
in red), commonly found in the central part of the catalytic domain, has been shown to be 
important for the catalytic activity of the enzyme. B) The MAPK signature motif is shown.
The area shown here is located just after the conserved TPY motif (shown with vertical 
black lines in Figure 3.5) and is characteristic of all MAPK. The F and C residues at the 
extremity of the region shown are MAPK
amino acids (R, E, R, D, K) are shared by additional kinases. The sequences are presented 
in single letter code. G: glycine, D: aspartic acid, K: lysine, F: phenylalanine, C: cysteine, 
R: arginine, E: glutamic acid. 
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Amino acid sequences were initially aligned in the ClustalW server. The 
alignment files were then further analysed in the MEGA5 software. The maximum 
likelihood method was used for phylogenetic reconstruction and statistical analysis, 
under the Jones-Taylor-Thornton (JTT) model of evolution, using the nearest-
neighbour-interchange (NNI) heuristic method of tree inference, with a 95% site 
coverage cut-off and 500 repetitions of bootstrap testing. Details about these models are 
given in Section 2.3.2 (page 80). 
The tree that was constructed is shown in Figure 3.9. Jnk1 is highlighted in blue, 
Jnk2 in red and Jnk3 in green. Zebrafish isoforms are illustrated in shaded boxes of the 
same colours, respectively. Jnk orthologs from other species, such as Drosophila, 
C.elegans, mouse and chicken were retrieved from Ensembl. D.melanogaster has only 
one jnk orthologue, called basket (Gettings et al., 2010, Riesgo-Escovar et al., 1996). 
C.elegans has two confirmed jnk orthologues, called jnk1 and kgb1 (Orsborn et al., 
2007). The phylogenetic relationships of all confirmed Jnk proteins in the species of 
interest are shown in Figure 3.9.  
C.elegans kgb1 seems to represent a more ancestral protein and appears to have 
been present even before the emergence of distinct jnk proteins. Similarly, basket in 
D.melanogaster diverged from the original common ancestor before the separation of 
the jnk lineage to jnk1, jnk2 and jnk3. The presence of a second jnk orthologue in 
C.elegans suggests that a duplication event might have taken place in its genome, 
giving rise to a new jnk isoform, which diverged to jnk1. C.elegans jnk1 might 
represent an ancestral form from which further duplication events and divergence led to 
the emergence of initially separate jnk1 and jnk2/jnk3 lineages and finally even further 
to separate jnk2 and jnk3 branches.  
 The separation of the jnk proteins in these three lineages (jnk1, jnk2 and jnk3) is 
quite distinct in all vertebrates examined: jnk1 proteins in one species only cluster with 
jnk1 in other species, jnk2 with jnk2 and jnk3 with jnk3. Also, not surprisingly, 
isoforms from one species tend to be closer to other isoforms of the same protein in the 
same species than to isoforms of the same protein in other species: for example, all 
zebrafish jnk3 isoforms are closer to each other than to the mouse jnk3 isoforms (Figure 
3.8). The fact that the zebrafish jnk1a and jnk1b clusters are so close and only one node 
away from each other, reinforces the notion that they may have arisen from a 
duplication of the original single jnk1 gene.  
 
 
 Figure 3. 9: Molecular phylogenetic analysis showing the evolutionary relation of Jnk proteins in different species: 
roundworm), Drosophila melanogaster (DM, fruitfly), 
history was inferred by using the maximum likelihood method based on the JTT matrix based model. The tree with the highest li
percentage of replicate trees in which the associated taxa clustered together in 
drawn to scale with branch lengths measured as the number of substitutions per site (the scalebar indicates 0.1 substitutions
31 amino acid sequences and was conducted in MEGA5. 
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Mus musculus (MM, mouse), Gallus gallus (GG, chicken), Danio rerio
the bootstrap test (500 replicates) is shown next to the branches. The tree is 
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Nevertheless, the bootstrap values for some of the nodes are relatively low, which 
suggests that the topology of these nodes is not very reliable. For example, the node that 
represents the hypothetical common ancestor of the mouse Jnk3 and the zebrafish jnk3 
is given a bootstrap value of 31. This means that the current conformation of this node 
was reproduced in 31% of the trees that were constructed by data re-shuffling, while in 
69% of the reconstructed trees the topology was different. Similarly, the node that 
separates Jnk2 (in all species) from chicken Jnk3 and the group of zebrafish jnk3/mouse 
Jnk3 was given a boostrap value of 34%. Higher, but still not sufficiently reliable, 
bootstrap values were given to the node separating the chicken and mouse Jnk2 (50%) 
and to the node that separates the C.elegans jnk1 with the common ancestor of all Jnk 
genes in mouse, chicken and zebrafish (54%).  The low reliability of the current protein 
tree is one of the reasons why a tree based on nucleotide sequences was also constructed 
(see below). 
 
3.3.3. Evolutionary conservation of Jnk nucleotide sequences 
 
After evaluation of the evolutionary relationship of the Jnk proteins between the species 
of interest, it became evident that the same should be carried out for the nucleotide 
sequences. The reasons for this were three. The first, as mentioned before, is that the 
tree, constructed based on the amino acid sequences, was not very reliable, as shown by 
low boostrap values (Figure 3.9). The second reason is related to the evolutionary 
pressure that proteins receive. As explained before, the amino acid conservation varies 
significantly in different regions of the protein: high conservation in the core part of the 
sequences, where the important function-related domains are, and low conservation in 
the rest of the sequence. Comparison of nucleotide instead of amino acid sequences can 
account for this uneven conservation since mutations at the DNA level are not related to 
the functionality of the protein and do not receive the same evolutionary pressure. 
Thirdly, not all mutations that happen at the DNA level are directly translated to amino 
acid changes because of the degeneration of the genetic code. For example the amino 
acid glycine can be encoded by four different codons (GGA, GGC, GGG and GGT) 
and, thus, any change in the last nucleotide of the codon will not be translated to an 
amino acid change. Therefore, phylogenetic trees based on nucleotide comparisons are 
likely to give better estimations of evolutionary time. For the reasons presented above, a 
tree based on the nucleotide sequences of jnk transcripts was also constructed (Figure 
3.10).
 Figure 3. 10: Molecular phylogenetic analysis showing the evolutionary relation of Jnk nucleotide sequences in different species: 
(CE, roundworm), Drosophila melanogaster (DM, fruitfly), 
Evolutionary history was inferred by using the maximum likelihood method based on the Tamura
The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (500 replicates) is shown next to the branches. The 
tree is drawn to scale with branch lengths measured as the number of substitutions per site (the scalebar indicates 0.1 subst
involved 36 nucleotide sequences and was conducted in MEGA5.
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Mus musculus (MM, mouse), Gallus gallus (GG, chicken), Danio rerio
-Nei model. The tree with the highest likelihood is shown. 
Caenorhabditis elegans 
 (DR, zebrafish). 
itutions per site). The analysis 
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No major differences were observed between the two trees (based on amino acid 
and nucleotide sequences). Clustering of Jnk2 and Jnk3 transcripts was as expected and 
as shown before in the protein phylogenetic tree (Figure 3.9).  The Jnk1 family was, 
however, more scattered. Mouse and chicken sequences clustered together, while 
zebrafish orthologues appeared in a separate subtree. Zebrafish jnk1a and jnk1b 
transcripts remained very closely related. The C.elegans Kgb1 transcript seems to 
correspond to an ancestral form, as was shown with the protein tree too. However, in 
this tree, contrarily to what was shown by the protein tree, the C.elegans Jnk1 isoform 
seems to have diverged before the emergence of a separate Jnk1 gene in other species. 
Although this finding is unexpected and difficult to interpret, its bootstrap value is 95%, 
which reinforces the reliability of the current tree conformation. The respective 
bootstrap value of that branch in the protein tree is a mere 54%, as explained before. In 
fact, the boostrap values in all nodes of the tree are high, with the lowest ones being 
55% and 60% (Figure 3.10). This highlights the reliability and robustness of the 
nucleotide-based tree, compared to the protein-based tree. Of note, any phylogenetic 
tree is as good as the data that were used to construct it. Additional information (using 
genes from more species for example) could generate some changes in the topology of 
the tree. For the purposes of this study, however, the analysis performed is adequate and 
reliable.   
Overall, the in silico investigation and subsequent bioinformatics analysis 
confirmed the presence of an additional jnk-like gene (jnk1b), ortholog to vertebrate 
Jnk1 and paralog to zebrafish jnk1a. Jnk1b showed high evolutionary conservation with 
other zebrafish jnk genes (jnk1, jnk2 and jnk3) and with Jnk genes from other species 
(mouse, chicken, fruit-fly and roundworm). Sites of high evolutionary similarity were 
located in the core part of the genes, which correspond to the essential activation and 
activity domains of the kinases, while lower conservation was observed in the two 
termini of the genes and subsequently of the proteins. It was, also, shown that 
phylogenetic trees based on nucleotide sequences are more reliable than trees based on 
amino acid sequences, as suggested by bootstrap analysis of both types of trees. The jnk 
gene-based phylogenetic tree revealed that kgb1 (one of the Jnk genes in C.elegans) 
might represent an ancestral form of the protein that gave rise to all different jnk genes.     
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3.4. In vivo analysis 
  
After in silico identification and characterization of the zebrafish jnk genes, the onset of 
their expression and their expression pattern were examined in detail. Two main tools 
were used in order to achieve this: reverse transcriptase (RT)-PCR to look at the 
temporal gene expression pattern in development and in adulthood and whole mount in 
situ hybridization to study the pattern of expression of these genes.  
RNA was extracted from three different batches of golden zebrafish embryos 
(biological replicates: 10-20 embryos, depending on the age, from three different 
clutches) at various developmental stages and was transcribed to cDNA. PCR reactions 
were repeated three times on each cDNA set (experimental replicates). Results from one 
representative set are shown here. Primers were designed to either bind specific 
isoforms only or to bind all isoforms of one gene, as shown in Figure 3.11 (primer 
sequences are shown in Table 3.2). Primer design was based on the gene information 
available at the time and therefore does not include all splice variants. Specifically, 
jnk1a.1, jnk1a.2, jnk3.1, jnk3.2 and jnk3.3 were the only variants that were individually 
detected. All other variants were detected by the common primer sets.  
The housekeeping gene β-actin was used as an internal control for RT-PCR, 
providing a reference of the cDNA input and the baseline gene expression. Primer sets 
(jnk and β-actin) were optimised individually but were found to work optimally under 
similar conditions, as they were designed to have similar properties (nucleotide length, 
GC content etc). The same number of PCR cycles was used for all reactions in order for 
the PCR products to be comparable between them. Also, the UV light exposure during 
agarose gel imaging was the same for all gels.  
Although semi-quantitation was possible with the technique used, the main aim of 
the current approach was to establish that the genes of interest were expressed during 
development and not to accurately characterize the levels of their expression. 
Quantitative RT-PCR (qPCR) could have been employed instead, if a precise 
expression analysis was required. A no-template control was included in all reactions to 
ascertain that the products were specific and not due to contamination. More details on 
practical aspects of these methods are given in Sections 2.1.7 (page 57, for wholemount 
in situ hybridization) and 2.1.10 (page 61, for RT-PCR). 
  
 
 
Figure 3. 11: Location of manually designed jnk primers. Black arrows represent primers that bind to all transcripts of one gene, while g
primers that are specific for one gene isoform. Although, the sequences between different genes appear indistingui
there are enough point mutations that allow for the design of gene
and jnk3) is shown in a separate box.  
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-specific primers that do not bind to any other jnk genes. Each gene (
reen arrows show 
jnk1a, jnk1b, jnk2 
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Whole mount in situ hybridization was performed three independent times on 
Golden zebrafish embryos of different clutches at different developmental stages. 20 
embryos were commonly used for each reaction. The most representative staining 
patterns are shown here. Probes were designed to either bind specific isoforms only or 
to bind all isoforms of one gene (sequences shown in Table 3.3), as explained in Section 
2.1.12 (page 61). Sense-probe and no-probe controls were used for confirmation of the 
specificity of the staining. Staining with a tbx5 (tbx5a) probe was used as a positive 
control. More details about this method are given in Section 2.1.7 (page 57).     
 
Genes Size (bp) Forward sequence Reverse Sequence 
β-actin 105 GAGCAGGAGATGGGAACC CAACGGAAACGCTCATTGC 
Pan-jnk1a 253 CGCTGAGAAGACCCCAGTGTT TACGCTGAGCAGACGATGCC 
Jnk1a.1 240 TCGGACCACAACAAACTCAA CCATTCCAGCACTTCCTTGT 
Jnk1a.2 190 GGGCATGGGTTATCAAGCTA   TCAATGGCAACACATATTAAGG   
Pan-jnk1b 179 CAGGGACCTGAAACCCAGTA ACACATCCACATTGGCTTGA 
Jnk2 407 TCACAGGGATCTGAAGCCCA TCTCTGATGGGAAGGCCCAG 
Pan-jnk3 290 GGGCATGGGCTACAAGGAGA GTGCCTGACTCGCTTTGAGT 
Jnk3.1 270 TCAGTCCTTTGGAGCTGCTT GTCCAGGACGGCATCATATC 
Jnk3.2 150 TGAGAAACCCTCCCATTGTG AACACTACAGCAAACAACACCA 
Jnk3.3 237 TGCCTTTTGTCAGGTGTGTG GTCCAGGACGGCATCATATC 
 
Table 3. 2: Zebrafish RT-PCR primer sequences. All jnk primer sets were manually 
designed to span exon-exon boundaries (when possible) in order to avoid genomic DNA 
contamination. The sequences of β-actin were retrieved from previously published work 
(McCurley and Callard, 2008).  
 
 
Target gene Forward sequence Reverse Sequence 
Pan-jnk1a CTGAGAAGACCCCAGTGTTT GCAGAGCATCTGATAGAGCA 
Jnk2 CAACGGTCAGTCATGCCACA  CAGAGCGGAGCAGACGATAC  
Pan-jnk3 TCTTACATTGCCCAGCATTA ATCCACGTTCTCCTTGTAGC 
Jnk3.3 CCATAATGGTACAGGCATCA  CAGCACACACTATTCCCTGA  
 
Table 3. 3: Sequences of zebrafish primers that were used for making the probes for 
wholemount in situ hybridization. Primer sets were designed to span different exons, when 
possible, to give large PCR products and not to recognize other jnk genes.  
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3.4.1. Temporal expression analysis of jnk in zebrafish 
 
As mentioned before, β-actin was used as a housekeeping gene for the RT-PCR analysis 
presented here. The expression of this gene, shown previously to be expressed at stable 
levels throughout development and following chemical treatment in zebrafish 
(McCurley and Callard, 2008), was used as a measure of the cDNA input for each PCR 
reaction. The same amount of cDNA was used for the β-actin reaction and for all jnk 
reactions at one specific developmental stage. 
As shown in Figure 3.12, the temporal expression profile of the various isoforms 
is distinct. Jnk1a.1 is expressed throughout development, from 20 minutes after 
fertilization onwards with small fluctuations in the levels of expression. Highest levels 
are observed at 3 hpf and after 48 hpf, as well as in day 5 (d5) embryos and in the adult 
heart. 3 hpf represents the mid-blastula transition, when the embryonic genome 
becomes activated (see Section 1.2.1 at page 2 for more details on this). Therefore, 
increased mRNA levels at that time point reflect the onset of expression of the 
embryonic jnk1a.1 gene. Before 3 hpf only maternal jnk1a.1 mRNA was probably 
present. Similarly, jnk1a.2 was maternally expressed at 20 minutes, reached maximal 
levels at 3 hpf, when embryonic expression started, and faded away after 48 hpf. Its 
expression in older embryos (5 days old) and in adult tissues (brain and heart) was 
abundant. RT-PCR with the pan-jnk1a primers recapitulates to some extent the 
expression patterns of jnk1a.1 and jnk1a.2. This suggests that the other jnk1a splice 
isoforms are either not expressed at the developmental stages examined or are expressed 
in a very similar pattern as jnk1a.1 and jnk1a.2.  
Jnk1b remained modestly expressed until 10 hpf, picked up between 20 hpf and 
48 hpf and disappeared at 72 hpf, while it became again abundantly present after 5 days 
of development. The fact that there was no peak at 3 hpf possibly indicates that the 
activation of embryonic jnk1b did not take place until later in development. Thus, it is 
possible that most of the jnk1b mRNA that was detected until 10 hpf was of maternal 
origin (Figure 3.12). Jnk2, although present since 20 minutes after fertilization, was 
expressed at very low levels throughout development with highest expression levels 
observed in d5 old fish and in adult tissues. As with jnk1b, no peak was observed at 3 
hpf and therefore, it is possible that most of the detected mRNA was of maternal and 
not embryonic origin until later in development.  
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Three jnk3 transcripts were examined: jnk3.1, jnk3.2 and jnk3.3. They showed a 
different pattern and a later onset of expression (Figure 3.12). Jnk3.1 and jnk3.2 were 
not expressed at all during development and were only found in the adult brain, while 
jnk3.3 was present after 36 hpf and was, also, expressed in d5 fish and in adult tissues, 
both the heart (at low levels) and the brain (at high levels). Its presence in the adult 
heart made it the only jnk3 isoform expressed in the fully formed and functional heart. 
Recapitulation of the jnk3.3 expression pattern with the pan-jnk3 primers suggests that 
the rest of the jnk3 variants are not expressed during development (like jnk3.1 and 
jnk3.2) or that they are expressed in a similar manner to jnk3.3. In either case, jnk3 was 
not expressed at all in the early stages of development. Therefore, only jnk1a, jnk1b and 
jnk2 are expected to be involved in most of the early events of gastrulation, cell 
specification, organogenesis and morphogenesis that happen before 36 hpf, when one of 
the jnk3 isoforms is firstly expressed.  
Taken together, the RT-PCR data revealed that mRNA of the isoforms of interest 
is produced in vivo. Also, it showed that jnk1a, jnk1b, jnk2 and jnk3 have distinct 
expression patterns, with jnk1a and jnk1b being the most highly expressed genes during 
the early embryogenesis stages. Next, the in vivo spatial expression profile of jnk during 
the first days of zebrafish development was investigated.  
 
3.4.2. Spatial expression analysis of jnk in zebrafish 
 
After jnk mRNA detection with RT-PCR that revealed the timely expression pattern of 
the genes, their spatial expression pattern was also examined at different time points. 
Four antisense probes were used in this assay: against jnk2, all jnk1a isoforms (pan-
jnk1a), all jnk3 isoforms (pan-jnk3) and jnk3.3. Since no other jnk3 transcript, besides 
jnk3.3, was expressed until adulthood, the pan-jnk3 probe was used as a control to 
confirm the specificity of jnk3.3 probe staining. Tbx5a was used as a positive control, 
while sense probes or no probes were used as negative controls at all ages examined. 
The sense jnk and the tbx5 staining are shown along with the antisense jnk staining 
(Figures 3.14, 3.15, 3.16 and 3.17) allowing for direct comparison of the expression 
patterns, while the negative controls are presented in a separate figure because of space 
limitation (Figure 3.13). Golden embryos were used for this analysis because, due to 
their low pigmentation, they allow for easier visualization.    
Whole mount in situ hybridization (WISH) without any probe (negative control) 
confirmed the absence of unspecific background staining (Figure 3.1.3). Tbx5 staining 
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followed the expected pattern of expression, as suggested by previously published work 
(Begemann and Ingham, 2000). It was shown to be expressed in the forming pectoral 
fin buds and subsequently in the developing fins, in the embryonic heart and in the eyes 
(Figures 3.14, 3.15, 3.16 and 3.17). The fact that tbx5 staining appeared as expected 
increased the reliability of the method and of the findings thereafter.   
WISH at 24 hpf with a pan-jnk3 and a jnk3.3 probe showed formation of blue 
precipitate in the area lining the yolk sac, covering the presumptive pharyngeal region 
and the area where the heart tube lies (Figures 3.14 and 3.15). The RT-PCR results 
presented in Figure 3.12 show that at 20 hpf none of the jnk3 transcripts was present, 
while at 36 hpf jnk3.3 was already quite highly expressed. Therefore, although 24 hpf is 
not included in the RT-PCR analysis in Figure 3.12, it seems likely from the WISH 
analysis that the onset of jnk3.3 (detected by both pan-jnk3 and jnk3.3 probes) 
expression was between 20 and 24 hpf. At 36 hpf staining with jnk3.3 and pan-jnk3 was 
more specific in the hypothalamus of the brain and the developing otic vesicles (Figures 
3.14 and 3.15). At 96 hpf expression of jnk3.3 was apparent in the area around the heart. 
Staining with the anti-jnk3.3 probe showed clearer staining in the heart area, where it 
was shown that possibly not the whole heart was stained (Figure 3.15). The gut was also 
stained at 96 hpf with both probes. The sense probes of both jnk3.3 and pan-jnk3 probes 
showed no staining at all, confirming that the expression pattern seen with the antisense 
probes was real and specific.  
Three ages were examined for jnk1a and jnk2 expression: 13, 24 and 36 hpf. At 
13 hpf both jnk1a and jnk2 appeared ubiquitously expressed, with possibly higher 
expression levels in the head (Figures 3.16 and 3.17). At 24 hpf jnk1a was highly 
expressed in anterior structures, covering the whole head, the heart area and most of the 
trunk. At 36 hpf staining with the pan-jnk1a probe was fairly faint but appeared in the 
presumptive gut area and possibly the eyes (Figure 3.16). Jnk2 followed a similar 
expression pattern. At 24 hpf it was present in the pharyngeal area and the presumptive 
gut and heart, while at 36 hpf it was found in the brain, the pharyngeal region and the 
heart (Figure 3.17). The sense probes for jnk1a and jnk2 showed some staining as well, 
but the areas in which it appeared generally overlapped with the areas stained by the 
antisense probes.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 13: Negative control for the in situ hybridization analysis
of these embryos. No staining was observed in any of the ages examined, suggesting that any staining that would appear in the
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. No probe was added to the hybridization mix during wholemount in situ hybridization 
 probed embryos is real.  
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Figure 3. 14: In situ hybridization of 24, 36 and 96 hpf golden zebrafish embryos with a 
pan-jnk3 probe. A) and D) show 24 hpf fish stained in the area lining the yolk sac, in the 
presumptive gut and heart regions. B) and E) show 36 hpf embryos stained in the 
hypothalamus (red arrow) and otic vesicles (black arrows). C) and F) show 96 hpf fish 
with staining in the heart (arrow) and gut regions. G-I) represent negative controls for 
each age, respectively. These were stained with sense probes that are not expected to bind 
to the target mRNA. (J-L) show 24, 36 and 96 hpf embryos stained with a tbx5 probe, used 
as a positive control. The arrow in (J) shows one of the fin buds, in (K) the heart region 
and in (L) the fins. Scale bars show 200µm.  
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Figure 3. 15: In situ hybridization of 24, 36 and 96 hpf golden zebrafish embryos with a 
tbx5 and a jnk3.3 probe. (A-C) Tbx5 staining of 24, 36 and 96 hpf embryos, respectively. 
The arrow in (A) shows one of the fin buds, in (B) the heart region and in (C) the fins. (D-
F) Antisense jnk3.3 staining. D) shows 24 hpf fish stained in the area lining the yolk sac, in 
the presumptive gut and heart regions. E) shows 36 hpf embryos stained in the 
hypothalamus and otic vesicles (arrows). F) shows 96 hpf fish stained in the heart (arrow) 
and gut regions. G-I) Sense jnk3.3 staining, used as negative controls for each age (24, 36 
and 96 hpf, respectively). These were stained with sense jnk3.3 probe that is not expected 
to bind to the target mRNA. Scale bars show 200µm.  
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Figure 3. 16: In situ hybridization of 13, 24 and 36 hpf golden zebrafish embryos with a 
pan-jnk1a probe. A) shows 13 hpf fish stained predominantly in the anterior area 
(anterior to the left). B) and D) show 24 hpf embryos stained heavily in the head (aarow). 
C) and E) show 36 hpf fish with faint staining in the head, presumptive gut regions and 
potentially the fin buds (arrow in C) and the heart (arrow in E). F-H) represent negative 
controls for each age, respectively. These were stained with sense probes that are not 
expected to bind to the target mRNA. Residual staining in the negative control is similar to 
the real staining. (I-K) show 24, 36 and 96 hpf embryos stained with a tbx5a probe, used as 
a positive control. The arrow in (I) shows one of the fin buds, in (J) the heart region and in 
(K) the fins. Scale bars show 200µm.  
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Figure 3. 17: In situ hybridization of 13, 24 and 36 hpf golden zebrafish embryos with a 
jnk2 probe. A) shows 13 hpf embryos stained predominantly in the anterior area (anterior 
to the left). B) and D) show 24 hpf embryos stained in the area lining the yolk sac and in 
the presumptive heart (arrow) and gut regions. C) and E) show 36 hpf fish with strong 
staining in the head and anterior structures (red arrow) and potentially in the heart (black 
arrow). F-H) represent negative controls for each age, 13, 24 and 36 hpf, respectively. 
These were stained with sense probes that are not expected to bind to the target mRNA. 
Residual staining in the negative control is similar to the real staining. (I-K) show 24, 36 
and 96 hpf embryos stained with a tbx5 probe, used as a positive control. The arrow in (I) 
shows one of the fin buds, in (J) the heart region and in (K) the fins. Scale bars show 
200µm.  
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Further analysis and undoubtful confirmation of the expression profiles of jnk 
during zebrafish embryonic development could have been achieved by embedding (in 
wax or resin for example) and sectioning stained embryos and closely looking at the 
staining pattern in structures of interest. Also, antibody analysis would have been useful 
for evaluating the presence, not only of the transcripts, but also of the protein products. 
However, time limitations did not allow for such analyses. Taken together, the temporal 
and spatial expression patterns of jnk genes were determined. RT-PCR analysis showed 
that jnk1a and jnk1b were the most predominantly expressed genes during early stages 
of embryogenesis, with jnk2 being expressed at very low levels and jnk3 only coming 
on later in development. WISH experiments revealed abundant expression of jnk1a and 
jnk2. In situ expression analysis provided insight into the spatial distribution of the 
genes but not in an absolutely conclusive manner because of the inability to visualize 
specific organs. Therefore, the exact domains of expression of the genes have not been 
determined due to, as explained above, time limitations. 
 
3.5. Discussion 
 
In this chapter zebrafish jnk genes and proteins were examined. Initially, a 
bioinformatics approach enabled thorough investigation of jnk splice variants and 
protein isoforms and confirmed the presence of an additional gene compared to 
mammals. In vivo and in situ studies of the identified genes confirmed their expression 
and showed differential temporal and spatial patterns.  
 
3.5.1. In silico identification of four jnk genes in zebrafish 
 
Rather than the expected three Jnk genes observed in other mammals, four jnk genes 
were found in zebrafish in online databases after thorough in silico investigation: jnk1, 
jnk2 and jnk3, orthologues of mammalian Jnk1, Jnk2 and Jnk3, and an additional jnk1-
like gene. The two jnk1 genes were called jnk1a and jnk1b following the official 
nomenclature for duplicated gene pairs. The locus in chromosome 13, where jnk1b lies, 
appears to be member of a duplicated pair that includes a region of chromosome 12, 
where jnk1a is located. Measurement of the evolutionary divergence of all jnk genes in 
zebrafish showed that jnk1a and jnk1b share significantly more similarities than jnk1b 
does with either jnk2 or jnk3. Subsequent phylogenetic analysis revealed the expected 
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clustering of zebrafish jnk genes and proteins with their corresponding orthologues in 
other species (chicken, mouse, roundworm and fruitfly). Jnk1b clustered with zebrafish 
jnk1a and with other Jnk1 orthologues. Interestingly, Jnk1 appears to have diverged 
from the common ancestor before the divergence of Jnk2 and Jnk3.  
Emergence of additional genes in zebrafish was not unexpected. A genome-wide 
duplication event took place approximately 350 million years ago in the lineage of ray-
finned fish, after its divergence from the lobe-fin lineage that includes avians and 
mammals. Therefore, many of the genes of land vertebrates are duplicated in zebrafish 
(Meyer and Van de Peer, 2005, Postlethwait et al., 2000). A usual but not certain fate of 
duplicated gene pairs is loss of one of the members by mutations; genes can either turn 
into pseudogenes (explained in detail below) and become inactive or they can be lost by 
further chromosomal rearrangements (Postlethwait et al., 2000, Watterson, 1983). 
Therefore, the number of duplicated genes that are present in two copies in the zebrafish 
genome is not known and possibly many duplicates remain unidentified to date 
(Amores et al., 1998, Ellies et al., 1997, Postlethwait et al., 2000). 
The process of identification of duplicated pairs may be further complicated by 
the excess of chromosome fusions that likely occurred in the fish lineage after 
duplication of its genome. This is suggested by the fish fusion model. According to this 
model, the fact that fish (25 chromosomal pairs) do not have twice as many 
chromosomes as humans (23 chromosomal pairs), although their whole genome was 
duplicated, is due to excessive fusion of chromosome segments that re-established the 
original number of chromosomes (Postlethwait et al., 2000). An alternative theory, 
supported by the tetrapod fission model, suggests that the ancestral state was of 
approximately 12 chromosomes, which doubled in the fish lineage and fragmented in 
tetrapod lineages (Postlethwait et al., 2000). Both these theories explain the current 
karyotypic status of fish and tetrapods but it still remains unclear which one more 
accurately describes the real evolutionary history (Goode et al., 2011).     
 
3.5.2. Pseudogenes and the fate of duplicated gene pairs 
 
As mentioned before, it is not uncommon for duplicated genes to become inactivated 
and turn into pseudogenes (Postlethwait et al., 2000, Watterson, 1983). Pseudogenes are 
DNA sequences that resemble functional genes but in fact do not have, or are thought 
not to have, any known function (Jacq et al., 1977). The loss of function of pseudogenes 
is usually due to either failure of transcription and/or translation or due to production of 
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a defective protein (Mighell et al., 2000, Vanin, 1985, Yao et al., 2006). They are 
commonly derived from duplications of existing genes and are located either at different 
chromosomes to their functional counterparts or in clusters with them (Lee et al., 2003, 
Long and Langley, 1993). They may be complete or incomplete copies of the original 
genes or they may comprise mixtures of different genes (Lee et al., 2003). Some form 
of short mRNA is likely to be produced from pseudogenes, depending on the mutations 
they have accumulated over time and the damage that has been caused to the original 
gene sequence, as shown for a few pseudogenes in the past (selected publications: 
Balakirev and Ayala, 2003, Berger et al., 2005, Edgar, 2002, Guo et al., 1998). Their 
full expression is, however, usually disrupted by misplaced stop codons, deletions, 
insertions or other kinds of mutations. It is thought that pseudogenes are good examples 
of common ancestry, when shared by different species, and are commonly used by 
evolutionary biologists for phylogenetic analysis (Balakirev and Ayala, 2003). It has, 
also, been shown that some pseudogenes serve as regulators of the expression levels of 
their paralogous coding genes (Hirotsune et al., 2003).   
Online databases are able to identify and highlight pseudogenes. Jnk1b was not 
identified as a pseudogene in online databases. Also, the confirmation of its presence in 
our in vitro approach and its alignment with jnk1a revealed that this gene was neither 
lost nor severely altered during fragmentation or rearrangement of chromosomes. Of 
note, the Ensembl genome database is an automated system and as such, it has both the 
benefits (objectivity, reproducibility and speed) and drawbacks (absence of the human 
expertise and curation) associated with automation. Automatic pseudogene annotation 
in the database relies on some basic criteria for pseudogene identification (presence of 
single exons, absence of methionine at the beginning of the translation start point, 
presence of in-frame stop codons etc). These are, however, only guidelines and are 
likely not to identify all pseudogenes in all occasions. Therefore, manual pseudogene 
flagging, on top of automatic predictions, is preferable. The HAVANA group at the 
Welcome Trust Sanger Institute provides manual curation of Ensembl predictions 
(confirmation of automatically collected data with human expertise) and displays its 
results in a separate track in the Ensembl browser. The conclusions drawn and presented 
here are based on information gathered by both automatic annotation and manual 
curation.    
Overall, it is most likely that the newly identified jnk1b gene has not been 
inactivated in the course of time since the duplication event. Also, the fact that in the 
meantime (as this work was being carried out) in vivo information about jnk1b was 
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published (Seo et al., 2010), does not allow for much doubt. However, the only definite 
confirmation for this would be the undoubtful detection of phospho-jnk1b levels (the 
activated form of jnk proteins) in vivo, which was not pursued here.  
 
3.5.3. Zebrafish jnk genes in the literature  
 
The two zebrafish jnk1 genes were described in the literature for the first time when the 
current study was being carried out (Seo et al., 2010). They presented four genes, jnk1a-
1, jnk1a-2, jnk2 and jnk3, among which the first three were found to be expressed 
during gastrulation. Knockdown of jnk1a-1 and jnk1a-2 with morpholino injections 
showed no gross morphological abnormalities, while jnk2 downregulation caused 
severe defects in anterior-posterior extension and mediolateral convergence of the body, 
producing a convergence-extension-like (CE-like) phenotype (Seo et al., 2010). It was, 
also, shown that Wnt11, a ligand of the non-canonical Wnt pathway, is a target of 
Mkk4-Jnk signalling and possibly mediates regulation of CE movements (Seo et al., 
2010). However, in this publication no gene expression or bioinformatics analyses of 
the newly identified genes were conducted. Given the lack of in silico investigation in 
the work by Seo et al. (2010), it is possible that their splice morpholinos, instead of 
knocking down jnk, may in fact have inadvertedly produced alternative jnk isoforms. 
This idea is supported by the bioinformatics approach presented in this thesis, which 
showed that most of the jnk splice variants differ very little between them.    
Therefore, there are three reasons why the current study is not severely 
compromised from the publication of the work just described. The first is that this 
publication did not address other features of zebrafish development, besides 
gastrulation. For example, formation of the heart, as well as formation of other organs, 
were not assessed but are of interest in this study (presented in the next chapter). The 
second reason is that Seo et al. (2010) did not take into account the different splice 
variants of the zebrafish jnk genes. From my work, it is evident that jnk genes have 
many splice variants, most of which produce potentially functional protein isoforms. 
These variants are shown to be expressed in a spatially and temporally specific manner. 
The fact that Seo et al. (2010) did not look at splice isoforms of the genes they 
examined, means that functional redundancy may have been overlooked. The splice 
morpholinos that were used in their study were designed against each gene (jnk1a-1, 
jnk1a-2, jnk2 and jnk3) but whether they blocked correct splicing of all variants was not 
specified (Seo et al., 2010). After a scrutinous investigation and comparison of the 
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available sequences in genome databases, it was revealed that the morpholinos designed 
against jnk1a-1, jnk1a-2, jnk2 and jnk3 in the work of Seo et al. (2010) bind to most but 
not all of the transcripts. Specifically, the short transcripts, shown in Figure 3.5 
(jnk1b.4, jnk3.7 and jnk3.8) were not targeted by these splice morpholinos. Although it 
is not clear whether these short isoforms are in fact functional, it is important to take 
into account that production of even small levels of properly spliced jnk mRNA could 
compensate to some extent for the loss of the other isoforms. This observation 
highlights the third reason why the work presented in this chapter is of importance: it 
provides a comprehensive and detailed analysis of the four jnk genes, their splice 
variants, their putative protein isoforms and their evolutionary and phylogenetic 
relations, which has not been conducted in the past. The presence of additional putative 
paralogs or variants (for example an additional jnk2 or jnk3 gene) was investigated 
thoroughly and was disproved. This observation is based on the information currently 
available in online databases (Ensembl release 62). Such an approach facilitates further 
investigation of the timely and spatial roles of individual genes or variants, avoiding 
unknown confounding redundancy effects.  
Previously published work carried out mainly on frog and mouse embryos has 
shown that the JNK signal transduction pathway is important in regulating CE 
movements (Asaoka and Nishina, 2010, Yamanaka et al., 2002). However, no 
distinction between different jnk genes was made in any of them. In the study by Seo et 
al. (2010) jnk2 was shown to have more important roles in the regulation of CE 
movements during gastrulation than jnk1 (jnk1a-1 and jnk1a-2) and jnk3 (Seo et al., 
2010). It has been suggested in the past that Jnk1 and Jnk2, although concurrently and 
ubiquitously expressed in mammalian embryos, may in fact have substantially different 
contributions in cellular processes depending on the physiological content, the presence 
or absence of interacting partners, the activating stimulus and the timing (reviewed by 
Bode and Dong, 2007). Intriguingly, most of the known Jnk substrates to date can be 
bound and become phosphorylated by all Jnk kinases (some exceptions are mentioned 
in Section 1.5.2, page 38) but to different degrees, with different affinities and with 
different, even contradictory, outcomes (Bode and Dong, 2007, Gupta et al., 1996, 
Hochedlinger et al., 2002, Sabapathy et al., 2004, Sabapathy et al., 2001, Sabapathy and 
Wagner, 2004); for example, Jnk2 has been shown to have a greater affinity for binding 
to c-Jun and targeting it for ubiquitination and degradation, while Jnk1 is more efficient 
in phosphorylating and thus activating it (Bode and Dong, 2007, Gupta et al., 1996). 
The function of each Jnk gene can be also greatly modified depending upon the 
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expression and activation status of the other Jnk genes; for example, Jnk1 was shown to 
be greatly upregulated in Jnk2-/- mouse embryonic fibroblasts and to compensate for the 
loss of Jnk2 activity (Jaeschke et al., 2006, Jaeschke et al., 2005). New specific targets 
for the three Jnk genes are yet to be identified but are likely to exist. Taken together, the 
data presented above highlight the necessity for investigation of the individual 
contributions of jnk genes and isoforms, which have been shown in the past to be 
differentially regulated.  
 
3.5.4. In vivo expression analysis of zebrafish jnk genes and proteins 
 
The expression pattern of the identified zebrafish jnk genes was examined with two in 
vivo complimentary methods: RT-PCR and in situ whole mount hybridization (WISH). 
The former was mainly used for establishment of the timing of jnk expression and the 
latter for establishment of the localization of jnk expression. Jnk1a was shown to be 
abundantly expressed from fertilization until late developmental stages, with zygotic 
(embryonic) gene expression possibly activated at approximately 3 hpf during the mid-
blastula transition, as shown by RT-PCR analysis. In situ spatial expression analysis 
confirmed abundant production of jnk1a mRNA, mainly in anterior structures, such as 
the brain and possibly the heart, but also in the presumptive gut. This pattern of 
expression fits in with previously published work that showed expression of zebrafish 
jnk1 throughout development, mainly localized in the telencephalon and hypothalamus 
of the brain and in the presumptive gut (Krens et al., 2006).  
Jnk2 was shown by RT-PCR analysis to be expressed at low levels during 
embryonic development, with a putative peak at the onset of gastrulation (5.25 hpf). In 
contrast, in situ hybridization with an anti-jnk2 probe showed abundant expression of 
this gene at 13, 24 and 36 hpf, very similar to the expression pattern of jnk1a. This 
discrepancy can be partly explained by the differential sensitivity and specificity of the 
two methods. PCR is a highly sensitive technique. However, its efficiency and 
reliability depend greatly on the quality of the primers and on the optimisation of the 
protocol; suboptimal conditions may have significantly reduced yield and provide 
underestimated levels of gene expression. Although primers were carefully designed 
and the reaction was thoroughly optimised, the possibility that further optimisation 
could have been achieved cannot be excluded. In turn, in situ hybridization is a highly 
sensitive technique that can detect even as little as 10-20 copies of mRNA per cell 
(Thisse et al., 2004, Thisse and Thisse, 2008). The design of long probes (of around 
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400-500 base pairs) that recognize and bind to a large area of the mRNA that is 
produced in the cell, enhances the specificity and intensity of the signal and provides a 
reliable read-out of the levels of gene expression. Optimisation is required for this 
technique as well, in order to achieve the best levels of resolution with the highest levels 
of stringency. Of note, neither of these techniques is suited for strict quantitative 
analysis and they are both used in this study for the qualitative detection (spatial and 
temporal) of jnk genes and not for accurate measurement of their expression levels. It is, 
therefore possible that the differences in the expression levels of jnk2 detected by RT-
PCR and by WISH are mainly due to the limitations of the two techniques in providing 
reliable quantitative information. If accurate quantitation of jnk expression levels was of 
interest here, quantitative real-time PCR could and would have been employed 
(described in Chapter 2, page 73 and used for the data presented in Chapters 5 and 6). 
Also, the use of different primers/probes suited to the optimal requirements of each 
technique individually (short in RT-PCR analysis for increased specificity and 
efficiency, long in WISH for enhanced signal detection and specificity), are likely to be 
another reason for the discrepancy. Given the data presented by Seo et al. (2010) that 
suggested jnk2 as being the most important jnk gene expressed during gastrulation (Seo 
et al., 2010), it is likely that the WISH results obtained here more accurately represent 
the real expression levels of jnk2 during zebrafish development than the RT-PCR 
results.   
Jnk3 expression was absent at 20 hpf and firstly detected by RT-PCR at 36 hpf. 
However, WISH analysis showed low levels of jnk3 expression already at 24 hpf, a time 
point not included in the PCR analysis. Thus, onset of expression of jnk3 is likely to be 
between 20 hpf and 24 hpf. At this stage (20-24 hpf) and up to at least 5 days of 
embryonic development only jnk3.3, among the jnk3 variants examined here, was found 
to be expressed, so any mRNA signal detected by WISH analysis with the pan-jnk3 
probe at 24, 36 and 96 hpf is likely to represent jnk3.3 mRNA. Hybridization with a 
specific anti-jnk3.3 probe reproduced the expression pattern detected by the pan-jnk3 
probe and reiterated the notion that throughout development only jnk3.3 mRNA, among 
the jnk3 splice variants, is produced.  
Sense probes were used as controls for each antisense probe. Antisense probes are 
designed so that they can bind to endogenously produced mRNA. Sense probes, in 
contrast, are designed to bind to antisense mRNA that is not commonly produced 
endogenously. So, it is commonly expected that staining with sense probes does not 
give any blue-purple precipitate, emphasizing the specificity of the antisense probe. 
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This was the case for sense jnk3 and jnk3.3 staining, but not for sense jnk1 and jnk2. A 
possible reason for detection of product after staining with sense jnk1 and jnk2 probes at 
13 and 24 hpf (no staining was observed at 36 hpf) is internal regulation of the levels of 
mRNA production: antisense mRNA may be produced endogenously as a regulatory 
mechanism for controlling the levels of expression of sense mRNA (that will be 
translated and will produce the corresponding protein). If this scenario is true, the 
expression domains of sense and antisense mRNA and thus the staining pattern of 
antisense and sense probes, respectively, are expected to be quite similar but possibly 
not identical (due to the effect of regulation). This is, in fact, what is observed here, 
with jnk1 and jnk2 sense probes giving a similar (anterior-dense) staining pattern as 
their antisense counterparts. Overall, the main areas of jnk expression, as revealed with 
the current approaches, are anterior structures, such as the brain, the heart, the otic 
vesicles, the presumptive gut and possibly the fin buds.  
 
3.5.5. Advantages and disadvantages of the current study 
 
In the current study three complementary methods were used for the identification of 
zebrafish jnk orthologs. In silico investigation and bioinformatics analysis were 
complemented by in vitro and in vivo gene expression examination, providing a 
thorough overview of zebrafish jnk genes. The most up to date information was used for 
all the analyses and, with the use of appropriate controls, comprehensive and reliable 
results were obtained. An obvious observation from the data presented in previous 
sections is the fact that not all jnk transcripts identified in silico were further examined 
in vivo and in situ. The main reason for that was the constant update of online databases. 
Ensembl provides very regular updates of its online information and different or newly 
predicted transcripts appear frequently. This made the follow up studies cumbersome 
and sometimes even impossible. For example, the identification of jnk1b (the ‘extra’ 
zebrafish jnk1 gene) took place after the completion of the in vivo zebrafish work 
(shortly before its publication by Seo et al., 2010) and therefore, could only be included 
in the in silico studies and the phylogenetic analyses (and not in the in situ expression 
analysis). Primers (against all transcripts of the gene at the time, Ensembl release 62) 
for RT-PCR analysis were however designed against jnk1b, as it was important to 
assess its presence, at least in vitro. Fortunately, the general jnk1a RT-PCR primers that 
were initially designed against common areas of jnk1a transcripts (two at the time), 
were found to also pick up the newly identified (after the initial primer design) jnk1a 
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transcripts (four currently, Ensembl release 62). So, the RT-PCR panel shows a 
representative illustration of the temporal expression pattern of jnk1a. Also, it is 
important to note that most of the information provided by the online databases 
corresponds to predictions, which do not necessarily respond to reality. The in silico and 
bioinformatics analyses were, thus, based on predicted sequences. In vivo analyses 
confirmed, at least some, of the predictions, by showing that mRNA of some of the 
newly identified jnk transcripts is produced in developing zebrafish embryos. A 
downside of the current study was the detection of mRNA only and not protein, during 
the in vivo approaches. As there are many steps after transcription that regulate gene 
expression and many steps of protein synthesis, maturation and modification before the 
production of a functional protein, production of mRNA is not linearly correlated with 
protein production. However, mRNA detection is commonly used as a method for 
assessing gene expression and functionality.  
 
3.5.6. Summary and conclusions 
 
In this chapter the zebrafish jnk genes were examined in detail. Initially, in silico 
investigation of online genomic databases revealed (or in fact confirmed) the presence 
of a fourth jnk gene, additional to the three known mammalian jnk orthologs. This gene, 
named jnk1b, following the ZFIN guidelines for naming genes of duplicated pairs, 
showed high evolutionary conservation with jnk1a and was, thus, classified as a 
duplicated jnk1a paralog. However, it is still not clear which one of the two is the 
original gene and which one arose after the duplication. Bioinformatics and 
phylogenetic analysis of the structure of zebrafish jnk genes and proteins revealed 
conservation of essential motifs and of the overall morphology of the kinases, which 
reinforces the possibility that the identified isoforms can, in fact, be functional if 
produced in vivo. This observation led us to the next milestone of the current study, 
which was the investigation of the in vivo production of jnk mRNA, which is a good 
indication of putative in vivo protein production. All of the isoforms examined were 
shown to be produced, at least at the mRNA level, in developing zebrafish embryos. 
Their expression patterns were distinct but were mainly localised in anterior structures 
(such as brain, heart, otic vesicles). In the next chapter, global inhibition of all jnk 
protein isoforms by a pharmacological agent (SP600125) is conducted, in order to 
elucidate their role during zebrafish development and in particular during zebrafish 
cardiogenesis.  
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Chapter 4. Investigation of the role of jnk during zebrafish 
embryogenesis 
 
4.1. Introduction 
 
In the previous chapter (Chapter 3), in silico investigation and bioinformatics analysis 
revealed the presence of four jnk genes in the zebrafish genome (jnk1a, jnk1b, jnk2 and 
jnk3), which are expressed and are potentially active during the first days of 
embryogenesis. In this chapter, the putative roles of jnk during zebrafish embryonic 
development are investigated. In order to achieve this, chemical inhibition of the 
activity of jnk proteins was performed at distinct time intervals during gastrulation, 
segmentation and later stages of zebrafish embryonic development. General body 
defects and, in particular, cardiac abnormalities arising after jnk inhibition were of 
interest. Below, an overview of the chemical inhibitor that was used in this study is 
presented.    
 
4.1.1. SP600125, a potent pharmacological inhibitor of Jnk 
 
SP600125 [anthra(1,9-cd)pyrazol-6(2H)-one] is a potent, cell-permeable, reversible 
ATP-competitive inhibitor that binds and inactivates Jnk (Bennett et al., 2001). It is a 
small hydrophobic molecule, with a nitrogen-containing ring system, which was shown 
to make optimal binding in the ATP pocket of Jnk. By binding to this area, SP600125 
prevents ATP from binding and therefore Jnk can no longer phosphorylate its 
downstream targets. The chemical structure of SP600125 (three fused rings containing 
nitrogen residues), which makes its affinity with the ATP pocket of Jnk strong, also 
makes the molecule poorly soluble in water, a difficulty easily overcome by the addition 
of dimethylsulfoxide (DMSO).  
SP600125 binds and inactivates all Jnk isoforms with half maximal inhibitory 
concentration (IC50) values for mammalian Jnk1, Jnk2 and Jnk3 being 40, 40 and 
90 nM, respectively (Bennett et al., 2001). It exhibits 300 fold greater selectivity for Jnk 
over related MAPK (Erk1 and p38) and between 10 fold and 100 fold selectivity over 
another 14 protein kinases tested. Interactions between SP600125 and Jnk have been 
explored by co-crystallization of SP600125 with Jnk3 (Scapin et al., 2003). It was 
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shown that residues specific for Jnk, but absent in related MAPK, such as p38, are 
important in producing a narrow ATP-binding pocket that can accommodate SP600125, 
contributing to the specificity of the drug (Scapin et al., 2003). These observations 
suggest high affinity and specific interactions of SP600125 with Jnk.  
Over 200 publications have reported the use of SP600125 as a chemical inhibitor 
for the assessment of Jnk-dependent events in cells and in vivo. Among others, 
SP600125 has been shown to inhibit a number of apoptotic events (activation of pro-
apoptotic Bcl2, release of mitochondrial cytochrome-c etc), to modulate immune 
responses and to prevent cells from entering mitosis (Bogoyevitch and Arthur, 2008). 
Despite its extensive use in both in vitro and in vivo studies, some scepticism 
surrounds its repeated use, mainly associated with the claimed specificity for Jnk. After 
its initial characterization (Bennett et al., 2001), subsequent testing has shown that 
SP600125 can also inhibit a number of other protein kinases, like serum and 
glucocorticoid-regulated kinase, AMP-dependent protein kinase and others (Bain et al., 
2003). Nevertheless, the concentration of the drug has to be quite high for these effects 
to take place (much higher than the IC50 of the drug) and for many years SP600125 
continued to be the preferred chemical Jnk inhibitor (Bogoyevitch and Arthur, 2008). In 
the present study, SP600125 was used as an inhibitor of Jnk at low, compared to 
previously published work, concentration (3µM and 5µM).  
Recently, new inhibitors of Jnk have started to be developed. The most specific 
and potent among the new drugs are peptide inhibitors that can interfere with protein-
protein interactions. Their main advantages are high specificity and reduced side effects 
compared to small molecule inhibitors. However, a great problem associated with their 
use is their rapid breakdown and their difficult delivery into the cell (Waetzig and 
Herdegen, 2005). Additionally, Jnk-interacting peptide (JIP)-targeting inhibitors have 
recently started to be developed. JIP are scaffolding proteins that contain a docking 
domain (D-domain, essential for binding to Jnk, further described in Section 3.1.2, page 
84) and interact with Jnk. This interaction has been shown to be essential for further 
activation of Jnk (Kallunki et al., 1996, Yang et al., 1998). Peptides that correspond to 
the D-domain of JIP or chemical inhibitors that target the JIP-Jnk interaction site have 
been shown to inhibit Jnk activity in a remarkably selective way (Barr et al., 2002, De et 
al., 2009a, De et al., 2009b, Heo et al., 2004). These inhibitors have, however, not been 
tested and used extensively yet. 
In summary, SP600125 is a selective Jnk inhibitor that competes with ATP for 
binding at a Jnk-specific site of the ATP-binding pocket. Although, new drugs are being 
 134
rapidly developed and the specificity of the existing inhibitors is coming into question, 
SP600125 remains a widely accepted and extensively used inhibitor of Jnk.      
 
4.2. Aims of the chapter 
 
JNK, as a member of the MAPK family and the Wnt/PCP pathway, has been shown to 
be involved in a vast array of cellular and morphogenetic processes. Members of both 
cascades (MAPK and PCP) have been shown to be involved in different aspects of heart 
development and disease, in animal models (mouse, chicken, frog, zebrafish) and in 
cultured cells (primary, carcinoma, embryonic stem cells). It was, thus, hypothesized 
that JNK may represent the culmination of the activity of the two highly conserved and 
important pathways during heart specification and development. Therefore, the main 
focus of the current study was to investigate the requirement of jnk signalling during 
zebrafish development. In order to achieve this the following aims were set: 
 
• Define the role of zebrafish jnk proteins (identified in the previous chapter) at 
distinct time intervals during embryonic development by inactivating them with 
SP600125 
• Determine their roles during zebrafish cardiogenesis with SP600125 treatment 
 
4.3. Chemical inhibition of jnk in zebrafish 
 
The contribution of jnk during zebrafish embryogenesis was investigated by chemically 
inhibiting all jnk protein isoforms with SP600125 at distinct time intervals. Initially, the 
dosage of the inhibitor was assessed and then its effects were analysed. Understanding 
how inactivation of jnk affects normal embryonic development generally was of 
interest, but also more specifically how it influences heart specification and 
morphogenesis. In all sections that follow the transgenic Tg(cmlc2;gfp) zebrafish line 
was used, unless otherwise stated. For more details about the transgenic lines refer to 
Chapter 2 (Section 2.1.1, page 53).       
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4.3.1. SP600125 dosage assessment  
 
Initially, a wide range of SP600125 dosages was examined in order to find the 
appropriate concentration for treatment of zebrafish embryos. SP600125 was diluted in 
dimethylsulfoxide (DMSO) because its ring structure makes it insoluble in water. 
Therefore, a control containing DMSO alone was, also, used alongside the E3 water 
control. Both controls are presented here. 50 zebrafish embryos were used for each 
treatment and for each control in every experiment. The overall number of embryos 
used for each condition is shown within the graphs. Each experiment was performed on 
the same clutch of eggs. Three repetitions of the experiment were performed at different 
days and with eggs from different clutches. The embryos were washed thoroughly after 
each treatment and were transferred into new dishes. The results presented here were 
collected at 72 hpf and represent the mean values of three experiments.  
In the preliminary dosage assessment experiments, the inhibitor was introduced 
into the water at distinct time intervals: 0-5.25 hpf, 5.25-10 hpf, 10-22 hpf and 22-30 
hpf. These intervals trail some of the important events during normal embryonic and 
heart development. 0-5.25 hpf is the time when cleavages take place and blastula 
embryos form; between 5.25 and 10 hpf gastrulation is under way, atrial and ventricular 
cells are being specified and myocardial precursors involute; at 10-22 hpf body 
segmentation occurs, most of the organ rudiments appear (otic vesicle, optic primordia, 
fin buds) and heart cells form the cone and later the heart tube; 22-30 hpf, is the time 
when pharyngeal arches develop, organs (including the heart) attain their final positions 
and conformation while the body straightens and lengthens (see Section 1.2 at page 2 
for more details on zebrafish embryonic development). Dosages ranging from 1 µM to 
25 µM were tested (1µM, 3µM, 6µM, 12µM and 25µM). These dosages were adjusted 
and expanded from previously published work on animal models and cells (Moon et al., 
2008, Nakaya et al., 2009, Naruishi et al., 2003, Tanemura et al., 2009, Zhu et al., 
2008). 
In Figure 4.1 an overview of the results obtained from the dosage assessment 
experiments is presented. Representative images of the SP600125-treated embryos are 
shown, when possible. When viability was very low after jnk inhibition and a 
representative image could not be obtained (very few embryos surviving with a variable 
phenotype), a graph showing the viability is shown instead. Results obtained from the 
3µM SP600125 experiments are not included in this figure but are presented in detail in 
the next sections.     
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Figure 4. 1: SP600125 dosage assessment. SP600125 was initially used at 5 different concentrations (1µM, 3µM, 6µM, 12µM and 25µM), four of which are 
shown here: (A) 1µM, (B) 6µM, (C) 12µM and (D) 25µM (the 3µM concentration is not shown here as it is the one used for the rest of the experiments, 
presented in the next sections). (E) Untreated and DMSO-treated (0-30 hpf) zebrafish embryos were used as controls. Treatment with the drug was 
conducted in four different time intervals: 0-5.25 hpf, 5.25-10 hpf, 10-22 hpf and 22-30 hpf. All figures represent representative images of the majority (but 
not all) of the embryos for each condition. High lethality was observed after 0-5.25 hpf treatment with 6, 12 and 25 µM SP600125, after 5.25-10 hpf 
treatment with 12 and 25 µM SP600125 and after the two late treatments (10-22 and 22-30 hpf) with 25µM SP600125. In the cases where high lethality was 
observed and therefore not enough embryos were available for phenotype assessment, a graph representing the survival curve of SP600125-treated embryos 
compared to DMSO-treated embryos is shown. In these graphs the survival rates of untreated embryos are not included for clarity of illustration, but were 
very similar to that of DMSO-treated embryos. Scale bars represent 200 µm. 
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The 25 µM SP600125 concentration was found to be lethal from fertilization until 
30 hpf (Figure 4.1). The period between fertilization and initiation of gastrulation (0-
5.25 hpf) is a tightly regulated, finely tuned and very important phase, commonly 
disturbed by chemical manipulation. Treatment with 12 µM of the inhibitor in the first 
two time intervals (0-5.25 hpf and 5.25-10 hpf) caused lethality to more than 90% of 
embryos, while its later administration proved viable but highly toxic (misshapen 
embryos). Similarly, 6 µM SP600125 treatment between fertilization and gastrulation 
(0-5.25 hpf) caused high levels of lethality, while between 5.25 and 30 hpf (5.25-10, 10-
22, 22-30 hpf) it was viable but toxic for the embryos (Figure 4.1). The most prevalent 
abnormalities caused by high dosages of SP600125 were severe cardiac oedema, yolk 
sac anomalies, tail shortening and curving and general body plan disturbance. In 
contrast, 1 µM of SP600125 had no superficial effect on the morphology and viability 
of the embryos (Figure 4.1). Comparisons were made to the two controls: E3 water and 
DMSO. It was therefore concluded that the most potent, but not toxic concentration to 
be used and assessed further was 3 µM. This concentration, however, caused high 
lethality at the time interval between fertilization and initiation of gastrulation (0-5.25 
hpf), which, as discussed before, is a highly sensitive period. The experiments presented 
and analysed in this section were performed using this concentration of SP600125. 3µM 
of SP600125 is considered a fairly low concentration, not likely to cause unspecific 
effects, as discussed in Section 4.1.1 (page 132).  
 
4.3.2. Analysis of the general phenotype of zebrafish embryos after SP600125 
treatment; convergence-extension-like phenotype observed 
 
Once the concentration of the inhibitor was decided (3µM), the temporal-specific role of 
jnk was further investigated. The following time intervals were investigated: 5.25-10 
hpf, 10-22 hpf and 22-30 hpf, excluding the 0-5.25 hpf phase, which, as shown before, 
was sensitive to treatment even with small concentrations of SP600125. Two methods 
were used to assess the phenotype in the domains of interest: microscopic observation 
and phenotypic scoring for qualitative assessment, and various body measurements for 
quantitative assessment. The following measurements were taken: the distance between 
the eyes (ocular distance), the width of the head, the length and width of the body. 
These body features are commonly disturbed in known mutant zebrafish lines 
(Heisenberg et al., 2000, Jessen et al., 2002, Kilian et al., 2003, Topczewski et al., 
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2001). When necessary, measurements were normalised against the body size (either 
body length or head width), as explained in more detail in Section 2.1.4 (page 54).  
 
4.3.2.1. Convergence extension-like phenotype 
 
Initially, we assessed the overall body size and shape of SP600125-treated embryos 
compared to controls, as explained in Section 2.1.4 (page 54). These features were of 
interest because they are commonly disturbed in PCP mutants that exhibit convergence-
extension abnormalities (see Section 1.4.2.1 at page 32). At 72 hpf, embryos of all 
treatment groups appeared significantly shorter than untreated and DMSO-treated 
(p=0.000) embryos, while the two latter groups did not show any differences between 
them (p=0.42) (Figure 4.2A). Specifically, 5.25-10 hpf SP600125-treated embryos were 
on average 4816µm long (standard error, se=322), 10-22 hpf SP600125-treated embryos 
were 5041µm long (se=36) and 22-30 hpf SP600125-treated embryos were 4669µm 
long (se=253) at 72 hpf. At the same stage of development, untreated fish were on 
average 5285µm long (se=50) and DMSO-treated embryos were 5337µm long (se=68). 
Overall, treatment of zebrafish embryos with 3µM SP600125 caused a severe decrease 
in body length, regardless of the time of drug administration.  
Next, the ratio of body width to body length (width:length) was investigated as it 
is a good indication of CE progression: if CE is defective, shorter and wider embryos 
(higher width:length ratio) are expected to develop. The width:length was only 
significantly increased in the first SP600125 treatment group (5.25-10 hpf, p=0.027), 
but was not altered in all later SP600125 treatment groups (p>0.06 for the 10-22 hpf and 
22-30 hpf) compared to both untreated and DMSO-treated embryos (Figure 4.2C). At 
72 hpf, 5.25-10 hpf SP600125-treated embryos had a width:length ratio of 
approximately 0.082, 10-22 hpf SP600125-treated fish 0.077, 22-30 hpf SP600125-
treated embryos 0.078, while untreated fish embryos had width:length ratios of 0.074 
and DMSO-treated embryos 0.076. No significant differences were observed between 
the two control groups. Overall, 5.25-10 hpf SP600125-treated zebrafish embryos had 
increased body width:length ratios, representing both wider and shorter body axes, a 
feature commonly seen in mutants with defective CE movements.  
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Figure 4. 2: Body measurements after jnk inhibition. A) The length of the body of treated 
embryos was significantly decreased at 72 hpf after 5.25-10, 10-22 and 22-30 hpf SP600125 
treatment compared to untreated and DMSO-treated embryos. B) The distance between 
the eyes, normalized against the width of the head was, also, shown to be statistically 
significant in all SP600125 treatment groups, compared to controls. A representative 
image of a control and a SP600125-treated embryo at 72 hpf is shown on the right. C) 
After 5.25-10 hpf SP600125 treatment a convergence-extension like phenotype was 
observed, with the body width to body length ratio severely affected. Later treatments (10-
22 and 22-30 hpf) did not affect the body shape. Statistical analysis was performed with 
one-way Anova testing, followed by a 2-sided Dunnet test. Asterisk (*) shows statistical 
significance compared to both control groups, with p<0.05.  
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4.3.2.2. Ocular distance abnormalities 
 
It was also of interest to score the distance between the eyes in SP600125-treated, 
DMSO-treated and untreated embryos, as disturbed ocular distance is one of the 
features commonly associated with, among others, PCP mutants (Heisenberg and 
Nusslein-Volhard, 1997, Heisenberg et al., 2000). Indeed, embryos of all SP600125 
treatment groups exhibited disturbances in the positioning of their eyes: eyes were 
located further apart from each other than in control embryos (Figure 4.2B). 
Specifically, at 72 hpf the ratio of the distance between the eyes normalised against the 
width of the head (eyes/width), to account for head size differences (associated with 
body size differences), was on average 0.260 for untreated, 0.257 for DMSO-treated, 
0.280 for 5.25-10 hpf SP600125-treated, 0.275 for 10-22 hpf SP600125-treated and 
0.302 for 22-30 hpf SP600125-treated embryos (Figure 4.2B). Differences between 
treatment groups and controls were found to be significant (p<0.05 for all groups 
compared to both DMSO and E3 controls). Overall, 3µM SP600125 treatment caused 
an increase in the ocular distance of developing zebrafish embryos, regardless of the 
time of drug administration. 
 
4.3.2.3. Jnk inhibition did not affect the formation of fins and somites but caused low 
prevalence abnormalities in the eyes, otic vesicles and tails 
 
I was then interested to look at how the general morphology of some important organs 
and structures of zebrafish embryos changed after inhibition of jnk, focusing mainly on 
the fins, the eyes, the otic vesicles, the somites and the tail (Figures 4.3 and 4.4). An 
unusual eye phenotype was observed in a small percentage (4%) of 10-22 hpf 
SP600125-treated embryos, whereby only half of the eye was pigmented, showing a 
coloboma-like phenotype. However, it was unclear whether the pigmentation only or 
the underlying structure as well was missing. DMSO-treated, untreated and 5.25-10 hpf 
and 22-30 hpf SP600125-treated embryos did not exhibit this phenotype (Figure 4.3A). 
Additionally, otic vesicle defects were observed in all groups, with the highest 
occurrence (but still fairly low) in the early treatment group (9% in 5.25-10 hpf 
SP600125-treated embryos) and decreasing incidence as development proceeded (5% in 
10-22 hpf and 1% in 22-30 hpf SP600125-treated embryos). These defects included 
small otic vesicles and otolith abnormalities, such as absence of one otolith, and smaller 
or malpositioned otoliths (Figure 4.3B).  
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Figure 4. 3: Eyes, otic vesicle and tail development after treatment with SP600125. A) 
Development of the eyes was not severely affected after 10-22 hpf SP600125 treatment. 
Only a small and not significant percentage of embryos exhibited a coloboma-like 
phenotype, shown in the figure on the right. B) The formation of the otic vesicles was 
defective after 5.25-10 hpf SP600125 treatment in 9% of the embryos. Later treatment 
groups (10-22 and 22-30 hpf) remained unaffected. The most common otic vesicle 
phenotypes are shown in the figure on the right. Otoliths were either missing, misplaced or 
smaller in size, compared to controls. C) Tail abnormalities were observed after the two 
early SP600125 treatments (5.25-10 and 10-22 hpf), but not after the 22-30 hpf SP600125 
treatment. Curved and kinked tails were most commonly seen in abnormal embryos. Data 
are tabulated underneath the graph.  Statistical significance was assessed with the χ2 test 
for association of categorical data and is shown with an asterisk (*p<0.05).  
 
  
Figure 4. 4: Development of the fins and somites after SP600125 treatment. A) Formation 
of the fins was not shown to be affected by any of the SP600125 treatments (5.25
and 22-30 hpf). B) Development of the somites was not significantly affected after jnk 
inhibition at any time interval examined here. Statistical significance was assessed with the 
χ
2
 test for association of categorical data. 
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Abnormalities associated with the tail were seen in all SP600125 treatment groups 
examined here. Their occurrence in the control groups (DMSO and E3) and in the late 
SP600125 treatment group (22-30 hpf) was only 1%, while this percentage was higher 
in the earlier SP600125 treatment groups: 17% in the 10-22 hpf and 21% in the 22-30 
hpf SP600125 treatment groups. Tail anomalies were mainly associated with a curly or 
kinky phenotype of the tip of the tail. 
In contrast, the development of the fins did not seem to be affected under any of 
the conditions, signifying that jnk is probably not important during this process (Figure 
4.4A). Similarly, formation of the somites was not severely affected, as only a few 
abnormal embryos were seen after the 5.25-10 hpf (1%) and the 22-30 hpf (2%) 
SP600125 treatments (Figure 4.4B). So, the development of the fins and the somites 
was not affected by jnk inhibition throughout embryonic development.  
Although differences in the fin, eye and somite development were observed 
between SP600125-treated and untreated or DMSO-treated embryos, in none of the 
treatment groups were the observed differences statistically significant compared to the 
two control groups. Statistical significance was assessed with the χ2 test for associations 
of categorical data and p was found to be higher than 0.05 for all SP600125 treatment 
groups for the fins, eyes and somites phenotypes. In contrast, formation of the otic 
vesicles and the tail was significantly abnormal (p<0.05 compared to both control 
groups) after 5.25-10 hpf SP600125 treatment (for the otic vesicle) and after the 5.25-10 
and 10-22 hpf SP600125 treatments (for the tail).  
Taken together, jnk inhibition at 5.25-10 hpf caused a significant occurrence of 
abnormalities in the development of the otic vesicles and the tail, while jnk inhibition at 
10-22 hpf caused a significant occurrence of tail abnormalities. The eye defects that 
were observed in the 10-22 hpf SP600125 treatment group, although interesting, were at 
low prevalence.    
 
4.3.3. Analysis of the heart phenotype after SP600126 treatment  
 
One of the main interests of the current study was to characterize putative roles of jnk 
during zebrafish cardiogenesis. In order to achieve this, the development of the 
embryonic zebrafish heart was examined after timely SP600125 treatment. More 
specifically, the segmentation of the heart into two chambers (atrium and ventricle), the 
relative sizes of the two chambers, the looping of the linear heart tube and formation of 
pericardial oedema were examined in detail. These features provide a good 
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morphological evaluation of progression of cardiogenesis the first 3 days of zebrafish 
embryonic development. 
Normal 72 hpf zebrafish hearts are expected to be segmented into equally sized 
chambers (an atrium and a ventricle), looped towards the right with the ventricle lying 
on the anterior and right side of the atrium (looking at the embryos dorsally) and 
without any noticeable cardiac oedema. As expected, under control conditions and after 
DMSO treatment, almost all of the embryos exhibited the features described above, 
with only an insignificant (p<0.05) 1% of them showing leftwards instead of rightwards 
looping.  
 
4.3.3.1. Small occurrence of mild pericardial oedema  
 
Pericardial oedema, commonly a marker of cardiac dysfunction or fluid homeostasis 
disruption, was absent after late SP600125 treatment (22-30 hpf) but present in embryos 
treated with SP600125 between 5.25-10 hpf and 10-22 hpf. 5.2% of early SP600125-
treated embryos (5.25-10 hpf) exhibited minimal enlargement of the pericardial cavity, 
2.8% of them had mild cardiac oedema and 92% were normal (Figure 4.5A). Illustration 
of the categorization of mild and minimal pericardial oedema is shown in Figure 4.5A 
(embryo images on the right). The respective percentages for 10-22 hpf SP600125-
treated fish were 4.5% (minimal), 7.5% (mild) and 88% (normal), showing increased 
severity of the phenotype. 
The overall number of embryos with abnormally swollen pericardial cavities was 
shown to be statistically significant compared to control embryos (p=0.009, shown with 
the χ2 test for associations). However, individual subcategories of abnormal embryos 
(with minimally and mildly swollen cardiac cavities separately) did not exhibit 
statistical significance compared to controls (p>0.1). Despite the significance shown by 
the statistical tests, in all treatment groups the pericardial cavity was only slightly 
enlarged (either minimally or mildly, as shown in Figure 4.5A), which is unlikely to be 
disruptive for proper heart morphology and function, as it does not seem to stretch and 
distort the heart.  
 
  
Figure 4. 5: Cardiac oedema and heart chamber segmentation after SP600125 treatment. 
A) Swelling of the pericardial cavity was observed in 8% and 12% of 5.25
hpf SP600125-treated embryos. The occurrence of abnormal pericardial oedema was 
significantly higher in treated compared to untreated and DMSO
(p=0.009). 65% of the embryos with abnormally enlarged cardiac cavities had minimal 
oedema (5.2% of the overall embryos), while 35% of them (2.8% of the overall embryos) 
showed mild oedema, as 
treated embryos showed abnormalities in the segmentation of their heart chambers, with 
8% of them having non
phenotype are shown on 
other treatment groups (5.25
was assessed with the χ
in the graphs (*p<0.05). 
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-treated embryos 
shown in the image on the right. B) Only 10
-segmented linear hearts at 72 hpf. Representative images of the 
the right side (ventral views of embryos, anterior to the top). The 
-10 and 22-30 hpf) were not affected. Statistical significance 
2
 test for association of categorical data and is shown with asterisks 
 
-10 and 10-22 
-22 hpf SP600125-
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4.3.3.2. Segmentation of the heart and relative chamber sizes were affected  
 
Next, heart chamber segmentation and proportions were of interest, in order to assess 
progression of cardiogenesis. There was only a minor percentage (8%) of zebrafish 
embryos treated with SP600125 between 10-22 hpf that showed non-segmented hearts 
(p=0.046), resembling primitive linear heart tubes, with no obvious distinction between 
an atrium and a ventricle (Figure 4.5B). No such phenotype was observed after 5.25-10 
hpf and 22-30 hpf SP600125 treatment (p>0.05) compared to both controls (DMSO and 
E3).  
The relative sizes of the two heart chambers were subsequently examined in 
untreated, DMSO-treated and SP600125-treated embryos. The ventricle and the atrium 
would normally be expected to be approximately equal to each other, as shown in the 
untreated and DMSO-treated embryos (Figure 4.6A). After SP600125 treatment, the 
heart chamber proportion was found to be altered. In 8% and 21% of zebrafish embryos 
treated with SP600125 at 5.25 hpf (until 10 hpf) and at 10 hpf (until 22 hpf), 
respectively, the atrium appeared bigger than the ventricle (A>V), due to either 
enlargement of the atrium or shrinkage of the ventricle (Figure 4.6A). This issue will be 
discussed in more detail later on, as, by counting the cells within the heart, it is possible 
to assess if the ventricle is smaller or if the atrium is bigger than normal.  
Statistical analysis showed significant differences in both groups compared to the 
two controls: p=0.016 and p=0.006 after 5.25-10 and 10-22 hpf SP600125 treatment, 
respectively. 22-30 hpf SP600125 treatment did not affect the relative sizes of the heart 
chambers (p=0.837 compared to controls). Overall, 5.25-10 hpf SP600125 treatment 
caused a significant occurrence of altered heart chamber proportions (A>V), 10-22 hpf 
SP600125 treatment caused significant occurrence of disturbed chamber morphogenesis 
(no obvious chamber segregation) and chamber proportions (A>V), while 22-30 hpf 
SP600125 treatment did not significantly alter the heart chambers.  
 
4.4.3.3. Looping of the heart was severely affected 
 
The most intriguing heart-related phenotype was the looping of the heart. Rightward 
looping was observed in 99% of control embryos (untreated and DMSO-treated) and 
leftward looping was seen in the remaining 1% of the embryos. The percentages were 
very similar (98% and 2%, respectively) for the late SP600125 treatment group (22-30 
hpf). However, in the other treatment groups the situation was different (Figure 4.6B).  
  
 
Figure 4. 6: Heart chamber size and cardiac looping after SP600125 treatment. A) The 
relative sizes of the heart chambers were altered after jnk inhibition. 8% and 21% of 5.25
10 and 10-22 hpf SP600125
ventricle (A>V), showing either enlargement of the atrium or shrinkage of the ventricle. 
Both values were found to be significantly different compared to controls (E3 and DMSO), 
with p values 0.016 and 0
hpf) was not affected. B) The looping of the heart was, also, affected after SP600125 
treatment. 73% of 5.25
heart, 20% had a leftwar
After the 10-22 hpf SP600125 treatment 68% of embryos exhibited normal looping, 2% 
showed reverse looping (p=0.387 compared to controls) and 30% had unlooped hearts 
(p=0.000 compared to control
right (ventral views, anterior to the top). Statistical significance, in comparison to both 
control groups, was assessed with the 
shown with asterisks in the graphs (*p<0.05). R: right, L: left, A: atrium, V: ventricle. 
 
150
-treated embryos, respectively, had an atrium bigger than the 
.006, respectively. The late SP600125 treatment group (22
-10 hpf SP600125-treated embryos had a normal rightward
d-looped heart (p=0.000) and 7% had unlooped hearts (p=0.046). 
s). Representative images of the phenotype are shown on the 
χ
2
 test for association of categorical data and is 
-
-30 
-looped 
 
 151
After the early (5.25-10 hpf) SP600125 treatment, only 73% of the embryos had a 
normal rightward-looped heart, while 20% had a leftward-looped heart (p=0.000 
compared to E3 and DMSO controls) and 7% had their segmented hearts positioned in 
the midline without any apparent looping (p=0.046 compared to controls). So, the 
occurrence of reverse looping increased approximately ten fold compared to controls, 
while the incidence of unlooped hearts was fairly small but still significantly different 
from controls (Figure 4.6B). The looping of the heart was also affected after the 10-22 
hpf SP600125 treatment: 68% exhibited normal looping (rightward), 2% showed 
reverse looping (leftward, p=0.387 compared to controls) and 30% had unlooped hearts 
positioned in the midline (p=0.000 compared to controls).  
Overall, the looping of the heart was a significantly affected feature in 5.25-10 
and 10-22 hpf SP600125-treated embryos, with the former exhibiting mainly leftward 
(reverse) looping and the latter showing predominantly absence of looping. Statistical 
significance was assessed with the χ2 test for association of categorical data.  
 
4.3.3.4. Heart cell counting revealed cell fate changes 
 
In order to elucidate whether atrial and ventricular cells were differentially affected by 
SP600125 treatment, as suggested by the morphological differences in the two 
chambers of SP600125-treated embryos compared to controls, the number of cells 
within the hearts of SP600125-treated, DMSO-treated and untreated embryos was 
measured. A method adapted from previously published work (Schoenebeck et al., 
2007) was employed. Tg(cmlc2;DsRed2-nuc) zebrafish embryos, counterstained with 
anti-DsRed and SV46 antibodies were used, as described in more detail in Chapter 2 
(Sections 2.1.5 and 2.1.6, pages 55 and 56). 10 embryos for each condition were 
counted in each of the three experiments and the averages are presented in the graph in 
Figure 4.7.  
It was shown that after 5.25-10 hpf SP600125 treatment, the overall number of 
heart cells was significantly decreased (p=0.0104 and p=0.0148 compared to untreated 
and DMSO-treated embryos, respectively): 89 cells (se=1) in the SP600125-treated, 101 
cells (se=6) in the untreated and 102 cells (se=11) in the DMSO-treated group. 
However, the relative proportion of atrial and ventricular cells was not altered (p=0.097 
and p=0.332 for atrial and ventricular cells, respectively, compared with the two 
controls); it remained at approximately 1.4 ventricular cell(s) for every atrial cell 
(ventricular:atrial=1.4, shown by the blue dashed line in Figure 4.7).  
  
 
Figure 4. 7: Counting of heart cells (atrial and ventricular) after treatment with SP600125, 
between 5.25-10, 10-22 and 22
experiments and error bars represent standard errors of the mean. The overall number of 
heart cells is indicated in the legend of the graph (101 cells for untreated, 102 cells for 
DMSO-treated, 89 cells for 5.25
treated and 98 cells for 22
tabulated underneath the graph. The blue dashed line represents the expected ratio 
between ventricular and atrial cells (1.4:1). Statistical significance was asse
way Anova, followed by a 2
their logarithmic values to attain normality and although statistical analysis was 
performed on the logarithms, the linear values are shown in the graph. 
cannot accurately represent a not normally distributed population but are used in this 
graph for easier visualization. Statistical a
representations.  
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The 10-22 hpf SP600125 treatment group also showed a significant reduction 
(p=0.011 and p=0.046 against E3 and DMSO controls, respectively) in the overall 
number of heart cells (85 cells, se=2) (Figure 4.7). Interestingly, the ventricular cells 
were more severely affected than the atrial cells; the ventricular:atrial ratio was close to 
1:1 compared to 1.4:1 in control conditions. Specifically, in the 10-22 hpf SP600125-
treated embryos there were 44 (se=1.2) ventricular and 41 (se=1.5) atrial cells, in the 
DMSO-treated embryos there were 59 (se=1.7) ventricular and 43 (se=1.3) atrial cells 
and in the untreated zebrafish embryos there were 58 (se=1.7) ventricular and 43 
(se=1.1) atrial cells. This showed a significant loss of ventricular cells after inhibition of 
jnk at 10-22 hpf (p=0.000 and p=0.004 compared with the E3 and DMSO controls, 
respectively), while atrial cell numbers were not significantly affected (p=0.097 for all 
groups compared with the two controls).  
As expected, after the late SP600125 treatment (22-30 hpf) no significant effect 
(p>0.1 for all groups compared with controls) on the number of heart cells (98 cells, 
se=3) or on the ventricular-to-atrial ratio (1.3 instead of 1.4) was observed (Figure 4.7). 
Overall, at 72 hpf, 5.25-10 hpf SP600125-treated embryos had smaller but correctly 
proportioned hearts, 10-22 hpf SP600125-treated embryos had smaller and 
disproportionate hearts (the loss in heart cell number was due to a specific loss of 
ventricular cells), while the hearts of 22-30 hpf SP600125-treated embryos remained 
unaffected.   
 
4.3.3.5. Heart cell loss compared to body length decrease 
 
It was previously shown (Section 4.3.2.1, page 139) that the body length of 5.25-10 hpf, 
10-22 hpf and 22-30 hpf SP600125-treated embryos was significantly decreased 
compared to controls. Concomitantly, the total number of cardiomyocytes was 
significantly decreased after 5.25-10 hpf and 10-22 hpf SP600125 treatment, as 
explained in detail in the previous section. What remained to be elucidated was whether 
the loss of heart cells in 5.25-10 hpf and 10-22 hpf SP600125-treated embryos was 
associated with an overall decrease in the size of the embryos, or whether there was a 
specific loss of heart cells after jnk inhibition. In order to address this, a graph 
illustrating changes in the length of the body against changes in the number of total 
heart cells was made (Figure 4.8). A line (blue dashed line in Figure 4.8) shows the 
known (experimentally defined) count of heart cells at two different body lengths 
(corresponding to 48 and 72 hpf untreated embryos). This line represents the expected 
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relationship between body length and number of cardiomyocytes at these two time 
points, based on experimental data. Significant differences in body length are shown 
with blue asterisks and significant differences in the number of cardiomyocytes are 
shown with black asterisks in Figure 4.8. Values above or below the dashed line deviate 
from the expected relationship between the number of heart cells and the length of the 
body. Embryos with values that fall above the dashed line are likely to show more 
severe disturbances in the number of cardiomyocytes than in their body size. This 
means that the reduction in the body length of these embryos cannot fully account for 
the reduction in the number of cardiomyocytes. In contrast, embryos with values below 
the line are expected to have more severely affected body size and less severely affected 
cardiomyocyte numbers. This suggests that the loss of cardiomyocytes observed in 
these embryos is mainly due to a general decrease in the size of the embryo and is not 
necessarily cardiac-specific. 
Figure 4.8 shows that the hearts of 5.25-10 hpf SP600125-treated embryos were 
not preferentially affected by jnk inhibition, as the decrease in the number of 
cardiomyocytes was accompanied by a concomitant decrease in the length of the body. 
In contrast, in 10-22 hpf SP600125-treated embryos, the significant decrease in the size 
of the embryo is not likely to fully account for the loss of cardiomyocytes, as explained 
before. This observation suggests that the loss of cardiomyocytes due to 10-22 hpf 
SP600125 treatment is not uniquely due to a decrease in the size of the embryos, but 
may in fact be caused by jnk-specific effects in the heart. Since loss of ventricular cells 
but not atrial cells was shown to cause the observed decrease in heart cell numbers in 
10-22 hpf SP600125-treated embryos, inhibition of jnk may have specific effects on the 
ventricle, rather than the whole heart. What these effects may be is discussed further in 
the next sections. In contrast, 22-30 hpf SP600125-treated zebrafish embryos, showed a 
significant decrease in body length but not in the number of cells within their hearts.       
  
4.3.4. Summary 
 
Overall, treatment with 3µM SP600125 was shown to affect many aspects of zebrafish 
embryogenesis. It was shown to cause low penetrance alterations in the body ratios of 
developing embryos producing a CE-like phenotype, in the localization of the eyes and 
in the formation of otic vesicles and of the tail. Higher prevalence phenotypes caused by 
SP600125 treatment were observed in the hearts of developing zebrafish embryos: 
swelling of the pericardial cavity, lack of segmentation of the linear heart tube, 
 alterations in the relative sizes of the heart chambers, lack or reversal of the
process and loss of ventricular cells. The way these abnormalities may have arisen, 
related to the timing of SP600125 treatment, is discussed in the next section.   
 
 
 
Figure 4. 8: Total cardiomyocyte count against embryo body length after jnk inhibition. 
The dashed line shows the expected relation between the two values. 5.25
SP600125-treated embryos showed equal decreases in their body length and heart cell 
count, 10-22 hpf SP600125
hpf SP600125-treated embryos had unaffected hearts but severely reduced body size. 
Mean values and standard errors of the mean are shown. Statistical significance was 
assessed for body length and heart cell count individually, as described before, and is 
shown with asterisks (blue asterisks for body length and black asterisks for heart cell 
count, *p<0.05).  
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4.4. Discussion 
 
In this chapter, inhibition of the activity of all zebrafish protein isoforms, identified in 
the previous chapter, by SP600125, a global jnk inhibitor, resulted in severe cardiac 
malformations in developing zebrafish embryos, associated with mild general body 
disturbances. In the following sections all these aspects are individually discussed.  
 
4.4.1. Jnk inhibition affects body measurements and general aspects of zebrafish 
embryonic development  
 
After initial identification and characterization of zebrafish jnk genes and proteins in 
Chapter 3, the next step was to globally inhibit all jnk isoforms at different time points 
during zebrafish development and to assess the resulting abnormalities. Interesting eye, 
ear and tail defects arose after jnk inhibition, concomitantly with a CE-like body 
phenotype. Although the prevalence of these defects was low, it is interesting to briefly 
mention them here, as they recapitulate the phenotype of known PCP mutants and, to a 
lesser degree, of MAPK mutants. Specifically, eyes were located further apart from 
each other, otic vesicles were malformed, containing no or small otoliths, the tail was 
curved or kinked and the body appeared shorter and fatter. Seo et al. (2010) reported 
severe abnormalities during gastrulation and CE-like defects after morpholino 
disruption of jnk genes in developing zebrafish embryos, but did not mention any 
defects associated with specific organs (Seo et al., 2010). In fact, the disruption of 
gastrulation movements, which in turn causes a CE phenotype, is characteristic of PCP 
mutations. Specifically, CE defects have been observed in many PCP zebrafish mutants, 
including pipe-tail (wnt5b) (Hammerschmidt et al., 1996, Rauch et al., 1997), 
silberblick (wnt11) (Heisenberg and Nusslein-Volhard, 1997, Heisenberg et al., 2000), 
knypek (glypican 4) (Solnica-Krezel et al., 1996, Topczewski et al., 2001) and trilobite 
(vang-like 2) (Hammerschmidt et al., 1996, Jessen et al., 2002, Solnica-Krezel et al., 
1996). Gastrulation defects have been observed in MAPK mutants (JNK, Erk1, Erk2, 
MAPKAPK2, p38) as well (Krens et al., 2008, Krens et al., 2006, Matsui et al., 2005, 
Schwarz-Romond et al., 2002). Abnormalities in the eyes and the otic vesicles, similar 
to the ones described in this study, have been observed in many of the PCP mutants 
presented above (Hammerschmidt et al., 1996, Heisenberg and Nusslein-Volhard, 1997, 
Heisenberg et al., 2000, Jessen et al., 2002, Rauch et al., 1997, Solnica-Krezel et al., 
1996, Topczewski et al., 2001). In fact, direct involvement of the Wnt pathway in some 
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of the processes disrupted in the jnk-inhibited embryos, has been previously reported. 
For example, induction of the eye field within the anterior neural plate (Wilson and 
Houart, 2004) and specification of the telencephalic and eye identity (Cavodeassi et al., 
2005, Heisenberg and Nusslein-Volhard, 1997, Houart et al., 2002, Kim et al., 2002) 
have been shown to be influenced by both canonical and non-canonical Wnt signals. 
Specifically, Wnt11 has been shown to promote coherence of eye field cells and to 
coordinate morphogenetic movements in the nascent eye in zebrafish embryos 
(Cavodeassi et al., 2005); its absence caused partial fusion of the eyes, possibly due to 
defective signalling from the underlying mesendoderm (Cavodeassi et al., 2005, 
Heisenberg and Nusslein-Volhard, 1997, Marlow et al., 1998). Of note, mkk4b (an 
activator of jnk) and jnk were shown to inhibit transcription of Wnt11 in developing 
zebrafish embryos (Seo et al., 2010). 
Members of the MAPK have not been extensively studied in zebrafish. However, 
mutations within the Ras/MAPK pathway are known to be involved in progression of 
the cardio-facio-cutaneous (CFC) syndrome in humans, characterized by a typical facial 
appearance, heart, skin and hair defects and mental retardation (Rodriguez-Viciana et 
al., 2006, Tidyman and Rauen, 2008). Similar defects were observed in CFC zebrafish 
mutants (Anastasaki et al., 2009). The phenotype was rescued by injection of erk (one 
of the Ras/Map kinases) mRNA (Anastasaki et al., 2009). Additionally, MAPK 
signalling, in association with fgf19, has been shown to regulate the development of the 
cornea in developing zebrafish embryos (Acharya et al., 2011, Tamimi et al., 2006). 
Also, activation of the Erk (member of the MAPK family) pathway in developing 
zebrafish embryos caused a dorsalized phenotype, rescued after activation of a 
phosphatase, inhibiting Erk (Furthauer et al., 2002, Snaar-Jagalska et al., 2003, Tsang et 
al., 2004). Similarly, inhibition of jnk (with morpholino injections) was shown to cause 
ventralization of the body of zebrafish embryos (Rui et al., 2007). Asymmetric 
activation of p38a (MAPK14a) was observed in zebrafish blastodiscs during the early 
cleavage period (0.75-2.25 hpf) and it was suggested to be related to the machinery that 
controls dorsalization signals (Fujii et al., 2000).  
The typical PCP eye phenotype, as described before, is decreased ocular distance 
or even partial fusion of the eyes (cyclopia) (Cavodeassi et al., 2005, Heisenberg and 
Nusslein-Volhard, 1997, Marlow et al., 1998). In this study, however, the opposite 
phenotype was observed: the eyes of SP600125-treated embryos were located further 
apart from each other. This observation is probably an indication that other pathways, 
along with the Wnt/PCP pathway, may in fact be altered by SP600125 treatment due to 
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jnk inhibition and thus, they may affect the formation, morphogenesis and localization 
of organs during zebrafish development.  
RhoA morphants (embryos that have been injected with RhoA morpholinos) show 
abnormalities very similar to the defects seen in jnk-inhibited embryos: short anterior-
posterior axis, reduced head structures, CE defects, impaired tail formation, loss of one 
otolith and increased apoptosis (Zhu et al., 2008, Zhu et al., 2006). RhoA is a small 
GTPase of the Ras family and is known to participate in the non-canonical Wnt/PCP 
pathway, whereby it acts by phosphorylating and thus activating ROCK. Nevertheless, 
RhoA has PCP-independent effects as well, activating a multitude of downstream 
targets (such as p21-activated kinase, myosin phosphatase, protein kinase-N) and 
participating in diverse biological processes (including actin cytoskeleton organization, 
microtubule dynamics, gene transcription, cell cycle progression) (reviewed by Boureux 
et al., 2007). Also, Shh mutants and morphants exhibit head deformities, 
underdevelopment and malpositioning of the eyes, tail bending and poor trunk 
formation (Ekker et al., 1995, Feijoo et al., 2011, Jackman et al., 2010, Ribes et al., 
2010, Strahle et al., 1996), similar to the defects seen in the jnk-inhibited embryos in 
this study. Taken together, although the overall resemblance between jnk-inhibited 
zebrafish embryos and PCP mutants is striking, contribution from other pathways in the 
establishment of this phenotype cannot be overlooked, as suggested by similar defects 
observed in mutants of other pathways.   
The general body and organ defects were only observed in a small percentage of 
SP600125-treated zebrafish embryos and only after 5.25-10 hpf (gastrulation period) 
and 10-22 hpf (segmentation period) treatments. This observation is not surprising, as 
the time interval between 5.25 hpf and 22 hpf is critical for proper cell migration, body 
patterning, tissue specification and organ morphogenesis. The RT-PCR data in Chapter 
3 showed that until 20-24 hpf only jnk1 (jnk1a and jnk1b) and jnk2 are expressed in 
detectable levels in developing zebrafish embryos. The absence of jnk3 expression at 
the time of the 5.25-10 hpf and 10-22 hpf SP600125 treatments suggests that any 
defects seen in the 5.25-10 hpf and 10-22 hpf treated embryos will be due to inhibition 
of jnk1 and jnk2 alone (assuming that protein levels correspond roughly to mRNA 
levels). The first day of development, jnk1 and jnk2 were expressed mainly in the 
anterior part of the embryos (Chapter 3); therefore, deformities associated with anterior 
structures, such as the brain (including the eyes), the ears (otic vesicles) and the heart 
would be expected to arise after jnk1 and jnk2 inhibition. They were, also, found to be 
expressed in the presumptive gut but abnormalities in this organ would likely not be 
 159
directly visible under a microscope because of its position within the embryonic body. 
Later treatment (22-30 hpf) did not cause abnormalities in the eyes, fins, somites, otic 
vesicles and tail. During this late treatment (22-30 hpf) inhibition of all three proteins 
(jnk1, jnk2, jnk3) by SP600125 is expected, since all three genes were shown to be 
expressed at that time (Chapter 3). Strong expression of jnk3 (specifically jnk3.3) in the 
otic vesicles and the hypothalamus of the embryos suggests that these structures are 
expected to be severely affected by SP600125 treatment. In contrast, only abnormalities 
in the length of the embryos (shorter than controls) and the ocular distance (larger than 
in controls) were observed. This discrepancy between expression pattern and 
abnormalities is probably due to the fact that many of the processes that establish body 
patterns and organ morphogenesis have either already been completed or are well 
underway and cannot be affected at that time (22-30 hpf) by SP600126 treatment. Of 
note, the examination of the general body morphology and the development of some 
organs was only conducted superficially with microscopic observation and thus, the 
presence of abnormalities that could not be detected with the current approach, cannot 
be excluded.   
 
4.4.2. Jnk inhibition causes abnormalities in the formation and morphogenesis of the 
hearts in developing zebrafish embryos  
 
Of pivotal importance for our research group, was the heart-related phenotype of 
SP600125-treated zebrafish embryos. A small but significant percentage of 5.25-10 hpf 
SP600125-treated embryos had abnormal hearts that were reversely (leftwards) looped 
and surrounded by mild pericardial oedema. A considerable percentage of 10-22 hpf 
SP600125-treated fish showed more severe and prevalent cardiac defects, including 
pericardial oedema, lack of chamber morphogenesis, disturbed chamber specification 
and absence of looping. In contrast, 22-30 hpf SP600125-treated embryos did not 
exhibit obvious cardiac-specific abnormalities, as assessed by the current approach.   
Swollen pericardial cavities in zebrafish embryos usually indicate problems with 
the function of the heart or with the circulation of fluid around the body and commonly 
disturb proper morphogenesis of the heart. Therefore, it seems possible that SP600125 
treatment affects the function of the heart or fluid homeostasis, as suggested by the 
formation of oedema around the heart, but the small size of the swelling is probably not 
sufficient for distortion of the heart itself.  
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4.4.2.1. Left-right patterning and looping morphogenesis 
 
Left-right patterning is a major determinant of correct heart morphogenesis and 
abnormal looping has been commonly associated with defects in this process (Bisgrove 
et al., 2000, Chen and Fishman, 2000a, Chen and Fishman, 2000b, Chen et al., 1997, 
Chin et al., 2000, Glickman and Yelon, 2002, Kathiriya and Srivastava, 2000, Yan et 
al., 1999). The initial symmetry breaking at the mouse node (or Kupffer’s vesicle in 
zebrafish) and the subsequent asymmetric gene expression at the lateral plate mesoderm 
(LPM) have been discussed thoroughly before (Section 1.2.4, page 6). The PCP 
pathway has been recently shown to be essential for correct (posterior) positioning of 
the cilia in the cells of the node (Borovina et al., 2010, Guirao et al., 2010, Okada et al., 
2005, Song et al., 2010). Posterior localization of the cilia dictates the direction of their 
rotation and enables proper establishment of left-right identities in the mouse embryo 
(Nonaka et al., 2005, Song et al., 2010). Translation of the initial asymmetric signals 
from the node to the LPM dictates the directionality of subsequent organ 
morphogenesis, such as the looping of the heart (Aw and Levin, 2008, Capdevila et al., 
2000, Collignon et al., 1996, Ibanes and Izpisua Belmonte, 2009, Kawasumi et al., 
2011). Nodal signalling, the main asymmetrically expressed cascade at the LPM, has 
been shown to determine, to a large extent, left-right patterning (Ahmad et al., 2004, 
Brennan et al., 2002, Duboc et al., 2005, Kawasumi et al., 2011, Saijoh et al., 2003). In 
zebrafish, three nodal genes have been described (cyclops, squint and southpaw), with 
different ranges of action but same targets (Erter et al., 1998, Feldman et al., 1998, Long 
et al., 2003, Schier, 2009).  
Interestingly, a connection between Nodal signalling (member of the TGFβ 
superfamily) and the MAPK pathway has been established (Dennler et al., 2000, 
Hagemann and Blank, 2001). Specifically, Smad proteins (Smad2/3), which are known 
downstream targets of Nodal signalling and participate in the establishment of 
asymmetric gene expression (Kawasumi et al., 2011, see section 1.2.4, page 6 for more 
details on this), have been shown to be activated by MEKK1 (MAPK/Erk kinase 
kinase1 or MAPKKK1, an upstream activator of MKK4 and MKK7, which in turn 
activate JNK). In fact, dominant-negative MEKK1 expression in cultured cells has been 
shown to inhibit TGFβ-mediated induction of Smad-regulated transcription. In contrast, 
JNK and c-Jun have been shown to mediate inhibition of Smad3, without affecting its 
cellular localization (Dennler et al., 2000). Overall, the TGFβ/MEKK1/JNK-mediated 
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regulation of Smad2 and Smad3 proteins is likely to be complex and still not fully 
elucidated.      
Symmetry breaking and left-right patterning are important for heart 
morphogenesis, as briefly mentioned before. In fact, the heart is the first organ, in most 
animals, to break the embryonic symmetry, in response to left-right asymmetry signals 
already established. Heart jogging at approximately 19 hpf is the first sign of cardiac 
left-right asymmetry in zebrafish (Baker et al., 2008, Kathiriya and Srivastava, 2000). 
Asymmetric Nodal signalling and subsequent asymmetric gene expression (such as 
Pitx2, Lefty-1, Lefty-2) have been shown to be highly involved in establishing the 
directionality of this process (Baker et al., 2008). In turn, the direction of heart jogging 
is highly correlated with the direction of looping in subsequent stages of heart 
development (starting at approximately 30 hpf). So, although heart looping itself is not 
directly dependent upon establishment of Nodal-induced asymmetric gene expression at 
the node and at the LPM, it relies on proper heart jogging (Baker et al., 2008). Incorrect 
jogging and/or looping (reverse, incomplete or absent) have been correlated with left-
right patterning defects or with inability to interpret left-right cues (Ahmad et al., 2004, 
Chin et al., 2000). Also, modifications in the proliferation, migration, differentiation and 
death levels of cells are suggested to be involved in the heart jogging and looping 
processes (Kathiriya and Srivastava, 2000).   
Inhibition of jnk during gastrulation (5.25-10 hpf), which caused a high incidence 
of reverse looping, is unlikely to directly affect jogging-related processes as these take 
place later (starting at approximately 19 hpf). Also, jnk proteins are not known to be 
directly involved in left-right patterning, although there is evidence to suggest that, 
directly or indirectly, the non-canonical Wnt/PCP pathway (Antic et al., 2010, Song et 
al., 2010) and members of the MAPK cascade (Dennler et al., 2000, Hagemann and 
Blank, 2001) are, as discussed before. Early inhibition of jnk may, therefore, indirectly 
affect establishment of the left-right axis, not specifically in the heart but globally in the 
whole embryo. It could affect the formation of the Kupffer’s vesicle, the initial 
localization of cilia within Kupffer’s vesicle cells (along with other PCP members), the 
establishment of the appropriate left-right gene expression pattern and/or the 
interpretation of left-right cues (possibly through Smad-related interactions), the 
transmission of the left-right asymmetry from the node to the LPM and the migration 
and polarization of cells during convergence and extension movements (through both 
PCP and MAPK interactions). Abnormalities in any of these procedures could cause 
defects or even randomization of left-right patterning, which would affect downstream 
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organ localization, directionality and morphogenesis. A number of zebrafish mutants 
show abnormalities in cardiac looping. In these mutants, reverse looping has been 
commonly associated with defective left-right patterning of the embryonic axis 
(Bisgrove et al., 2000, Chen et al., 1997, Chin et al., 2000, Glickman and Yelon, 2002, 
Yan et al., 1999). These are only hypotheses, based on current information about the 
activity of Jnk, that need further work in order to be elucidated.  
SP600125 treatment during the segmentation period (10-22 hpf), which caused 
high occurrence of absence of looping, could have broader effects than the gastrulation 
treatment, as it encompasses many processes. During the first hours of the treatment 
(10-19 hpf), inhibition of jnk may affect processes preceding cardiac jogging, such as 
the ones described above (Kupffer’s vesicle formation, ciliogenesis, left-right gene 
expression patterning and cell migration and/or polarization). However, defects in these 
processes would be expected, as described above, to cause reversal or randomisation of 
looping (as observed after the 5.25-10 hpf SP600125 treatment) and not to inhibit it 
altogether, since they are not directly related with looping morphogenesis but mainly 
affect left-right patterning. After 19 hpf, jogging-related modifications in cell 
proliferation, apoptosis, migration, differentiation and gene expression take place 
(Kathiriya and Srivastava, 2000). Treatment with SP600125 at that time interval is 
likely to affect the directionality of jogging through deregulation of one or more of 
these processes, as jnk has been shown to be highly involved in these procedures in 
other contexts (reviewed by Bogoyevitch and Kobe, 2006). Specifically, jnk could be 
affecting the tilting and migration of the cardiac cells during jogging of the cardiac 
cone, which starts at approximately 19 hpf and is complete by 22-24 hpf (Chen et al., 
1997, Rohr et al., 2008, Stainier and Fishman, 1992, Yelon and Stainier, 1999). 
Defective migration could lead to improper jogging, abnormal positioning and possibly 
formation of the heart tube and could cause complications in downstream cardiac 
morphogenesis events. Alternatively, jnk could be affecting the expression of genes 
within the heart population, possibly through differential effects on atrial and 
ventricular cells. The dynamics of cell proliferation, death and differentiation could also 
be affected by inhibition of jnk, influencing majorly the process of cardiac jogging and 
subsequently of cardiac looping. Absence of looping has been previously linked with 
defects in the interpretation of left-right cues or in the molecular mechanisms that guide 
and orchestrate looping in zebrafish mutants (Ahmad et al., 2004).  
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4.4.2.2. Chamber specification 
 
Another aspect of heart formation that was investigated was chamber specification. 
5.25-10 hpf SP600125 treatment caused increased atrial compared to ventricular size in 
significantly more embryos than no treatment or DMSO treatment did, but this change 
was not accompanied by a difference in the numbers of atrial and ventricular cells in the 
two chambers. This probably indicates that the observed size difference was due either 
to a swelling of the atrium or an increase in the size of the cells, which were not 
accompanied by an increase in cell numbers. Further work counting proliferating cells 
(BrdU staining) and cells undergoing programmed cell death (TUNEL staining) would 
be required in order to fully elucidate how inhibition of jnk between 5.25 and 10 hpf 
causes the observed phenotype.   
Chamber specification was dramatically affected after the 10-22 hpf SP600125 
treatment. The atrium appeared markedly larger than the ventricle after microscopical 
observation and this was found to be due to a specific loss of ventricular cells and, thus, 
shrinkage of the ventricle, rather than to an enlargement of the atrium. Ventricular and 
atrial cell specification takes place very early during zebrafish development. Already in 
late blastula-stage embryos (at 40% epiboly, approximately 5 hpf) ventricular and atrial 
myocardial progenitors are thought to be differentially positioned, with ventricular cells 
located closer to the embryonic margin and towards the dorsal midline than atrial cells 
(Keegan et al., 2004). Subsequent migration during gastrulation (5.25-10 hpf) maintains 
the physical separation of these cell populations so that in the LPM ventricular 
progenitors become positioned medially and rostrally in relation to atrial progenitors 
(Keegan et al., 2004, Yelon and Stainier, 1999). It is, thus, evident that jnk inhibition 
between 10 and 22 hpf could not explain a difference in atrial versus ventricular 
specification, as this has taken place before administration of the drug. The proliferation 
and apoptosis rates of cardiomyocytes could be, however, affected by jnk inhibition. 
Previous studies have shown that smaller hearts or hearts with one smaller chamber can 
be caused by defective proliferation of cardiomyocytes during the heart tube stage, 
while programmed cell death is not a major contributor to the first days of cardiac 
morphogenesis (Ribeiro et al., 2007, Sedletcaia and Evans, 2011). The fact that JNK is 
thought to be important in regulation of both apoptosis and proliferation rates in many 
different contexts (reviewed by Bogoyevitch and Kobe, 2006) suggests that SP600125 
treatment between 10 and 22 hpf may have detrimental effects on the proliferation of 
both or one of the heart chambers. The reason why one of the heart lineages (atrial or 
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ventricular cells) might be more severely affected than the other by the absence of jnk 
remains to be determined; differential expression of jnk proteins and/or protein isoforms 
in the two presumptive chambers (which was not examined here) is a possible 
explanation.  
 
4.4.2.3. Overview of the known contribution of MAPK and Wnt/PCP in the heart 
 
The MAPK and the Wnt/PCP signalling pathways have been studied extensively in 
heart development and disease in the past (reviewed by Muslin, 2008, Rose et al., 
2010). The three main MAPK cascades involve ERK, p38 and JNK and are shown to be 
involved in many aspects of cell physiology (Raman et al., 2007). Most of the 
contribution of ERK1/2 signalling to heart development is due to its role in FGF and 
other growth factor signalling. However, its role is not fully established. ERK1/2 has 
been shown to be vital for cardiogenesis and for differentiation of beating clusters in 
ES-derived EB (Dell'Era et al., 2003, Schonwasser et al., 1998). Also, ERK1/2 
mediating FGF signalling has been suggested to play critical roles in morphogenesis 
and growth throughout cardiac development (Lincoln et al., 2006, Zhao et al., 2007). 
Deletion of ERK5 in mouse embryos caused underdevelopment of the myocardium, 
disorganization of trabeculae, vascular defects and early leathality (Hayashi and Lee, 
2004, Regan et al., 2002). However, in other studies, inhibition of ERK1/2 has been 
shown not to affect cardiomyocyte differentiation (Davidson and Morange, 2000, 
Eriksson and Leppa, 2002). Importantly, members of the ERK branch of the MAPK 
cascade were found to be causative for Noonan Syndrome (Carta et al., 2006, Roberts et 
al., 2007, Schubbert et al., 2006) and involved in Costello and Cardio-Facio-Cutaneous 
syndromes (Aoki et al., 2005, Niihori et al., 2006, Schubbert et al., 2007). All of these 
syndromes in humans are associated with congenital heart defects, including 
hypertrophic cardiomyopathy, electrophysiological abnormalities and septal defects 
(briefly discussed in Section 1.1 page 1).  
Similarly, p38 is thought to be an important regulator of cardiomyocyte 
differentiation. Among others, it has been shown to be required for cardiac 
differentiation of P19 carcinoma cells (Eriksson and Leppa, 2002), to promote 
cardiogenesis over neurogenesis in ES cells (Aouadi et al., 2006) and to be implicated 
in reactive oxygen species (ROS)-mediated cardiac differentiation of mouse ES cells 
(Ding et al., 2008, Wo et al., 2008). In contrast, inhibition of p38 has been shown to 
promote differentiation of human ES cells into cardiomyocytes (Graichen et al., 2008). 
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Interestingly, this effect was only seen in low concentrations of the p38 inhibitor, while 
in high concentrations cardiogenesis was strongly inhibited (Graichen et al., 2008). A 
similar controversy about the role of p38 exists in the field of cardiac disease. It is 
generally believed that activation of p38 is detrimental for cardiac pathology and 
recovery after ischemia and therefore its inhibition has beneficial outcomes (Ma et al., 
1999, Mackay and Mochly-Rosen, 1999). However, some reports suggest protective 
effects of p38 MAPK activation in cardioprotection (Maulik et al., 1998, Mocanu et al., 
2000, Muslin, 2008, Rose et al., 2010, Weinbrenner et al., 1997). Overall, p38 is 
thought to have both protective and pathological roles in the differentiation, 
proliferation and function of the heart (Kerkela and Force, 2006, Liao et al., 2002, 
Muslin, 2008, Rose et al., 2010).  
The JNK pathway has also been studied during heart development and disease. Its 
role is best characterized through its function in the non-canonical Wnt/PCP signalling, 
which is a known important player in cardiogenesis. Activation of the PCP pathway has 
been shown to promote cardiogenic differentiation and cardiac gene expression in 
cultured cells and in animal models (Belema Bedada et al., 2005, Eisenberg and 
Eisenberg, 1999, Eisenberg et al., 1997, Garriock et al., 2005, Pandur et al., 2002, 
Schulze et al., 2005, Terami et al., 2004), while deletion of upstream or downstream 
effectors of the pathway has been shown to cause severe cardiac defects in mouse and 
zebrafish embryos (Hamblet et al., 2002, Henderson et al., 2001, Matsui et al., 2005, 
Phillips et al., 2007, Wei et al., 2001). Additionally, JNK, activated by the Wnt/PCP 
pathway (Wnt11) and acting through TGFβ-2, has also been shown to be required for 
proper outflow tract formation in the mouse (Zhou et al., 2007). What is not clear from 
the studies that are available to date is the extent to which Jnk is involved in these 
Wnt/PCP-mediated functions, as Jnk-deficient mice have not been shown to display 
significant defects in cardiogenesis (Gerits et al., 2007). This might, however, reflect the 
early lethality of double Jnk1 and Jnk2 mouse mutatnts (Jnk1-/-;Jnk2-/-) due to brain 
abnormalities (Aouadi et al., 2006, Kuan et al., 1999), which does not allow for further 
investigation of the heart phenotype, and putative redundancy in other combinatorial 
deletions (Jnk1-/-;Jnk2+/-, Jnk1+/-;Jnk2-/-, Jnk2-/-;Jnk3-/- or Jnk1-/-;Jnk3-/-), which do not 
allow for the whole spectrum of actions to be revealed. Interestingly, c-Jun-/- (direct 
target of Jnk) mouse embryos show malformations of the cardiac outflow tract that 
resemble truncus arteriosus persistens (Eferl et al., 1999). The role of Jnk in cardiac 
disease has also been the focus of many studies in the past; however, a lot of 
controversy surrounds the data available to date. Overall, it has been shown to have 
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both protective and pathological roles in cardiac physiology (including regulation of 
hypertrophy, cardiomyocyte death and survival, remodelling after ischemia) depending 
on the context, the cell type and the timing (reviewed in (Rose et al., 2010) and 
described in detail in Section 1.5.6, page 43).  
Taken together, JNK, as a member of the MAPK family and a downstream 
effector of the non-canonical Wnt/PCP pathway, is involved in a variety of cellular and 
morphogenetic processes throughout development and in adulthood. In the context of 
this study, the roles of JNK within the two cascades (MAPK and Wnt) cannot be 
distinguished and are likely to be tightly interconnected, with complex interactions and 
extensive cross talk between them. Analysis of the known roles of other MAPK and 
PCP members in development and cardiogenesis highlights the complex and often 
contradictory contributions of the two pathways and partially explains the discrepancy 
between some of the observations made in this study and published work. The strong 
and weak features of this study are analysed below.     
 
4.5. Advantages and disadvantages of this study 
 
In the current study the role of jnk during zebrafish development was investigated by 
using a chemical inhibitor, SP600125. The use of SP600125 was an advantage of the 
current study. This chemical is a specific inhibitor of Jnk with an IC50 (half maximal 
inhibitory concentration) for Jnk much lower (40, 40 and 90 nM for Jnk1, Jnk2 and 
Jnk3, respectively) than the IC50 for other kinases of the same family. The second 
lowest IC50 after Jnk is 400 nM against Mkk4 (Bennett et al., 2001), which is primarily 
an upstream activator of Jnk and to a lesser degree of p38 (Gerits et al., 2007). Although 
recent studies have questioned its claimed specificity (Bain et al., 2003), it continues to 
be used extensively as an inhibitor against Jnk (Bogoyevitch and Arthur, 2008).  
In this study, SP600125 was preferred over morpholino injections (these are 
discussed in detail in Section 4.6, page 169) for two essential reasons. The first was the 
fact that it inactivates all Jnk proteins, even unidentified isoforms, as it targets the ATP 
binding pocket of the enzyme, which is highly conserved and omnipresent in all active 
forms of Jnk proteins. This is very important because it avoids modification of the 
observed phenotype due to redundancy. Morpholinos, on the contrary, are designed 
against specific transcripts or isoforms and simultaneous injection of multiple constructs 
would be required in order to get global inhibition of Jnk proteins. This is practically 
impossible, since injection of more than 2-3 morpholinos is unreliable and can cause 
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severe unspecific morphological defects. It is also problematic if not all isoforms have 
been identified, as the design of the constructs has to be tailor-made against specific 
sequences.  
The second reason for choosing SP600125 in this study was the need for timely 
inhibition of the proteins of interest. The drug can be administered at any 
experimentally defined time during development and for as long as it is required. In this 
way, specific developmental processes can be targeted, which could not be achieved 
with morpholino injections that have to be carried out at the 1-2 cell stage. Thus, the use 
of a chemical inhibitor allowed for a more comprehensive and global investigation of 
the effects of jnk inactivation during zebrafish development. Although chemical 
inhibition was the preferred approach for this study for the reasons described above, 
morpholino injections have significant advantages that cannot be overlooked and are, 
thus, analysed in Section 4.6 (page 169). The main one of these advantages is the 
specificity. Although SP600125 is a specific inhibitor, its specificity (in fact the 
specificity of any chemical inhibitor) cannot reach the tailor-made specificity of 
morpholinos, which are designed to target only one specific gene and not a whole 
family.   
Another positive feature of the current study was the fact that the analysis of 
cardiac-specific phenotypes, which were the main interest here, was carried out 
concomitantly with analysis of the general phenotype. This is essential when analysing 
organ-specific abnormalities because it puts them into context and does not isolate them 
from the events that take place in the rest of the body due to the drug. In this study we 
observed severe cardiac defects in a large proportion of SP600125-treated embryos and 
it was important to assess whether these abnormalities arose from a general 
disorganization of the body plan and of surrounding tissues, or whether they were 
intrinsic to the heart. Put simply, it was important to examine whether what we 
observed was an abnormal heart within a severely abnormal body or a defective heart 
within a normal body. Only a small percentage of embryos exhibited cardiac-unrelated 
abnormalities, much smaller than the percentage with cardiac defects, and these 
anomalies were not severe. However, the length of the body of SP600125-treated 
embryos (5.25-10, 10-22 and 22-30 hpf) was significantly decreased compared to 
controls. This was shown to probably be the main reason (or one of them) for the 
reduced heart cell count observed in 5.25-10 hpf SP600125-treated embryos; the 
reduction in heart cells (both atrial and ventricular) was accompanied by a concurrent 
decrease in the length of the body. This did not hold true for 10-22 hpf SP600125-
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treated embryos, which had more severely reduced heart cell numbers (ventricular cells 
more affected than atrial cells) compared to the reduction of their body size. Thus, both 
extra- and intra- cardiac effects caused by absence of jnk are likely to account for the 
observed phenotype, possibly depending on the timing of the drug administration. One 
of the extra-cardiac effects is the putative reversal of left-right patterning of the body 
that in turn affects the directionality and positioning of the heart, as described in 
previous sections. Closer examination of the positioning and morphogenesis of other 
organs, such as the gut, would elucidate whether left-right patterning was indeed 
reversed or randomized, or whether the heart was specifically affected.    
Additionally, the use of transgenic zebrafish lines greatly improved the resolution 
of our observations and allowed for accurate scoring and measurement of the features of 
interest. Both lines used, Tg(cmlc2:GFP) (Huang et al., 2003b) and Tg(cmlc2:DsRed2- 
nuc) (Mably et al., 2003), had cardiac-specific constructs that facilitated visualization of 
the heart from early developmental stages onwards and made even early observations 
possible.  
Finally, in depth and accurate statistical analysis was another positive attribute of 
the current study. Assumptions that couldn’t be tested were not made and for all data, 
the appropriate parametric or non-parametric tests were used, after thorough 
investigation of the fitness of each test and its suitability for the current data sets. Also, 
categorical data, which are usually troublesome in their statistical analysis, were 
examined under the correct null hypotheses and using suitable tests (Ennos, 2006).   
However, some aspects of the current work could be improved. An important 
downside of the present study was the lack of investigation of the effectiveness of the 
drug. This was due to the fact that commercial antibodies (against phospho-Jnk, as the 
one used in Chapter 5) did not specify their cross-reactivity with zebrafish and it was 
uncertain whether they would specifically bind the activated form of the protein. This 
was exacerbated by analysis of the predicted protein weights of different jnk isoforms 
that were between 46 and 50 kDa for most proteins, differing from mammalian jnk 
proteins that give 46 and 54 kDa bands in SDS-Page electrophoresis (Chan et al., 1997, 
Masamune et al., 2004). These are the reasons why western blot analysis was not 
conducted on SP600125-treated embryos to affirm effective downregulation of jnk. This 
issue could be overcome by using splice-blocking morpholino injections to confirm the 
phenotype, since the end point of such an inactivation is readily testable with RT-PCR 
analysis. Splice morpholinos have already been designed against jnk1a, jnk1b and jnk2 
(jnk3 is only expressed after 20-24 hpf) and the work is due to be carried out in the near 
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future by new members of our research group. The advantages and disadvantages that 
morpholino work entails are described below.  
Also, rescue experiments should have ideally been conducted in order to assess 
the specificity of the drug. This is usually performed with injection of mRNA of the 
gene of interest at the 1-2 cell stage. This would not be useful for reversing (rescuing) 
the effect of SP600125 treatment, since the drug acts on the protein and inhibits its 
association with ATP, but is not expected to affect the transcription levels of the gene. 
Expression of a dominant active form of the protein, not affected by the drug, would be 
a better candidate for rescue experiments.  
 
4.6. Further work 
 
The next step to take in order to advance this study would be, as described before, to 
perform morpholino injections. Morpholinos are synthetic sequences of nucleotides that 
can silence transcription or translation of the genes of interest. Their backbone is made 
of 6-membered morpholine rings that carry one of the four known bases of DNA/RNA 
molecules and can be microinjected into the cytosol of zygotes for targeted gene 
inactivation. There, they block mRNA splicing or initiation of translation by preventing 
the respective complexes (the splicing or ribosomal machinery, respectively) to bind to 
the substrate (Sumanas and Larson, 2002). The main asset of using morpholinos for 
gene inactivation is their specificity. Careful design of morpholinos according to 
published guidelines (Eisen and Smith, 2008, Kamachi et al., 2008, Morcos, 2007) can 
lead to the production of highly specific products that reliably and efficiently inactivate 
the gene(s) of interest. Moreover, targeting of specific transcripts or individual genes 
that are very similar to other genes of the same family, can be achieved. Another 
important benefit of using splice-blocking (but not translation-blocking) morhpolinos is 
the fact that their effectiveness can be readily detected by PCR analysis: misplicing of 
an mRNA product will change (usually shorten) its size, which can be easily visualized 
after PCR analysis on an agarose gel (Eisen and Smith, 2008). Detection of the end 
point of translation-blocking morpholinos can be achieved, similarly to chemically 
inhibited products, with western blot analysis for detection of the absence of the protein 
of interest. In this case, though, antibodies that recognize the protein and not necessarily 
the active form of the protein (as would be required for chemical inhibition) can be 
used.  
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Disadvantages of the morpholino approach, as briefly mentioned before (Section 
4.5, page 166), include off-target effects due mainly to activation of p53 (Sumanas and 
Larson, 2002), inability to cross the plasma membrane (which dictates their injection 
only during the first few cell divisions), delivery inconsistencies due to subjective 
evaluation of the size of the morpholino droplet and dependence of the efficiency of 
gene inactivation (and absence of redundancy) upon knowledge of all protein-coding 
transcripts. The reasons, why chemical inhibition by SP600125 was preferred over 
moprholinos in this study, are clear and are explained before (Section 4.5, page 166). 
However, confirmation of the observed phenotype, extension of the findings and 
analysis of putative redundancy between jnk isoforms using morpholino injections 
would be important.       
In addition to morpholino injections, it would also be interesting to find the 
mechanism of how jnk exerts its effects on the heart during development. Five main 
ideas, some of which are already being implemented by new members of our research 
group, could significantly move this project further. They are explained in detail below. 
The first one is the examination of cell death and proliferation rates in the hearts 
of developing SP600125-treated and untreated embryos. Jnk is a major regulator of both 
these processes (reviewed by Bogoyevitch and Kobe, 2006) and, as suggested by the 
reduction of ventricular cells in hearts of SP600125-treated embryos, its inactivation 
could cause destabilization of their intricate balance. Assessment of cell death and 
proliferation rates is readily achievable by TUNEL and BrdU staining in zebrafish 
hearts, respectively (Ribeiro et al., 2007, Sedletcaia and Evans, 2011).  
The second future plan is the investigation of the specification and migration of 
cardiac cells. Myocardial cells can be followed through their migratory journey by in 
situ hybridization with a cmlc2 probe at different time intervals during zebrafish 
development. Comparing the correlation of somite numbers (indication of overall 
developmental progression) with cmlc2 expression pattern (bilaterally, V-shaped, cone, 
linear heart tube etc) between treated and untreated embryos, would give us an 
indication of how migration progresses. For an earlier visualization of cardiac 
progenitors a different approach can be employed. Goosecoid-mCherry transgenes 
constructed using the Tol2-Gateway system (currently being established in the lab by 
David Burns) can be injected into zebrafish eggs with KikGR mRNA (coding for a 
photo-convertible green-to-red fluorescent protein). After identification of the first two 
tiers in the margin of the embryo (see Section 1.3.2 and 1.3.3 at pages 11-13 for details) 
photo-activation of the desired cells or layers of cells will be achieved with UV light 
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exposure. Photo-activated precursors, turned red after UV exposure, can be followed 
using time-lapse fluorescence microscopy and the directionality and rate of their 
migration can be measured. Changes in these procedures after jnk inactivation (by 
chemical inhibition or by morpholino injections) would reveal how (and if) jnk is 
involved in them.  
Thirdly, examination of the function of the hearts of SP600125-treated (or 
morpholino-injected) and untreated fish embryos would add invaluable understanding to 
the role that jnk plays during zebrafish heart development. The function of the heart and 
the flow of blood have been shown to be important in shaping the heart itself (Bartman 
and Hove, 2005, Hove et al., 2004, Ingber, 2006); so analysis of potential defects in 
heart function and blood circulation could shed more light in our current knowledge of 
why jnk inhibition causes heart defects. These analyses can be achieved by counting 
heart rates and by high-speed video recording of circulating red blood cells in the dorsal 
aorta. This work is currently being conducted in the lab by a new PhD student, Paul 
Chrystal.  
Moreover, investigation of putative alterations in the expression of essential genes 
after inactivation of jnk enzymatic activity would, also, be interesting and beneficial. 
For example, changes in the expression levels or patterns of important early cardiac 
regulators, such as gata-4 and nkx2.5, could have detrimental effects on the 
specification and differentiation of myocardial progenitors. Analysis of their spatial 
expression pattern before and after SP600125 treatment could be achieved by in situ 
hybridization, while potential alterations in their expression levels could be revealed by 
quantitative RT-PCR. 
Lastly, examination of left-right patterning defects in SP600125-treated embryos 
would be of relevance and of interest. Establishment of the left-right axis could be 
assessed by looking at organs or structures that commonly exhibit left-right 
directionality (such as the heart and the gut) and by defining asymmetric gene 
expression in the LPM and thereafter. Nodal (cyclops, squint, southpaw) and 
downstream genes (lefty-1, lefty-2, pitx2) are expected to be predominantly expressed 
on the left side of the midline in the LPM of forming zebrafish embryos. Also, cyclops, 
lefty-1 and pitx2 have been shown to be preferentially expressed in the left 
diencephalon, cyclops, lefty-2 and pitx2 in the left heart field and cyclops and pitx2 in 
the left gut primordium (Bisgrove et al., 2000). These asymmetries are useful predictors 
of organ situs. If reversed or randomized left-right body patterning is observed, then 
investigation of the underlying mechanism would follow: formation of the Kuppfer’s 
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vesicle, ciliogenesis, polarized positioning of cilia within the cells, transmission of left-
right signal(s) from the Kuppfer’s vesicle to the LPM and correct interpretation of the 
left-right cues for subsequent organ morphogenesis would be examined.    
Finally, a correlation between the age of the embryos and their developmental 
progression should also be carried out and has, to some extent, been carried out (not 
presented here because, due to technical reasons, it was not repeated sufficient times in 
order to give a reliable pattern). This can be achieved by correlating the number of 
somites with the age of developing embryos, which is a good indication of 
developmental progression and can be readily performed under a dissecting microscope. 
Developmental delay of SP600125-treated embryos, if any, would be revealed with this 
method. Embryos that are developmentally delayed are expected, despite their age, to 
exhibit premature features of younger embryos, such as a linear instead of a looped 
heart tube at 48 or 72 hpf.  
 
4.7. Conclusion 
 
In the work presented in this chapter, inhibition of all proteins produced by the jnk 
genes, identified in Chapter 3, was achieved with the chemical SP600125. Inactivation 
of jnk during gastrulation (5.25-10 hpf) caused low occurrence of ocular distance, CE 
and otic vesicle abnormalities and higher incidence of abnormally formed tails, cardiac 
oedema, atrium enlargement and reverse cardiac looping. Similarly, inhibition of jnk 
during the segmentation period (10-22 hpf) generated embryos with ocular distance, 
CE, otic vesicle and tail defects in small percentages and abnormalities associated with 
the pericardial cavity, heart chamber segmentation, heart chamber specification and/or 
expansion and cardiac looping in higher occurrence. In contrast, treatment with 
SP600125 later in zebrafish development (22-30 hpf) affected only the ocular distance 
(it increased it) and the body length (it decreased it) of treated embryos. Overall, jnk 
was found to play significant roles during heart formation in zebrafish. So, the next aim 
of this study was to investigate the role of Jnk in mouse embryonic stem (ES) cells 
(Chapter 5). This was pursued for two reasons. Firstly, in vitro experiments, due to the 
simpler organization and easier manipulation of the system, can reveal additional 
information, especially about the early stages of commitment and specification of the 
cells that are more difficult to approach in a whole organism. Secondly, the origin of ES 
cells from a different species (mouse instead of zebrafish) is expected to provide a more 
comprehensive insight to evolutionarily conserved roles of jnk.  
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Chapter 5. Investigating the role of Jnk during mouse 
embryonic stem cell differentiation 
 
5.1. Introduction 
 
In this chapter, evaluation of the role of Jnk signalling during differentiation of mouse 
embryonic stem (ES) cells is conducted. Inhibition of Jnk at distinct time intervals 
throughout in vitro differentiation was performed with SP600125 (a specific 
pharmacological agent against Jnk, discussed in Section 4.1.1, page 132 and Section 
4.5, page 166) and the results obtained are presented below. A short introduction on the 
ES cell line used in this study (ES-D3) and its special maintenance requirements are 
discussed in the following section, followed by a brief overview of the genes that have 
been used as markers of various lineages and differentiation-associated procedures in 
the PCR analysis.   
 
5.1.2. ES-D3 stem cell line and STO fibroblasts 
 
ES-D3 was one of the first murine ES cell lines to be established, isolated from day 4 
129S2/SvPas blastocysts (Doetschman et al., 1985). Its in vitro optimal maintenance has 
been shown to be dependent on the presence of a fibroblast feeder monolayer, LIF and 
stem cell qualified serum (see Section 1.6.1.1, page 45 for details) (Doetschman et al., 
1985, Pease et al., 1990, Toumadje et al., 2003), as explained in more detail below.  
The fibroblast feeder layer consists of mitotically inactivated fibroblasts that 
provide the necessary attachment surface and soluble factors (LIF, nutrients and growth 
factors) important for the long-term survival and growth of stem cells in an 
undifferentiated state (Smith et al., 1988). There are two main types of feeder cells that 
can be used: mouse embryonic fibroblasts (MEF) or Sim-Thioguanine-Ouabain (STO) 
fibroblasts. MEF are primary cells that provide a reliable, potent and reproducible 
source of feeder cells after their mitotic inactivation (Evans and Kaufman, 1981). 
However, as primary cells, they have a limited life span and cannot be maintained 
indefinitely in culture. In fact, they can only be used efficiently as feeders and support 
stem cell culture during their first 3-6 passages in vitro. Their tedious isolation from 
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E12.5-E14.5 mouse embryos and their continuous need for stock replenishing make 
their use difficult and time-consuming (Notarianni and Evans, 2006). Despite these 
disadvantages, they are extensively used in stem cell research, as they can be obtained 
relatively cheaply from wild type mice and they have proven to be efficient and reliable. 
STO on the other hand is an established cell line derived from Sandos Inbred Mouse 
(SIM) fibroblasts (Notarianni and Evans, 2006). These cells are thioguanine and 
ouabain resistant, grow well and effortlessly in culture and are easy to obtain, with no 
need for tedious and lengthy methods of stock replenishing. However, they are 
expensive and, as they can be kept for long periods in culture, their quality and health 
can be significantly diminished if optimal conditions are not maintained throughout 
(Notarianni and Evans, 2006). The ES-D3 cell line, used for all experiments described 
in this chapter, was obtained from the American Type Culture Collection (ATCC). The 
stem cell maintenance protocol was performed exactly as recommended by the provider 
in order to achieve optimal culture conditions, as described in detail in Chapter 2.  
 
5.1.3. Genes used as markers  
 
JNK is a major regulator of transcription and has been shown to affect several cellular 
processes (reviewed by (Bogoyevitch and Kobe, 2006). The expression of several genes 
that mark some of these processes was assessed after inhibition of Jnk. Cardiac-related 
genes, associated with important cardiac differentiation procedures, are examined in this 
chapter and have been presented before (Section 1.3.5, page 14). Cardiac-unrelated 
genes are examined as well and are presented below.  
 
5.1.3.1. Markers of cell lineages 
 
Markers of four cell populations outside the cardiac lineage were examined. Brachyury, 
marker of mesoderm, Hex, marker of endoderm and early hematopoietic precursors, 
Flk1, marker of early hemangioblasts and endothelial cells, and CD31, marker of 
endothelial cells.    
Brachyury (Bry), also known as T, is a transcription factor essential for the 
activation of genes required for mesoderm formation and differentiation. It is transiently 
expressed throughout the primitive streak and nascent mesoderm (Herrmann and 
Kispert, 1994) and is required for axis development and notochord formation (Technau, 
2001). Its connection with β-catenin signalling has been known for years: it was initially 
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shown to be a direct target of the canonical Wnt pathway (Arnold et al., 2000, Vonica 
and Gumbiner, 2002, Yamaguchi et al., 1999) and more recently it was suggested to 
participate in a positive autoregulatory loop with β-catenin that maintains mesodermal 
progenitors and facilitates posterior somite development (Martin and Kimelman, 2008).   
Haematopoietically-expressed homeobox (Hex) is a homeobox gene expressed in 
many tissues during early embryonic development, including primitive endoderm, some 
endoderm-derived tissues and endothelial and haematopoietic precursors. However, its 
expression is turned off during terminal differentiation of endothelial and 
haematopoietic cells (Bedford et al., 1993, Pellizzari et al., 2000, Thomas et al., 1998). 
Hex has also been shown to have a cardiogenic function, as suggested by experiments in 
frogs and chicks (Schneider and Mercola, 2001, Yatskievych et al., 1999), in human and 
murine ES cells (Mummery et al., 2003) and in mouse (Hallaq et al., 2004). Recently, a 
connection between the Wnt network and Hex was unravelled. Specifically, 
experiments on Xenopus showed that during early embryonic development Hex has an 
amplifying effect on canonical Wnt signalling by repressing Wnt antagonists 
(Zamparini et al., 2006), while later it seems to be induced by canonical Wnt 
antagonists (such as Dickkopf-1) in the endoderm. This, in turn, activates a yet 
unknown diffusible factor that acts on mesoderm, where it promotes early heart 
induction (Foley et al., 2006, Foley and Mercola, 2005). However, it is known that Hex 
can activate early cardiac genes, such as Nkx2.5 and Tbx5, but not later myocardial 
markers, like cardiac myosins and troponins (Foley et al., 2006, Foley and Mercola, 
2005). 
The mouse gene Flk1, also known as VEGFR-2 (Vascular endothelial growth 
factor receptor-2), codes for the main receptor of vascular endothelial growth factor-A 
(Vegf-A). It plays an essential role during the development of the vascular and 
haematopoietic system in the early embryo (Ema et al., 2006, Shalaby et al., 1997). This 
gene is traditionally used as a marker of haemangioblasts, the common mesodermal 
progenitors of the haematopoietic and vascular lineages, in mouse, differentiating ES 
cells and zebrafish (Huber et al., 2004, Vogeli et al., 2006). However, there is evidence 
to suggest that Flk1 expression marks mesodermal cells with broader differentiation 
potential (Yamashita et al., 2000). Specifically, it was shown that Flk1-/Bry+ 
mesodermal cells can sequentially give rise to two distinct Flk1+/Bry+ cell populations 
in culture; the first one is the haemangioblast mentioned earlier and the second one is a 
common progenitor for cardiac myocytes (of both the PHF and SHF), vascular smooth 
muscle and endothelial cells. The latter population is commonly referred to as the 
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cardiovascular colony-forming cell (further discussed in Section 1.3.2, page 11) and 
expresses Flk1 and Bry prior to early cardiac markers, such as Nkx2.5, Gata-4 and 
Mef2c (Garry and Olson, 2006, Kattman et al., 2006). Concomitantly, it was shown that 
Nkx2.5+ cells do not express endothelial cell markers, suggesting that the endothelial 
and myogenic cell lineages have already diverged before the onset of Nkx2.5 expression 
(Garry and Olson, 2006, Wu et al., 2006).  
Platelet endothelial cell adhesion molecule-1 (PECAM-1 or CD31) is a signalling 
and cell adhesion molecule, expressed on the membrane of haematopoietic and 
endothelial cells (Albelda, 1991, Albelda et al., 1991, Tang et al., 1993, Zehnder et al., 
1992). This protein is vital for the regulation of angiogenesis and inflammatory 
responses, facilitating leukocyte migration, transducing mechanical signals in 
endothelial cells, suppressing pro-inflammatory cytokine production, maintaining 
vascular integrity and more (reviewed by Privratsky et al., 2010). It is normally found in 
endothelial cells, platelets and macrophages. It is commonly used as an endothelial cell 
marker (Luu et al., 2003). 
 
5.1.3.2. Wnt targets 
 
Great overlap between the canonical and non-canonical Wnt pathways has been 
revealed over the past few years (selected publications: Caneparo et al., 2007, Maye et 
al., 2004, Tahinci et al., 2007, for more details refer to Section 1.4.4, page 35). 
Therefore, it was important to assess the cross talk between them, when manipulating 
either of them individually. Dickkopf-1 and Lef-1 were used in this study to assess the 
effects of Jnk inhibition on the canonical Wnt pathway.   
Dickkopf-1 (Dkk-1) is a secreted antagonist of the canonical Wnt/β-catenin 
pathway (shown in Figure 1.8, page 26). It has been shown to bind to the LRP5/6 co-
receptor and prevent the formation of an active Wnt-Frizzled-LRP5/6 complex, thus 
blocking transmission of canonical Wnt signal (Bafico et al., 2001, Kawano and Kypta, 
2003, Mao et al., 2001). Surprisingly, the activation of β-catenin has positive effects on 
the transcription of Dkk-1, creating a negative feedback loop (Gonzalez-Sancho et al., 
2005). A characteristic developmental function of Dkk-1 is its head-inducing capacity 
by antagonizing the posterior-inducing activity of canonical Wnt signals (Glinka et al., 
1998, Mukhopadhyay et al., 2001). Dkk-1 has also been shown to be an important 
regulator of programmed cell death, an effect exerted mainly through activation of c-
Jun (Grotewold and Ruther, 2002b), but also through signals from BMP, FGF and Wnt 
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(Grotewold and Ruther, 2002). c-Jun was shown to be able to induce Dkk-1 expression 
in vivo, while the expression of both c-Jun and Dkk-1 was shown to be rapidly 
downregulated after serum withdrawal (Grotewold and Ruther, 2002b).    
Lymphoid enhancer-binding factor-1 (Lef-1) encodes a transcription factor that 
can bind to T-cell factor (TCF) proteins, forming potent transcriptional complexes. 
These complexes participate in the canonical Wnt signalling pathway by recruiting β-
catenin, which lacks the ability to directly bind DNA, to Wnt-target genes (Barolo, 
2006, Behrens et al., 1996, Huber et al., 1996, Roel et al., 2002, Seidensticker and 
Behrens, 2000). In many developmental systems, Lef-1 has been shown to be sufficient 
for inducing a Wnt-like developmental process (Hammerlein et al., 2005, Kengaku et 
al., 1998, Merrill et al., 2004) and null mutations in Lef-1/TCF-1 generated a mouse 
phenotype identical to that seen in Wnt3a-deficient mice (Galceran et al., 1999). It was 
recently suggested that Lef-1 itself may in fact be a transcriptional target of β-catenin, 
either through activation by a β-catenin/TCF-1/Lef-1 complex (Hovanes et al., 2001, 
Hovanes et al., 2000, Vadlamudi et al., 2005) or through Wnt-induced non Lef/TCF-
mediated activation (Filali et al., 2002). Although, it is evident that Lef-1 is an important 
regulator of the canonical Wnt pathway and participates in a positive feedback loop 
enhancing its activity, it has also been shown to be activated by TGF-β signalling in 
SMAD-dependent (Cordray and Satterwhite, 2005) and SMAD-independent ways 
(Labbe et al., 2000).   
 
5.1.3.3. Proliferation markers 
 
JNK has been shown to be a critical regulator of proliferation levels in cells (reviewed 
by Bogoyevitch and Kobe, 2006). Therefore, progression of the cell cycle was assessed 
by examining the expression levels of Cyclin-D2 and c-Myc.  
Cyclin-D2, encoded by the gene Ccnd2, belongs to the D-type cyclins, which are 
regulatory subunits of cyclin-dependent kinases (CDK). Their main role is to regulate 
G1 phase progression during the cell cycle; their degradation during the G1 phase 
correlates with the cell failing to enter the S-phase, while its overexpression at that time 
considerably shortens the G1 interval (reviewed in (Satyanarayana and Kaldis, 2009). 
Cyclin-D2 is a very labile protein and degrades rapidly after removal of mitogens or 
other factors that promote cell cycle progression (Schang, 2003, Sherr, 1995). 
Transgenic mice expressing Cyclin-D2 in the myocardium (αMHC-CycD2) showed 20-
30% increase in the size of their hearts, increased DNA synthesis and increased 
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cardiomyocyte numbers (Lafontant and Field, 2006, Pasumarthi et al., 2005, Soonpaa et 
al., 1997). Deregulation of D-type cyclins has been associated with cancer progression 
(Bai et al., 2005, Denicourt et al., 2008).  
The gene c-Myc encodes an evolutionarily conserved basic Helix-Loop-
Helix/Leucine Zipper transcription factor that is known to regulate the expression of a 
vast array of genes upon stimulation by mitogenic signals (Brenner et al., 2005, 
Grandori et al., 2000). It has been shown to be activated by Wnt (He et al., 1998, Myant 
and Sansom, 2011, Sansom et al., 2007, You et al., 2002), Shh (Rao et al., 2003), 
MAPK/Erk (Armstrong et al., 2006) and other signals and to be involved in a range of 
downstream cellular processes, such as proliferation and cell growth regulation (Amati 
et al., 2001, de Alboran et al., 2001, Eilers, 1999, Heikkila et al., 1987), apoptosis and 
stem cell self-renewal (Smith and Dalton, 2010). Aberrant regulation of the gene that 
leads to upregulation of its activity has been associated with cancer (reviewed by 
Pelengaris et al., 2002). JNK (Gupta and Davis, 1994, Noguchi et al., 1999, Alarcon-
Vargas and Ronai, 2004) and cyclins (Kanazawa et al., 2003) are known interacting 
partners of c-Myc. In fact, it has been shown that c-Myc promotes cell cycle 
progression at least in part through the transcriptional upregulation of Cyclin-D2, with 
which it can bind directly (Bouchard et al., 2001, Bouchard et al., 1999, Coller et al., 
2000). c-Myc is not only activated by Wnt signals but it can also activate the canonical 
Wnt pathway by suppressing Wnt inhibitors, such as Dkk-1 (Cowling and Cole, 2007, 
Cowling et al., 2007).  
 
5.1.3.4. Connexin-43, a marker of gap junctions 
 
Connexin-43 (Cx-43) is encoded by the gene Gja1 (Gap Junction α1) and belongs to a 
family of oligomerizing transmembrane proteins that form hexameric structures, called 
connexons. These structures form channels, called gap junctions, which connect 
neighbouring cells and allow for the transfer of ions and small metabolites (Prochnow 
and Dermietzel, 2008, Sohl et al., 2003). Cx-43 is expressed in many tissues, including 
epithelium, myocardium and smooth muscle and its expression is regulated through 
complex mechanisms, often cell- or tissue-specific (Granot et al., 2002, Pfeifer et al., 
2004). Their export to the plasma membrane, their assembly into junctions and their 
degradation are all regulated via post-translational modifications and, since many of the 
connexins are phosphoproteins, phosphorylation and dephosphorylation are likely to be 
essential regulators of their activity (Lampe and Lau, 2004, Solan and Lampe, 2005, 
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Solan and Lampe, 2009). In fact, MAPK, among others, have been shown to 
phosphorylate Cx-43 and downregulate gap junction communication (Cameron et al., 
2003, Solan and Lampe, 2008). More specifically, activation of JNK in cardiomyocytes 
resulted in significant reduction in Cx-43 expression at both mRNA and protein levels 
and caused impaired cell-cell communication (Petrich et al., 2002).      
 
5.2. Aims of the chapter 
 
Jnk is involved in a variety of cellular processes, ranging from cell proliferation and 
apoptosis to cell migration and differentiation. As a member of the MAPK family and a 
downstream effector of the non-canonical Wnt/PCP pathway, it is expected to 
participate, among others, in the transduction of essential signals during cardiac 
development, possibly affecting the proliferation or apoptosis levels and the 
differentiation potential of cells. Therefore, the main focus of the current chapter was to 
investigate whether Jnk is required during mouse ES cell-derived cardiogenesis. In 
order to achieve this the following aims were set: 
 
• Establish the effect of DMSO (in which SP600125 is diluted) on the 
differentiation of ES-D3 cells by looking at their morphology, general 
properties, beating behaviour and gene expression profiles 
• Determine the involvement of Jnk signalling on the morphology and growth of 
differentiating ES-D3 cells during EB formation by inhibiting it with the 
pharmacological agent SP600125 
• Elucidate the effect of suppression of the Jnk pathway by SP600125 on the 
beating behaviour of differentiating ES-D3 cells, before and after initiation of 
beating 
• Confirm the findings related to the beating behaviour of ES-D3 cells with 
differentiating E14 ES cells 
• Analyse the gene expression profiles of differentiating ES-D3 cells under timely 
inhibition of the Jnk pathway by SP600125 and determine its involvement in the 
process 
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5.3. Assessment of the effect of DMSO on differentiating ES-D3 cells 
 
DMSO was used as the experimental solvent of SP600125, the chemical inhibitor of 
Jnk. Thus, experiments conducted in the presence of DMSO alone (0.1% DMSO, 
corresponding to the amount used for SP600125 dilution) should always be included in 
the analysis in order to ascertain that any observations made after SP600125 treatment 
were not caused by DMSO but by the drug itself. Therefore, before analysing the effect 
of the drug on differentiating ES cells, it was important to examine whether DMSO on 
its own had any effects. The shape, size and morphology of the cells, as well as their 
beating behaviour and their gene expression profiles were assessed, after administration 
of DMSO during the ES cell differentiation assay. Briefly, EB were formed in hanging 
drops from ES-D3 cells between days 0 and 2 of differentiation, were grown in 
suspension for another three days (d2-d5) and were then plated in 48-well plates (d5-
d11). The properties, the morphology and the beating behaviour of the forming EB were 
assessed at d5 onwards. An untreated group, grown in differentiation media with no 
additions, was used as the basic comparator.  
 
5.3.1. 0.1% DMSO did not alter the properties and morphology of the cells 
 
Untreated and DMSO-treated EB did not look considerably different at days 5-11, as 
examined by microscopical observation. At d5, EB, still in suspension, appeared like 
large spherical, well-formed and well-defined aggregates under both conditions. 
Between days 5 and 6, cells started migrating away from the adhesion point and EB 
started to spread along the surface of the well (Figure 5.1). At d8, many cells had 
migrated away from the initial attachment point but this was still identifiable. At d10, 
cells had covered a large part of the well surface and EB had spread excessively. All 
these processes took place in a very similar manner between untreated and DMSO-
treated EB.  
In parallel, some important cell measurements were taken: the diameter, 
circularity and viability of the cells were measured and the total number of cells within 
each EB was assessed. In order to achieve this a Vi-Cell XR-2.03 Counter was 
employed, details about which are given in Section 2.2.9 (page 71). Cells from 10-12 
EB from each condition were pooled together and measured. Three biological replicates 
(different cells, different days) were assessed for each condition. No significant 
differences were observed in any of these measurements between the no-treatment and 
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DMSO-treatment groups. All numerical data are analytically presented in tables and 
illustrated in graphs.  
The average diameter of each cell for the media control group was 10.4µm 
(se=0.2), 10.3µm (se=0.2) and 9.8µm (se=0.9) at d5, d8 and d11, respectively. The 
values for the DMSO treatment were found to be similar to that of the no-treatment 
control: 10.5µm (se=0.2), 9.7µm (se=0.2) and 8.6µm (se=0.2) at d5, d8 and d11, 
respectively (Figure 5.2). Similarly, the average circularity (counted in units, with 1 
being a perfectly circular cell, see Section 2.2.9, page 71) of the cells within untreated 
and DMSO-treated EB was not affected. For the untreated group it was 0.8 (se=0.02), 
0.7 (se=0.01) and 0.7 (se=0.01) at days 5, 8 and 11, respectively. The circularity values 
for the DMSO treatment group were 0.7 (se=0.01), 0.7 (se=0.01) and 0.7 (se=0.01) at 
days 5, 8 and 11, respectively.  
At d5, the viability of the cells within each EB was 77% (se=1) for the no-
treatment and 76% (se=2) for the DMSO-treatment group, which means that at the time 
of the measurement approximately 77% of the cells within each EB under control 
conditions were alive. The viability was also measured at days 8 and 11 and was found 
to be very similar between the two groups examined here: it was 80% (se=4) and 77% 
(se=3) for the untreated and the DMSO-treated EB at d8, and 74% (se=8) and 67% 
(se=3) for the respective groups at d11. The total number of cells (dead and alive at the 
time of the measurement) within each EB was also counted at d5, d8 and d11. The 
average number of cells per EB was 60174 cells (se=8623), 170247 (se=42049) and 
355443 (se=9042) at days 5, 8 and 11 for the media control and 67449 cells (se=10158), 
210208 (se=110409) and 478050 (se=101843) at days 5, 8 and 11 for the DMSO 
control. All experiments started with the same amount of cells (450 cells per hanging 
drop) so any difference in the number of cells that make up each EB would be expected 
to be due mainly to different levels of proliferation and cell death. The survival levels 
(% viability) could be correlated with the levels of cell death within the developing EB 
at the time of the measurement.  
From the data presented above it is clear that no major differences were observed 
in the morphology and properties of the cells within untreated and DMSO-treated 
conditions, which suggests that DMSO did not have any adverse effect on the cells. 
These differences were statistically examined and were found not significant, with p 
values consistently above 0.1.  
 
  
 
 
 
 
Figure 5. 1: DMSO did not affect the morphology of differentiating EB. Control and 0.1% DMSO
resembled EB in suspension with only a few cells migrating away from the main mass of cells. Three days after plating (d8) many cells have 
migrated away from the attachment point and have differentiated towards other cell lineages. At d10, a large proportion of th
well was covered by cells and the initial attachment point of the EB was no longer visible. No major differences were observe
untreated and DMSO-treated EB during this process. Scale bars show 200 
182 
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e surface of the 
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Figure 5. 2: DMSO did 
not affect the basic cell 
properties of 
differentiating EB. 
Control and 0.1% 
DMSO-treated EB at 
days 5, 8 and 11 did not 
show statistically 
significant differences in 
the circularity (A), total 
count (B), diameter (C) 
and viability (D) of their 
cells. The circularity, 
diameter and viability did 
not considerably change 
in either group (no 
treatment and DMSO-
treatment) between days 
5 and 11, while there was 
a gradual increase in the 
total number of cells per 
EB from d5 to d11. All 
numerical data are shown 
in the tables underneath 
the graphs. Statistical 
analysis was performed 
using one-way Anova 
testing.  
 
 
 5.3.2. 0.1% DMSO did not alter the beating behaviour of the EB
 
The beating behaviour of EB after DMSO treatment was
beating behaviour of untreated EB. It was shown that DMSO did not affect the beating 
behaviour of the cells within EB in three independent experiments, compared to 
untreated cells (Figure 5.3). The onset of contraction was at
DMSO, when approxima
spontaneous contraction. Subsequently, with a gradual increase from d7 to d11, the 
maximal number of EB with beating 
only and the DMSO, respectively. The percentages of EB that contained beating foci at 
days 5-11 without any treatment and after DMSO treatment are presented in a table and 
graph format in Figure 5.3.
 
Figure 5. 3: DMSO did not affect the beating behaviour of differentiating EB. No major 
differences were observed in the beating capacity of untreated (control) and 0.1% DMSO
treated (DMSO) EB. Initiation of contraction occured at d7, with 5% and 11% of EB 
containing beating foci in the no
gradual increase from d7 onwards led to 51% and 46% beating EB at d11 for the two 
groups, respectively. All numerical data are tabulated underneath the graph. Statistical 
significance was assessed with the non
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 examined in comparison to the 
 d7 for both media alone and 
tely 5% (se=3) and 11% (se=2) of the EB had already initiated 
foci was 51% (se=4) and 46% 
 
-treatment and DMSO-treatment group, respectively. A 
-parametric Mann Whitney test.    
 
(se=6) for the media 
-
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From the data presented above it is evident that DMSO did not positively or 
negatively influence any of the aspects of cell differentiation examined here and could, 
therefore, reliably be used as an experimental control instead of the no-treatment 
control. However, it was, also, important to assess the gene expression profile of 
DMSO-treated EB compared to untreated EB.   
 
5.3.3. DMSO treatment did not alter the gene profile of differentiating EB 
 
The expression of several genes of interest was examined in untreated (media) and 0.1% 
DMSO-treated (DMSO) EB, in order to assess the effect of DMSO in their 
differentiation potential.  Most of the genes examined (shown in detail below) were not 
altered after 0.1% DMSO treatment at days 0, 5 and 11, compared to the gene 
expression profile of untreated EB. Lineage markers (cardiac, endothelial, 
haematopoietic, mesodermal), Wnt targets (Lef-1, Dkk-1), proliferation markers (c-
myc, cyclin-D2) and others (Connexin-43) were examined, before and after 0.1% 
DMSO treatment. 
Initially, lineage markers were examined. Brachyury met a 35 and 40 fold 
increase from d0 to d5 and a 9 and 2 fold decreased from d5 to d11 in its expression in 
the media and DMSO groups, respectively (Figure 5.4). CD31 transiently decreased at 
d5 (10 fold from d0 to d5 for both groups) and then increase at d11 (14 fold from d5 to 
d11 for both groups). Hex expression gradually increased from d0 to d11: it increased 
2.5 and 5 fold at d5 and then, 8 and 3 fold at d11 in the media and DMSO groups, 
respectively. The expression of Flk1 was transiently increased at d5 (3 and 2 fold 
compared to d0 for media and DMSO, respectively) and then was decreased to levels 
similar to d0 (Figure 5.4). No statistically significant differences were observed in these 
genes between untreated and 0.1% DMSO-treated EB at days 5, 8 and 11: p>0.1 at all 
cases as assessed with the one-way Anova test.  
Cardiac lineage markers were also assessed. Mlc2a decreased approximately 2 
fold from d0 to d5 and then increased 3 fold from d5 to d11 in the media control, while 
it remained unchanged between days 0 and 5 and increased approximately 3 fold from 
d5 to d11 in the DMSO control (Figure 5.5). Mlc2v and Gata-4 expressions were 
gradually increased from d0 to 11 in the two groups. Expression of Mlc2v was increased 
2.5 fold from d0 to d5 and then, 3 and 4 fold from d5 to d11 for the two controls, 
respectively. Gata-4 met a 10 and 8 fold increase at d5, followed by a 6 and 9 fold 
 increase at d11, for media and DMSO, respectively (Figure 5.5). Although some small 
fluctuations in the expression levels of these genes were observed between untreated 
and 0.1% DMSO-treated EB, no statistical significance was found in any of them at 
days 0, 5 and 11 (p>0.06).      
 
 
 
 
Figure 5. 4: qPCR analysis of lineage markers after 0.1% DMSO treatment. Addition of 
DMSO in the culturing media between days 0 and 11 did not severely affect the expression 
of the lineage markers examined here. The expression levels of 
Hex were examined at days 0, 5 and 11. All genes were normalized against two 
housekeeping genes (β
equal to 1).  Relative quantities expressed as fold changes are shown in the graphs. Mean 
values of three independent experiments are represented in the graphs, with error bars 
showing standard errors of 
Anova testing, followed, when necessary by a 2
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Brachyury, CD31, Flk1 
-actin and Rps9) and compared to d0 values (set as the calibrator, 
the mean. Statistical significance was assessed using one
-sided Dunnett test.  
and 
-way 
  
Figure 5. 5: qPCR analysis of cardiac markers after 0.1% DMSO treatment. Addition of 
DMSO in the culturing media between days 0 and 11 did not severely affect the expression 
of the lineage markers examined here. The expression levels of 
were examined at days 0, 5 and 11. All genes were normalized against two housekeeping 
genes (β-actin and Rps9
Relative quantities expressed as fold changes are shown in the graphs. Mean values of 
three independent experiments are represented in the graphs, with error bars showing 
standard error of the mean. Statistical significance was assessed using one
testing.  
 
Other genes, like proliferation and gap junction markers, inhibitors and 
downstream components of the Wnt pathway and 
5.6). Expression of c-
for media and DMSO, respectively) and remained fairly unchanged at d11. 
expression gradually increased from d0 to d5 (4 and 5 fold for media and DMSO, 
respectively) and then to d11 (8 and 6 fold for media and DMSO, respectively). 
Connexin-43 and Jnk
and 4 fold for Jnk, for media and DMSO) and a fall from d5 to d11 (4 and 2 fold for 
43 and 2 and 3 fold for 
upregulated 80 and 59 fold from d0 to d5 and downregulated 4 and 3 fold from d5 to 
d11, in the media and DMSO groups, respectively. No statistically significant difference 
was observed between the two groups (untreated and 0.1% DMSO
genes examined here at days 0, 5 and 11 as assessed with the one
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) and compared to d0 values (set as the calibrator, equal to 1).  
Jnk itself were also examined (Figure 
Myc showed a high increase at d5 for both groups (11 and 12 fold 
 met a transient increase from d0 to d5 (51 and 39 fold for 
Jnk, for media and DMSO). Similarly, Dkk
-way Anova test.
and Gata-4 
-way Anova 
Cyclin-D2 
Cx-43, 3 
Cx-
-1 expression was 
-treated EB) for the 
 
  
Figure 5. 6: qPCR analysis of downstream Wnt targets, proliferation markers and 
genes after 0.1% DMSO treatment. Addition of DMSO in the culturing media between 
days 0 and 11 did not severely affect the expression of the genes examined here, at days 0, 
5 and 11: c-Myc, Cyclin
against two housekeeping genes (
calibrator, equal to 1).  Relative quantities expressed as fold changes are shown in the 
graphs. Mean values of three independent experiments are represented in t
error bars showing standard errors of the mean. Statistical significance was assess
one-way Anova testing
 
 
Lef-1 was the only gene that showed differential levels of expression between the 
media and DMSO groups. At d5 its expression was 35 and 22 fold higher than d0 for 
the two controls respectively, but at d11 its levels dropped in the media control (3 fold), 
while they increased in the DMSO control, almost 2 fold (Figure 5.6). This difference 
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was shown to be statistically significant by one-way Anova testing (p=0.029). This 
observation will be important when assessing the levels of expression of SP600125-
treated EB in the next section.     
From the data presented in this section, it becomes evident that administration of 
0.1% DMSO during embryonic stem differentiation did not severely affect the gene 
expression profile (except Lef-1) and, thus, the differentiation potential and progression 
of cells. Taken together, the use of DMSO as the solvent of SP600125 dictates its use as 
an experimental control throughout all data analysis and since 0.1% DMSO was not 
shown to considerably change the properties, morphology and behaviour of 
differentiating cells, it can be used as the only control from this point forward.     
Importantly, the expected expression profiles of the genes of interest during ES 
cell differentiation were revealed in the last section under both control conditions. This 
pattern will be used as a comparator for subsequent analysis of the effect of SP600125 
administration, and therefore Jnk inhibition, on the differentiation potential of cells.  
 
5.4. Assessment of SP600125 dosage 
 
Initially, the dosage of SP600125 was assessed. After a wide literature search, four 
concentrations were selected: 1µM, 5µM, 10µM and 20µM (selected publications: (Lu 
et al., 2008, Moon et al., 2008, Renlund et al., 2008, Tanemura et al., 2009). All four 
concentrations were tested throughout the experimental time frame, from day 0 until 
day 11, in order to assess their effectiveness and their potential toxicity at all stages. 
Once this was completed, the most appropriate concentration, as assessed by the 
morphology and the beating behaviour of the treated cells compared to controls, was 
further used for targeted temporal experiments. 
 
5.4.1. High dosages of SP600125 affected the morphology and size of growing EB  
 
After treatment with SP600125 between days 0 and 11 we observed a dose-dependent 
decrease in the size of the EB at d5: the 20 µM treatment had a detrimental effect on the 
size and morphology of the EB, the 10 µM had a severe effect, the 5 µM had a mild 
effect, while the 1 µM treatment did not considerably change their overall morphology 
(Figure 5.7). The 20 µM SP600125-treated EB, the most severely affected treatment, 
looked like irregular-shaped, small clumps of cells rather than well-formed multi-
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cellular, round and well-defined aggregates. Cell counting was performed using 
specialised equipment, as described in Sections 2.2.9 (page 71).  
 
5.4.2. The beating pattern of EB was affected in a dose-dependent manner  
 
Next, the beating behaviour of 0.1% DMSO-treated and SP600125-treated EB (at 
different concentrations) was examined, in order to elucidate which dosage of 
SP600125 was the most potent and less toxic to be used in further experiments. The 
beating pattern of SP600125-treated EB was altered compared to the DMSO control in a 
dose-dependent manner. As described before, DMSO-treated EB initiated spontaneous 
contraction at d7 (11% beating EB, se=2) and reached a maximum plateau phase at d11, 
whereby 46% (se=6) of DMSO-treated EB were beating. In contrast, 10 µM and 20 µM 
SP600125-treated EB showed considerable decreases in their beating ability (not 
statistically significant, p=0.069, for the 10 µM treatment, but statistically significant, 
p=0.028, for the 20 µM treatment at d11, compared to DMSO), with the first reaching a 
maximum of 32% (se=7) beating at d11 and the latter not showing any beating at all, 
probably reflecting the abnormal differentiation of these EB (Figure 5.8). Interestingly, 
1 µM and 5 µM SP600125-treated EB showed increased beating (not statistically 
significant, p=0.067, and statistically significant, p=0.046, respectively, at d11 
compared to DMSO), reaching a maximum of 57% (se=13) and 72% (se=13) beating 
EB, respectively. Although the 1 µM and 10 µM data were not significantly distinct 
from controls for most time points between d5 and d11, the 5 µM and 20 µM data were 
significantly different. The statistically assessed significance values (p) for the 1µM 
treatment group were higher than 0.05 at d6-d11 compared to DMSO, indicating that no 
significant differences were observed between the two groups throughout ES cell-
derived differentiation. For the 10µM SP600125 treatment statistical significance was 
observed only at d7 (p=0.046 compared to DMSO), but no significant changes were 
found at d8 onwards (p>0.05 for d8-d11 compared to DMSO). For the 20µM SP600125 
treatment p<0.05 at all time points, indicating significant reductions in the beating 
capacity of the cells. In contrast, after the 5µM treatment p>0.06 at days 7 and 8 (no 
statistically significant difference compared to DMSO) and p<0.05 at d9-d11, showing 
significant increase in the beating behaviour of the cells compared to DMSO. These 
results were highly reproducible; the pattern was the same in all three independent 
experiments examined. Under all treatments analysed here, the timing of onset of 
 beating was not altered; it remained at d7, except after the 20
beating was observed at all. 
 
 
Figure 5. 7: Morphology of EB after SP600125 treatment at various dosage
SP600125-treated EB were similar in size with DMSO
20 µM SP600125-treated EB showed a dose
and 10 µM treated EB appeared like normal, albeit smaller, EB, while 20 
appeared like small, irregularly shaped and unhealthy clumps of cells. Scale bars show 
200 µm.  
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µM treatment, whereby no 
 
-treated EB, while 5 
-dependent decrease in their size at d5. 5 
s. 1 µM 
µM, 10 µM and 
µM 
µM treated EB 
  
Figure 5. 8: Dose-dependent effect of SP600125 on the beating behaviour of EB. All 
treatments were performed between days
experiments are shown here, with error bars representing the standard errors of the 
mean. 0.1% DMSO-treated EB showed a gradual increase in their beating ability from d7 
(11%, se=2) to d11 (46%, se=6). 1 
controls with an increase from 19% (se=7) beating at d7 to 57% (se=13) beating at d11. 5 
µM SP600125-treated cells showed a marked upregulation in their beating behaviour: 
already at d7 22% (se=3) of EB contained 
72% (se=13). Treatment with 10 
initiated spontaneous contraction: 3% (se=1) and 32% (se=7) beating EB were seen at d5 
and d11, respectively. Addition of 20 
effect on the beating behaviour and the overall differentiation of the cells, as none of them 
achieved contraction within the 11 days of the experiment. Statistical significance, shown 
with asterisks (*p<0.05) in the graph, was assessed using the non
Whitney test.  
 
We can therefore conclude that, of the doses tested, 5 
which the inhibitor exerts its maximal positive effect on the differentiation of the cells. 
20 µM is highly toxic for the cells, while 1 
the drug to exert its full effect: 1
levels of toxicity that do not allow for the drug to exert its effects. In the following 
sections, experiments performed with 1, 5 and 10 
only the intermediate concentration (5 
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 0 and 11. Mean values from three independent 
µM SP600125-treated EB behaved similarly to DMSO 
beating foci and at d11 this percentage reached 
µM SP600125 slightly affected the number of EB that 
µM SP600125 in the culture media had a detrimental 
-parametric Mann 
µM is the concentration at 
µM and 10µM are probably not adequate
µM is possibly very low and 10µM may show low 
µM of SP600125 are presented, b
µM) was used for the more refined experiments.  
 for 
ut 
 
 5.4.3. Effective down
treatment 
 
Before further usage of the drug at 5 
efficiency. 10 µg of d5 total protein lysate from cells grown under different conditions 
were probed with a specific anti
specifically recognizes endogenous levels of the 46 kDa (Jnk1) and 
Jnk3) Jnk proteins, dually phosphorylated at threonine 183 and tyrosine 185. Adult 
mouse brain, where Jnk is known to be highly active 
Martin et al., 1996, Mohit et al., 199
µM SP600125 between days 0 and 5 significantly decreased the levels of active Jnk 
proteins at d5, although the knock
the proteins was achieved rapidly afte
treated protein lysate at d5 (Figure 5.9)
 
 
 
 
 
 
 
 
 
 
Figure 5. 9: Western blot analysis of d5 DMSO
levels of phospho-Jnk were examined 
brain, d0-d5 SP600125, d0
phospho-Jnk in d0-d5 SP600125
EB at d5, showing a significant decrease in the levels of active protein. In contrast, the 
levels of phospho-Jnk in d0
DMSO-treated EB, indicating that the effect of the drug is reversible. 10
lysate were loaded on the SDS
showed stable expression levels in all samples. The image shown here is representative of 
images taken from three independent experiments.  
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-regulation of the levels of activated Jnk after 5
µM, it was essential to assess it
-phospho-Jnk antibody on a western blot. This antibody 
(Bogoyevitch and Kobe, 2006, 
5) was used as a positive control. Treatment with 5 
-down was not complete. Recovery of the activity of 
r removal of the drug, as shown by the d0
, as assessed by densitometry analysis
-treated and SP600125
and measured with densitometry 
-d2 SP600125 and DMSO-treated EB at d5. The levels of 
-treated EB were 6 fold lower than that of DMSO
-d2 SP600125-treated EB was only 2 fold lower compared to 
-Page. β-tubulin, which was used as a loading control, 
 
µM SP600125 
s inhibitory 
54 kDa (Jnk2 and 
-d2 
. 
-treated EB. The 
in adult mouse 
-treated 
µg of each protein 
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5.5. Examination of the effect of serum during the differentiation assay 
 
Next, the effect of foetal calf serum (FCS) on the differentiation of ES cells into 
cardiomyocytes, in the presence and absence of SP600125, was examined (see Section 
1.6.1.1 for a thorough discussion of serum in stem cell culture). Initially, the 
morphology and beating ability of EB were examined under serum-free conditions and 
then in serum-free and JNK-free (in the presence of SP600125) conditions. Serum 
removal was only performed after d5 as up until that time point it was essential for 
proper growth of the cells within the EB; its earlier removal did not allow the formation 
of EB at all (refer to Section 2.2.6, page 68 for more details on this).  
 
5.5.1. Serum starvation reduced the adhesion properties and spreading ability of EB 
in the presence and absence of SP600125 
 
Removal of FCS after d5 caused considerable changes in the morphology, but not the 
size, of growing EB. EB grown under serum-containing conditions became attached to 
the bottom of the well soon after their plating at d5. Rapidly, cells started migrating 
away from the initial adhesion centre and spread out, covering, by the end of the 
experimental period (d11), a large part of the well. In contrast, EB grown under serum-
free conditions did not attach well to the bottom of the wells after plating at d5 and did 
not spread. Instead they retained, in most cases, their spherical appearance and their 
contacts with the bottom of the well were minimal (Figure 5.10).   
 
5.5.2. Serum starvation reduced the beating capacity of EB in the presence and 
absence of SP600125 
 
Removal of FCS caused a severe reduction in the beating ability of EB. Cells grown 
under serum-free conditions attained a mere 13% (se=4) beating by d11, compared to 
the DMSO control (EB grown in DMSO- and serum-containing conditions) that 
exhibited a percentage of 46% (se=6) beating EB at d11 (Figure 5.11). This suggests 
that one factor, or more likely a combination of factors, within the FCS was important 
for cells to differentiate properly and to initiate spontaneous contraction.  
  
 
  
 
Figure 5. 10: Morphology of EB in the presence of DMSO or SP600125 after serum 
starvation. A) d6, B) d7, C) d8, D) d9, E) d10 and F) d11 EB are shown. 
EB failed to properly adhere to the bottom of the culture dish and to spread allowing for 
differentiation of the cells. The presence of SP600125 did not alter this effect and did not 
manage to further promote differentiation. Scale bars show 200 
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µm.
Serum-deprived 
 
 Figure 5. 11: Beating assessment after serum removal in the presence of SP600125. 
Absence of serum in the presence of SP600125 had similar effects as in the DMSO
EB: it did not allow beating to occur at the expected levels. In the presence o
72% and 69% of DMSO
EB exhibited spontaneous contraction, respectively, while after serum starvation the 
respective percentages were 13%, 10% and 23%. In the absence of serum, the 
upregulation of the beating activity of EB observed after SP600125 treatment was lost. 
Statistical significance, shown with asterisks (*p<0.05), was assessed using the non
parametric Mann Whitney test. 
 
 
As already mentioned, inhibition of Jnk with 5
occurrence of beating during ES cell differentiation (Section 5.4.2
5.8) while removal of serum did not allow proper differentiation and cardiogenesis to 
take place (Figure 5.11). The next question that arose was how wo
in serum-free conditions affect the beating behaviour of the cells. In order to answer this 
question 5µM SP600125 was added to both serum
at different time intervals during ES cell differentiation: d0
medium was only used after d5, as explained in Chapter 2. 
Addition of SP600125 in this context did not cause an increase in the occurrence 
of beating (Figure 5.11) as it did when serum was present. In fact, addition of SP600125 
in serum-free media did not seem to have any effect on the beating ability of EB 
compared to serum-free media alone. 2% and 10% beating EB were seen at d7 and d11 
196
-treated, d0-d11 SP600125-treated and d5-d11 SP600125
 
µM SP600125 increased the 
-free and serum-
-d11 and d5
 
-treated 
f serum 46%, 
-treated 
-
, page 190, Figure 
uld inhibition of Jnk 
containing medium 
-d11. Serum-free 
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after d0-d11 SP600125 treatment under serum-free conditions, compared to 22% and 
72% under serum-containing conditions, respectively. Similarly, after d5-d11 SP600125 
treatment in the absence of serum, only 2% and 23% of EB contained beating foci at d7 
and d11, respectively, while the respective percentages in the presence of serum were 
16% and 69%. So, it is the combination of serum and SP600125 after d5 that increased 
the beating ability of the cells, since either one on its own did not have this effect. Also, 
the presence of SP600125 and serum in the period between d0 and d5 did not seem to 
be sufficient for upregulation of contraction, if serum was removed after d5. Therefore, 
the results presented in this chapter hereafter were obtained from experiments 
performed in the presence of FCS throughout the differentiation period.  
 
5.6. Examination of the beating behaviour of EB after timely inhibition of Jnk 
 
The 5 µM SP600125 concentration was used throughout the experiments, as it was 
found to promote beating with no evidence of toxicity. However, as mentioned before, 
the 1 µM and 10 µM SP600125 dosages were also included in some of the assessments 
because it was thought that these dosages given for shorter amounts of time might have 
different effects and could provide useful comparisons. The time intervals for SP600125 
treatment had to be refined, as we were interested in understanding the precise temporal 
role of Jnk during ES cell differentiation into cardiomyocytes. Our interest was mainly 
focused on pre-beating stages of differentiation that are related to zebrafish heart tube 
stages before the initiation of spontaneous contraction, as discussed in Chapter 4. 
However, we also wanted to gain insight into the later stages of differentiation. 
Therefore, we selected the following time treatments: d0-d5 for three dosages (1µM, 
5µM and 10µM) and d0-d2, d2-d5 and d5-d11 for the optimal dosage only (5µM).     
 
5.6.1. 1µM and 10µM SP600125 did not exhibit a stage-specific effect on beating 
 
When SP600125 was added at a concentration of 1 µM between days 0 and 5 only, the 
beating behaviour of the cells was not altered compared to DMSO-treated cells. 10% 
(se=5) and 50% (se=12) of EB were beating at d7 and d11, respectively, after d0-d5 
treatment with 1µM SP600125. The respective percentages for DMSO-treated EB were 
11% (se=2) and 45% (se=6) and for d0-d11 treated EB they were 19% (se=7) and 57% 
(se=13) at days7 and 11, respectively (Figure 5.12).  
 Figure 5. 12: Timely assessment of the beating behaviour of 1
treated EB. No major differences were observed in their beating capacity regardless of 
when and for how long the dru
beating at d7 and d11, r
and 5, while the respective percentages for the d0
and 57% (se=13). Similarly, at d7 15% (se=8) and 3% (
EB were beating and a
These percentages did not show considerable differences compared to DMSO controls: at 
d7 11% (se=2) and at d11 45% (
Statistical significance, shown with asterisks (*p<0.05) in the graph, was assessed using the 
non-parametric Mann Whitney test. 
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  Similarly, addition of 10µM SP600125 to the culture media at d0-d5 did not 
considerably alter the beating ability of EB, compared to DMSO-treated EB. 22% 
(se=7) of EB were beating at d11 after d0-d5 Jnk inhibition with 10µM SP600125 
compared to 45% (se=6) of DMSO-treated beating EB. The respective percentage of 
d0-d11 SP600125 (10µM)-treated EB was 32% (se=7) at d11 (Figure 5.12). 
Interestingly, at d7, only the d0-d11 but not the d0-d5 SP600125 treatment caused a 
transient but significant decrease in the beating ability of EB (asterisk in Figure 5.12).  
These observation support the suggestion that 1µM is possibly a very low dosage 
for Jnk inhibition, regardless of the timing of the treatment and that 10 µM is not an 
appropriate concentration to be used, since it probably shows some levels of toxicity.   
 
5.6.2. 5µM SP600125 exhibited a stage-specific effect on beating  
 
Focusing more on the concentration of interest, as explained before, 5 µM, both pre-
beating (d0-d2 and d2-d5) and post-beating (d5-d11) treatment stages were examined 
and compared to the DMSO control. Treatment between days 0 and 2 did not affect the 
beating activity of the cells (Figure 5.13). The percentages of EB with beating foci at 
days 7 and 11 were 20% (se=2) and 52% (se=6) for this group, compared to 11% (se=2) 
and 46% (se=6) for the DMSO group, respectively, with p values higher than 0.05 at all 
time points. The d2-d5 and d5-d11 treatment groups exhibited similar patterns between 
them, but were markedly different to that of the DMSO group, especially at later stages 
of differentiation (after d8).  
Similarly to the d0-d11 treatment discussed earlier (Section 5.4.2, Figure 5.8), d2-
d5 and d5-d11 Jnk inhibition (5 µM SP600125) caused an increase in the beating 
capacity of EB. At d7 30% (se=1) and 16% (se=2) of d2-d5 and d5-d11 SP600125-
treated EB were beating, showing no major differences compared to DMSO (p=0.064 
and p=0.384, respectively), but at d11 the respective percentages were 62% (se=7) and 
69% (se=7), which were both significantly different compared to DMSO (p=0.046 and 
p=0.023, respectively). Of note, d5-d11 SP600125-treated EB exhibited a significant 
increase in their beating behaviour only at d10 and d11, while d2-d5 SP600125-treated 
EB showed significantly increased beating already at d8. This delay may be attributed 
to a delay in the action of the drug and to the different phase that cells are going 
through, depending on their differentiation status at the time that the drug is 
administered. 
  
Figure 5. 13: Time effect of 5 
cells. No major differences were observed in the beating capacity
treated EB compared to the DMSO control (p>0.05 at d6
(se=6) of beating EB were observed after d0
similar to DMSO (11% and 46% at days 7 and 11, respectively). After the d2
d11 treatment, though, a clear upregulation of the beating capacity of the EB was 
observed after (including) d8 and d10, respectively. At d7 30% (se=1) and 16% (se=2) and 
at d11 62% (se=7) and 69% (se=7) of beating EB were observed in the d2
SP600125 treatment groups, respectively. At d11 the respective percentages were 62% 
(se=7) and 69% (se=7). Statistical significance, shown with asterisks (*p<0.05) in the 
graph, was assessed using the non
  
Therefore, it is concluded that between days 0 and 2, Jnk either does not play an 
important role in regulating the events that lead to the emergence of beating, or is not 
highly expressed (or highly activated) and, thus, its inhibition does not severely affect 
the behaviour of the cells.  After d2, however, the timing of Jnk inhibition does not 
seem to play an important role in cardiogenesis; its effect is always the same (increased 
beating) regardless of the time of the drug administration. It is only the timing 
duration of the effect that differs between the two later SP600125 treatments (d2
d5-d11).  
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 5.6.3. 5 µM SP600125 had similar effects on the beating ability of E14 ES cells
 
The effect of Jnk inhibition was also assessed on differentiating E1
described for ES-D3 cells. This comparison was performed in order to assess whether 
the observed effect of the SP600125 drug on differentiating ES
specific to this cell line, or whether it was a more general effect.
comparison with the data obtained from the E14 cell line, presented in Chapter 6. The 
beating graph obtained from this experiment is shown in Figure 5.14. 
 
 
 
 
Figure 5. 14: Time effect of 5 
differentiating E14 ES cells. A slight but not significant upregulation of beating was 
observed after d0-d5 and d5
and 85% (se=11) of EB contained beating foci under control, DMSO, d0
d5-d11 treatment conditions, respectively. In this graph, the mean values of 3 independent 
experiments are shown, with error bars representing standard error of the mean. 
Statistical significance was assessed using the non
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SP600125 introduced in the media between days 0 and 5 and days 5 and 11 was 
shown to increase the beating ability of differentiating E14 ES cells (Figure 5.14), in a 
similar way to what is shown in Figures 5.8 and 5.13 for ES-D3 cells. However, its 
effect was not statistically significant (p>0.05 at all time points, compared to DMSO), 
likely due to increased biological variability, indicated in the graph (Figure 5.14) with 
large error bars that represent the standard errors of the mean. More repetitions would 
probably be required for statistical significance to be observed.  
 
5.7. Examination of the effect of Jnk inhibition on the size, shape, viability and 
numbers of cells within EB 
 
In parallel, we also looked at the size, shape and viability of the cells within EB grown 
under different conditions at d5, d8 and d11. This would give us an insight into how 
cells are behaving within the EB and it would allow us to understand how inhibition of 
Jnk can interfere with it. For the d5 measurements, EB treated with 5 µM SP600125 
between d0-d2 and d2-d5 were used, while for the d8 and d11 measurements EB treated 
with 5 µM SP600125 between d0-d2, d2-d5 and d5-d11 were used. 10 EB, thoroughly 
disaggregated with trypsin (refer to Section 2.2.9 for more details), were used for the 
measurements for each condition and the experiment was repeated three times. Average 
values from three independent experiments are shown in the graphs, with error bars 
representing standard errors of the mean and asterisks indicating statistical significance, 
as assessed with the parametric one-way Anova test, followed when necessary (as 
explained in Section 2.6, page 81) with a 2-sided Dunnett test.    
 
5.7.1. Jnk inhibition did not affect the shape and size of cells 
 
Initially, the size and shape of the cells within the EB were of interest so we counted the 
diameter and circularity of the cells in all groups using a Vi-Cell XR-2.03 Counter, as 
described in more detail in Section 2.2.9 (page 71). The diameter of the cells is an 
indication of their size, while the circularity is an indication of how regular their shape 
is. All numerical data are tabulated underneath the graphs for easier observation (Figure 
5.15). The average diameter of each cell for the DMSO control group was 10.5µm 
(se=0.2), 9.7µm (se=0.2) and 8.6µm (se=0.2) at d5, d8 and d11, respectively. No 
statistically significant differences were observed between the DMSO and the 
SP600125 treatment groups (p>0.06 in all cases). D0-d2 SP600125-treated cell diameter 
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was 10.9µm (se=1.3), 9.9µm (se=0.4) and 8.6µm (se=0.3) at d5, d8 and d11, 
respectively. The average values for d2-d5 SP600125-treated cells were 11.7µm 
(se=0.3), 9.7µm (se=0.3) and 8.9µm (se=0.3) at d5, d8 and d11, respectively, and for 
d5-d11 SP600125-treated cells 9.3µm (se=0.6) and 8.1µm (se=0.1) at d8 and d11, 
respectively (at d5 the drug was not yet applied). These findings indicate that the size of 
the cells was not altered after inhibition of Jnk (Figure 5.15). 
Similarly, the circularity of the cells was shown not to be affected after SP600125 
treatment. At d5 this value was 0.7 (se=0.01), 0.8 (se=0.02), 0.8 (se=0.01) and 0.8 
(se=0.02) for the DMSO, d0-d2, d2-d5 and d5-d11 SP600125 treatment, respectively, 
with values closer to 1 showing perfect circularity and values closer to 0 showing 
irregular cell shape (Figure 5.15). The respective values for d8 were 0.7 (se=0.01), 0.7 
(se=0.01), 0.7 (se=0.02) and 0.7 (se=0.02) and for d11 they were 0.7 (se=0.01), 0.8 
(se=0.02), 0.7 (se=0.02) and 0.8 (se=0.01). Statistical significance was low for the 
observed minor differences between the different groups with p>0.35 in all cases. 
Therefore, no difference was observed in the shape of the cells after inhibition of Jnk.  
 
5.7.2. Jnk inhibition did not affect the viability of cells but reduced the number of 
cells per EB at d8  
 
At d5, the average viability was 76% (se=2) for the DMSO control, which means that at 
the time of the measurement approximately 76% of the cells within one EB, under 
control conditions, were alive. Viability was not severely altered after d0-d2 and d2-d5 
5µM SP600125 treatment. The respective percentages were 81% (se=3) and 83% 
(se=5). The viability was also measured at days 8 and 11 but no significant differences 
were observed at either time point for any of the conditions (Figure 5.16). At d8, the 
percentage of viable cells was 77% (se=3), 74% (se=9), 80% (se=6) and 78% (se=3) for 
the DMSO control, d0-d2, d2-d5 and d5-d11 SP600125 treatment groups, respectively.  
Similarly, at d11 the respective percentages were 67% (se=3), 64% (se=7), 65% (se=4) 
and 59% (se=0.04). Although there was some variation in the survival rates of cells 
within treated and untreated EB at days 5, 8 and 11, the differences were not statistically 
significant (p>0.09 for all groups compared to DMSO). Survival could be used as a 
measure of the levels of cell death.  
 
 Figure 5. 15: Cell diameter and circularity at days 5, 8 and 11 after Jnk inhibition. Neither 
the size nor the shape of the cells was affected (p>0.06) at the time points examined by any 
of the SP600125 treatments (d0
over time in all groups from on average 11 
circularity transiently decreased from d5 (0.76 units) to d8 (0.74 units) and then increased 
again at d11 (0.75 units). These changes were observed in all groups. Sta
significance was assessed with one
204
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 Figure 5. 16: Cell viability and total cell count at d5, d8 and d11 after Jnk inhibition. The 
viability of the cells was not significantly affected after any of
any of the time points examined here, compared to DMSO (p>0.09). The total cell count, 
though, was significantly reduced at d8 after the d2
to DMSO: p=0.02 and p=0.04, respectively, shown with t
the differences were not significant. Statistical significance was assessed using one
Anova, followed by a 2
205
 the SP600125 treatments at 
-d5 and d5-d11 treatments compared 
he asterisks in (A). At d5 and d11 
-sided Dunnet test, in SPSS.  
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The total number of cells in each EB was also counted at d5, d8 and d11. All 
experiments started with the same amount of cells (450 cells per hanging drop) so any 
difference in the number of cells that make up each EB will be due to different levels of 
proliferation and cell death. In the DMSO group the average number of cells per EB 
was 67449 cells (se=10158), 210208 (se=110409) and 478050 (se=101843) at days 5, 8 
and 11, respectively. After 5 µM d0-d2 SP600125 treatment the amount of cells per EB 
was not significantly affected (p>0.40) compared to controls: 52402 cells (se=11745), 
241421 (se=51608) and 402798 (se=107417) at days 5, 8 and 11, respectively (Figure 
5.16).  
Similarly, after 5 µM d2-d5 SP600125 treatment the number of cells was not 
significantly altered (p>0.28) at days 5 and 11, but it was significantly affected at d8 
(p=0.02 compared to DMSO). The counts were 35210 (se=18287), 158556 (se=47253) 
and 398896 (se=23003) cells at days 5, 8 and 11, respectively. D5-d11 SP600125 
treatment had a similar effect: at d8 there was a significant reduction in the overall 
number of cells between SP600125-treated and DMSO-treated EB (p=0.04), whereas 
the differences at d11 were insignificant. The actual numbers were: 139139 (se=35065) 
and 381083 (se=1382) cells at days 5, 8 and 11, respectively (Figure 5.16). The 
observed reduction in the total amount of cells at d8 is in keeping with the 
morphological observations, presented before, that showed smaller EB, probably 
consisting of fewer cells, after 5 µM SP600125 treatment compared to controls.  
 
5.8. Quantitative PCR analysis: treatment with SP600125 caused considerable 
changes in the expression profiles of differentiating stem cells 
 
The expression profile of SP600125-treated and DMSO-treated EB was also examined 
by quantitative PCR analysis at days 0, 5 and 11. Changes in gene expression reflect 
potential changes in the differentiation potential and status of the cells and were, 
therefore, considered essential in our assessment of the effect of Jnk during ES cell 
differentiation. The genes used here were described earlier (Sections 1.3.5, page 14 and 
5.1.3, page 174): Brachyury, CD31, Flk1, Hex, Mlc2v, Mlc2a, Gata-4, c-Myc, Cyclin-
D2, Connexin-43, Jnk, Lef-1, Dkk-1. Comparison of the expression profile of untreated 
and DMSO-treated EB was presented in Section 5.3.3 (page 185) and revealed the 
baseline expression of the genes of interest. Here the expression profiles of the genes of 
interest after SP600125 treatment (d0-d2, d2-d5 and d5-d11) are shown in comparison 
to DMSO alone. The mean values of three independent experiments are shown in the 
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graphs that follow. All reactions were performed in triplicates (for each biological 
repetition) and data were analysed manually using the ∆∆Ct method (refer to Section 
2.2.13.4, page 74, for details). Significance was assessed with one-way Anova test, 
followed when necessary by a 2-sided Dunnett test, as explained in detail in Section 2.6 
(page 81).  
Some of the lineage markers examined showed considerable changes in their 
expression levels after Jnk inhibition (Figure 5.17). At d5 expression of Brachyury was 
unaltered after d0-d2 SP600125 treatment and was 5 fold decreased (not statistically 
significant, p=0.06) after d2-d5 SP600125 treatment, while at d11, although some 
changes were observed, the expression levels were practically the same in all groups. 
The expression of Flk1 at d5 was affected in a similar way to Brachyury (no statistical 
significance, p>0.06 for all groups compared to DMSO) but at d11 there was a 3 fold 
significant increase after d0-d2 treatment (p=0.046), while d2-d5 and d5-d11 SP600125 
treatments caused a slight but not significant decrease in its expression. Hex and CD31 
expressions were not severely affected by SP600125 treatment: their levels after Jnk 
inhibition were similar to the DMSO levels, with only a slight, but not significant, 
decrease (2 fold) in CD31 expression at d11 after d5-d11 SP600125 addition (Figure 
5.17). These observations indicate that no major changes in the expression profiles of 
lineage markers were observed after SP600125 treatment. This means that inhibition of 
Jnk did not have adverse effects on the differentiation potential of ES cell towards 
mesodermal, endothelial and hematopoietic cell fates. However, significantly increased 
expression of Flk1 at d11 after d0-d2 SP600125 treatment indicates an increase in 
endothelial and/or hematopoietic cells.   
Interestingly, the levels of Mlc2a were unaltered at d5 after all SP600125 
treatments compared to DMSO, but were downregulated at d11 (3, 8 and 8 fold 
decrease after d0-d2, d2-d5 and d5-d11 treatments, respectively), as shown in Figure 
5.18. The respective significance values (p) at d11 compared to DMSO were: 0.386, 
0.046 and 0.029, showing that only the two latter groups were significantly altered. 
MLc2v was affected in the opposite way but not to a significant extent (p>0.05 at all 
time points and for all treatments): at d5 its levels were unaffected but at d11 they were 
increased (2 and 2.5 fold after d0-d2 and d5-d11 treatments, respectively) or remained 
unchanged (no change after d2-d5 treatment). Gata-4 remained unchanged at d5 but 
was upregulated at d11 after d0-d2 and d2-d5 treatments (4 and 3 fold with p=0.029 and 
p=0.038, respectively) and remained unaltered after d5-d11 treatment (Figure 5.18). 
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Cx-43 expression was significantly downregulated at d5 after d0-d2 and d2-d5 
SP600125 reatments (20 fold, p=0.029) but was not significantly different at d11 after 
d2-d5 (2 fold decrease compared to DMSO) and d5-d11 (2 fold reduction compared to 
DMSO) SP600125 treatments (Figure 5.19). It was, however, significantly reduced at 
d11 after d0-d2 SP600125 treatment (3 fold decrease compared to DMSO, p=0.046). 
Cx-43 is a marker of cellular gap junctions. The decrease in its expression levels after 
SP600125 treatment, if translated into decreased protein production and activity of the 
protein, could adversely affect the formation and effectiveness of gap junctions and 
thus, decrease the communication between the cells. 
Surprisingly, expression of Jnk was reduced at d5 (20 fold decrease after d0-d2 
and d2-d5 SP600125 treatments, p=0.039) (Figure 5.19). At d11 its expression was 
significantly 4 fold increased after d0-d2 SP600125 treatment (p=0.046), unaltered after 
d2-d5 SP600125 treatment and slightly decreased (2 fold) after d5-d11 treatment 
(p=0.137). These are surprising findings as SP600125 has not been shown to have direct 
effects on the transcription of Jnk, but rather only affects the activation and activity 
status of the protein (Bennett et al., 2001).  
Lef-1 showed decreased, but not to a significant extent, expression levels at d5 
after d0-d2 and d2-d5 SP600125 treatments (3 and 2 fold decrease, p>0.05). At d11 its 
expression was significantly 2 fold higher (p=0.029), unaltered (p=0.230) and 
significantly 4 fold lower (p=0.046) than DMSO after d0-d2, d2-d5 and d5-d11 
SP600125 treatments, respectively (Figure 5.19). Lef-1 was shown to be upregulated 
after DMSO treatment alone (refer to Section 5.3.3, page 185 and Figure 5.6, page 188) 
at d11, so its increased expression levels after d0-d2 SP600125 at d11 could be mainly 
due to the effect of DMSO. In contrast, decreased expression levels at d11 after d5-d11 
SP600125 treatment indicate a severe reduction in canonical Wnt signalling.  
Dkk-1 expression, although not affected by Jnk inhibition at d5 and d11 after d0-
d2 and d2-5 treatments, was significantly 5 fold higher (p=0.037) at d11 compared to 
DMSO after d5-d11 SP600125 treatment (Figure 5.19). Dkk-1 is an inhibitor of the 
canonical Wnt pathway (Bafico et al., 2001, Kawano and Kypta, 2003, Mao et al., 
2001) and therefore, it is likely that its increased expression at d11 after d5-d11 
treatment will adversely affect signalling through the canonical Wnt cascade.  
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5.9. Organization of beating clusters within treated and untreated EB 
 
The examination of the gene expression profile of differentiating EB before and after 
SP600125 administration was revealing about how Jnk could be involved in the process. 
However, the morphology of the beating clusters within the EB was also of interest, in 
order to elucidate how the beating cells are organized and arranged within the EB. 
Cardiac TroponinI (cTnI) is present in beating cells and is commonly used as a marker 
of differentiated cardiomyocytes, as described before (Kattman et al., 2011). So, by 
staining d11 EB grown under different conditions with an anti-cTnI antibody it was 
possible to visualize beating foci. EB were grown on gelatin-coated glass coverslips and 
only the beating ones were selected for antibody staining. The images shown in Figure 
5.20 are representative images of EB from three independent experiments. Untreated 
EB, along with DMSO-treated EB, are also shown here (Figure 5.20) in order to 
emphasize the reproducibility of the phenotype before SP600125 treatment.    
As expected, the negative control (probed only with secondary antibody) showed 
no staining under identical experimental conditions and light exposure. cTnI-positive 
cells were scattered throughout the EB in untreated and DMSO-treated EB, as shown by 
the green staining in Figure 5.20. A noticeable difference was observed in the 
SP600125-treated EB. Although the overall area covered by the staining did not seem to 
be significantly altered, the pattern of organization of the positive cells was intriguingly 
different: there were patches of tightly packed cTnI-positive cells in the d2-d5 and d5-
d11 SP600125-treated EB, a conformation not seen in the control EB. The pattern of 
organization of d0-d2 SP600125-treated cells, although not identical to controls, was 
however not as distinct as in the other SP600125 treatment groups.  
Although counting the overall number of cTnI-positive cells would give us useful 
insight into whether Jnk inhbition also affects the number of beating cells (technique 
currently being optimised in the lab), the way these cells are organized in beating 
clusters is also important, as shown here. The fact that enhanced beating, observed after 
Jnk inhibition (d2-d5 and d5-d11 SP600125 treatments), could be related to the 
organization of beating cells and not to their cardiogenic potential is intriguing, as will 
be discussed in the next section.    
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 20: Cardiac TroponinI (cTnI) antibody staining on whole EB grown on glass coverslips. Blue shows nuclear DAPI staining, while g
cytoplasmic cTnI staining. The negative control showed no staining in the absence of primary antibody. Untreated and DMS
scattered cTnI staining, intermingled with cells without staining. SP600125
shown to be grouped in clusters, possibly corresponding to beating foci. This o
groups. Scale bars represent 200 µm.         
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5.10. Discussion 
 
JNK, as a downstream effector of the non-canonical Wnt pathway and a member of the 
MAPK family, has been recognised as an important player in many cellular and 
physiological processes. In this chapter, the role of Jnk during in vitro ES cell-derived 
cardiogenesis was investigated.  
In summary, treatment with SP600125, a specific inhibitor of Jnk1, Jnk2 and 
Jnk3, caused a considerable increase in the beating ability of EB in a time-specific 
manner. Jnk inhibition between days 0 and 2 did not affect cardiogenesis, but all later 
SP600125 treatments (d2-d5 and d5-d11) increased the occurrence of spontaneous 
contraction. However, the cardiac genes that were examined did not show significant 
changes after SP600125 treatment, suggesting that specification of cardiac progenitors 
took place normally. It was initially thought that alterations in the levels of Connexin-
43, a downstream target of Jnk (Petrich et al., 2002), could be a defining factor. 
Inhibition of Cx-43 (at both transcriptional and translational/post-translational level) 
caused by activation of Jnk has been shown before to impair cell-cell communication 
via gap junctions (Petrich et al., 2002). Therefore, it would be possible that inhibition of 
Jnk in this study may cause an upregulation in Cx-43 levels, which would then allow for 
the formation of more gap junctions. This, in turn, could have positive effects on the 
communication and propagation of signals between cells, which in cardiac cells could 
be manifested with more and better coordinated beating. Nevertheless, a decrease, 
instead of an increase, in the expression levels of Cx-43 was observed after inactivation 
of Jnk, a finding that does not support the proposed hypothesis. The question, however, 
about how inhibition of Jnk may have affected post-translational modifications of this 
protein, as shown in previous studies (Cameron et al., 2003, Petrich et al., 2002, Solan 
and Lampe, 2008), remains unanswered.   
On a similar note, cardiac Troponin I (cTnI) antibody staining on treated EB 
revealed a clear change in the organization of beating areas, rather than an obvious 
alteration in the overall number of beating cells (cTnI-positive, which were not, 
however, counted), compared to control EB. Beating cells were organized in clusters in 
a much more packed conformation after SP600125 treatment compared to untreated and 
DMSO-treated EB. This was highly reproducible in the three experiments performed in 
the current study. An additional important observation was also made: d0-d2 SP600125-
treated EB did not show such a marked change in the organization of beating clusters as 
the d2-d5 and d5-d11 SP600125-treated EB. This is intriguing since d0-d2 treated EB 
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did not exhibit as profound differences in their beating behaviour as did d2-d5 and d5-
d11 SP00125-treated EB. Although more work is required in order to definitely 
conclude that a conformational change in the arrangement of beating cells rather than a 
change in the specification of cardiac cells explains the differences in the beating 
behaviour of the cells, it remains a fascinating hypothesis.               
Interestingly, a significant loss of atrial-marker gene expression was observed in EB 
after d2-d5 and d5-d11 SP600125 treatment. This decrease was not accompanied by a 
concomitant increase in ventricular-marker gene expression. It would be interesting to 
count atrial and ventricular cells accurately in order to investigate whether the observed 
differences in the gene expression profiles of Mlc2a and Mlc2v recapitulate changes in 
the specification status of the treated cells. Also, given that Mlc2a and Mlc2v are not 
chamber-specific at all times (see Section 1.3.4, page 13) (Bruneau et al., 2000, 
Christoffels et al., 2000, Kubalak et al., 1994, O'Brien et al., 1993, Small and Krieg, 
2004), the expression levels of these genes in differentiating ES cells are not directly 
correlated with specification towards one of the two lineages.  
An additional interesting finding was the observation that SP600125-treated EB 
(5µM) were smaller than their control counterparts at d5 of differentiation. This 
observation was, however, not associated with decreased cell diameter (an indication of 
decreased cell size) or decreased cell count within the treated EB. In fact, only a 
transient decrease in the number of cells within treated EB was observed at d8. 
Therefore, the fact that EB appeared smaller but did not contain smaller or less cells 
after Jnk inhibition suggests either that cells are more tightly packed within treated EB 
or that the cavity, which occupies the centre of the EB at d5 (Hernandez-Garcia et al., 
2008), is not properly formed when Jnk is inhibited. Defects in the formation of the 
central cavity in EB have been associated in the past with anomalous differentiation 
(Hernandez-Garcia et al., 2008), but not with increased beating or upregulation of 
cardiogenesis. Also, there is no evidence in the literature to suggest that abnormal 
cavitation preferentially affects the differentiation of one lineage over others; for 
example, it could affect endoderm that is essential for cardiac differentiation or neuronal 
development that is inhibitory for cardiogenesis in vitro. Therefore, whether increased 
beating is associated with the different size of treated EB remains to be elucidated. Of 
note, Jnk deficiency (Jnk1-/-;Jnk2-/- cells) has been associated with defective EB 
cavitation and growth (Xu and Davis, 2010).  
The complex interplay between canonical and non-canonical Wnt pathways and 
the importance of integrative approaches that include the whole network and not 
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individual pathways have been discussed before (Section 1.4.4, page 35). Thus, possible 
alterations in the canonical Wnt pathway caused by Jnk inhibition were also examined. 
Specifically, the expression levels of Dkk-1 and Lef-1 were analysed. Dkk-1 is an 
inhibitor of the canonical Wnt pathway (Bafico et al., 2001, Kawano and Kypta, 2003, 
Mao et al., 2001) but also a downstream target of β-catenin (Gonzalez-Sancho et al., 
2005) and c-Jun (Grotewold and Ruther, 2002). The latter protein is a transcription 
factor, firstly identified as an important and direct target of Jnk (Derijard et al., 1994). 
Dkk-1 was found to be significantly upregulated at d11 after d5-d11 SP600125 
treatment in this study. Lef-1 is a downstream target of β-catenin and an effector of the 
canonical Wnt pathway (Barolo, 2006) and was found to be significantly upregulated 
after d0-d2 SP600125 treatment and significantly downregulated after d5-d11 treatment. 
The observed increase after the d0-d2 SP600125 treatment could be due to the presence 
of DMSO and not to the drug, as it was shown that DMSO alone also caused a 
significant upregulation in the expression levels of Lef-1 at d11, compared to its levels 
without any treatment. Activation of the canonical Wnt pathway by either DMSO or 
SP600125, shown by increased Lef-1 transcription after d0-d2 SP600125 treatment, 
could have severe effects on the beating ability of differentiating cells, as will be 
discussed in Chapter 6 in detail (activation of the canonical Wnt pathway was shown to 
severely suppress the beating ability of EB). The observed downregulation of Lef-1 
(downstream effector of the canonical Wnt pathway) at d11 after d5-d11 SP600125 
treatment did not come as a surprise since levels of Dkk-1 (inhibitor of canonical Wnt 
signalling) were increased after d5-d11 SP600125 treatment and thus, canonical Wnt 
signalling was expected to be inhibited. The cross talk between the different Wnt 
pathways is crucial and needs to be taken into account, since, as described in Section 
1.4.4 (page 35), they work as a network and not independently.   
Downstream targets of Jnk, which are also associated with the canonical Wnt 
pathway and with regulation of proliferation, were concomitantly assessed. The 
expression of c-Myc was decreased at d5 after d0-d2 and d2-d5 SP600125 treatment but 
remained unaffected at d11 after all treatments. In contrast, Cyclin-D2 expression levels 
were significantly downregulated at d5 and d11 after d2-d5 SP600125 treatment. These 
proteins are common markers of proliferation; they participate in cell cycle progression 
in response to mitogenic signals and their inhibition has been associated with decreased 
cell turnover (Brenner et al., 2005, Grandori et al., 2000, Satyanarayana and Kaldis, 
2009). Mitogenic signals, such as MAPK (Armstrong et al., 2006) and Wnt (He et al., 
1998, Myant and Sansom, 2011, Sansom et al., 2007, You et al., 2002), are able to 
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activate c-Myc. In turn, c-Myc has been shown to activate the highly labile protein 
Cyclin-D2 and to suppress inhibitors of the canonical Wnt pathway, like Dkk-1 
(Cowling and Cole, 2007, Cowling et al., 2007). Decreased levels of c-Myc at d5 were 
associated with significantly increased expression of Lef-1 at d11 (after d0-d2 
SP600125 treatment), showing a potential effect on the canonical Wnt pathway (Arce et 
al., 2006, Barolo, 2006). Inhibition of c-Myc and Cyclin-D2, especially after the d2-d5 
SP600125 treatment, possibly reflects decreased levels of proliferation at d5. Although 
the total number of cells in each SP600125-treated EB was not altered at d5, it was 
significantly, albeit transiently, decreased at d8. It is, therefore, possible that decreased 
activity of c-Myc and Cyclin-D2 at d5 caused a transient halt of cell proliferation in 
treated EB between days 5 and 8, which in turn reduced the total number of cells that 
each SP600125-treated EB contained at d8. Removal of the drug allowed for the 
expression levels of c-Myc and Cyclin-D2 to recover and for cell cycle progression to 
be restored; hence the normal cell count in treated EB at d11.    
Jnk is part of the non-canonical Wnt pathway and as such it might be expected to 
enhance cardiogenesis, as discussed in Section 1.4.2.2 at page 33 (Garriock et al., 2005, 
Pandur et al., 2002, Terami et al., 2004). Therefore, its reduction after inhibition by 
SP600125 would be expected to deplete cardiogenesis or to downregulate it to some 
extent. However, data obtained from the present study showed the exact opposite: 
inhibition of Jnk after d2 of differentiation enhances the beating capacity of cells. It is 
not clear whether this observation is necessarily associated with increased cardiac 
differentiation, as discussed earlier in this section, but it is still contradictory to the 
expected effect after depletion of the non-canonical Wnt pathway. Previous work (MSc 
dissertation) on differentiating E14 stem cells (shown in the appendix) showed that 
inhibition of the non-canonical components Rac (NSC23766 drug, n=5) and ROCK 
(Y17632 drug, n=4) had similar effects on the beating behaviour of cells: early 
inhibition (between days 0 and 5) had no effect on beating, whereas late inhibition 
(between days 5 and 11) significantly increased the occurrence of beating. These 
findings, although performed on a different cell line (E14 instead of ES-D3), are 
indicative of a common mechanism or pathway for the observed changes in beating. It 
is, however, noteworthy that the data are not identical between Jnk and Rac/ROCK 
inhibition. SP600125 (Jnk) treatment between days 2 and 5 caused an upregulation in 
the occurrence of beating, while NSC23766 (Rac) and Y27632 (ROCK) treatments did 
not. This discrepancy suggests that Jnk may have additional roles during the 
differentiation process, independent of the Wnt pathway. The fact that Jnk is also 
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activated by the MAPK cascade and is highly involved in regulating and responding to 
stress (Xie et al., 2006, Zhong et al., 2007, Zhong and Kyriakis, 2007), may partly 
explain the additional effects that Jnk inhibition is causing during ES cell 
differentiation. In effect, the stress levels of different systems, which determine to some 
extent the phosphorylation and, therefore, activation status of Jnk and other stress-
activated protein kinases, have been shown to markedly affect the differentiation 
process (Zhong et al., 2007). Although it is not possible to measure the stress levels of 
the system used here, it is important to take into account that differentiation is a 
stressful condition for the cells and activation of Jnk may be an important protection 
mechanism.   
An evident observation from the data presented in the current chapter is that the 
canonical and non-canonical Wnt pathways may overlap, interact and antagonize each 
other more than previously thought. This study highlights the importance of 
investigating the Wnt network as a whole and not individually. The following chapter 
deals with the effect of the activation of the canonical Wnt pathway in ES cell 
differentiation and cardiogenesis and underpins the aforementioned concept. Also, 
additional roles for Jnk, potentially independent of Wnt, were unravelled. Although 
with the current tools it is not possible to definitely distinguish between Wnt-related and 
Wnt-independent effects of Jnk, it appears likely that both paths are involved.  
 
5.11. Advantages and disadvantages of the study 
   
Some features of this study make it reliable, powerful and comprehensive and it is 
important to emphasize them. Firstly, the confirmation of successful downregulation of 
the target protein was essential. The levels of phospho-Jnk (Jnk1, Jnk2 and Jnk3) were 
markedly reduced after SP600125 treatment, indicating that the activity of the kinase 
was severely compromised. The broad range of downstream targets of phospho-Jnk and 
the multitude of other signalling pathways that activate the same targets, did not allow 
for further confirmation of inhibition of the activity of Jnk. The efficacy and specificity 
of the drug have been discussed before (Sections 4.1.1, page 132 and 4.5, page 166). Of 
note, the specificity of the drug has not been tested in this study (by looking at how 
SP600125 affects the activation status of other related kinases) and is essential to take it 
into account.   
Secondly, the assay itself provided a reliable framework for the studies performed 
here. Differentiation of ES cells into EB using the hanging drop method has been shown 
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to be highly reliable, reproducible and uniform (Dang et al., 2002, Kurosawa, 2007), 
compared to other methods, such as spontaneous aggregation of cells in low-adherens 
plates (Ng et al., 2005) or in suspension culture in semi-solid methylcellulose media 
(Kurosawa, 2007, Kurosawa et al., 2003) The controlled aggregation of an 
experimentally predetermined number of ES cells (450 cells here) in hanging drops 
allows for the formation of homogeneous and comparable EB and reduces variability 
within individual EB and between different batches (experiments) of EB. Formation of 
EB with the hanging drop method has been used to generate a broad spectrum of cell 
lineages, including cardiomyocytes (Metzger et al., 1994, Takahashi et al., 2003, Wobus 
et al., 1991), neurons (He et al., 2006), haematopoietic cells (Dang et al., 2002) and 
smooth muscle cells (Drab et al., 1997, Yamada et al., 2002). The disadvantages of this 
method are mainly practical: setting cells in hanging drops is time-consuming, while 
media exchange and direct microscopic observation, when cells are in hanging drops, 
are difficult or even impossible (Kurosawa, 2007).  
The detailed and thorough deconstruction of the differentiation assay into shorter 
intervals, during which inhibition of Jnk was examined, boosted the efficiency and 
comprehensibility of the data obtained. The reproducibility of the findings was also an 
important positive aspect of the assay; even if the actual numbers were different, the 
pattern was similar in all experiments performed. An additional confirmation of the 
validity of the obtained data came from the verification that inhibition of Jnk had 
similar effects on a different cell line. The variability in the new cell line (E14) was 
greater than in the old one (ES-D3) but the trend was the same.  
Additionally, thorough statistical analysis was performed, using the appropriate 
parametric or non-parametric tests in each occasion, without making assumptions that 
could not be supported by the available data. This is an essential aspect of biological 
data analysis, as variation, both experimental and biological, can significantly mislead 
interpretation of the results.  
Nevertheless, some assets of the assay could be altered and improved. One of 
them is the inclusion of FCS in the culturing media. I showed that serum starvation after 
d5 was not beneficial for the growth and differentiation of ES-D3 cells. Specifically, a 
severe reduction in the beating ability and the adhesive and spreading properties of EB 
was observed after serum removal. Although enhancement of cardiogenesis has been 
observed after serum withdrawal in some studies in the past (Gissel et al., 2006, 
Goldman and Wurzel, 1992, Sachinidis et al., 2003), serum is generally considered an 
essential additive to ES cell culture and its removal is usually accompanied by 
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substitution with chemically defined serum replacement factors (Sachinidis et al., 2003). 
Even in the presence of SP600125, the absence of serum was sufficient to deter 
differentiation. BMP4 is commonly thought to be an essential component of serum (ten 
Berge et al., 2008), in the absence of which differentiation in general and cardiogenesis 
particularly cannot proceed. In the current study the absence of serum and the lack of 
use of serum replacement factors did not allow for proper stem cell differentiation. This 
forced us to include serum in all subsequent studies on this cell line, which may hinder 
some aspects of the differentiation process.     
The second aspect of the assay that could be improved is associated with accurate 
counting of cardiomyocytes. Although measurements about the expression levels of 
cardiac genes are useful in understanding how the process of cardiogenesis is affected 
by treatment with SP600125, the exact number of cardiomyocytes that are produced in 
the absence and presence of the drug would be a valuable addition to our understanding 
of the system. A reliable way to achieve this would be via the establishment of a 
reporter system that marks cardiomyocytes in vitro. For example a reporter, such as 
GFP, driven by the promoter of a cardiac gene, like cardiac Toponin I (cTnI), could be 
used as a marker of cardiomyocytes, which could then be analysed and measured using 
fluorescence-activated cell sorting (FACS). An alternative approach that involves 
fluorescence staining of unlabelled differentiated cells with an anti-cTnI antibody, 
followed by FACS, is under optimisation in the laboratory and has been used in the past 
for similar analyses (Kattman et al., 2011b, Kattman et al., 2011a). The latter technique 
avoids time consuming transfections and laborious establishment of transfected cell 
lines.    
Additionally, an altogether different approach could have been employed in order 
to establish the role of Jnk signalling in differentiating ES cells. Jnk-/- ES cells, isolated 
from genetically modified mouse blastocysts could have been used. With this approach 
the use of a chemical inhibitor would have been avoided and the specificity problems 
associated with it would have been overcome. However, three main drawbacks are 
correlated with this method. The first one is the need for establishment of a genetically 
modified mouse strain (Jnk-/-), which is both time-consuming and expensive. The 
second is associated with the existence of more than one Jnk genes. In fact, there are 
three Jnk genes in mouse, all of which would have to be genetically inactivated in order 
to avoid redundancy between them. This would require more time-consuming mouse 
crosses and expensive maintenance of additional mouse colonies. Thirdly, investigation 
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of time-specific roles of Jnk could not be conducted since Jnk would be genetically and 
irreversibly inactivated.      
Finally, although analysis of mRNA levels of the genes of interest is an essential 
component of unravelling the effect of the drug, especially since most of the targets of 
the protein that is being inhibited are transcription factors, mRNA levels are not always 
directly associated with protein levels and even more so with the levels of active 
protein. Therefore, more protein analysis could be employed in similar studies in the 
future. This, however, entails disadvantages itself, with the most important one being 
the high cost of antibodies, whereas qPCR analysis is a fairly inexpensive technique. 
Also, as mentioned before, it is not just the presence of the protein that is important to 
be detected, but the presence of the active form of the protein. This, in some cases, may 
depend on complex post-translational modifications that are not always detectable by 
commercial antibodies.    
 
5.12. Further work 
 
This work could be extended in a number of ways in order to further advance our 
understanding and our knowledge on Jnk signalling. Firstly, it would be interesting to 
rescue the phenotype. Activation of the non-canonical Wnt pathway is not expected to 
fully counteract the observed changes caused by Jnk inhibition, because, as mentioned 
before, Jnk has pleiotropic inputs and outputs that are not all related to the Wnt cascade. 
Secondly, as described before, counting of cardiomyocytes using FACS would 
enrich our understanding on how SP600125 and inhibition of Jnk signalling affects 
cardiogenesis and beating. It would also be interesting to look into the morphology of 
individual cells within the EB in order to evaluate possible changes in their 
conformation, their communication and their adhesion properties.  
Lastly, a thorough analysis of the effects of inhibitors of other components of the 
Wnt and MAPK cascades would provide valuable insight about the cross talk between 
the two pathways and the divergence of their activities. In fact, analysis of the effect of 
a canonical Wnt pathway activator has already been carried out and is discussed in the 
next chapter, while inhibition of p38, a downstream effector of the MAPK pathway, is 
being currently carried out in the laboratory by other members of the research group. 
Preliminary results from that study show very similar responses.  
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5.13. Summary and conclusion 
 
In this chapter, I showed that treatment of differentiating ES cells with a specific Jnk 
inhibitor upregulated the beating ability of cells in a time-specific manner; 
undifferentiated cells treated with the drug did not show altered beating behaviour, 
while cells that were undergoing differentiation, either at early (d2-d5) or late stages 
(d5-d11), exhibited increased occurrence of beating after inhibition of Jnk. This increase 
did not seem to be associated with amplified cardiogenic specification and 
differentiation, but rather appeared to be a result of changes in the organization and 
conformation of cells within the EB. Transient alterations in the cell cycle regulation of 
EB caused a temporary decrease in their proliferation rates and their size, which, 
however, did not negatively affect their differentiation potential. Considerable 
alterations in the expression levels of downstream targets of the canonical Wnt pathway 
were observed after SP600125 treatment (Jnk inhibition), which highlight the 
importance of examining the Wnt pathways as a network and not individually. Based on 
this observation and on previously published work linking Jnk with the canonical Wnt 
pathway (Esufali and Bapat, 2004, Liao et al., 2006, Wu et al., 2008), it was decided 
that manipulating the canonical Wnt pathway and examining the resulting effects would 
be important in further elucidating the role of both pathways during in vitro 
cardiogenesis and understanding their cross talk. The next chapter addresses this issue.  
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Chapter 6. The Wnt/β-catenin pathway during in vitro 
cardiogenesis  
 
 
6.1. Introduction 
 
The Wnt pathway has been the focus of research over the last decades in many different 
contexts and has been shown to play essential roles during embryonic development and 
stem cell biology. The canonical branch of this pathway, which signals through β-
catenin, was shown to participate in heart development in vertebrates and in in vitro 
differentiation of stem cells into cardiomyocytes. However, its suggested role in these 
processes has often met controversy. In the introduction of this chapter, some general 
aspects that are associated with the data presented here will be discussed. Genes that 
have been used as markers of lineages or of specific processes in the PCR analysis are 
presented below, along with some details about the cell line used in this study (E14 ES 
cell line) and its special requirements. BIO, the pharmacological agent that was used 
throughout this study for canonical Wnt activation is also presented.    
 
6.1.1. The genes used as markers 
 
In this study, I was interested in studying the progression of stem cell differentiation 
into cardiomyocytes and in understanding how this process is affected by activation of 
the canonical Wnt pathway. In order to do this, a range of pluripotency and 
differentiation markers was used to look at different aspects of this process. Most of the 
genes used as markers here have been discussed in detail in previous chapters (Sections 
1.3.5, page 14 and 5.1.3, page 174). These are cardiac genes, such as Nkx2.5, Gata-4, 
Tbx5, Isl1, Mlc2a, Mlc2v, cTroponinI and Tnnt2, and other lineage markers, such as 
Hex, Flk1 and Brachyury.  
Additional genes were also employed for the expression profile analysis of 
differentiating ES cells in this study. As pluripotency markers we used the commonly 
used trinity of Nanog, Oct4 and Sox2 (briefly mentioned in Section 1.6.1.1, page 45). It 
has been shown that it is not their individual presence or absence within a cell, but the 
integrated activity of all three of them as a network that is essential for maintenance of 
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pluripotency (Kalmar et al., 2009). For example, it has been suggested that loss of 
Nanog expression may increase the probability of differentiation but does not abolish 
pluripotency altogether (Silva et al., 2008). The SON (Sox2, Oct4, Nanog) network 
within the cell prevents differentiation by suppressing the activity and expression of 
lineage-specific factors (Niwa, 2007, Smith, 2005).   
Mesodermal differentiation was of particular interest here, as the canonical Wnt 
pathway has been shown to be involved in mesoderm induction (Arnold et al., 2000, 
Martin and Kimelman, 2008, Vonica and Gumbiner, 2002, Yamaguchi et al., 1999). 
Therefore, an additional and earlier mesodermal marker was employed, alongside 
Brachyury. Goosecoid (Gsc) is a homeobox gene that has been implicated in a variety 
of key developmental processes. It was initially found in the vertebrate organizer, where 
it was shown to be involved in dorsoventral patterning of mesoderm and in organizing 
the embryo (Boncinelli and Mallamaci, 1995, Nakaya et al., 2008). Gsc has also been 
found during organogenesis in tissues undergoing morphogenesis, most notably the 
brain, limbs and ventrolateral body wall (Gaunt et al., 1993, Yamada et al., 1995). It is 
widely used as an early mesodermal marker, most commonly in association with Bry.  
 
6.1.2. E14 stem cell line 
 
In these experiments the E14Tg2A stem cell line was used. This line is a spontaneous 
hypoxanthine phosphoribosyltransferase (HPRT) deficient derivative of the wild type 
E14 line, which was isolated from 129P2/OlaHsd mouse blastocysts (Brennan and 
Skarnes, 1999, Hooper et al., 1987, Magin et al., 1992). These cells are resistant to 0.06 
mM 6-thioguanine, are easy to maintain and significantly reduce the amount of tissue 
culture required. It is a feeder-free cell line and therefore requires exogenous addition of 
LIF for self-renewal. E14Tg2A cells have been extensively used in a variety of in vitro 
differentiation studies. Specifically, they have been differentiated, among others, into 
cardiomyocytes (Yamashita et al., 2005, Deacon et al., 1998), neurons (Gaspard et al., 
2009) and adipocytes (Dani et al., 1997).     
 
6.1.3. BIO, as a potent pharmacological activator of β-catenin signalling 
 
Until recently only a limited number of pharmacological inhibitors of glycogen synthase 
kinase-3 (GSK3) were available (Martinez et al., 2002) with lithium chloride (LiCl) 
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being one of the most frequently used. However, its half maximal inhibitory 
concentration (IC50) is relatively high (10–20 mM) and its additional effects on inositol 
phosphatases are widely known (Patel et al., 2002, Sinha et al., 2005).  
BIO, (2'Z,3'E)-6-Bromoindirubin-3'-oxime, is an ATP-competitive, cell-
permeable and reversible GSK3 inhibitor (IC50 value is 5nM). Its bromine group makes 
strong bonds with hydrophobic residues (commonly Leucine) in the ATP pocket of 
GSK3 (Meijer et al., 2003), making it unavailable for binding of ATP molecules and 
therefore rendering the kinase unable to phosphorylate its downstream targets. Due to 
its preference for hydrophobic environments, BIO is poorly soluble in water and 
requires the presence of dimethylsulfoxide (DMSO) for increased solubility (Meijer et 
al., 2003).   
BIO has also been tested for its specificity against other common kinases, 
including MAPK (mitogen-activated protein kinases), PKA (protein kinase A), PKC 
(protein kinase C) and others, but its IC50 for these proteins is more than 10µM (Meijer 
et al., 2003, Polychronopoulos et al., 2004). Therefore, its effect at small concentrations 
is expected to be highly specific for GSK3.  
GSK3 inhibits the canonical Wnt pathway by phosphorylating and inactivating β-
catenin. So, BIO, by inhibiting GSK3, in fact activates the pathway and stabilizes the 
levels of β-catenin (Meijer et al., 2003). In previous studies, BIO was shown to sustain 
pluripotency (Sato et al., 2004), to induce self-renewal in human and murine ES cells, 
and to induce differentiation of neonatal cardiomyocytes (Tseng et al., 2006).  
Although BIO has been shown to be specific for GSK3 (Meijer et al., 2003), it is 
important to note that GSK3 is not only part of the canonical Wnt pathway. It, also, 
participates in the Hedgehog signalling pathway, where it facilitates proteolysis of the 
protein Cubitus interruptus (Ci) (Kalderon, 2002, Nusse, 2003). Therefore, when using 
BIO it is essential to take into account this additional activity area of GSK3. However, 
BIO has been extensively used as an activator of the canonical Wnt pathway and has 
been shown to recapitulate the axis-duplication phenotype caused by other Wnt 
activators (Manisastry et al., 2006, Martin et al., 2010, Meijer et al., 2003, Ueno et al., 
2007).    
 
6.2. Aims of the current study 
 
The canonical Wnt/β-catenin pathway and its involvement in various developmental 
processes, including cardiogenesis, have been extensively studied in the past. However, 
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controversy still prevails in the field as to the exact role that β-catenin signalling plays 
during the commitment, specification and differentiation of cardiac progenitors and 
during subsequent heart morphogenesis. The main focus of the current study was to 
shed more light to the cardiogenic role of β-catenin. Specifically, the aim of this study 
was to investigate the requirement of canonical Wnt signalling during ES cell-derived 
cardiogenesis. In order to achieve this, the following aims were set: 
• Establish the effect of DMSO (in which the drug BIO is diluted) during 
differentiation of E14 ES cells by looking at their morphology, beating 
behaviour and expression profiles 
• Elucidate the effect of canonical Wnt activation by treatment with BIO on the 
morphology and growth of differentiating E14 ES cells  
• Define the effect of canonical Wnt activation by treatment with BIO on the 
beating behaviour of differentiating E14 ES cells, focusing on individual time 
intervals during differentiation 
• Confirm the findings related to the beating behaviour of E14 cells with 
differentiating ES-D3 cells 
• Establish the gene expression profiles of differentiating ES-D3 cells under 
timely activation of the canonical Wnt pathway by BIO 
 
6.3. Investigation of the effect of DMSO on the morphology, growth and beating 
potential of EB 
 
DMSO was used as the experimental solvent for BIO, the chemical used in this study 
for canonical Wnt signalling activation. Thus, experiments conducted in the presence of 
DMSO alone (0.1% DMSO, corresponding to the amount used for BIO dilution) should 
always be included in the analysis in order to ascertain that any observations made after 
BIO treatment were not caused by DMSO but by the drug itself. Therefore, it was 
important to examine whether DMSO on its own had any effects. The shape, size and 
morphology of the cells, as well as their beating behaviour and their gene expression 
profiles were assessed, after administration of DMSO during ES cell differentiation. 
Briefly, EB were formed in hanging drops from E14 ES cells between days 0 and 2 of 
differentiation, were grown in suspension for another three days (d2-d5) and were then 
plated in 96-well plates (d5-d11). The properties, the morphology and the beating 
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behaviour of the forming EB were assessed at d5 onwards. An untreated group, grown 
in differentiation media with no additions, was used as the basic comparator.  
A similar assessment of the effect of DMSO on differentiating ES cells is 
presented in Chapter 5. However, it has to be reminded that two different cell lines were 
used in the two studies: ES-D3 cells in Chapter 5 and E14 ES cells here (Chapter 6). So, 
it was important to examine the effect of DMSO on this new cell line before use of the 
inhibitor and to define the expected morphology, properties and expression profiles of 
differentiating E14 cells. Data from the DMSO treatment of E14 cells that were similar 
to that with ES-D3 cells are presented in the appendix, while here only deviations from 
the previously described expected patterns (Chapter 5, DMSO on ES-D3 cells) are 
shown.  
 
6.3.1. 0.1% DMSO did not alter the properties and morphology of the cells 
 
The morphological and cell measurement data after DMSO treatment are all presented 
here, as they are intrinsic to each cell line and are expected to be even slightly different 
between ES-D3 cells (Chapter 5) and E14 ES cells (here). The EB that formed within 
the hanging drops were initially small (hardly detectable with naked eye) and uniform in 
size. The uniformity is, in fact, one of the main advantages of using the hanging-drop 
method for generating EB (Dang et al., 2002, Kurosawa et al., 2003). EB were then left 
in suspension, where they grew in size as cells proliferated and differentiated. After d5, 
when EB were plated, cells attached to the bottom of 96-well plates and spread in all 
directions, covering, after a few days, a large proportion of the well. No noticeable 
differences were observed in the morphology of untreated and DMSO-treated EB, as 
shown in Figure 6.1. They both appeared like large spherical, well-formed and well-
defined aggregates under both conditions. Therefore, DMSO did not adversely affect 
the morphology of forming and developing EB.  
In parallel, some important cell measurements were taken at d5: the diameter, 
circularity, total cell count and viability of the cells. A Vi-Cell XR-2.03 Counter was 
employed for these measurements (Section 2.2.9, page 71). No significant differences 
were observed in any of these measurements between the two groups. Small differences 
in the various cell measurements were observed between the E14 cell line, used in this 
study, and ES-D3 cells, used in Chapter 5 (highlighted in the next sections). All 
numerical data are presented in tables and illustrated in graphs (Figure 6.2). Twelve EB 
 were pooled together for each measurement and each cond
repeated on samples from three independent experiments. 
Figure 6. 1: Morphology of EB after DMSO treatment. Shown are bright
images of d5 untreated and 0.1% DMSO
noticeably affect the size and morphology of EB at d5. Untreated and DMSO
do not differ in size. Scale bars represent 200 
 
The average diameter of E14
9.8 µm (se=0.5) and for the DMSO 
difference was observed between these values (p=0.447). Similarly, the average 
circularity of E14-derived cells within untreated and DMSO
not to be affected. For the untreated group it was 0.81 (se=0.01) and for 
group it was 0.79 (se=0.01). 
were not significantly differen
circularity and hence the shape of 
DMSO-treated ES-D3
but slightly larger (10.45 
The viability of E14
treatment and 71% (se=3) for the DMSO
time of the measurement on average 77% of the cells within each EB under control 
conditions were alive (Figure 6.2). Although a small decline in the viability of the cells 
was observed after DMSO treatment, this decrease was not found to be statistically 
significant (p=0.171). The total number of cells within each EB was also counted at d5 
and revealed no changes between untreated and DMSO
(p=0.748). The average number
(se=4485) for the media control and 51500 cells (se=4991) for the DMSO control. 
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ition. All measurements were 
 
-treated EB. Addition of DMSO did not 
µm.  
-derived cells for the media control group at d5 was 
8.7 µm (se=0.5) (Figure 6.2). No significant 
-treated EB at d5 was found 
A high p value (p=0.163) showed that these measurements 
t from each other and therefore DMSO did not affect the 
differentiating cells (Figure 6.2). Untr
-derived cells at d5 were equally circular (0.76 units on average) 
µm on average) than E14-derived cells.  
-derived cells within each EB was 83% (se=3) for the no
-treatment group at d5, which means that at the 
-treated E14
 of cells per EB (E14-derived) was 52300 cells 
-field microscopy 
-treated EB 
the DMSO 
eated and 
-
-derived EB 
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Control ES-D3-derived EB were more cell-dense (63500 cells per EB on average) than 
E14-derived EB, but had the same viability rates (77% on average).  
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Figure 6. 2: 
DMSO did not 
affect the basic cell 
properties of 
differentiating EB. 
Untreated and 
0.1% DMSO-
treated EB at d5 
did not show 
statistically 
significant 
differences in the 
circularity (A), 
total count (B), 
diameter (C) and 
viability (D) of 
their cells. All 
numerical data 
are shown in the 
tables underneath 
the graphs. 
Statistical analysis 
was performed 
using one-way 
Anova testing.  
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From the data presented above, it is evident that no statistically significant 
differences were observed in the morphology and properties of cells within untreated 
and DMSO-treated E14-derived EB, which suggests that DMSO did not have any 
adverse effects on the cells. Additionally, no major differences in the cell measurement 
data between the two cell lines (ES-D3 and E14) were observed. The next step was to 
assess how DMSO could be affecting the beating behaviour of differentiating E14 ES 
cells, as the main focus of the current study was the process of cardiogenesis.  
 
6.3.2. 0.1% DMSO did not alter the beating behaviour of the EB 
 
The beating behaviour of E14-derived EB after DMSO treatment was examined in 
comparison to the beating behaviour of untreated E14-derived EB. DMSO did not affect 
the beating behaviour of the cells within EB in three independent experiments, 
compared to untreated cells (Figure 6.3). DMSO was introduced into the media at 5 
different intervals, reflecting the time intervals during which BIO would be 
administered. These were d0-d2, d2-d5, d5-d7, d7-d9 and d9-d11. No significant 
differences were observed between the different DMSO treatment groups or between 
the DMSO treatment and the no treatment groups (Figure 6.3).  
Untreated E14-derived EB first exhibited contractile activity at day 6, when on 
average 28% (se=5) of the EB were beating. By d11, approximately 69% (se=2) of the 
EB showed signs of contraction and were grouped as beating EB. By comparing 
untreated EB and DMSO-treated EB at all time intervals examined (d0-d2, d2-d5, d5-
d7, d7-d9 and d9-d11), no difference was observed (Figure 6.3). This confirmed the 
common notion that DMSO at very low concentrations (0.1% in this study) does not 
severely alter the in vitro behaviour of ES cell-derived cardiac cells, although in higher 
concentrations it has been used as a cardiac-enhancing factor (McBurney et al. 1982, 
Ventura and Maioli 2000, Sachinidis et al. 2003). The percentages of EB that contained 
beating foci at days 5-11 without any treatment and after all DMSO treatments are 
presented in a table and graph format in Figure 6.3. 
 
 
  
Figure 6. 3: DMSO did not affect the beating behaviour of differentiating EB. No major 
differences were obser
treated EB. Initiation of contraction occured at d6
beating foci in the no-
increase from d6 onwards led to 
respectively. All numerical data are tabulated underneath the graph. Statistical 
significance was assessed with the non
 
 
 
 
 
 
 
The contractile behaviour
different. ES-D3-derived EB initiated spontaneous contraction at d7 instead of d6 and 
gradually reached a maximum of 51% (untreated EB) and 46% (DMSO
beating by d11, compared to 73% (untreated EB) and 6
E14-derived EB. These differences did not come as a surprise, since different cell lines 
are expected to show distinct behaviours and possibly divergent differentiation timing. 
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From the data presented above it becomes clear that DMSO did not positively or 
negatively influence any of the aspects of cell differentiation examined so far. Before 
concluding that DMSO can be used as an experimental control for all future 
experiments with BIO, it was essential to examine the gene expression profile of 
DMSO-treated E14-derived EB compared to untreated E14-derived EB.  
 
6.3.3. 0.1% DMSO treatment did not alter the gene profile of differentiating EB 
 
Next, the gene expression profile of differentiating E14 cells under no treatment and 
DMSO treatment was examined. Quantitative PCR analysis was performed on samples 
collected from three independent experiments. Typically, at least 30 d5 EB and 10 d11 
EB were collected at the respective time point for gene expression analysis. All 
reactions were performed in triplicate. The ∆∆Ct method was used for data analysis 
(Section 2.2.13.4, page 74, for more details on this method). Day 0 samples were used 
as the comparator, against which fold changes were measured. 14 genes of the 
following categories were analysed: pluripotency markers (Oct4, Nanog, Sox2), markers 
of the cardiac lineage (Islet1, Nkx2.5, Gata-4, Tbx5, Mlc2v, Mlc2a, cTroponinI), 
markers of other lineages and Wnt targets (Brachyury, Goosecoid, Flk1, Hex and Lef-1). 
Details about what each one of those genes represents and why we used it in this study 
are given in Sections 1.3.5 (page 14), 5.1.3 (page 174) and 6.1.1 (page 223). Expression 
of Flk1, Brachyury, Mlc2a, Mlc2v, Hex and Lef-1 after DMSO treatment in 
differentiating E14 cells was similar to that of differentiating ES-D3 cells and is shown 
in the appendix. The expression of the rest of the genes is presented below.   
 
6.3.3.1. Pluripotency genes 
 
As expected, the Oct4 stemness marker was highly expressed when cells were still 
pluripotent (d0) and then its expression quickly dropped by approximately 5 fold, 
reaching minimal levels by days 5 and 11, when most of the cells were fully 
differentiated. The expression patterns of Sox2 and Nanog were similar with 2.5-5 fold 
and 1-5 fold changes, respectively, in their expression at days 5 and 11 compared to d0 
(Figure 5.4). No significant differences were observed between untreated and DMSO-
treated EB.  
 
 
  
Figure 6. 4: Pluripotency gene expression analysis after 0.1% DMSO treatment. 
Treatment of differentiating ES cells with DMSO did not markedly alter their expression 
profile. The expression of pluripotency markers dropped by about 5 fold fr
with small variations between control (media only) and DMSO treatment. No statistical 
significance was observed between any of the groups, as assessed by the one
test.  
 
 
6.3.3.2. Mesodermal and cardiac genes
 
Markers of the mesoderm
study. Gsc, a mesodermal marker, followed a similar expression pattern to that of 
Brachyury (another mesodermal marker shown in the appendix), with increased levels 
at d5 (1.8 fold increase from d
levels for both groups) (Figure 6.5). 
The early cardiac marker 
high levels of expression by d5, when cardiac cells had been specified (20 fold an
fold higher than d0 in media and DMSO control, respectively), and remained fairly 
unchanged between days 5 and 11, after cardiac differentiation had occurred 
(insignificant 2 fold and 1.2 fold decrease in media and DMSO controls compared to 
d5, respectively) (Figure 6.5). 
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al and cardiac cell lineages were of major interest in this 
0 for both groups) and decreased levels at d11 (back to d0 
 
Gata-4 was only minimally expressed at d0, reached 
 
 
om d0 to d11 
-way Anova 
d 10 
   
Figure 6. 5: Gene expression analysis of mesodermal and cardiac markers after DMSO 
treatment. Treatment of differentiating ES E14 cells with DMSO did not markedly alter 
their gene expression profile. Th
the absence and presence of DMSO at days 5 and 11. The pattern of cardiac gene 
expression remained unaffected after DMSO treatment: 
showed similar levels of expression at 
a marked increase in their expression levels at d11 in both groups. Statistical significance 
was assessed by one-way Anova testing.
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e expression levels of Gsc were practically unchanged in 
Gata-4, Isl1
days 5 and 11, while Nkx2.5, Tbx5 
 
 and cTroponinI 
and Tnnt2 showed 
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Isl1, an important early regulator of cardiogenesis, followed a similar expression 
pattern to that of Gata-4: the media control showed a 6.5 fold increase in Isl1 
expression at d5 compared to d0 and a small and insignificant 1.2 fold decrease at d11 
compared to d5, while DMSO showed a 4.5 fold increase and a 1.1 fold decrease at 
days 5 and 11 compared to days 0 and 5, respectively. Nkx2.5 and Tbx5 followed a 
different expression pattern: they were low at d0 and gradually increased at days 5 and 
11. Specifically, the expression of Nkx2.5 in the media control increased 7.5 fold from 
d0 to d5 and 1.7 fold from d5 to d11, while in the DMSO control it did not increase 
between days 0 and 5 and showed a 5 fold increase at d11. The expression of Tbx5 
increased 5 and 4 fold from d0 to d5 and 2.2 and 2.8 fold from d5 to d11 in media and 
DMSO controls, respectively (Figure 6.5). No significant differences were observed 
between the untreated and DMSO-treated EB in the expression levels of early cardiac 
markers.  
Late cardiac markers, such as Mlc2a and Mlc2v (shown in the appendix), were 
expressed at high levels only after cell plating (d5) and especially at d11. Another late 
cardiac gene, Tnnt2, which is a component of the contractile apparatus, was present 
most notably d5 onwards: at d5 both media and DMSO controls showed increased 
expression compared to d0 (3 and 2.5 fold, respectively) and at d11 the expression was 
even higher (5 and 9.6 fold compared to d5, respectively). Another component of the 
contractile apparatus of beating cells is carciac Troponin I (cTnI): its expression at d5 
was 9 fold higher than d0 and at d11 3 fold lower than d5 in the media control, while it 
was 1.5 fold higher at d5 compared to d0 and 1.3 fold higher at d11 compared to d11 in 
the DMSO control. Any observed differences between the two control groups examined 
here were not found to be statistically significant (Figure 6.5).  
Although some of the differences in gene expression levels between media and 
DMSO may seem considerable, it is important to note that the pattern of expression 
was, in most cases, the same in both categories and that large differences were usually 
accompanied by large error bars, indicating high variability at that specific time point 
and sample. No statistically significant difference (p>0.1 for all) was observed between 
media and DMSO in any of the genes studied here, as assessed with one-way Anova 
testing. 
The expression profile of the genes presented above under control conditions 
(media only and DMSO) was as expected. Markers of stemness are expected to 
decrease after d0 as cells lose their pluripotency and cardiac markers are expected to 
increase after d0: early cardiac cells come on approximately at d5 and either remain 
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high or disappear at d11, while late cardiac genes come on later and remain present. 
Markers of mesoderm are expected to come on at d5 or before and then decrease as 
mesodermal cells acquire their subsequent fates and lose their transient mesodermal 
signature. Finally, Hex and Flk1 are expected, as markers of endoderm and 
hemangioblast cells and their derivatives, respectively, to come on at d5 or earlier and 
either remain constant or increase at d11. Therefore, it seems reasonable to use the 
DMSO qPCR data as a baseline comparator for the following data analysis.  
Taken together, the data presented so far illustrate that DMSO can reliably be 
used as a control for further experiments with BIO, as it did not significantly affect any 
of the aspects of ES cell differentiation that we examined. Therefore, in all data 
presented below only the DMSO control will be presented, alongside the experimental 
data. Also, the fact that no major differences in the patterns of gene expression were 
observed between the two cell lines (E14 and ES-D3), suggests that both the qPCR 
method and the stem cell differentiation assay are reliable and reproducible and that the 
two cell lines are comparable to each other.    
 
6.4. The morphology and general properties of differentiating E14 ES cells after 
treatment with BIO 
 
Preliminary work that was performed on differentiating E14 stem cells, presented in a 
previous report (MSc report, submitted in August 2007), showed that 1µM BIO was the 
most appropriate concentration to be used. It was initially used throughout the assay and 
showed reproducible results, with no signs of toxicity, against higher (5µM) and lower 
(0.2µM) dosages also tested. Therefore, it was decided that BIO would be used at a 
concentration of 1µM, diluted in DMSO. Five time points were used for the treatment 
with BIO: day 0 – day 2 (d0-d2), when cells in hanging drops start forming EBs, day 2 
– day 5 (d2-d5), when EBs are in suspension and have started differentiating, day 5 – 
day 7 (d5-d7), when beating cardiomyocytes first appear and most of the lineages are 
already defined, day 7 – day 9 (d7-d9), when most of the cells that are destined to 
become cardiac cells have initiated spontaneous contraction and day 9 – day 11 (d9-
d11), when cardiomyocytes and cells of other lineages are considered to be 
differentiated.  
The use of fetal calf serum (FCS), an essential yet confounding factor in ES cell 
culture, has also been assessed in a previous report (MSc report, submitted in August 
2007). It was shown that withdrawal of FCS before d5 of differentiation had adverse 
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effects on the differentiation potential of the cells, while serum starvation after d5 
enhanced the beating potential of differentiating EB, without affecting their general 
morphology and size. It was, thus, concluded that FCS would be used from d0-d5 and 
removed from the media between d5-d11 (or d5-d15).    
 
6.4.1. The morphology and size of differentiating EB after BIO treatment   
 
No major differences were observed either in the appearance of BIO-treated and 
DMSO-treated EB while in suspension or in their spreading capacity after plating. Two 
important observations were, however, made. Firstly, EB that were treated with BIO 
between days 2 and 5 appeared larger than DMSO-treated EB (Figure 6.6) in three 
independent experiments. This implies either that the cells in the EB were larger than 
DMSO-treated EB or that there were more cells within each treated EB compared to 
untreated ones. This issue is addressed below with the cell counting data. Secondly, 
treatment of cells with BIO before d5 caused a decrease in the attachment ability of the 
cells. This became obvious during media changing, when most of the d0-d2 and d2-d5 
BIO-treated EB were lost during pipetting, something that rarely happened for DMSO-
treated EB. Looking more closely at the cells it became evident that they were loosely 
attached to the bottom of the wells and, therefore, even minor disturbances would make 
them detach.   
The morphology and viability of the cells within each EB under different 
treatment conditions were also assessed, as described below. Cells from 5 days old d0-
d2 and d2-d5 BIO-treated EB were measured, right before plating. Twelve EB were 
pooled together for each measurement and each condition. All measurements were 
repeated on samples from three independent experiments. 
 
6.4.2. d0-d2 and d2-d5 BIO treatment did not affect the viability of the cells 
 
Initially, the viability of the cells after d0-d2 BIO treatment was analyzed. Viability was 
not altered under the conditions examined, although a small but not significant decrease 
was observed between d0-d2 BIO-treated (71%, se=7) and DMSO-treated (71%, se=3) 
EB (p=0.171). Similarly, the viability after d2-d5 BIO treatment was not significantly 
altered (75%, se=8, p=0.136 compared to DMSO) (Figure 6.7). We can therefore 
conclude that the viability of the cells at d5 was not affected by treatment with BIO.  
 Figure 6. 6: Morphology of EB after BIO treatment. Addition of BIO between days 0 and 
2 did not affect the size of EB, while treatment between days 2
are bright-field microscopy images of 0.1% DMSO
BIO-treated EB. Scale bars represent 200 
 
6.4.3. d0-d2 BIO treatment did not affect while the d2
cell count per EB 
 
The total number of cells (including dead and alive cells) per EB at d5 was of interest, 
in order to assess proliferation and cell death levels. The total cell count seemed to be 
affected by BIO, only when this was added between days 2 and 5, in 
experiments. Each EB consisted of 51500 cells (se=4991) after DMSO treatment, 44300 
cells (se=15817) after d0
treatment (Figure 6.7). The difference between the latter group and t
was found statistically significant, with a p value lower than 0.05 (p=0.023 compared 
DMSO-treated EB), as calculated with one
test (shown by the asterisk in Figure 6.7). The significance between the othe
was p>0.748. As the starting number of cells for each EB was always the same (450 
cells in each 30µl hanging drop), changes in the proliferation and death levels of cells 
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Figure 6. 7: Viability and cell count of BIO
treated, d0-d2 BIO-treated and d2
statistical significance was observed between all groups and the DMSO. (B) D0
treatment did not affect the total cell count of EB at d5, while d2
significantly increased it (0.023). *p<0.05, as assessed by one
of 3 experiments are shown. Error bars represent standard errors of the mean.  
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6.4.4. d0-d2 and d2-d5 BIO treatment did not affect the size and shape of the cells 
 
Concomitantly, we analyzed the size and shape of the cells, by looking at their diameter 
and circularity (Figure 6.8). No statistically significant differences were observed in any 
of the treatment groups examined (p=0.447 for the diameter and p=0.163 for the 
circularity for all groups against DMSO). The average cell diameter was 8.7µm (se=0.5) 
for the DMSO-treated, 8.5µm (se=1.1) for the d0-d2 BIO-treated and 9.5µm (se=1.1) 
for the d2-d5 BIO-treated cells. The average circularity, measured in units with 1 
showing a perfectly circular cell, was 0.79 (se=0.01) for the DMSO-treated, 0.83 
(se=0.01) for the d0-d2 BIO-treated and 0.78 (se=0.01) for the d2-d5 BIO-treated cells 
(Figure 6.8). These values indicate that the cells within the EB are not different in size 
and shape after treatment with BIO.  
 
6.5. Investigation of the beating behaviour of differentiating E14 ES cells after 
treatment with BIO 
 
One of the main focuses of the current study was the investigation of the effect of 
canonical Wnt pathway activation on the process of cardiogenesis. Therefore, 
examination of the beating behaviour of BIO-treated EB was of interest. Spontaneous 
contraction was initiated after EB were plated in 96-well plates at d5. The number of 
EB with beating foci increased gradually from d6 to d11 (or d15). The data presented 
below represent the mean values of at least three independent experiments and are 
shown in % percentages. For each experiment at least one 96-well plate, with one EB 
per well, was used for each condition. Scoring of beating areas was conducted under a 
brightfield microscope; each EB with at least one beating area was scored as a beating 
EB. One-way anova testing, followed when necessary by a 2-sided Dunnett test (see 
Section 2.6, page 81 for more details) was used for assessing statistical significance.  
 
 
 
  
Figure 6. 8: Cell size and shape of BIO
(B) of the cells are shown in this graph. (A) The average circularity was 0.79 (se=0.01), 
0.83 (se=0.01) and 0.78 (se=0.01) for the DMSO
BIO-treated cells, respectively. (B) The average diameter was 9.8
(se=0.5), 8.5µm (se=1.1) and 9.5
d2-d5 BIO-treated cells, respectively. No statistical significance was observed between 
of these groups and the control groups (p=0.447 and p=0.163 for diameter and circularity 
against DMSO), as assessed by one
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 6.5.1. BIO treatment at d0
 
Initially, we looked at the beating behaviour of differentiating E14 ES cells and 
assessed how this changed after BIO treatment. We were interested in the onset of 
spontaneous contraction and the number of EB that attain a cardiac fate at d11 and d15. 
Addition of 1µM BIO to E14 ES cells between d0 and d2 caused a significant 
suppression of cardiogenesis after d6 (Figure 6.9). Only approximately 11% (se=6) of 
the differentiating EB developed contracting foci until d11 and they only started doing 
so after d8 in all experiments, while DMSO
(p=0.014, 0.006, 0.006, 0.007, 0.007 and 0.007 for days 5 to 11, respectively, compared 
to DMSO). The observed decrease in the beating potential of the cells could be due to 
developmental delay 
other lineages. However, extending the experimental period to 15 days did not alter the 
behaviour and differentiation status of the cells; it seems that the cells were not able to 
become beating cardiomyocytes regardless of how long they stayed in culture (Figure 
6.9).  
Figure 6. 9: Beating graphs after d0
caused a detrimental decrease in the ability of differentiating ES
spontaneous contraction. The average percentages of beating cells are shown in the table. 
The onset of contraction was also affected: it occurred at d8 after d0
compared to d6 for controls. The graphs show the mean value
experiments and error bars represent standard errors of the mean. Statistical significance 
is indicated with asterisks: *p<0.05, **p<0.01, as calculated by the Mann Whitney test. 
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 6.5.2. BIO treatment at d2
 
Addition of BIO between days 2 and 5 had a dramatic effect on the occurrence of 
beating (Figure 6.10). Only 4% (se=0.9) and 5% (se=1.7) of the EB at d11 and d15, 
respectively, were found to contain contracting areas and the onset of contraction 
considerably later (d9) than in the DMSO group (d6) (p=0.007, 0.003, 0.003, 0.003, 
0.003 and 0.003 for days 5 to 11, respectively, compared to DMSO). It is, therefore, 
apparent that activation of the canonical Wnt pathway during this interval is detrim
for heart cell differentiation. 
 
 
Figure 6. 10: Beating graphs after d2
caused a detrimental decrease in the ability of differentiating cells to initiate spontaneous 
contraction. The average percentages of beating cells are shown in the table, below the 
graph. Spontaneous contraction initiated at d9 after d2
for DMSO. The graphs show the mean values of five independent experiments and error 
bars represent standard errors of the mean. Statistical significance is indicated with 
asterisks: **p<0.01, as calculated by the Mann Whitney non
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 6.5.3. BIO treatment between days 5 and 11 repressed spontaneous contraction
 
Treatment with BIO at any time between d5 and d11 inhibited beating (Figures 6.11 and 
6.12). When BIO was added at d5 (until d7) no contractile foci appeared until d11, 
indicating a significant decrease in the beating ability of EB (p=0.02 for d5 and p=0.01 
for d6-d11 compared with DMSO). Extension of the observation period to 15 days did 
not reveal a late onset of spontaneous contraction; only on average 1% of EB contained 
beating foci at d11, compared to 70% of DMSO
interestingly, when BI
(until d9) or at d9 (until d11), most of the beating activity halted and it only partially 
recovered after removal of the drug (Figure 6.12). Specifically, at d7, just before the d7
d9 BIO treatment, approximately 71% of cells were beating (no difference from DMSO, 
p=728) and this number was reduced to 18% at d8 after d7
(significantly different with p=0.003 compared to DMSO). 
 
Figure 6. 11: Beating graph after d5
caused a detrimental decrease in the ability of differentiating cells to initiate spontaneous 
contraction. In fact, no beating was observed after d5
mere 1% of EB contained beating foci, compared to 70% of DMSO
shows the mean values of seven independent experiments and error bars represent 
standard errors of the mean. Statistical significance is indicated with asterisks: **p<0.01, 
as calculated by the Mann Whitney non
245 
-treated EB (Figure 6.11). Most 
O was added after beating areas had already appeared, either at d7 
-d9 BIO treatment 
 
-d7 BIO treatment. BIO treatment between d5 and d7 
-d7 BIO treatment until d13, when a 
-
-parametric test.  
 
-
treated EB. The graph 
   
 
 
 
 
 
 
 
 
 
 
Figure 6. 12: Beating graphs after d7
after initiation of beating had taken place caused a halt in beating, which only partially 
recovered after removal of the drug. One day after addition of the drug, a significant 4 
fold (p=0.003) and 5 fold (p=0.002) decrease in the occurrence of beating was observed 
after d7-d9 and d9-d11 BIO treatments, respectively. The rescue after removal of the drug 
was only partial until d15. The graphs show the mean values of seven independent 
experiments and error bars represent standard errors of the mean. Statistical significance 
is indicated with asterisks: *p<0.05, **p<0.01, as calculated by the Mann Whitney non
parametric test.  
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At d11, only 22% (se=9.2) of d7-d9 BIO-treated cells were beating, significantly less 
than DMSO-treated EB (p=0.023 compared to DMSO). Similarly, at d9, just before d9-
d11 BIO treatment, on average 94% (se=2) of cells were beating (no difference with 
p=0.302 compared to DMSO), while at d10 and d11 after d9-d11 BIO treatment only 
20% (se=9) and 25% (se=9) of EB were beating, respectively (both significantly 
different from DMSO with p=0.002 and p=0.008, respectively). The recovery of the 
beating activity was never complete even if the assay was extended to d15, when the 
number of beating EB seemed to have reached a plateau phase (Figure 6.12). However, 
the differences between d7-d9 and d9-d11 BIO-treated cells and DMSO-treated cells 
were not found to be significant after d13. The percentages of beating EB at d15 were 
51% (se=11.5) and 62% (se=8) for the d7-d9 and d9-d11 BIO treatments, accounting 
for an approximately 50% and 60% recovery, respectively (p=0.083 and p=0.110, 
respectively).    
 
6.6. Treatment with BIO had similar, albeit less severe effects on ES-D3 cells 
 
It was also of importance to assess whether the two cell lines used in this thesis (ES-D3 
in Chapter 5 and E14 in the current chapter) behaved in a similar way after the same 
treatment. Comparison of the two cell lines in Section 5.6.3 showed that both E14 and 
ES-D3 cells respond similarly to treatment with SP600125. The effect of BIO, 
administered between d0-d5 and d5-d11, was also examined on ES-D3 cells. As shown 
in Figure 6.13, addition of DMSO alone did not affect the beating behaviour of 
differentiating cells compared to the media control, as expected from the data presented 
in Chapter 5. Treatment with BIO, however, was shown to significantly (p<0.05 at d8-
d11 for both treatments compared to DMSO) reduce contraction: only 7% (se=4) and 
8% (se=4) of EB contained beating foci at d11 after d0-d5 and d5-d11 BIO treatment, 
compared to 51% (se=11) and 46% (se=13) after no treatment and DMSO treatment, 
respectively.    
  
Figure 6. 13: Treatment with BIO had similar effects on ES
BIO between d0-d5 and d5
onwards. Initiation of beating occurred at d8 and at d7 after d0
treatment, respectively. At the end of the experimental period, only 7% and 8% of EB 
contained beating foci after d0
significant reduction compared to 51% and 46% beating EB in the control and DMSO 
groups. Statistical significance was assessed using the non
Asterisks indicate significance with p<0.05. 
  
 
 
The data presented here alongside the results shown in Chapter 5 (Section 5.6.3
page 201) reiterate the notion that the two cell
similar way and respond similarly to various treatments. This will be of particular 
importance when the data from the two chapters (Chapters 5 and 6) are examined 
together in order to establish a common role for t
differentiation and cardiac development (in Chapter 7). 
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6.7. Gene expression analysis of differentiating cells after BIO treatment  
 
After analyzing the qPCR data from untreated and DMSO-treated differentiating E14 
ES cells (Section 6.3.3, page 232) and assessing that their profiles fit in with the 
generally accepted physiological role that these genes play during development, the 
changes in the expression profiles of these genes were examined after activation of the 
canonical Wnt pathway by treatment with BIO. The DMSO data are included in all 
graphs and are used as controls. All time points represent the mean values of three 
independent experiments, with error bars showing standard errors of the mean. 
Asterisks indicate statistical significance, with p values lower than 0.05 shown with one 
asterisk. The ∆∆Ct method was used for analysis of the qPCR data, as described in 
Section 2.2.13.4 (page 74). All values are expressed as fold changes compared to the 
calibrator (d0, set as 1). The results from d0-d2 and d2-d5 BIO treatments are presented 
first, followed by the results from the d5-d7, d7-d9 and d9-d11 BIO treatments.    
Activation of the canonical Wnt pathway was confirmed by increased Lef-1 
expression, a direct downstream target of β-catenin (Behrens et al. 1996, Huber et al. 
1996, Tutter et al. 2001). After d0-d2 BIO treatment the expression of Lef-1 at d5 was 
slightly but not significantly (p=0.103) upregulated (Figure 6.14). However, after d2-d5 
BIO treatment its expression at d5 was 2.5 fold higher than that of the DMSO control, 
indicating a considerable increase (p=0.030 compared to DMSO). The fact that the 
effect of the drug is reversible explains the discrepancy: at d5 the effect of the d0-d2 
BIO treatment had already worn off because the drug had been removed since d2, 
whereas the effect of the d2-d5 BIO treatment was still ongoing. At d11 expression of 
Lef-1 has regressed back to normal levels, comparable to the DMSO treatment.    
 
6.7.1. After d0-d2, but not after d2-d5, BIO treatment pluripotency markers were 
severely affected 
 
Initially, the expression of pluripotency genes (Sox2, Nanog, Oct4) after d0-d2 and d2-
d5 BIO treatment was examined. D0-d2 BIO treatment caused an increase in the 
expression levels of these three genes compared to controls at d5, suggesting that BIO-
treated cells maintained their undifferentiated status for longer than control cells (Figure 
6.15). Expression of Sox2, Oct4 and Nanog at d5 was 4.5, 30 and 40 fold higher, 
respectively, compared to the DMSO values. The difference was statistically significant 
between DMSO-treated and BIO-treated samples at d5 for Sox2 and Nanog but not for 
 Oct4 (p=0.002, p=0.280 and p=0.034 for 
However, at d11 the levels of expr
controls (0.1, 0.9 and 1.9 fold changes for 
values higher than 0.1 (p=0.263, p=0.562 and p=0.113 for 
respectively, compared to DMSO), wh
differentiated and have stopped expressing stemness markers. 
 
Figure 6. 14: Expression analysis of 
treatment between d0
target of β-catenin at d5 but not at d11. At d5 the levels of 
significantly upregulated after BIO tre
statistically significantly (p=0.030) increased after d2
DMSO-treated EB. Its levels regressed to normal levels at d11. Statistical significance was 
assessed with the one-
 
 
In contrast, d2-d5 addition of BIO did not affect the expression levels of 
Nanog and Oct4 at days 5 and 11. Expression of 
treated EB was 10, 3 and 3 fold lower than
controls at d11 (Figure 6.15). No statistical significance was observed between BIO
treated and DMSO-treated EB for most samples, with p values higher than 0.06. D11 
Sox2 expression was, however, significantly
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 to DMSO-treated EB, a finding with probably little physiological significance (p=0.068, 
p=0.219 and p=0.137 at d5 and p=0.033, p=0.265 and p=0.212 at d11 for 
and Nanog, respectively, compared to DMSO). 
 
 
 
Figure 6. 15: Pluripotency gene expression analysis after d0
at days 0, 5 and 11. BIO treatment between days 0 and 2 affected the differentiation status 
of EB, while d2-d5 BIO treatment did not. Plu
were upregulated at d5 after d0
compared to the DMSO control. At d11 the expression levels of the three genes were 
indistinguishable from controls. Asterisks sho
DMSO control, with *p<0.05, as calculated by one
Dunnett test.  
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Next, the expression levels of various lineage markers were assessed (Figure 6.16). The 
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Figure 6. 16: Expression levels of markers of various cell lineages after BIO treatment. 
Flk1 showed a decrease in its expression levels at days 5 and 11 after both d0
treatments, but none was found to be significant, compared to DMSO. The expression of 
Hex was unaltered at d5 but showed a significant (p=0.011) 2.2 fold increase at d1
compared to the DMSO control. 
p=0.02945, respectively) in their expression levels at d5 (3.5 and 6.6 fold, respectively), 
while at d11 only Gsc 
Statistical significance was assessed with one
Dunnett test and is shown with asterisks in the graph: *p<0.05. 
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Flk1 (insignificantly 2 fold lower after d0-d2 BIO treatment compared to DMSO, 
p=0.332) and Hex (insignificantly 2 fold higher after d0-d2 BIO treatment compared to 
DMSO, p=0.346) expression levels at d5 were practically unaltered after d0-d2 BIO 
addition compared to the DMSO values. Similarly, at d11 Flk1 (1.7 fold lower, 
p=0.924) expression was unaltered between d0-d2 BIO-treated and DMSO-treated EB. 
However, expression of Hex was found to be significantly higher (2.4 fold higher, 
p=0.011) after d0-d2 BIO treatment than DMSO at d11 (Figure 6.16). After d2-d5 BIO 
treatment, Flk1 and Hex at both days 5 and 11 were not considerably different to 
controls. Flk1 was 2.7 (p=0.305) and 1.8 (p=0.241) fold lower than DMSO at d5 and 
d11, respectively, and Hex was 1.7 fold higher (p=0.671) and 1.5 fold lower (p=0.606) 
than controls at d5 and d11, respectively.  
 
 6.7.3. After d0-d2 and d2-d5 BIO treatments cardiac genes were severely affected  
 
Clearly, the genes of most relevance to our study were the early and late cardiac genes. 
At d5 Tbx5, Nkx2.5 and Gata-4 showed biphasic, although not statistically different 
from controls, responses to BIO treatment: after d0-d2 BIO treatment expression of 
Tbx5 was 1.5 fold higher (p=0.621), of Nkx2.5 2.2 fold lower (p=0.249) and of Gata-4 2 
fold lower (p=0.139) compared to DMSO, while after d2-d5 BIO treatment their 
respective expressions were 2.5 fold lower (p=0.212), 1.3 fold higher (p=0.953) and 3.2 
fold higher (p=0.315) than controls (Figure 6.17). The expression of Isl1 was 
significantly decreased at d5 compared to DMSO after d0-d2 (p=0.047) and d2-d5 BIO 
treatments (p=0.038). At day 11 after d0-d2 treatment, the expression of Gata-4 
dropped 1.3 fold (p=0.495), of Nkx2.5 5.8 fold (p=0.196), of Tbx5 1.4 fold (significant, 
p=0.049) and of Islet1 1.5 fold (significant, p=0.046), compared to DMSO. At d11 after 
d2-d5 BIO treatment, the fold changes were 2.1 (p=0.128) for Gata-4, 9.7 (p=0.148) for 
Nkx2.5, 2.7 (p=0.125) for Tbx5 and 2.2 (significant, p=0.018) for Islet1 compared to 
DMSO. The late cardiac genes examined here showed no changes in their expression 
levels at d5 but severe changes at d11 after either one or both treatments (Figure 6.17). 
Specifically, expression of MLC2v dropped 2.4 fold (significant, p=0.029), Tnnt2 1.8 
fold (p=0.069) and MLC2a 1.3 fold (significant, p=0.047) after d0-d2 BIO treatment, 
while after d2-d5 BIO treatment the significant fold changes were 18 fold (p=0.001) for 
MLC2v, 3.4 (p=0.047) for Tnnt2 and 13 (p=0.001) for MLC2a, compared to DMSO. 
Expression of cTnI at d11 was biphasic: 1.1 fold increase (p=0.367) after d0-d2 and 4.5 
fold decrease (significant, p=0.047) after d2-d5 BIO treatments.  
  
Figure 6. 17: Expression profile of cardiac genes after BIO treatments. 
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 6.7.4. BIO treatment between days 5 and 11 reduced expression of cardiac genes but 
did not alter other lineage markers
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Figure 6. 18: Gene expression analysis of 
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(p=0.026), 3.2 fold (p=0.037) and 3.3 fold (p=0.047) fall after d5
BIO treatments, respectively, compared to DMSO (Figure 6.19). The expression of 
Mlc2v was differentially but not significantly affected by each of the BIO treatment: d5
d7 addition of BIO caused a 30 fold drop in its expression levels (p=0.137) compared to 
DMSO, d7-d9 BIO treatment caused a 1.2 fold increase (p=0.224), while d9
treatment caused a 2 fold increase in its expression levels (p=0.067). 
Figure 6. 19: Gene expression analysis of cardiac genes after late (d5
d11) BIO treatments. D0 and d5 data were identical to the DMSO control because no 
treatment has been applied yet until that time point. 
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6.8. Discussion 
 
A number of studies have shown that manipulation of the Wnt cascade during formation 
of EB in vitro greatly influences cell differentiation (Aubert et al., 2002, Gadue et al., 
2006, Lindsley et al., 2006, ten Berge et al., 2008). β-catenin is a major regulator of 
gene transcription and even small or transient alterations in its stability and/or activity 
can cause significant changes in the expression of downstream genes (Barker et al., 
2001, Hecht and Kemler, 2000, Tutter et al., 2001, Vleminckx et al., 1999). In this 
assay, activation of the canonical Wnt signalling throughout mouse ES cell 
differentiation, prevented induction of cardiac transcriptional regulators and blocked 
spontaneous contraction.  
One of the genes that appeared to be reproducibly and reliably affected by all 
treatments was Tbx5. This gene has been suggested to be the beating gene (Takeuchi 
and Bruneau, 2009), that is a gene in the absence of which beating is unlikely to occur, 
or at least an essential gene for generation of beating cardiomyocytes (Ieda et al., 2010). 
Specifically, Takeuchi and Bruneau (2009) found that Gata-4, Tbx5 and Baf60c (a 
subunit of the Swi/Snf-like BAF chromatin remodelling complex) were sufficient for 
differentiation of non-cardiogenic mesoderm to cardiomyocytes. Nxk2.5, although not 
part of the minimal set of factors that were required for cardiac differentiation in the 
work by Takeuchi and Bruneau (2009), was subsequently induced by the combinatorial 
activity of Gata-4 and Baf60c (Takeuchi and Bruneau, 2009). Absence of Tbx5 in this 
context did not allow beating foci to appear (Takeuchi and Bruneau, 2009). More 
recently, trans-differentiation of postnatal mouse cardiac and dermal fibroblasts into 
functional, beating cardiomyocytes was achieved by the combined activation of Gata-4, 
Mef2c and Tbx5, selected among 14 cardiomyocyte-inducing candidates (Ieda et al., 
2010). There is an obvious discrepancy between the two studies: the former suggests 
Gata-4, Tbx5 and Baf60c (Takeuchi and Bruneau, 2009) and the latter Gata-4, Tbx5 and 
Mef2c (Ieda et al., 2010) as the minimal requirement for the cardiogenic program to 
occur. The main difference between the two systems is the differentiation status of the 
target cells: unspecified mesodermal cells (transient identity) in the former and fully 
differentiated fibroblasts (cardiac and dermal) in the latter. This difference may account 
for the distinct transcriptional requirements of the two systems, as it is not surprising 
that diverse starting material will respond differently to induction even by the same 
factors. Although a single master regulator of beating probably does not exist, and 
despite the fact that universal consensus on the minimal transcriptional requirement for 
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cardiac induction has not been reached, Tbx5 has been shown to be an interesting 
candidate (Bruneau et al., 2001, Horb and Thomsen, 1999, Ieda et al., 2010, Liberatore 
et al., 2000, Takeuchi and Bruneau, 2009).  
Another important early regulator of cardiogenesis, majorly affected in the current 
study, was Islet1. This gene was initially introduced as a marker of the secondary heart 
field (SHF) (Cai et al., 2003) but is nowadays considered an early cardiac transcription 
factor that controls, in a spatially and temporally specific way, the activation and 
activity of downstream cardiac genes in both PHF and SHF cells (Meilhac et al., 2004, 
Moretti et al., 2006). Its inhibition in most of the BIO-treated EB (d0-d2, d2-d5, d5-d7 
and d9-d11 treatment groups) in this study indicates a severe compromise in the 
cardiogenic potential of the cells. Downregulation of Isl1 after BIO treatment did not 
come as a surprise: β-catenin, which is stabilized after BIO treatment, has been shown 
to inhibit Isl1 both in vivo and in vitro (Kwon et al., 2009). This downregulation has 
been associated with expansion of cardiac progenitor populations, which has however 
not been accompanied by increased presence of terminally differentiated cardiac cells; 
later on in the differentiation process the appearance of beating foci was severely 
compromised and so was the expression of cardiac sarcomeric genes, such as Myh6, 
Myh7, Mlc2a, Mlc2v (Kwon et al., 2009), similar to what is seen here. Interestingly, the 
two early BIO treatments (d0-d2 and d2-d5) did not affect atrial and ventricular cell 
fates differentially; they both significantly decreased the expression of Mlc2v and 
Mlc2a, markers of the two lineages respectively, at d11. The fact that early cardiac 
markers, such as Gata-4 and Nkx2.5, were not severely affected by any of the BIO 
treatments indicates that initial specification of cardiac progenitors probably took place 
properly. 
An indirect effect of BIO could also be related to the role that β-catenin plays in 
the cell membrane. There, it is found associated with adherens junctions in complexes 
with E-Cadherin and α-catenin, connecting the cytoskeleton of neighbouring cells 
(Drees et al., 2005, Yamada et al., 2005). The control of the dual functions of β-catenin 
in either cellular adhesion or in transcriptional regulation is of paramount importance 
for normal cellular function and is controlled by an array of factors (reviewed by 
Brembeck et al., 2006). Its regulation and stabilization by the Wnt pathway is one of 
them. Activated canonical Wnt signalling has been suggested to favour the nuclear 
function of β-catenin as a transcriptional co-activator in the expense of its membrane 
function (Gottardi and Gumbiner, 2004, Munemitsu et al., 1995). Therefore, hyper-
activation of the canonical Wnt pathway by BIO in our system may have reinforced the 
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nuclear localization of β-catenin and have exhausted it from the cell membrane, 
affecting adhesion and communication between adjacent cells. Impaired communication 
between cardiomyocytes could affect spontaneous contraction, as it may inhibit signal 
transduction and cell coupling.     
Currently, the canonical Wnt pathway is thought to have bi-phasic, stage-specific 
and antagonistic roles during cardiogenesis: early differentiation requires β-catenin 
signalling for the commitment of mesodermal cells into the cardiac lineage (Gadue et 
al., 2006, Lindsley et al., 2006, Wawrzak et al., 2007), while later in differentiation, 
proliferation and maturation of committed cardiomyocytes is inhibited by β-catenin 
(Naito et al., 2006). Similarly, fine-tuned regulation of canonical Wnt signals is required 
for hematopoietic stem cell self-renewal and differentiation (Naito et al., 2006). 
Activation of the canonical Wnt pathway in this assay did not produce a similar bi-
phasic response: both early and late activation caused severe reduction in the 
cardiogenic potential of differentiating cells. The use of different cell culture systems 
and inhibitors/activators (general upstream ligands or inhibitors, downstream effectors) 
and the use or avoidance of serum may be the main reasons for the observed 
discrepancy. The timing of differentiation depends on the properties and growth 
requirements of each type of cells and is distinct for different cell lines. Of paramount 
importance is, also, the specific assay used for formation of EB: hanging drops, 
methylcellulose medium and low attachment dishes are only a few of the available 
methods (Dang et al., 2002, Mogi et al., 2009). The starting amount of cells that will 
form the EB is another essential determinant of the progression of cell differentiation. It 
has been suggested that the greater the initial amount of cells the more uniform and the 
more reliable the downstream processes are (Dang et al., 2002). In this study, 450 cells 
were set into each hanging drop for the formation of individual EB, similar to what 
Naito et al. (2006) used (Naito et al., 2006).  
Importantly, in the current study, two different mouse cell lines were used: E14 
ES cells and ES-D3 cells. They both responded similarly to BIO treatment at the time 
intervals examined, reinforcing the reliability and reproducibility of my findings. 
Moreover, in previous studies Wnt ligands (Wnt3a) and upstream inhibitors (Dkk-1, 
Fz8/Fc) of the canonical Wnt pathway were used, which may have a broad effect on the 
Wnt pathway, not only instructing canonical Wnt but also potentially non-canonical 
Wnt signalling (Caneparo et al., 2007). BIO, as an inhibitor of a downstream component 
of the canonical Wnt pathway (GSK3), is expected to act more selectively on the 
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canonical versus the non-canonical Wnt pathway, although as mentioned before, the 
Hedgehog pathway is likely to be affected as well.  
In this study, upregulation of the canonical Wnt pathway when cells are still in 
hanging drops, greatly increased the presence of mesodermal cells but decreased the 
occurrence of beating, while in another study (Naito et al., 2006) early inhibition of β-
catenin signalling did not affect mesoderm formation but abrogated cardiac 
differentiation. The canonical Wnt pathway has well-established and widely known 
roles in promoting mesodermal specification in many contexts (Gadue et al., 2006, 
Lekven et al., 2001, Lindsley et al., 2006, Wawrzak et al., 2007), reinforcing the 
reliability of our findings. The suggested late role of the canonical Wnt pathway agrees 
between the two studies with the presence of β-catenin being inhibitory for 
proliferation, maturation and expansion of cardiac cells. It is important to note at this 
point that although a bi-phasic response was not observed in the beating behaviour of 
the cells, a stage-specific response in the expression of some genes was noticed. 
Although not all differences were statistically significant it is worth mentioning the 
general trend of the gene expression profile of important genes. Nkx2.5 and Gata-4 
showed decreased expression after d0-d2 treatment and increased expression after d2-d5 
treatment, while Tbx5 showed an increase and a decrease, respectively. Other key 
transcriptional regulators, though, did not share this response, possibly explaining the 
lack of enhanced cardiogenesis after the early activation of the canonical Wnt pathway. 
As explained before, Isl1 may be an important factor affecting the expression of 
downstream cardiac genes.     
Another interesting finding was the fact the d2-d5 BIO-treated EB contained 
significantly more cells at d5 than controls. The viability of the cells was not altered 
though, which suggests that the increased cell count arose from an increase in both dead 
and alive cells within each EB and that the cell death levels at that time were not 
severely affected. Such an effect is, therefore, possibly due to increased proliferation the 
first days of in vitro differentiation. This finding fits in with the current knowledge 
about β-catenin: downstream targets of the canonical Wnt cascade, such as c-Myc, Lef-1 
and Tcf, have been implicated with regulation of proliferation (Bernard and Eilers, 
2006, Demeterco et al., 2002, Desbarats et al., 1996, Quasnichka et al., 2006) and 
activation of β-catenin itself has been shown to affect cellular proliferation (Adachi et 
al., 2007, Shang et al., 2004).  
Additionally, activation of the canonical Wnt pathway has been shown to have the 
ability to prolong pluripotency and prevent differentiation (Anton et al., 2007, Sato et 
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al., 2004). Treatment with BIO in the current study had a similar effect: the three genes 
of the SON network (Sox2, Oct-4 and Nanog) showed a considerable increase in their 
expression levels at d5 after the d0-d2 BIO treatment. This finding suggests that some 
of the cells within the EB still retain their stem cell identity at d5, a time when most, if 
not all, of the cells within the EB should have committed and started differentiating 
towards other cell lineages.  
In vivo work carried out by Dr. Nicholas Child in our laboratory (unpulished) 
using BIO and Dkk-1 in zebrafish embryos, reinforced the findings of the current study. 
He found that addition of BIO at different time points during development of zebrafish 
embryos (during and around gastrulation) always caused a reduction in the total number 
of cardiomyocytes and considerable abnormalities in the morphology of the heart. He, 
just like in the work presented here, could not find a bi-phasic response similar to the 
one reported in the literature (Naito et al., 2006, Ueno et al., 2007).  
Given the agreements and discrepancies described so far, it becomes clear that 
different cell assay systems that employ distinct experimental methods and varying 
analysis tools are difficult to amalgamate and directly compare. The current study 
highlights this issue and reinforces the notion that complementary in vivo models can 
prove invaluable in promoting and extending our knowledge from in vitro studies. Also, 
the use of more than one cell lines for confirmation of the obtained data is shown here 
to be beneficial.  
 
6.9. Advantages and disadvantages of this study 
 
Some important aspects of this study make it comprehensive, reliable and powerful. 
Two of its main advantages are its power and reproducibility. All of the beating 
experiments were repeated at least four independent times (some reaching even seven 
repetitions), with all showing the same pattern. There was no experiment throughout 
this study that did not agree with the data presented here.  
Additionally, systematic statistical analysis was performed. Normality of the data 
was assessed individually at each occasion and statistical significance was examined 
using the appropriate parametric or non-parametric tests as required. This approach 
allowed for a thorough statistical analysis that did not rely on crude and often mistaken 
assumptions. Interpretation of the statistical differences, however, depends on the 
biological context, which should always be taken into account.  
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Another important and powerful asset of the current study was the assay itself. 
The hanging drop method that was used in the current work has been shown to be 
reliable, reproducible and consistent (Dang et al., 2002, Kurosawa, 2007), as discussed 
extensively in Section 5.11 (page 218). Additionally, the absence of serum in the cell 
differentiation culture system after d5 reinforced the establishment of a controlled 
environment, free of unknown confounding effects that may hinder unambiguous 
characterization of the differentiation process.  
However, some aspects of the assay could be improved. The first is associated 
with the accurate measurement of the levels of β-catenin before and after activation of 
the canonical Wnt pathway by the pharmacological agent BIO. Although BIO has been 
extensively used as an upregulator of β-catenin in many different contexts (Manisastry 
et al., 2006, Martin et al., 2010, Meijer et al., 2003, Ueno et al., 2007), it is always 
advisable to assess the efficacy of the treatment. In this assay, the expression levels of 
Lef-1 were used as an indication of the stabilization and increased transcriptional 
activity of β-catenin. This has been shown to be a reliable measure (Filali et al., 2002, 
Hovanes et al., 2001, Hovanes et al., 2000, Vadlamudi et al., 2005). Nevertheless, Lef-1 
is only one of the targets of β-catenin and although its activation is essential for further 
activation of downstream β-catenin targets through the β-catenin/TCF/Lef complex 
(Behrens et al., 1996, Huber et al., 1996, Roel et al., 2002, Seidensticker and Behrens, 
2000), it is a relatively partial measure, possibly not accurately reflecting the fine 
fluctuations in the activity levels of β-catenin. A more direct method, like a lucipherase 
assay (TOPFlash, β-catenin-Fluc, β-catenin-CBG) that measures the transcriptional 
activity of β-catenin (Naik and Piwnica-Worms, 2007), could have been employed. The 
difficulty with the latter technique is the requirement for time-consuming transfections 
of various constructs, which is not always straightforward in stem cell culture. Analysis 
of the levels of β-catenin by western blotting, as performed in Chapter 5 for the levels 
of phospho-Jnk, would not have been useful. This is due to the fact that the levels of the 
protein are not necessarily affected by BIO; what is affected is its association with the 
APC/Axin/GSK3 inhibitory complex and its localization within the cell. Translocation 
of stabilized β-catenin from the cytoplasm to the nucleus has been used in the past as a 
measure of increased β-catenin signalling (Westfall et al., 2003). Immunohistochemistry 
experiments to identify this translocation were performed by other research group 
members with poor success, as it was difficult to assess the differences in staining 
between BIO-treated (increased nuclear staining) and untreated (mainly cytoplasmic 
staining) samples. Further optimization of the technique and improvement of the 
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imaging would probably meet the standards of previously published work (Westfall et 
al., 2003) and would reliably reveal activation of β-catenin signalling.     
Another aspect of the assay that could be improved is associated with accurate 
counting of cardiomyocytes, involving FACS. Analysis of the suggested technique has 
been carried out in Section 5.10. With this approach, it would be possible to further 
elucidate how the process of cardiac specification, differentiation and expansion is 
affected by treatment with BIO and subsequent activation of the canonical Wnt 
pathway.  
Additionally, as mentioned before, BIO, by inhibiting GSK3, not only activates 
the canonical Wnt pathway but also affects, to a lesser degree, the Hedgehog pathway 
(Li et al., 2007). Alternative or additional Wnt activators could have been used in this 
assay to confer more specificity to the pathway in question. However, most of the 
alternative options would be upstream activators of the pathway, which, due to their 
position, could potentially influence the non-canonical Wnt pathway as well. Overall, 
although other options were available, the most widely used and well-accepted 
downstream canonical Wnt activator remains BIO (Meijer et al., 2003).  
Lastly, a multitude of other genes could have been used in the qPCR analysis, in 
order to identify possible changes in the expression profile and signature of BIO-treated 
cells. For example, neuronal markers (such as Nestin or Otx1) could have been used for 
characterization of ES-derived neuronal cells, which have been shown in the past to be 
antagonistic with cardiomyocytes in some contexts (Notarianni and Evans, 2006). 
Earlier and more global cardiac markers than the ones used, could have also been 
employed, such as Mesp1 and Mef2c. Mesp1, as described in Section 1.3.2 (page 11), is 
considered the first pan-cardiac marker that is transiently expressed in mesodermal cells 
of cardiogenic potential (Bondue et al., 2008, Saga et al., 1999, Wu, 2008). Additional 
Wnt targets, of both the canonical and non-canonical Wnt pathway, could have, also, 
been studied. For example, Dkk-1, which is a known inhibitor of the canonical Wnt 
pathway (Bafico et al., 2001, Kawano and Kypta, 2003, Mao et al., 2001) is also a target 
of both the canonical Wnt (Gonzalez-Sancho et al., 2005) and the non-canonical 
Wnt/Jnk branches (Grotewold and Ruther, 2002b). Interestingly, Dkk-1 was, recently, 
found to activate the PCP pathway and regulate CE movements (Caneparo et al., 2007). 
It would have, thus, been an interesting candidate to look at, in order to elucidate the 
cross talk between the canonical and non-canonical Wnt pathway. Moreover, cell death 
and proliferation markers (such as c-Myc and cyclin-D2) could have been used in order 
to study the effect of activated β-catenin signalling in the survival of ES-derived cells. 
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Canonical Wnt signalling has been shown, in the past, to affect proliferation (Tseng et 
al., 2006). 
   
6.10. Future work 
 
In order to extend this work further a number of issues could be addressed and some 
experiments could be pursued. Firstly, it would be interesting to rescue the phenotype. 
This could be achieved by inhibiting the canonical Wnt pathway in parallel to its 
activation by BIO, in order to assess how specific the effect of the drug is; if complete 
rescue was observed then there would be good evidence to suggest that BIO acts solely 
or primarily through activation of the canonical Wnt pathway, while if the rescue was 
not complete or clear it would suggest that BIO may act, as discussed before, through 
other pathways as well. A caveat with this approach is the fact that GSK3 is 
downstream in the Wnt pathway and therefore, inhibition of the pathway by upstream 
molecules, such as Dkk-1 or Frizzled8/Fc (soluble Wnt antagonists) that are commonly 
used for this purpose, would possibly not completely counteract the effects of BIO. A 
good alternative candidate would be a dominant negative form of TCF4 that blocks 
transcription through β-catenin. This has, however, been shown to also affect Hedgehog 
signalling (Li et al., 2007).   
Secondly, as described before, counting of the cardiomyocytes using FACS would 
further extend our understanding of how BIO and activation of the canonical Wnt 
pathway affect the formation of fully differentiated cardiac cells. It would also be of 
interest to study the morphology of individual cells within the EB in order to evaluate 
and analyse why they cannot initiate spontaneous contraction and how far in the cardiac 
differentiation lineage they have gone.  
 
6.11. Summary and conclusion 
 
Overall, in the work presented in this chapter I have shown that specific activation of 
the canonical Wnt pathway severely compromised the beating behaviour of 
differentiating ES cells. It is suggested that Tbx5 and Islet1, important early cardiac 
regulators, are mediators of this effect as they were shown to be significantly and 
consistently inhibited under all conditions examined here. It is, also, important to note 
that in the current study there was no evidence of a positive effect of the canonical Wnt 
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signalling pathway on cardiogenesis, contradicting the current notion in the literature 
that suggests a bi-phasic and stage-specific role for this pathway during cardiac 
differentiation. My findings are in keeping with previous in vivo work carried out by 
other members of our research group, which showed that increase in Wnt/β-catenin 
signalling reduced the production of beating tissue in developing zebrafish embryo (Dr. 
Nicholas Child, unpublished).  
In the next chapter, the findings from this chapter, studying the canonical Wnt 
pathway in differentiating mouse ES cells, will be discussed alongside the findings from 
previous chapters that focused on Jnk signalling, both in developing zebrafish embryos 
and in differentiating mouse ES cells. This will give us an insight into the role that the 
Wnt signalling network, as a whole, plays in cardiogenesis in different systems.       
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Chapter 7. Final discussion 
 
7.1. Introduction 
 
This thesis aimed at studying Jnk and canonical Wnt signalling in cardiogenesis. Jnk is 
a downstream effector of the non-canonical Wnt/PCP pathway, but it is also an 
important regulator of MAPK signalling. As both the Wnt and the MAPK pathways 
have been shown in the past to regulate heart development, it was hypothesized that Jnk 
might be an important mediator of cardiac differentiation, receiving input from Wnt and 
MAPK signals. Similarly, the canonical Wnt/β-catenin cascade has been shown to have 
essential roles during early and late cardiogenesis. Its role, however, has not been fully 
elucidated because of recent controversial reports. One of the goals of this study was to 
shed light on the controversy. The cross talk between Jnk and β-catenin was, also, of 
interest, as it has been suggested that the Wnt pathways (canonical and non-canonical) 
in fact work together, synergistically and/or antagonistically, and form a complex 
network that coordinates varied and even seemingly contradictory procedures.  
Two models were used in this study: mouse embryonic stem (ES) cells and 
zebrafish embryos. Mouse ES cells, due to their pluripotency and their ability to 
differentiate into many cell types, provide a useful tool for the study of in vitro 
cardiogenesis. The events that lead from an undifferentiated naïve ES cell to a 
mesodermal cell, which will then further differentiate to a cardiac precursor and will 
finally form a cardiomyocyte, are thought to recapitulate at least some of the events that 
take place during induction, specification and differentiation of cardiomyocytes in vivo.     
ES cell-derived cardiomyocytes have been shown in the past to share many 
electrophysiological, morphological and genetic features with embryonic and postnatal 
cardiomyocytes (Boheler et al., 2002, Fijnvandraat et al., 2003, Hescheler et al., 1997, 
Hidaka et al., 2003, Sachinidis et al., 2003). In vivo zebrafish experimentation allowed 
for a comprehensive analysis of cardiogenesis-associated events at an organismal level, 
reflecting, not only cell-restricted processes, but also multifaceted tissue interactions. As 
cardiac development is not an isolated event, but depends upon movement of other 
tissues, responds to signalling cues from surrounding tissues and interacts with them, it 
is evident why its investigation in an animal is beneficial.   
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7.2. Summary of findings 
 
The Jnk signalling pathway was investigated both in vitro and in vivo while the 
canonical Wnt pathway was examined in vitro. In summary, it was shown that in 
zebrafish there are four instead of the three Jnk genes that have been identified in 
mammals. Alternative splicing is expected to give rise to approximately 17 different 
protein-coding variants. Expression analysis of some of these variants showed 
differential timing and distribution, which possibly reflects distinct areas of activity (not 
further investigated here). Global inhibition of the kinase activity of jnk (inhibition of 
all isoforms in the whole embryo) at distinct time intervals during zebrafish embryonic 
development caused a range of defects. The formation of the ears and the eyes, as well 
as the patterning of the tail, were affected, but the most severely, reproducibly and 
frequently affected structure was the heart. The hearts of a significant percentage of 
gastrulation-inhibited (5.25-10 hpf) embryos were reversely looped (leftwards) and 
surrounded by pericardial oedema, while the hearts of a large number of segmentation-
inhibited (10-22 hpf) embryos were unlooped, surrounded by oedema and had disturbed 
atrial-ventricular proportions. The proportions of the body (length and width) were also 
altered after jnk inhibition, causing a convergence extension (CE)-like phenotype. 
Inhibition of the activity of Jnk in differentiating mouse ES cells also caused a 
cardiac-related phenotype: it significantly increased beating. It is still unclear whether 
the observed increase was due to enhanced cardiogenesis (more cells attaining a cardiac 
fate) or to improved communication and coordination between the cells resulting in 
enhanced signal propagation, although the evidence so far point to the latter. Temporal 
specific alterations of canonical Wnt targets after Jnk inhibition emphasized the need 
for investigation of the Wnt pathway as a network, examining both canonical and non-
canonical contributions. For this reason, the effect of timely canonical Wnt activation in 
differentiating mouse ES cells was also examined. It was shown to delay differentiation, 
to inhibit the beating ability of cells and to reduce the expression of two essential 
cardiac regulators, Tbx5 and Islet1. No positive effect of canonical Wnt activation on 
cardiogenesis was observed. All of these findings are further discussed below.   
 
7.3. Manipulation of canonical Wnt and Jnk signalling 
 
In the current study the canonical Wnt pathway and the Jnk signalling cascade were 
manipulated (activated and inhibited, respectively) in developing zebrafish embryos and 
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differentiating mouse ES cells, in order to establish their roles during cardiogenesis. 
Chemical inhibitors were used in order to achieve this purpose; BIO, was used as an 
activator of the canonical Wnt pathway and SP600125 as an inhibitor of Jnk signalling. 
The main advantage of chemical inhibition is the fact that it can be administered at 
specific intervals and for the required length of time during development, therefore, 
targeting specific processes. This important attribute is commonly counteracted by lack 
of specificity since closely related and similar proteins are likely to be targeted by the 
same chemicals. This more global effect can, however, also be a benefit for studies like 
the one presented here (the zebrafish study), whereby not all isoforms to be targeted are 
known and, therefore, design of specific inhibitors would be difficult if not impossible. 
Another disadvantage of chemical inhibitors is that since the activity of the protein is 
targeted (which makes the effects of the drug reversible) and not the producing gene, 
inefficiency (not achievement of the full effect) is more likely to be observed. In fact, 
such a phenomenon was observed to some extent in the ES cell work in the present 
study, whereby western blot analysis showed significant but not complete inhibition of 
phospho-Jnk. Knockout and knockdown technologies are expected to be more specific 
and efficient than chemical inhibition since they target specific genes, but in turn lack 
the ability for timely administration, temporal control and reversibility. Taken together, 
although alternatives were available for achieving the goals set in this study, the use of 
chemical inhibition was preferred because of its temporal amenability, which was of 
great interest here. Ideally, all experiments should be repeated and confirmed by using 
morpholino injections against specific genes or by establishing gene knockout strains.   
 
7.4. Jnk signalling 
 
Jnk signalling was the main focus of this thesis. In this section, the involvement of Jnk 
in the non-canonical Wnt and the MAPK cascade is discussed, along with potential 
cross talk with the canonical Wnt pathway.  
 
7.4.1. Jnk acts in the Wnt network and in the MAPK pathway 
 
Jnk is a kinase that belongs to the MAPK family and exerts its effects through signals 
relayed from the MAPK cascade and from the non-canonical Wnt pathway. 
Distinguishing the involvement of Jnk in either pathway is not straightforward in most 
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contexts, as overlapping domains of activity have been observed between the two 
pathways.  
The in vivo work, presented in this study, revealed general body and specific heart 
abnormalities in developing zebrafish embryos after inhibition of jnk. These included 
low occurrence of eye and otic vesicle defects, alongside high prevalence body ratio 
disturbances and cardiac specification and morphogenesis defects. Gastrulation defects 
that may lead to a CE-like phenotype have been reported in both PCP and MAPK 
zebrafish mutants and morphants (Anastasaki et al., 2009, Hammerschmidt et al., 1996, 
Heisenberg et al., 2000, Jessen et al., 2002, Krens et al., 2008, Krens et al., 2006, 
Matsui et al., 2005, Park and Moon, 2002, Rauch et al., 1997, Schwarz-Romond et al., 
2002, Seo et al., 2010, Solnica-Krezel et al., 1996, Topczewski et al., 2001, Zhu et al., 
2008, Zhu et al., 2006). Also, abnormalities in the eyes and the otic vesicles have been 
previously observed in PCP mutants (Hammerschmidt et al., 1996, Heisenberg et al., 
2000, Jessen et al., 2002, Park and Moon, 2002, Solnica-Krezel et al., 1996, 
Topczewski et al., 2001). Similar defects have not been reported in MAPK mutants and 
morphants but members of the MAPK family are known to be involved in head-
associated morphogenesis (Acharya et al., 2011, Anastasaki et al., 2009, Furthauer et 
al., 2002, Rodriguez-Viciana et al., 2006, Snaar-Jagalska et al., 2003, Tidyman and 
Rauen, 2008, Tsang et al., 2004).  
The heart defects observed in this study after Jnk inhibition were mainly 
associated with left-right patterning (of the body and subsequently of the heart), cardiac 
looping and atrial/ventricular fate specification and/or expansion. Members of the PCP 
pathway have been, recently, associated with establishment of the body left-right axis 
identities (Borovina et al., 2010, Guirao et al., 2010, Nonaka et al., 2005, Okada et al., 
2005, Song et al., 2010). Members of the MAPK family have, in turn, been associated 
with regulation of the Nodal/Smad signalling cascade (Dennler et al., 2000, Hagemann 
and Blank, 2001), which is a major determinant of left-right patterning, both at the node 
and at the lateral plate mesoderm (LPM) (Ahmad et al., 2004, Baker et al., 2008, 
Brennan et al., 2002, Duboc et al., 2005, Kawasumi et al., 2011). Abnormalities in the 
initial left-right patterning are known to cause cardiac looping anomalies, including 
reverse looping and absence of looping (Bisgrove et al., 2000, Chen and Fishman, 
2000a, Chen and Fishman, 2000b, Chen et al., 1997, Glickman and Yelon, 2002, 
Kathiriya and Srivastava, 2000, Yan et al., 1999), defects reminiscent of the jnk-
inhibited phenotype observed here.  
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Since both pathways (Wnt and MAPK) have been shown to be active and to 
participate in zebrafish development and since inhibition of either has been individually 
shown to cause defects similar to the ones observed in this study, it is not possible to 
distinguish which pathway Jnk is mainly acting through in this context. It would not be 
surprising if Jnk responded to signals from both cascades during development, with 
each one potentially playing more important specific roles at discrete time intervals.  
The in vitro work on Jnk (presented in Chapter 5) revealed increased beating, 
transient decrease in cell proliferation and late (at d11) loss of atrial gene expression. 
Jnk deficiency has been shown to cause severe defects in mesodermal and ectodermal 
development in vitro (Xu and Davis, 2010). P38 MAPK, another member of the MAPK 
family, has been shown to act as a switch between the neuronal and cardiac cell fate 
(inhibiting neurogenesis and promoting cardiomyogenesis) and to regulate the levels of 
apoptosis during ES cell culture (Aouadi et al., 2006). Erk/MAPK in turn, has been 
shown to promote differentiation of ES cells and to transiently induce proliferation 
(Marshall, 1995, Rose et al., 2010). Interestingly, in previous work (MSc report, 
submitted in August 2007) inhibition of other components of the non-canonical 
Wnt/PCP pathway (Rac and ROCK) on mouse E14 ES cells showed a similar increase 
in the contractile behaviour of differentiating ES cells, compared to what was observed 
after Jnk inhibition.  
The findings and observations presented above highlight how interconnected the 
Wnt and MAPK pathways may be in the context of ES cell differentiation, causing 
similar and sometimes overlapping defects when disturbed. Although intriguing 
similarities were observed between the Jnk-, Rac- and ROCK-inhibited experiments, 
which would suggest a major contribution of the PCP pathway in the process of in vitro 
cardiogenesis, the involvement of MAPK cannot be excluded.  
Taken together, with the tools used in the current study and with the information 
that is currently available in the literature, it has not been possible to distinguish the 
roles that Jnk plays in the context of the Wnt/PCP and the MAPK pathways. If this was 
required, additional work would have to be carried out, involving the use of inhibitors 
of other PCP and MAPK components, rescue experiments with effectors of both 
pathways and detection of the mRNA and protein levels as well as post-translational 
modifications (for example phosphorylation) of the molecules-targets involved.      
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7.4.2. Canonical and non-canonical Wnt/Jnk interplay 
 
The interplay between canonical and non-canonical Wnt pathways was of interest in 
this study. It has been shown before that components of one pathway may affect signal 
relay through the other pathway and vice versa. Upstream in the two pathways, Wnt 
ligands, Frizzled receptors and Dishevelled proteins, although thought to participate in 
the canonical and non-canonical Wnt branches through different members of their 
families or through different domains of their proteins, have been shown to have a 
broader area of action than initially thought, at least in some contexts (Bryja et al., 2009, 
Caneparo et al., 2007, Davidson et al., 2005, Kestler and Kuhl, 2008, Maye et al., 2004, 
Mikels and Nusse, 2006, Tahinci et al., 2007, Tamai et al., 2000). Similarly, 
downstream effectors of the two pathways have been shown to participate, in some 
contexts, in both pathways (Esufali and Bapat, 2004, Kestler and Kuhl, 2008, Liao et 
al., 2006, Wu et al., 2008). In particular, Jnk has been shown in many publications to act 
in both the canonical and non-canonical Wnt pathways. Rac-1 and Jnk, PCP 
components, have been suggested to be important regulators of the translocation of β-
catenin into the nucleus and activation of gene transcription through TCF (Esufali and 
Bapat, 2004, Wu et al., 2008). Activated by a canonical Wnt ligand (Wnt3a), Rac-1 in 
turn activates Jnk, which then acts on β-catenin (Wu et al., 2008). Inhibition of Jnk in 
this context had dramatic effects on Lef-1 luciferase exression (marker of canonical 
Wnt activation) (Wu et al., 2008). Another study showed that activation of c-Jun by Jnk, 
in response to signals from a Wnt-LRP5/6 complex in zebrafish, enhanced the 
formation of a Dishevelled/c-Jun/β-catenin/TCF complex in the nucleus that activated 
Wnt target gene transcription (Gan et al., 2008). In contrast, in mammalian cells, Jnk 
was shown to inhibit β-catenin-mediated gene transcription, while its inhibition in 
Xenopus embryos induced β-catenin target gene expression (Liao et al., 2006).  
Initially, it was believed that the relation between the canonical and non-canonical 
Wnt pathways was antagonistic and thus, activation of one of them dictated inhibition 
of the other (Bryja et al., 2009, Caneparo et al., 2007, Davidson et al., 2005, Liao et al., 
2006, Maye et al., 2004, Tahinci et al., 2007, Tamai et al., 2000, Zeng et al., 2005). 
However, nowadays with a multitude of studies having shown synergistic rather than 
antagonistic interactions between the two pathways (Esufali and Bapat, 2004, Gan et al., 
2008, Upadhyay et al., 2008, Wu et al., 2008), it is believed that the outcome from the 
activation of one or the other pathway depends on the context and cannot be predicted 
(reviewed by Kestler and Kuhl, 2008).  
 272 
In this study, severe disturbances in the canonical Wnt pathway were observed 
after Jnk inhibition but only late in differentiation, at d11, when the induction and 
specification of cardiac cells had already taken place. It is, therefore, unlikely that the 
detected alterations in the canonical Wnt pathway in this context had direct effects on 
the observed outcome. Nevertheless, it is noteworthy that subtle fluctuations in the 
activity of β-catenin signalling might not have been detected by the qPCR analysis 
performed here, because this did not include all days of differentiation and it did not 
look at other targets of the pathway. Given the studies published to date (some of which 
are presented above), Jnk could have undetected effects on the canonical Wnt pathway.  
Taken together, although no major alterations in canonical Wnt-associated gene 
transcription (Lef-1, Dkk-1) were detected in this study during the early (and critical) 
stages of differentiation, it is possible, as suggested by numerous studies to date, that 
the Wnt/β-catenin pathway or at least some of its downstream targets are affected by 
SP600125 treatment. Although the published work so far points potentially to both 
activation and/or inhibition of canonical Wnt-mediated transcription after inhibition of 
Jnk, in the present study it is more likely that Jnk inhibition after SP600125 treatment 
caused a decrease in β-catenin signalling. This observation is based on the data from the 
BIO treatment (activation of canonical Wnt, Chapter 6) that showed decrease or even 
halt of beating.  
 
7.5. Jnk signalling in cardiogenesis 
 
Most of the cardiac defects observed in jnk-inhibited zebrafish embryos seem to be 
associated indirectly with the cardiogenic process. Looping defects are possibly 
associated with defective left-right patterning of the body that in turn disturbs the 
directionality of the jogging and looping processes and causes cardiac defects. 
Similarly, alterations in atrial and ventricular cell fates occurred when the drug 
(SP600125) was administered long after the specification events had taken place and 
had been completed. It was suggested that the observed changes in ventricular cell 
numbers were due to disturbances in proliferation levels rather than to defects in the 
specification process.  
However, these indirect effects of SP600125 administration seem to have specific 
effects on the heart, although other organs were not investigated in much detail. The 
overall morphology of the developing embryos, though, was not severely affected so the 
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disturbances described above had, not exclusive, but probably more severe, effects on 
proper formation and morphogenesis of the heart.  
In vitro, increased contractile behaviour of differentiating ES cells was observed 
after Jnk inhibition but this was not accompanied by a concomitant increase in the 
expression of cardiac genes. Also, the fact that this increase was observed even after 
late (d5-d11) SP600125 administration, when cells have already been irreversibly 
specified towards a cardiogenic fate, and the fact that cardiac Troponin-I staining 
showed a more clustered organization of beating cells after Jnk inhibition, support the 
idea that the observed enhancement in the beating ability of the cells is probably 
correlated not with enhanced cardiac specification but with alterations in the cellular 
conformation and organization of the beating cells.  
Overall, both the in vitro and the in vivo data point to an extra-cardiac role of Jnk 
in heart differentiation. Further analysis of the cardiac phenotype of jnk-inhibited 
zebrafish embryos (looking at cell migration, cardiac function and cardiac cell 
specification) and of Jnk-inhibited differentiating mouse ES cells, would reveal the 
mechanism(s) through which Jnk exerts its effects in both contexts.  
 
7.6. Canonical Wnt signalling in cardiogenesis 
 
Canonical Wnt signalling has been shown to be an important determinant of 
cardiogenesis during early (Marvin et al., 2001, Schneider and Mercola, 2001) and late 
(Cohen et al. 2007) stages. In contrast to recently published studies (Naito et al., 2006, 
Ueno et al., 2007), in vitro data obtained in this study showed that activation of the 
canonical Wnt pathway, both at pre-beating and post-beating stages, had a consistently 
negative effect on ES-derived cardiogenesis, as identified by the reduction, or even 
absence, of the beating ability of the cells.     
These findings are supported by previous work conducted in our research group 
by Dr. Nicholas Child on developing zebrafish embryos. Wnt/β-catenin was shown to 
negatively influence heart development throughout gastrulation. Specifically, abnormal 
cardiac morphology, reduced cardiomyocyte numbers and altered cell fates (more atrial 
cells and less ventricular cells) were observed. An extension of the dhand expression 
field rostrally and of the nkx2.5 field caudally resulted in increased overlap of the 
cardiac field with the notochord, which has been shown in the past to be inhibitory for 
induction of cardiogenic mesoderm (Goldstein and Fishman, 1998, Serbedzija et al., 
1998, Tzahor and Lassar, 2001).  
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Of note, in both studies no positive effect of activated canonical Wnt signalling 
was observed, at any time interval examined. Prevailing studies have suggested a bi-
phasic and stage-specific role for canonical Wnt in cardiogenesis, promoting it at early 
stages and inhibiting it later in development (Naito et al., 2006, Ueno et al., 2007). The 
data obtained from this study contradict this idea. Interestingly, two more recent 
publications (Afouda et al., 2008, Wang et al., 2011) reinforce the traditional notion that 
β-catenin is inhibitory for cardiogenesis (Marvin et al., 2001, Schneider and Mercola, 
2001). Afouda and colleagues (2008) showed that in Xenopus explants the canonical 
Wnt pathway causes suppression of cardiogenesis, at least in part, through inhibition of 
Gata-4 (Afouda et al., 2008). In turn, Wang and colleagues (2010) used two mouse ES 
cell lines to show that timely inhibition of the canonical Wnt pathway (with Dkk-1 and 
XAV939) induced cardiomyogenesis (Wang et al., 2011). The work presented by 
Afouda and co-workers (2008) and Wang and colleagues (2010) emphasizes the fact 
that the conflict in the literature about the role that the canonical Wnt pathway plays 
during cardiogenesis remains unresolved (Afouda et al., 2008, Wang et al., 2011).  
 
7.7. Conclusions  
 
In summary, the aims of the current thesis were to establish the role of Jnk signalling 
during in vivo and in vitro cardiogenesis and to elucidate the temporal specific 
contribution of the canonical Wnt pathway during in vitro cardiac differentiation. It was 
hypothesized that inhibition of Jnk in developing zebrafish embryos and differentiating 
mouse ES cells would cause severe defects in cardiac induction and progression, as both 
non-canonical Wnt and MAPK pathways are known players in the cardiogenic process. 
Severe defects were, indeed, observed in zebrafish embryos after jnk inhibition during 
gastrulation and segmentation, including looping anomalies and ventricular cell 
expansion defects. However, in mouse ES cells inhibition of Jnk caused an increase in 
the occurrence of beating. Although more work needs to be carried out in order to fully 
elucidate the mechanism through which Jnk enhances beating in this context, there is 
evidence to suggest that this is not due to enhanced cardiogenesis (more cells attaining 
the cardiac fate) but to reorganization and clustering of the existing beating cells. The 
questions that have arisen from the differences between the in vivo and the in vitro 
models are where does the Jnk signal originate from, in which cells or tissues is its 
expression essential for induction of cardiogenesis and how does its inhibition produce 
 275 
the observed phenotype. Answering these questions, which is not possible with the data 
obtained in this study, will probably shed more light in the underlying mechanism.  
It was also hypothesized that manipulation of the canonical Wnt pathway would 
reveal stage-specific roles in cardiac development, both inhibiting or enhancing it, 
depending on the timing of the manipulation. Analysis of the beating pattern and the 
cardiac gene expression of differentiating mouse ES cells disproved this hypothesis and 
showed that activation of the Wnt/β-catenin pathway, irrespective of the timing of the 
treatment, severely and consistently decreased the beating occurrence of differentiating 
cells and the expression of major cardiac gene regulators. Further investigation is 
needed in order to fully elucidate the contradictory roles that have been suggested for 
the canonical Wnt pathway and to understand the differences observed between 
different systems and methods.   
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Chapter 8. Appendix 
 
 
Genes Forward sequence Reverse Sequence 
β-actin GCTGGTCGTCGACAACGGCTC CAAACATGATCTGGGTCATCTTTTC 
Rps9 TGTTGACGCTAGACGAGAAGG AATGAAGGATGGGATGTTCACC 
Oct4 CACCATCTGTCGCTTCGAG ACTCCACCTCACACGGTTCT 
Nanog AAGGCAGCCCTGATTCTTCT GTGCTGAGCCCTTCTGAATC 
Sox2 GCGGAGTGGAAACTTTTGTCC CGGGAAGCGTGTACTTATCCTT 
Brachyury TGCTGCAGTCCCATGATAAC TGTGCGTCAGTGGTGTGTAA 
Goosecoid ACCATCTTCACCGATGAGCAGC CTTGGCTCGGCGGTTCTTAAAC 
Hex ACTACACGCACGCCCTACTC ACTTGACCGCCTTTCCTTTT 
Flk1 TTTGGCAAATACAACCCTTCAGA GCAGAAGATACTGTCACCACC 
CD31 GAGAGTGACAGCGGGGAGTA GTGGTAAGTGATGGGTGCAG 
Gata-4 TCAAACCAGAAAACGGAAGC GTGGCATTGCTGGAGTTACC 
Nkx2.5 CCACTCTCTGCTACCCACCT CCAGGTTCAGGATGTCTTTGA 
Tbx5 GGAGCCTGATTCCAAAGACA TTCAGCCACAGTTCACGTTC 
Islet-1 GTTTGTACGGGATCAAATGC ATGCTGCGTTTCTTGTCCTT 
MLC-2a TCAGCTGCATTGACCAGAAC AAGACGGTGAAGTTGATGGG 
MLC-2v AAAGAGGCTCCAGGTCCAAT CCTCTCTGCTTGTGTGGTCA 
cTroponin-T GAGGAGGTGGTGGAGGAGTA GGCTTCTTCATCAGGACCAA 
Tnnt2 CAACATGATGCACTTTGGAGGGTAC TCGCAGAACGTTGATTTCGTATTTC 
Dkk-1 TCTGTCTGGCTTGCCGAAAG TGTGGTCATTACCAAGGTTTTCA 
Connexin-43 GAACACGGCAAGGTGAAGAT GACGTGAGAGGAAGCAGTCC 
Lef-1 TGTTTATCCCATCACGGGTGG CATGGAAGTGTCGCCTGACAG 
Jnk AGCAGAAGCAAACGTGACAAC CGCTTAGCATGGGTCTGATTC 
c-Myc CTGGATTTCCTTTGGGCGTT TGGTGAAGTTCACGTTGAGGG 
Cyclin-D2 TGGGCTTCAGCAGGATGATG ACGGAACTGCTGCAGGCTGT 
 
Table 8. 1: Sequences of mouse qPCR primer sequences. All primer sets were retrieved 
from previously published work. They were selected to span exon-exon boundaries, when 
possible, in order to avoid genomic DNA contamination.  
 
 
  
Figure 8. 1: Inhibition of Rac (with NSC23766) and ROCK (with Y27632) in 
differentiating E14 ES cells. In both cases late addition of the drug (d5
significant activation of beating, while early drug administration (d0
beating behaviour of the cells. This work has been previously presented in my MSc report 
(submitted in August 2007
the graph, was assessed using the non
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). Statistical significance, shown with asterisks (*p<0.05) in 
-parametric Mann Whitney test.
 
-d11) caused 
-d5) did not alter the 
 
  
Figure 8. 2: qPCR analysis of differentiating E14 ES cells after DMSO treatment. The 
expression pattern of 
are shown here. The rest of the genes that were used as markers in t
Chapter 6, as their expression profile was slightly altered to that of DMSO
cells, presented in Chapter 5, and had to be discussed thoroughly. 
was assessed using one
test   
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Flk1, Hex, Lef-1, Brachyury, MLC2v and MLC2a
Statistical significance 
-way Anova testing, followed, when necessary by a 2
 
 at days 0, 5 and 11 
his study are shown in 
-treated ES-D3 
-sided Dunnett 
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